<SEC-DOCUMENT>0001104659-11-022513.txt : 20110427
<SEC-HEADER>0001104659-11-022513.hdr.sgml : 20110427
<ACCEPTANCE-DATETIME>20110426183645
ACCESSION NUMBER:		0001104659-11-022513
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20110524
FILED AS OF DATE:		20110427
DATE AS OF CHANGE:		20110426
EFFECTIVENESS DATE:		20110427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		11781231

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a11-10911_2def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">UNITED   STATES</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;font-weight:bold;">SCHEDULE 14A</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proxy   Statement Pursuant to Section 14(a) of<br>   the Securities Exchange Act of 1934 (Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;)</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filed by the Registrant&nbsp;&nbsp;</font><font face="Wingdings">x</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filed by a Party other than the   Registrant</font>&nbsp;&nbsp;<font face="Wingdings">o</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box:</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preliminary Proxy Statement</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Confidential, for   Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitive Proxy Statement</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitive Additional Materials</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Soliciting Material Pursuant to   &#167;240.14a-12</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CYCLACEL   PHARMACEUTICALS, INC.</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name   of Registrant as Specified In Its Charter)</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name   of Person(s) Filing Proxy Statement, if other than the Registrant)</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Payment of Filing Fee (Check the   appropriate box):</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No fee required.</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fee computed on table below per   Exchange Act Rules 14a-6(i)(1) and 0-11.</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font></p>    </td>
<td width="90%" valign="top" style="padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title of each class of securities to   which transaction applies:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>    </td>
<td width="90%" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Aggregate number of securities to   which transaction applies:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>    </td>
<td width="90%" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Per unit price or other underlying   value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth   the amount on which the filing fee is calculated and state how it was   determined):</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>    </td>
<td width="90%" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proposed maximum aggregate value of   transaction:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font></p>    </td>
<td width="90%" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total fee paid:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fee paid previously with preliminary   materials.</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check box if any part of the fee is   offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing   for which the offsetting fee was paid previously. Identify the previous   filing by registration statement number, or the Form or Schedule and the date   of its filing.</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amount Previously Paid:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form, Schedule or Registration   Statement No.:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filing Party:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date Filed:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="38" style="border:none;"></td>
<td width="33" style="border:none;"></td>
<td width="2" style="border:none;"></td>
<td width="675" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105538\11-10911-2\task4639339\10911-2-ba.htm',USER='105538',CD='Apr 26 15:30 2011' -->


<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Cyclacel Pharmaceuticals,&nbsp;Inc. <br> 200 Connell Drive, Suite&nbsp;1500 <br> Berkeley Heights, New Jersey 07922 <br> United States of America</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">April&nbsp;26, 2011</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dear Stockholder,</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You are cordially invited to attend the 2011 Annual Meeting of the Stockholders of Cyclacel Pharmaceuticals,&nbsp;Inc. (the &#147;<b>Company</b>&#148;) to be held at 12:30&nbsp;p.m., E.S.T., on May&nbsp;24, 2011, at our corporate headquarters at 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey, 07922. The attached Notice of Annual Meeting and proxy statement describe the business we will conduct at the annual meeting and provide information about us<b>  </b>that the holders of our common stock (the &#147;<b>Common Stock</b>&#148;) and 6% Convertible Exchangeable Preferred Stock (the &#147;<b>Preferred Stock</b>&#148;) should consider when voting.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">At the annual meeting, the holders of our Common Stock are being asked to elect Spiro Rombotis and Dr.&nbsp;David U&#146;Prichard, nominees for Class&nbsp;2 directors, to our Board of Directors. In addition, we will ask the holders of our Common Stock to ratify the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for our fiscal year ending December&nbsp;31, 2011. The Board of Directors recommends the approval of each of these proposals.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Also at the annual meeting, the holders of our Preferred Stock may elect two directors to fill the newly created directorships on our Board of Directors that will be created pursuant to the terms of the Certificate of the Powers, Designations, Preferences and Rights governing the Preferred Stock if candidates are elected.&#160; Lloyd Sems and Gregory T. Hradsky have been nominated by a holder of our Preferred Stock for these directorships.&#160; The Board of Directors makes no recommendation with respect to this proposal.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Such other business will be transacted as may properly come before the annual meeting and at any adjournments or postponements thereof.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We hope you will be able to attend the annual meeting. Whether you plan to attend the annual meeting or not, it is important that you cast your vote either in person or by proxy. You may vote over the Internet as well as by telephone or by mail. Therefore, when you have finished reading the proxy statement, you are urged to vote in accordance with the instructions set forth in this proxy statement. We encourage you to vote by proxy so that your shares will be represented and voted at the annual meeting, whether or not you can attend.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you wish to attend the annual meeting in person, you will need to register with us in advance. You can register by contacting our investor relations office by no later than May&nbsp;17, 2011, by telephone at (908) 517-7330, by mail at Cyclacel Pharmaceuticals,&nbsp;Inc., 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey, 07922, by fax at (866) 271-3466, or by e-mail to ir@cyclacel.com.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Thank you for your ongoing support of Cyclacel Pharmaceuticals,&nbsp;Inc. We look forward seeing you at the annual meeting.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sincerely,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   <i>Spiro Rombotis</i></font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Spiro   Rombotis</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President   and Chief Executive Officer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt 3.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105538\11-10911-2\task4639339\10911-2-bc.htm',USER='105538',CD='Apr 26 15:32 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Cyclacel Pharmaceuticals,&nbsp;Inc. <br> 200 Connell Drive, Suite&nbsp;1500 <br> Berkeley Heights, New Jersey 07922 <br> United States of America</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">April&nbsp;26, 2010</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NOTICE OF 2011 ANNUAL MEETING OF STOCKHOLDERS</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TIME:</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">12:30&nbsp;P.M., E.S.T.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DATE:</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">May&nbsp;24, 2011</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PLACE:&#160; 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey, 07922</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PURPOSES:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.&#160; For the holders of our common stock (&#147;<b>Common Stock</b>&#148;) to elect Spiro Rombotis and Dr.&nbsp;David U&#146;Prichard as Class&nbsp;2 directors to serve three<b>-</b>year terms expiring at the annual meeting in 2014.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.&#160; For the holders of our Common Stock to ratify the appointment of Ernst&nbsp;&amp; Young LLP as the Company&#146;s independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2011.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.&#160; For the holders of our 6% Convertible Exchangeable Preferred Stock (the &#147;<b>Preferred Stock</b>&#148;) to elect two directors to serve until the earlier of (a)&nbsp;a term expiring at the 2013 annual meeting of stockholders, in the case of one director, and a term expiring at the 2014 annual meeting, in the case of the other director, and (b)&nbsp;such time as all accrued and unpaid dividends on the Preferred Stock have been declared and paid or set apart for payment.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, the Company will transact any other business that may properly be presented before the annual meeting or at any adjournment or postponement thereof.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHO MAY&nbsp;VOTE?</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You may vote if you were the record holder of our Common Stock and/or Preferred Stock at the close of business on April&nbsp;4, 2011. A list of stockholders of record will be available at the annual meeting and during the ten days prior to the annual meeting at the office of our Secretary at the above address.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">The presence, in person or by proxy, of the holders of a majority of the issued and outstanding shares of Common Stock entitled to vote at the annual meeting is required to constitute a quorum for the proposals to be voted on by the holders of our Common Stock. The presence, in person or by proxy, of the holders of a majority of the issued and outstanding shares of Preferred Stock entitled to vote at the annual meeting is required to constitute a quorum for the proposal to be voted on by the holders of our Preferred Stock. Accordingly, whether you plan to attend the annual meeting or not, we ask that you complete, sign, date and return the enclosed proxy card for the holders of Common Stock and Preferred Stock, as applicable, as soon as possible in accordance with the instructions on the proxy card. A pre-addressed, postage prepaid return envelope is enclosed for your convenience. In the event you are able to attend the annual meeting, you may revoke your proxy and vote your shares in person.</font></b></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">If you plan to attend the annual meeting, you must register in advance by contacting our investor relations office by telephone at (908) 517-7330, by mail at Cyclacel Pharmaceuticals,&nbsp;Inc., 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey, 07922, by fax at (866) 271-3466, or by e-mail to ir@cyclacel.com. Only record and beneficial owners will be permitted to register. Requests for registration will be processed in the order in which they are received and must be requested by no later than May&nbsp;17, 2011. Please note that seating is limited and registration of stockholders will be accepted on a first-come, first-served basis. On the day of the annual meeting, each stockholder will be required to present a valid picture identification such as a driver&#146;s license or passport. Seating will begin at 11:30&nbsp;a.m. and the meeting will begin at 12:30&nbsp;p.m.</font></i></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BY   ORDER OF THE BOARD OF DIRECTORS</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/<i>s/ Paul McBarron</i></font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Paul   McBarron, Secretary</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt 3.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105538\11-10911-2\task4639339\10911-2-bc.htm',USER='105538',CD='Apr 26 15:32 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="TableOfContents"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TABLE OF CONTENTS</font></u></b></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="95%" colspan="3" valign="bottom" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="4%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:4.68%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Page</font></b></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#GeneralInformationAboutTheAnnualM_103414" title="Click to goto ">GENERAL INFORMATION ABOUT THE ANNUAL MEETING</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#SecurityOwnershipOfCertainBenefic_104208" title="Click to goto ">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND   MANAGEMENT</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#ManagementAndCorporateGovernance_105110" title="Click to goto ">MANAGEMENT AND CORPORATE GOVERNANCE</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#ExecutiveOfficerAndDirectorCompen_105135" title="Click to goto ">EXECUTIVE OFFICER AND DIRECTOR COMPENSATION</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#ReportOfAuditCommittee_104426" title="Click to goto ">REPORT OF AUDIT COMMITTEE</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Section16abeneficialOwnershipRepo_104616" title="Click to goto ">SECTION&nbsp;16(a)&nbsp;BENEFICIAL OWNERSHIP REPORTING   COMPLIANCE</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#CertainRelationshipsAndRelatedPer_104658" title="Click to goto ">CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#ProposalsToBeVotedUponByStockhold_104730" title="Click to goto ">PROPOSALS TO BE VOTED UPON BY COMMON STOCKHOLDERS</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Proposal1ElectionOfClass2Director_104758">PROPOSAL 1: </a></font></p>    </td>
<td width="77%" valign="top" style="padding:0in 0in 0in 0in;width:77.24%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Proposal1ElectionOfClass2Director_104758">ELECTION OF   CLASS&nbsp;2 DIRECTORS</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Proposal2RatificationOfAppointmen_104938">PROPOSAL 2: </a></font></p>    </td>
<td width="77%" valign="top" style="padding:0in 0in 0in 0in;width:77.24%;">
<p style="margin:0in 0in .0001pt 2.9pt;text-indent:-2.9pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Proposal2RatificationOfAppointmen_104938">RATIFICATION   OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#PreferredDirectorElectionProposal_105258" title="Click to goto ">PREFERRED DIRECTOR ELECTION PROPOSAL: ELECTION OF   CLASS&nbsp;1 AND 2 DIRECTORS</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#CodeOfConductAndEthics_105331" title="Click to goto ">CODE OF CONDUCT AND ETHICS</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#OtherMatters_105339" title="Click to goto ">OTHER MATTERS</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="95%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:95.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#StockholderProposalsAndNomination_105344" title="Click to goto ">STOCKHOLDER PROPOSALS AND NOMINATIONS FOR DIRECTOR</a></font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i<a name="PB_i_103035_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='i',FILE='C:\JMS\105538\11-10911-2\task4639339\10911-2-bc.htm',USER='105538',CD='Apr 26 15:32 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Cyclacel Pharmaceuticals,&nbsp;Inc. <br> 200 Connell Drive, Suite&nbsp;1500 <br> Berkeley Heights, New Jersey 07922 <br> United States of America</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PROXY STATEMENT FOR THE CYCLACEL PHARMACEUTICALS,&nbsp;INC.<br> 2011 ANNUAL MEETING OF STOCKHOLDERS <br> TO BE HELD ON MAY&nbsp;24, 2011</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">GENERAL INFORMATION ABOUT THE ANNUAL MEETING</font></b><a name="GeneralInformationAboutTheAnnualM_103414"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Why Did I Receive this Proxy Statement as a Holder of Common Stock?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You received this proxy statement and the enclosed proxy card because the Board of Directors of Cyclacel Pharmaceuticals,&nbsp;Inc. (the &#147;<b>Company</b>&#148;) is soliciting your proxy to vote at the 2011<b>  </b>annual meeting, and any adjournments or postponements of the meeting, to be held at 12:30&nbsp;p.m., E.S.T., on May&nbsp;24, 2011 at our corporate headquarters at 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey 07922. The holders of our Common Stock are entitled only to vote on Proposal 1, the election of Class&nbsp;2 directors, and Proposal 2, the ratification of the appointment of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm, each as described in more detail in this proxy statement.&#160; This proxy statement, along with the accompanying Notice of Annual Meeting of Stockholders, summarizes the purposes of the annual meeting and the information that holders of our Common Stock need to know to vote at the annual meeting.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Why Did I Receive this Proxy Statement as a Holder of Preferred Stock?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You received this proxy statement and the enclosed proxy card because the holders of 6% Convertible Exchangeable Preferred Stock (the &#147;<b>Preferred Stock</b>&#148;) of the Company, are currently entitled to vote and elect directors to fill two newly created directorships to be created on the Company&#146;s Board of Directors.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In the Fall of 2010, Lloyd I. Miller, a holder of 10% or more of the Preferred Stock requested that the Company call a special meeting of the holders of our Preferred Stock to vote and elect the two directors entitled to be elected by the holders of Preferred Stock.&#160; The Company called and attempted to hold a special meeting of the holders of Preferred Stock for such purpose on October&nbsp;4, 2010.&#160; Because a quorum was not present at such time, the meeting was adjourned until November&nbsp;1, 2010, at which time a quorum of holders of Preferred Stock was again not present and the meeting was terminated without further adjournment.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the terms of the Company&#146;s Certificate of the Powers, Designations, Preferences and Rights governing the Preferred Stock (the &#147;<b>Certificate</b>&#148;), holders of the Preferred Stock are entitled to receive, when, as and if declared by the Board of Directors, out of the funds of the Company legally available therefor, cash dividends payable in equal quarterly installments on February&nbsp;1, May&nbsp;1, August&nbsp;1 and November&nbsp;1.&#160; The Certificate further provides that, if the Company is in arrears in an aggregate amount equal to at least six quarterly dividends (whether or not consecutive), the number of members of the Company&#146;s Board of Directors will be increased by two, effective as of the time of election of such directors, and the holders of Preferred Stock, voting separately as a class, will have the right to vote and elect such two additional directors. This right accrued to the holders of our Preferred Stock as of August&nbsp;2, 2010. &#160;Although a dividend was paid on February&nbsp;1, 2011, and one has been declared and is payable on May&nbsp;2, 2011 the Company is still in arrears in an aggregate amount equal to six quarterly dividends on the Preferred Stock.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In light of the continuing right of the holders of Preferred Stock to elect two directors, Mr.&nbsp;Miller has re-nominated Lloyd Sems and Gregory T. Hradsky to serve as such additional directors. We have not received any other nominations for directors by the holders of the Preferred Stock. Pursuant to the terms of the Certificate, the Board of Directors shall determine which class of directors on the Company&#146;s classified board to appoint any individuals elected by the holders of Preferred Stock.&#160; The Board of Directors has determined that Mr.&nbsp;Sems, if elected, would be appointed to Class&nbsp;2, with a term expiring at the Company&#146;s 2014 annual meeting of stockholders, and Mr.&nbsp;Hradsky, if elected, would be appointed to Class&nbsp;1, with a term expiring at the Company&#146;s 2013 annual meeting of stockholders.&#160; If elected, Messrs.&nbsp;Sems and Hradsky would serve as directors until the earlier of (a)&nbsp;the annual meeting of stockholders at which the class of directors to which such individual has been appointed expires and such individual&#146;s successor is duly elected and qualified, and (b)&nbsp;such time as all accrued and unpaid dividends on the Preferred Stock have been declared and paid or set apart for payment.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1<a name="PB_1_103102_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='1',FILE='C:\JMS\105538\11-10911-2\task4639339\10911-2-bc.htm',USER='105538',CD='Apr 26 15:32 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The holders of the Preferred Stock are entitled only to vote on the proposal relating to the election of Messrs.&nbsp;Sems and Hradsky, as described in more detail in this proxy statement (the &#147;<b>Preferred Director Election Proposal</b>&#148;). This proxy statement, along with the accompanying Notice of Annual Meeting of Stockholders, summarizes the purposes of the annual meeting and the information that holders of our Preferred Stock need to know to vote at the annual meeting.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING TO BE HELD ON MAY&nbsp;24, 2011.&#160; THE PROXY STATEMENT AND ANNUAL REPORT TO STOCKHOLDERS FOR 2011 ARE AVAILABLE AT <i>WWW.PROXYVOTE.COM</i>.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On or about April&nbsp;26, 2010, we began sending this proxy statement, the attached Notice of Annual Meeting of Stockholders and the enclosed proxy card to all stockholders entitled to vote at the annual meeting. Although not part of this proxy statement, we are also sending along with this proxy statement, our 2010 Annual Report, which includes our financial statements for the fiscal year ended December&nbsp;31, 2010. You can also find a copy of our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2010 on the Internet through the SEC&#146;s electronic data system called EDGAR at <i>www.sec.gov </i>or through the Investor Relations section of our website at <i>www.cyclacel.com</i>.&#160; </font><font size="2" style="font-size:10.0pt;">The information in our website is not a part of this proxy statement and is not incorporated by reference into this proxy statement. You may also obtain a printed copy of our Annual Report on Form&nbsp;10-K, including our financial statements, free of charge, from us by sending a written request to 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey 07922, Attention: Secretary. Exhibits will be provided upon written request and payment of an appropriate processing fee.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Who Can Vote at the Annual Meeting?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Only stockholders who owned our Common Stock and/or Preferred Stock at the close of business on April&nbsp;4, 2011 are entitled to vote at the annual meeting. On this record date, there were 46,598,688&nbsp;shares of our Common Stock and 1,213,142 shares of our Preferred Stock issued and outstanding and entitled to vote on the proposals submitted to the holders of our Common Stock and Preferred Stock, respectively.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You do not need to attend the annual meeting to vote your shares. Shares represented by valid proxies, received in time for the annual meeting and not revoked prior to the annual meeting, will be voted at the annual meeting. For instructions on how to change or revoke your proxy, see &#147;May&nbsp;I Change or Revoke My Proxy?&#148; below.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the ten-day period immediately prior to the annual meeting, the list of the stockholders of record entitled to vote at the annual meeting will be available for inspection at our offices at 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey, 07922, by stockholders for such purposes as are set forth in the General Corporation Law of the State of Delaware. Such list will also be available for inspection at the annual meeting.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">How Many Votes Do I Have?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each share of Cyclacel Common Stock that you own entitles you to one vote with respect to each of Proposals 1 and 2.&#160; Each share of Cyclacel Preferred Stock that you own entitles you to one vote with respect to the Preferred Director Election Proposal.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">How Do I Vote?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Whether you plan to attend the annual meeting or not, we urge you to vote by proxy. If you vote by proxy, the individuals named on the proxy card applicable to your class of stock, or your &#147;proxies,&#148; will vote your shares in the manner you indicate. If you are a holder of our Common Stock, you may specify whether your shares should be voted for all, some or none of the nominees for director or withheld from all or any one of the nominees for director and whether your shares should be voted for, against or abstained with respect to the proposal to ratify the selection of our independent registered public accounting firm. If you are a holder of our Preferred Stock, you may specify whether your shares should be voted for all, some or none of the nominees for director or withheld from all or any one of the nominees for director. Voting by proxy will not affect your right to attend the annual meeting. If your shares are registered directly in your name through our transfer agent, American Stock Transfer and Trust Company, or you have stock certificates registered in your name, you may submit a proxy to vote:</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">By Internet or by telephone.</font></b><font size="2" style="font-size:10.0pt;">&#160; Follow the instructions attached to the proxy card applicable to your class of stock to submit a proxy to vote by Internet or telephone.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_103200_2897"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\105538\11-10911-2\task4639339\10911-2-bc.htm',USER='105538',CD='Apr 26 15:32 2011' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">By mail.</font></b><font size="2" style="font-size:10.0pt;">&#160; Complete and mail the enclosed proxy card applicable to your class of stock in the enclosed postage prepaid envelope. Your proxy will be voted in accordance with your instructions. As a holder of shares of Common Stock, if you sign the proxy card but do not specify how you want your shares voted, they will be voted as recommended by our Board of Directors.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">In person at the meeting.</font></b><font size="2" style="font-size:10.0pt;">&#160; If you attend the annual meeting, you may deliver your completed proxy card in person or you may vote by completing a ballot, which will be available at the annual meeting. You are required to register in advance of the annual meeting if you plan to attend the annual meeting in person. If you wish to register in advance of the annual meeting, please contact our investor relations office by no later than May&nbsp;17, 2011, by telephone at (908) 517-7330, by mail at Cyclacel Pharmaceuticals,&nbsp;Inc., 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey, 07922, by fax at (866) 271-3466, or by e-mail to ir@cyclacel.com.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telephone and Internet voting facilities for all stockholders of record will be available 24-hours a day and will close at 11:59&nbsp;p.m., E.S.T., on May&nbsp;23, 2011.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If your shares are held in &#147;street name&#148; (held in the name of a bank, broker or other nominee who is the holder of record), you must provide the bank, broker or other nominee with instructions on how to vote your shares and can do so as follows:</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">By Internet or by telephone.</font></b><font size="2" style="font-size:10.0pt;">&#160; Follow the instructions you receive from the record holder to vote by Internet or telephone.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">By mail.</font></b><font size="2" style="font-size:10.0pt;">&#160; You should receive instructions from the record holder explaining how to vote your shares.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">In person at the meeting.</font></b><font size="2" style="font-size:10.0pt;">&#160; Contact the broker, bank or other nominee who holds your shares to obtain a broker&#146;s proxy card and bring it with you to the annual meeting. You will not be able to vote at the annual meeting unless you have a proxy card from your broker, bank or other nominee.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">How Does the Board of Directors Recommend That I Vote on the Proposals?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors recommends that you vote as follows:</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">As a holder of Common Stock, &#147;<b>FOR</b>&#148; the election of Spiro Rombotis and Dr.&nbsp;David U&#146;Prichard, nominees for Class&nbsp;2 directors;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">As a holder of Common Stock, &#147;<b>FOR</b>&#148; ratification of the selection of our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2011; and</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">As a holder of Preferred Stock, &#147;<b>NO RECOMMENDATION</b>&#148;<b>  </b>on whether to vote in favor of or against the election of Lloyd Sems, as a Class&nbsp;2 director, and Gregory T. Hradsky, as a Class&nbsp;1 director.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If any other matter is properly presented at the annual meeting, your proxy provides that your shares will be voted by the proxy holder listed on the proxy card in accordance with his or her best judgment. We know of no matters that need to be acted on at the annual meeting, other than those described in this proxy statement.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">May&nbsp;I Change or Revoke My Proxy?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you submit a proxy, you may change or revoke it at any time before the annual meeting. You may change or revoke your proxy in any one of the following ways:</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">By submitting a new proxy card with a date later than your previously delivered proxy and submitting it as instructed above or by providing written notice of revocation to us before the annual meeting at 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey, 07922, </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3<a name="PB_3_103723_7748"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\rcheney\11-10911-2\task4641052\10911-2-be.htm',USER='rcheney',CD='Apr 26 15:47 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention: Paul McBarron, Executive Vice President&#151;Finance, Chief Financial Officer, Chief Operating Officer and Secretary;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">By submitting a later proxy by Internet or by telephone as instructed above; or</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">By attending the annual meeting in person and voting in person. Attending the annual meeting in person will not, in and of itself, change or revoke a previously submitted proxy unless you specifically request it or vote by ballot at the annual meeting.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Your most current proxy card or proxy submission by telephone or Internet is the one that will be counted.</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">What if I Receive More Than One Proxy Card?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Separate proxy cards are being sent to holders of Common Stock and to holders of Preferred Stock.&#160; If you hold only shares of Common Stock, you will receive only the proxy card for holders of Common Stock.&#160; If you hold only shares of Preferred Stock, you will receive only the proxy card for holders of Preferred Stock.&#160; If you hold both shares of Common Stock and Preferred Stock, you will receive both proxy cards, and you should complete both proxy cards if you wish to vote your respective interests in both the Common Stock and Preferred Stock.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, you may receive more than one proxy card or voting instruction form if you hold shares of our Common Stock or Preferred Stock in more than one account, which may be in registered form or held in street name. Please vote in the manner described under &#147;How Do I Vote?&#148; for each account to ensure that all of your shares are voted.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Will My Shares be Voted if I Do Not Vote?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If your shares are registered in your name, they will not be voted if you do not return your proxy card by mail or vote by Internet, telephone or at the annual meeting, as described above under &#147;How Do I Vote?&#148;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If your shares are held in street name and you do not provide voting instructions to the broker, bank or other nominee who holds your shares as described above under &#147;How Do I Vote?,&#148; the bank, broker or other nominee that holds your shares has the authority to vote your unvoted shares of Common Stock on Proposal 2 even if it does not receive instructions from you. We encourage you to provide voting instructions. This ensures your shares will be voted at the annual meeting in the manner you desire. However, your broker, bank or other nominee cannot vote your shares on Proposal 2 or the Preferred Director Election Proposal if it has not received instructions from you because such matters are considered non-routine under applicable law. Where your broker, bank or other nominee does not vote on a matter for which it does not have discretionary voting authority, this is referred to as a &#147;broker non-vote.&#148;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">What Vote is Required to Approve Each Proposal and How are Votes Counted?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.32%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Proposal   1: Holders of Common Stock to Elect Two Class&nbsp;2 Directors</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="61%" valign="top" style="padding:0in 0in 0in 0in;width:61.54%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The   two nominees for director who receive the most votes (also known as a   &#147;plurality&#148; of the votes cast) will be elected. You may vote either FOR all   of the nominees, WITHHOLD your vote from all of the nominees or WITHHOLD your   vote from any one or more of the nominees. Votes that are withheld will not   be included in the vote tally for the election of directors. Brokerage firms   do not have authority to vote customers&#146; unvoted shares held by the firms in   street name for the election of directors. As a result, any shares not voted   by a customer will be treated as a broker non-vote. Such broker non-votes   will have no effect on the results of this vote.</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4<a name="PB_4_103838_141"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\rcheney\11-10911-2\task4641052\10911-2-be.htm',USER='rcheney',CD='Apr 26 15:47 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.32%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Proposal   2: Holders of Common Stock to Ratify Selection of Our Independent Registered   Public Accounting Firm</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="61%" valign="top" style="padding:0in 0in 0in 0in;width:61.54%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The   affirmative vote of a majority of the shares of Common Stock cast for this   proposal is required to ratify the selection of our independent registered   public accounting firm. Abstentions will have no effect on this proposal.   Brokerage firms have authority to vote customers&#146; unvoted shares held by the   firms in street name on this proposal. If a broker does not exercise this   authority, such broker non-votes will have no effect on the results of this   vote. We are not required to obtain the approval of our holders of Common   Stock to select our independent registered public accounting firm. However,   if our holders of Common Stock do not ratify the selection of   Ernst&nbsp;&amp; Young LLP as our independent registered public accounting   firm for the year ending December&nbsp;31, 2011, our Audit Committee of our   Board of Directors will reconsider its selection.</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.32%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="61%" valign="top" style="padding:0in 0in 0in 0in;width:61.54%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.32%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Preferred   Director Election Proposal</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="61%" valign="top" style="padding:0in 0in 0in 0in;width:61.54%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The   two nominees for director who receive the most votes (also known as a   &#147;plurality&#148; of the votes cast) will be elected. You may vote either FOR all   of the nominees, WITHHOLD your vote from all of the nominees or WITHHOLD your   vote from any one or more of the nominees. Votes that are withheld will not   be included in the vote tally for the election of directors. Brokerage firms   do not have authority to vote customers&#146; unvoted shares held by the firms in   street name for the election of directors. As a result, any shares not voted   by a customer will be treated as a broker non-vote. Such broker non-votes   will have no effect on the results of this vote.</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">What is the Effect of Not Casting Your Vote?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you hold your shares of Common Stock or Preferred Stock in street name, it is critical that you submit a proxy or instruct your bank, broker or other nominee to cast your vote if you want your vote to be counted for the election of directors (Proposal 1 of this proxy statement, if you are a holder of Common Stock; Preferred Director Election Proposal in this proxy statement, if you are a holder of Preferred Stock). In the past, if you held your shares in street name and you did not indicate how you wanted your shares voted in the election of directors, your bank, broker or other nominee was allowed to vote those shares on your behalf in the election of directors in the bank, broker or other nominee&#146;s discretion.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Recent changes in regulation were made to take away the ability of your bank, broker or other nominee to vote your uninstructed shares in the election of directors on a discretionary basis. Thus, if you hold your shares in street name and you do not instruct your bank, broker or other nominee how to vote in the election of directors, no votes will be cast on this proposal on your behalf. Your bank, broker or other nominee will, however, continue to have discretion to vote any uninstructed shares of Common Stock on the ratification of the appointment of the Company&#146;s independent registered public accounting firm (Proposal 2 of this proxy statement). If you are a holder of Common or Preferred stock of record and you do not cast your vote, no votes will be cast on your behalf on any of the items of business at the annual meeting on which your class of stock is entitled to vote.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Is Voting Confidential?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We will keep all of the proxies, ballots and voting tabulations private. We only let our Inspector of Election, a representative of Broadridge Financial Solutions,&nbsp;Inc.,<i>  </i>examine these documents. Management will not know how you voted on a specific proposal unless it is necessary to meet legal requirements. Broadridge, however, will forward to management any written comments you make, on the proxy card or elsewhere.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">What Are the Costs of Soliciting these Proxies?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The solicitation of proxies in the enclosed form is made on behalf of the Board of Directors. The entire cost of soliciting these proxies, including the costs of preparing, printing and mailing this proxy statement and accompanying materials, will be borne by us. We have engaged Morrow&nbsp;&amp; Co., LLC, 470 West Ave., Stamford, CT 06902, to assist us with the solicitation of proxies with respect to Proposals 1 and 2 for a fee of $5,500, plus expenses. In addition, proxies may be solicited personally, by telephone or otherwise, by our officers, directors and employees, and, with respect to the Preferred Director Election Proposal, by Messrs.&nbsp;Lloyd Miller, Lloyd Sems and Gregory T. Hradsky, none of whom will receive any compensation for these services. Mr.&nbsp;Miller has engaged Okapi Partners LLC, 437 </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5<a name="PB_5_103915_7608"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='5',FILE='C:\JMS\rcheney\11-10911-2\task4641052\10911-2-be.htm',USER='rcheney',CD='Apr 26 15:47 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Madison Avenue, 28</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font><font size="2" style="font-size:10.0pt;">&#160;Floor, New York, NY 10022, at his own expense, to assist in the solicitation of proxies of holders of our Preferred Stock with respect to the Preferred Director Election Proposal, for a fee of $15,000, plus expenses.&#160; We will ask banks, brokers and other nominees to forward these proxy materials to their principals and obtain authority to execute proxies. We will then reimburse such parties for their reasonable expenses incurred in connection with these activities.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">What Constitutes a Quorum for the Annual Meeting?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">With respect to Proposals 1 and 2, the presence, in person or by proxy, of the holders of a majority of the issued and outstanding shares of our Common Stock entitled to vote at the meeting is necessary to constitute a quorum at the annual meeting.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">With respect to the Preferred Director Election Proposal, the presence, in person or by proxy, of the holders of a majority of the issued and outstanding shares of our Preferred Stock entitled to vote at the meeting is necessary to constitute a quorum at the annual meeting.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Votes of stockholders of record of each class who are present at the annual meeting in person or by proxy and abstentions are counted for purposes of determining whether a quorum exists as to each such class of capital stock.&#160; Broker non-votes will be counted for purposes of determining whether a quorum exists with respect to the Common Stock Proposals 1 and 2, but will not be counted with respect to the Preferred Director Election Proposal.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">What Dissenters&#146; Rights Do I Have?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Under Delaware law, none of our stockholders are entitled to rights of appraisal on any proposal referred to herein.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Attending the Annual Meeting</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The annual meeting will be held at 12:30&nbsp;P.M., E.S.T.,<b>  </b>on May&nbsp;24, 2011, at our corporate headquarters at 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey 07922. When you arrive at our corporate headquarters, signs will direct you to the appropriate meeting room. You need not attend the annual meeting in order to vote.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you plan to attend the meeting, you must register in advance by no later than May&nbsp;17, 2011. Registration will be granted only to record and beneficial owners. You may register by contacting our investor relations office by telephone at (908) 517-7330, by mail at Cyclacel Pharmaceuticals,&nbsp;Inc., 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey 07922, by fax at (866) 271-3466, or by e-mail to ir@cyclacel.com.&#160; When contacting us, please provide the class of shares you hold and the name under which you hold shares of record or the evidence of your beneficial ownership of shares described below.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please note that if you hold your shares in &#147;street name&#148; (that is, through a broker, bank or other nominee), you will need to send a written request for registration either by regular mail, fax or e-mail, along with proof of share ownership, such as a copy of the portion of your voting instruction form showing your name and address, a bank or brokerage firm account statement or a letter from the broker, bank or nominee holding your shares, confirming ownership. Requests for registration will be processed in the order in which they are received and must be requested no later than May&nbsp;17, 2011. Please note that seating is limited and requests for registration will be accepted on a first-come, first-served basis. On the day of the annual meeting, each stockholder will be required to present a valid picture identification such as a driver&#146;s license or passport. Seating will begin at 11:30&nbsp;A.M. and the meeting will begin at 12:30&nbsp;P.M.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Householding of Annual Disclosure Documents</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In December&nbsp;2000, the Securities and Exchange Commission, or the SEC, adopted a rule&nbsp;concerning the delivery of annual disclosure documents. The rule&nbsp;allows us or your broker, bank or other nominee to send a single set of our annual report and proxy statement to any household at which two or more of our stockholders reside, if we or your broker, bank or other nominee believe that the stockholders are members of the same family. This practice, referred to as &#147;householding,&#148; benefits both you and us. It reduces the volume of duplicate information received at your household and helps to reduce our expenses. The rule&nbsp;applies to our annual reports, proxy statements and information statements. Once you receive notice from your broker, bank or other nominee or from us that communications to your address will be &#147;householded,&#148; the practice will continue until you are otherwise notified or until you revoke your consent to the practice. Each stockholder will continue to receive a separate proxy card or voting instruction card.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6<a name="PB_6_103937_8146"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='6',FILE='C:\JMS\rcheney\11-10911-2\task4641052\10911-2-be.htm',USER='rcheney',CD='Apr 26 15:47 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If your household received a single set of disclosure documents this year, but you would prefer to receive your own copy, please contact Broadridge Financial Solutions,&nbsp;Inc., by calling their toll free number,<b>  </b>1-888-237-1900.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you do not wish to participate in &#147;householding&#148; and would like to receive your own set of our annual disclosure documents in future years, follow the instructions described below. Conversely, if you share an address with another holder of our Common Stock and together both of you would like to receive only a single set of our annual disclosure documents, follow these instructions:</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">If your shares are registered in your own name, please contact Broadridge Financial Solutions,&nbsp;Inc., and inform them of your request by calling them at 1-888-237-1900 or writing them at 51 Mercedes Way, Edgewood, New York, 11717.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">If a broker, bank or other nominee holds your shares, please contact the broker, bank or other nominee directly and inform them of your request. Be sure to include your name, the name of your brokerage firm and your account number.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Electronic Delivery of Company Stockholder Communications</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Most stockholders can elect to view future proxy statements and annual reports over the Internet instead of receiving paper copies in the mail.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You can choose this option and save the cost of producing and mailing these documents by:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">following the instructions provided on your proxy card or voter instruction form;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">following the instructions provided when you submit a proxy to vote over the Internet; or</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">going to<i> www.proxyvote.com</i> and following the instructions provided.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7<a name="PB_7_103952_7091"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='7',FILE='C:\JMS\rcheney\11-10911-2\task4641052\10911-2-be.htm',USER='rcheney',CD='Apr 26 15:47 2011' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</font></b><a name="SecurityOwnershipOfCertainBenefic_104208"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table sets forth certain information with respect to the beneficial ownership of our Common Stock and Preferred Stock as of April 18, 2011 for (a) the executive officers named in the Summary Compensation Table on page 17 of this proxy statement, (b) each of our directors and director nominees, (c) all of our current directors and executive officers as a group, and (d) each stockholder known by us to own beneficially more than 5% of each class of our Common and Preferred Stock, relying solely upon the amounts and percentages disclosed in their public filings.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. We deem shares of common stock that may be acquired by an individual or group within 60 days of April 18, 2011 pursuant to the exercise of options or warrants to be outstanding for the purpose of computing the percentage ownership of such individual or group, but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person shown in the table. Except as indicated in footnotes to this table, we believe that the stockholders named in this table have sole voting and investment power with respect to all shares of stock shown to be beneficially owned by them based on information provided to us by these stockholders.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Percentage of ownership is based on 46,601,758 shares of Common Stock and 1,213,142 shares of Preferred Stock outstanding as of April 18, 2011.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The address for each of the directors and named executive officers is c/o Cyclacel Pharmaceuticals, Inc., 200 Connell Drive Suite 1500, Berkeley Heights, New Jersey 07922. Addresses of other beneficial owners are noted in the table.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="37%" valign="bottom" style="padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.2%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number&nbsp;of&nbsp;Shares<br>   of&nbsp;Common&nbsp;Stock<br>   Beneficially&nbsp;Owned(1)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage&nbsp;of<br>   Common&nbsp;Stock<br>   Owned</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.2%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number&nbsp;of&nbsp;Shares<br>   of&nbsp;Preferred&nbsp;Stock<br>   Beneficially&nbsp;Owned(1)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage&nbsp;of<br>   Preferred&nbsp;Stock<br>   Owned</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><i><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Directors, Director Nominees and   Executive Officers</font></u></i></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" style="padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;Nicholas Bacopoulos (2) </font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">42,309</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sir John Banham(3) </font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">132,514</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" style="padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;Judy&nbsp;Chiao(4) </font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">359,955</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;Christopher&nbsp;Henney(5) </font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">218,419</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" style="padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Paul McBarron(6) </font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">561,622</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.20</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Spiro Rombotis(7) </font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,050,385</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.23</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" style="padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel K. Spiegelman(8) </font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">126,370</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;David U&#146;Prichard(9) </font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">230,183</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" style="padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lloyd Sems </font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gregory T. Hradsky </font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" style="padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive officers and directors as a group (9&nbsp;persons)(10)   </font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,834,922</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.84</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><i><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">5% or more stockholders</font></u></i></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" style="padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Austin   W. Marxe and David M. Greenhouse(11) </font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">527   Madison Avenue, Suite&nbsp;2600, New York, NY 10022</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9,911,148</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.69</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="37%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.1%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lloyd I. Miller(12) </font></p>
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4550 Gordon Drive, Naples, FL 34102</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">245,163</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20.21</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="2" style="font-size:10.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Represents beneficial ownership of less than 1% of the outstanding shares of our Common Stock.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Beneficial ownership also includes shares of Common Stock subject to options and warrants currently exercisable or convertible, or exercisable or convertible within 60 days of April 18, 2011. Except as indicated by footnote, to our knowledge, all persons named in the table </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8<a name="PB_8_104934_455"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='8',FILE='C:\JMS\C900805\11-10911-2\task4640480\10911-2-bg.htm',USER='C900805',CD='Apr 26 23:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">above have sole voting and investment power with respect to all shares of Common Stock shown as beneficially owned.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Includes options to purchase 39,809 shares of Common Stock that are exercisable within 60 days of April 18, 2011.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Includes options to purchase 95,667 shares of Common Stock that are exercisable within 60 days of April 18, 2011.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Includes options to purchase 286,787 shares of Common Stock that are exercisable within 60 days of April 18, 2011.&#160; Also includes 9,893 restricted stock units.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Includes options to purchase 211,252 shares of Common Stock that are exercisable within 60 days of April 18, 2011.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Includes options to purchase 385,568 shares of Common Stock that are exercisable within 60 days of April 18, 2011.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Includes options to purchase 492,227 shares of Common Stock that are exercisable within 60 days of April 18, 2011. Also includes 19,786 restricted stock units. Of the shares of Common Stock reported, 1,000 shares are held indirectly by Mr. Rombotis through his IRA account.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-22.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(8)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Includes options to purchase 126,370 shares of Common Stock that are exercisable within 60 days of April 18, 2011.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(9)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Includes options to purchase 204,877 shares of Common Stock that are exercisable within 60 days of April 18, 2011.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(10)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">See footnotes (2)-(9). Also includes options to purchase 113,165 shares of Common Stock held by Robert Sosnowski, our Vice President, Sales &amp; Marketing, which are exercisable within 60 days of April 18, 2011.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Based on a Schedule 13G filed on February 11, 2011 with the SEC by Austin W. Marxe (&#147;Marxe&#148;) and David M. Greenhouse (&#147;Greenhouse&#148;). Marxe and Greenhouse share sole voting and investment power over 4,106,900 shares of common stock, 2,724,073 warrants to purchase shares of common stock, 176,200 warrants (not currently exercisable) and options to purchase 2,053,450 units (each unit consists of one share of common stock and warrant to purchase 0.5 of common stock). This amount includes 547,600 shares of common stock, 381,965 warrants to purchase shares of common stock, 26,400 warrants (not currently exercisable) and options to purchase 273,800 units (each unit consists of one share of common stock and warrant to purchase 0.5 of common stock) owned by Special Situations Private Equity Fund, L.P., 684,500 shares of common stock, warrants to purchase 342,250 shares of common stock and options to purchase 342,250 units (each unit consists of one share of common stock and warrant to purchase 0.5 of common stock) are owned by Special Situations Cayman Fund, L.P., 2,053,400 shares of common stock, 1,459,360 warrants to purchase shares of common stock, 114,000 warrants (not currently exercisable) and options to purchase 1,026,700 units (each unit consists of one share of common stock and warrant to purchase 0.5 of common stock) owned by Special Situations Fund III QP, L.P. and 821,400 shares of common stock, 540,498 warrants to purchase shares of common stock, 35,800 warrants (not currently exercisable) and options to purchase 410,700 units (each unit consists of one share of common stock and warrant to purchase 0.5 of common stock) owned by Special Situations Life Sciences Fund, L.P. Marxe and Greenhouse are the controlling principals of AWM Investment Company, Inc., the general partner of and investment adviser to Special Situations Cayman Fund, L.P. AWM also serves as the general partner of MGP Advisers Limited Partnership, the general partner of Special Situations Fund III QP, L.P. Marxe and Greenhouse are members of MG Advisers L.L.C., the general partner of Special Situations Private Equity Fund, L.P. Marxe and Greenhouse are also members of LS Advisers L.L.C., the general partner of Special Situations Life Sciences Fund, L.P. AMW serves as the investment adviser to Special Situations Private Equity Fund, L.P., Special Situations Fund III QP, L.P. and Special Situations Life Sciences Fund, L.P.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Based on a letter dated February 16, 2011, sent to the Company by Mr. Miller.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9<a name="PB_9_105105_4141"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='9',FILE='C:\JMS\C900805\11-10911-2\task4640480\10911-2-bg.htm',USER='C900805',CD='Apr 26 23:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">MANAGEMENT AND CORPORATE GOVERNANCE</font></b><a name="ManagementAndCorporateGovernance_105110"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">The Board of Directors</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, as amended, provide that our business is to be managed by or under the direction of the Board of Directors. Our Board of Directors is divided into three classes for purposes of election. One class is elected at each annual meeting of stockholders to serve for a three-year term. Our Board of Directors currently consists of seven members, classified into three classes as follows: (1) Sir John Banham and Daniel K. Spiegelman constitute Class 1, with a term ending at the 2013 annual meeting; (2) Spiro Rombotis and David U&#146;Prichard, Ph.D. constitute Class 2, with a term ending at the 2011 annual meeting; and (3) Paul McBarron, Nicholas Bacopoulos, Ph.D. and Christopher S. Henney, Ph.D., D.Sc. constitute Class 3, with a term ending at the 2012 annual meeting.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On March 30, 2011, our Board of Directors voted to nominate Spiro Rombotis and David U&#146;Prichard, Ph.D., for election as Class 2 directors at the annual meeting for a term of three years to serve until the 2014 annual meeting of stockholders, and until their respective successors have been elected and qualified.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, the holders of our Preferred Stock, voting separately as a class, are entitled to vote and elect two additional directors pursuant to the terms of the Certificate.&#160; Lloyd Sems and Gregory T. Hradsky have been nominated by a holder of our Preferred Stock. Thus, after the annual meeting (and assuming a quorum of the holders of Preferred Stock is obtained at the annual meeting), our Board of Directors will consist of nine members, provided that the right of the holders of our Preferred Stock to elect directors as a separate class will end at such time as all accrued and unpaid dividends on the Preferred Stock have been declared and paid or set apart for payment. Such directorships shall also expire at such time.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Set forth below are the names of the persons nominated as directors and our current directors, their ages, their offices in the Company, if any, their principal occupations or employment for the past five years, the length of their tenure as directors and the names of other public companies in which such persons hold or have held directorships during the past five years. In addition, the following paragraphs include specific information about the experience, qualifications, attributes or skills of each of our directors, other than Messrs. Sems and Hradsky, who were nominated by Mr. Miller, that led the Board of Directors to the conclusion that the individual is qualified to serve on the Board of Directors as of the time of this filing, in light of our business and structure.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="20%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:20.3%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Name</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="4%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:4.9%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Age</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="70%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:70.64%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Position</font></b></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:20.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Spiro   Rombotis</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:4.9%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:70.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President   and Chief Executive Officer; Common Stock Nominee for Class&nbsp;2 Director</font></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" style="padding:0in 0in 0in 0in;width:20.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Paul   McBarron</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.9%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive   Vice President&#151;Finance, Chief Financial Officer, Chief Operating Officer and   Secretary; Class&nbsp;3 Director</font></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;Nicholas   Bacopoulos</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.9%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">62</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Class&nbsp;3   Director</font></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" style="padding:0in 0in 0in 0in;width:20.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sir&nbsp;John   Banham</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.9%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Class&nbsp;1   Director</font></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;Christopher   Henney</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.9%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice   Chairman; Class&nbsp;3 Director</font></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" style="padding:0in 0in 0in 0in;width:20.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel   K. Spiegelman</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.9%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Class&nbsp;1   Director</font></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;David   U&#146;Prichard</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.9%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">62</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chairman   of the Board of Directors; Common Stock Nominee for Class&nbsp;2 Director</font></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" style="padding:0in 0in 0in 0in;width:20.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lloyd   Sems</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.9%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">39</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preferred   Stock Nominee for Class&nbsp;2 Director</font></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gregory   T. Hradsky</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.9%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preferred   Stock Nominee for Class&nbsp;1 Director</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Preferred Stock Nominee for Class&nbsp;1 Director (Term to Expire in 2013)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Gregory T. Hradsky.&#160; </font></i></b><font size="2" style="font-size:10.0pt;">Based on information provided to us by Mr. Miller, Mr. Hradsky has been an independent financial consultant since February 2006. He has served on the board of directors of Sielox, Inc. since June 2008 where he is Chairman of the Audit Committee. Between May 2003 and February 2006, Mr. Hradsky was a Vice President of Avenue Capital Group, a global investment firm, where he managed a portfolio of distressed securities, post-reorganization equities and other investments. From 1999 until 2003, Mr. Hradsky was the founder and Managing Partner of Bellport Capital, an investment firm specializing in distressed securities. Prior to that, </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10<a name="PB_10_105227_8627"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='10',FILE='C:\JMS\C900805\11-10911-2\task4640480\10911-2-bg.htm',USER='C900805',CD='Apr 26 23:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. Hradsky was a Managing Director and Head of the Distressed Securities Group at UBS Securities LLC from 1993 until 1998. Mr. Hradsky joined UBS in 1991 as a research analyst focusing on distressed credits. Prior to UBS, Mr. Hradsky was a member of the Distressed Securities Group and the High Yield Research Department at the First Boston Corporation from 1988-1991. He began his career at T. Rowe Price Associates in 1983 and worked in the Fixed Income Department until 1986. Mr. Hradsky has a B.A. from Loyola College in Maryland and an M.B.A. from the Wharton School of the University of Pennsylvania.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Only a holder of our Preferred Stock as of the record date is entitled to vote with respect to the election of Mr. Hradsky.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Continuing Class 1 Directors (Terms to Expire in 2013)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Sir John Banham</font></i></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">.</font></b><font size="2" style="font-size:10.0pt;">&#160; Sir John Banham is currently the Chairman of Johnson Matthey plc and Sultan Scientific Limited, and senior non-executive director of Invesco Limited. He is past Director General of the Confederation of British Industry (CBI) and past Chairman of Whitbread plc, Geest plc, ECI Partners LLP, Tarmac plc and Kingfisher plc. His public sector appointments comprise first Controller of the Audit Commission and first Chairman of the Local Government Commission for England. He was formerly Honorary Treasurer of the United Kingdom&#146;s Cancer Research Campaign prior to its merger with Imperial Cancer Research. He is a graduate of Cambridge University in Natural Sciences and has honorary degrees from a number of British universities.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sir John Banham is qualified for service on our Board of Directors based on his professional experience and public service involvement in the business and scientific arenas in which our Company operates.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Daniel K. Spiegelman</font></i></b><font size="2" style="font-size:10.0pt;">,<b><i style="font-weight:bold;"> M.B.A.</i></b>&#160; Mr. Spiegelman had served as one of Xcyte&#146;s directors since September 2004, and continued on as a director of the Company. Mr. Spiegelman had served as the Senior Vice President and Chief Financial Officer of CV Therapeutics, Inc. since September 1999. From January 1998 to September 1999, Mr. Spiegelman served as the Vice President and Chief Financial Officer of CV Therapeutics, Inc. From 1991 until 1998, Mr. Spiegelman was employed by Genentech, Inc., a biotechnology company, holding various positions in the Treasury department, including the position of Treasurer from 1996 to 1998. Mr. Spiegelman also serves as a member of the board of directors of Affymax, Inc., Omeros Inc, Oncothyreon, Inc. and Anthera Pharmaceuticals Inc, publicly-traded biopharmaceuticals companies, as well as some private biotech companies. Mr. Spiegelman holds a B.A. in Economics from Stanford University and an M.B.A. from Stanford Graduate School of Business.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:21.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. Spiegelman is qualified for service on our Board of Directors based on his extensive background in finance as well as his senior management experience with other biotechnology public companies. In addition, his current service on the board of directors of other public companies in the biopharmaceutical industry brings invaluable expertise to our Board of Directors.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Common Stock Nominees for Class 2 Directors (Terms to Expire in 2014)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Spiro Rombotis.&#160; </font></i></b><font size="2" style="font-size:10.0pt;">Mr. Rombotis joined Cyclacel in August 1997 and has over 28 years of experience with pharmaceutical and biotechnology companies. He was previously Vice President of International Operations and Business Development; Managing Director, Europe; and Director, Japanese joint venture, at The Liposome Company, Inc. He also served as Vice President of Pharmaceuticals for Central and Eastern Europe and as Director of International Marketing at Bristol-Myers Squibb Company. He was Head of European Marketing and Sales, Head of Corporate Development and one of the first employees of Centocor, Inc. and worked in Business Development at Novartis AG. He holds a B.A. from Williams College and an M.B.A. and Master&#146;s degree in Hospital Management with honors, from the Kellogg Graduate School of Management, where he serves on the Kellogg Biotech Advisory Board.&#160; He also serves on the Board of Trustees of BioNJ, the biotechnology industry trade group in New Jersey.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. Rombotis is qualified for service on our Board of Directors due to his many years of experience in the pharmaceutical and biotechnology industries as well as his managerial expertise and leadership skills. As the Company&#146;s Chief Executive Officer, Mr. Rombotis brings to the Board of Directors valuable knowledge of the Company&#146;s business, operations, strategy and future development prospects.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Only a holder of our Common Stock as of the record date is entitled to vote with respect to the election of Mr. Rombotis.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11<a name="PB_11_105250_7906"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='11',FILE='C:\JMS\C900805\11-10911-2\task4640480\10911-2-bg.htm',USER='C900805',CD='Apr 26 23:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">David U&#146;Prichard</font></i></b><font size="2" style="font-size:10.0pt;">,<b><i style="font-weight:bold;"> Ph.D.</i></b>&#160; Dr. U&#146;Prichard joined the Board of Directors of Cyclacel in May 2004. He is currently President of Druid Consulting LLC, a pharmaceutical and biotechnology-consulting firm, providing customized services to life sciences clients in the United States and Europe. He is also a Venture Partner with Red Abbey Venture Partners, private equity providers. Previously, he was Chief Executive Officer of 3-Dimensional Pharmaceuticals, Inc. from 1999 to 2003. In addition, he held a variety of positions within the pharmaceutical and biotechnology industries, including, President and Chairman of Research and Development for SmithKline Beecham Pharmaceuticals; Executive Vice President and International Research Director, and a Member of the Board of Management of Zeneca Pharmaceuticals; General Manager, Research Department, ICI Pharmaceuticals, and Vice President Biomedical Research, ICI Pharmaceuticals; and Senior Vice President and Scientific Director for Nova Pharmaceutical Corporation. He is a director of Life Technologies, Inc. and Silence Therapeutics plc. and he served as a director of Alpharma, Inc., Guilford Pharmaceuticals Inc. and Lynx Therapeutics, Inc. He is the non-executive Chairman of Oxagen Ltd and he was Chairman of the Pennsylvania Biotechnology Association in 2004-2005. From 1992 to 1997, he was a member of the board of directors of the Biotechnology Industry Organization (BIO). He received a B.Sc. in Pharmacology from University of Glasgow in 1970 and a Ph.D. in Pharmacology from University of Kansas in 1975.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. U&#146;Prichard is qualified for service on our Board of Directors based on his significant senior level pharmaceutical industry experience and his extensive background in the consulting and financing realms of the pharmaceutical industry.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Only a holder of our Common Stock as of the record date is entitled to vote with respect to the election of Dr. U&#146;Prichard.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Preferred Stock Nominee for Class 2 Directors (Terms to Expire in 2014)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Lloyd Sems.</font></i></b><font size="2" style="font-size:10.0pt;">&#160; Based on information provided to us by Mr. Miller, Mr. Sems has served as President of Sems Capital, LLC and of Capital Edge, LLC, both of which he founded, since October 2003. He has also served as a director of Selectica, Inc. since June 2, 2008, and as Chairperson of the Nominating/Corporate Governance Committee of the Selectica Board since May 20, 2009. Previously, Mr. Sems served as Director of Research and Portfolio Manager for Watchpoint Asset Management. Mr. Sems holds a Bachelor of Science degree in Business Administration and Finance from Albright College. Mr. Sems also serves on the Board of Directors of Sport-Haley, Inc. (OTC Pink Sheets: SPOR), which he joined in April 2009. Mr. Sems also served on the Board of Directors of EMAK Worldwide, Inc. from February 2010 to April 2010.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Only a holder of our Preferred Stock as of the record date is entitled to vote with respect to the election of Mr. Sems.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Continuing Class 3 Directors (Terms to Expire in 2012)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Paul</font></i></b><b><i><font size="2" style="font-size:10.0pt;font-style:italic;font-weight:bold;"> McBarron</font></i></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">.</font></b><font size="2" style="font-size:10.0pt;">&#160; </font><font size="2" style="font-size:10.0pt;">Mr. McBarron joined Cyclacel in January 2002 and has over 20 years of experience with pharmaceutical and biotechnology companies.&#160; He has served as a financial executive at Sterling Drug, Sanofi-Winthrop and SmithKline Beecham and most recently, from 1996 to 2001, as a senior member of the finance team at Shire Pharmaceuticals plc, where he held the positions of Director of Corporate Finance and Group Financial Controller. He joined Shire when it was an emerging public company. He qualified as a chartered accountant with Ernst &amp; Young and serves on the Life Sciences Industry Advisory Board for the Scottish Government.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. McBarron is qualified for service on our Board of Directors based on his financial expertise and his extensive experience in the pharmaceutical industry. As the Company&#146;s Chief Financial Officer and Chief Operating Officer, Mr. McBarron also provides the Board of Directors with unique insight into the Company&#146;s financial and operations, as well as the Company&#146;s strategy.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Nicholas Bacopoulos</font></i></b><i><font size="2" style="font-size:10.0pt;font-style:italic;">,<b> Ph.D.&#160; </b></font></i><font size="2" style="font-size:10.0pt;">Dr. Bacopoulos joined the Board of Directors of Cyclacel in September 2008. He is currently the Chief Executive Officer of. Mersana Therapeutics, a private biotechnology company. Prior to that, Mr. Bacopoulos was a consultant to biotech and pharmaceutical companies. His previous leadership roles include Chief Executive Officer and President of Aton Pharma, Inc., where he led the development of Zolinza&#174;, approved for the treatment of cutaneous T-cell lymphoma. Aton was subsequently acquired by Merck &amp; Co., Inc. He was previously President and Head of Research and Development at OSI Pharmaceuticals, Inc. where he was involved with the global development of Tarceva&#174;, approved for the treatment of non-small cell lung cancer and pancreatic cancer. Dr. Bacopoulos also worked for 17 years at Pfizer, where he held senior positions within Pfizer Central Research </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12<a name="PB_12_105336_3736"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='12',FILE='C:\JMS\C900805\11-10911-2\task4640480\10911-2-bg.htm',USER='C900805',CD='Apr 26 23:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and Corporate Strategic Planning. He led the company&#146;s Cancer and Neuroscience Research groups, which developed several marketed drugs, including Geodon&#174; and Zoloft&#174;, and produced a significant pipeline of oncology drug candidates, several of which are in clinical trials. Dr. Bacopoulos also serves on the board of directors of Mersana Therapeutics, Inc. and Medexis Biotech, S.A., both privately-held biotechnology companies. He received his B.A. degree from Cornell College and his Ph.D. from the University of Iowa. He completed additional coursework and obtained a postdoctoral fellowship at Yale University School of Medicine.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. Bacopoulos is qualified for service on our Board of Directors based on his senior executive level experience in pharmaceutical companies, his educational background and his breadth of knowledge in the development of drugs for cancer, which enable Dr. Bacopoulos to contribute to the Company&#146;s strategy and strategic initiatives.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Christopher S. Henney</font></i></b><font size="2" style="font-size:10.0pt;">, <b>Ph.D.&#160; D.Sc.</b>&#160; Dr. Henney had served as one of Xcyte&#146;s directors since March 2005, and continued on as Vice Chairman of the Company. Previously, Dr. Henney co-founded three major publicly held U.S. biotechnology companies, Immunex, ICOS and Dendreon, and held a seat on the board of directors and executive positions at each company. From 1995 to January 2003, Dr. Henney was Chairman and Chief Executive Officer of Dendreon Corporation. Dr. Henney currently serves as the Chairman of Oncothyreon, Inc. and Anthera Pharmaceuticals, Inc. Dr. Henney received a Ph.D. in experimental pathology from the University of Birmingham and a D.Sc. from the same university for contributions to the field of immunology.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. Henney is qualified for service on our Board of Directors based on his senior executive experience in biotechnology companies. Dr. Henney has extensive knowledge and educational background in the relevant industry and he provides the Board of Directors with valuable leadership skills.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Director Independence</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our Board of Directors has reviewed the materiality of any relationship that each of our directors has with the Company, either directly or indirectly. Based upon this review, our Board of Directors has determined that each of the following directors is an &#147;independent director&#148; as such term is defined by rules of The NASDAQ Stock Market, Inc., or NASDAQ:</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Nicholas Bacopoulos, Ph.D.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Sir John Banham</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Christopher Henney, Ph.D, D.Sc.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Daniel K. Spiegelman, M.B.A.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">David U&#146;Prichard, Ph.D.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors has established three standing committees, (1) the Compensation and Organization Development Committee, (2) the Audit Committee, and (3) the Nominating and Corporate Governance Committee. The Board of Directors has also determined that each member of these committees meets the independence requirements applicable to each such committee as prescribed by NASDAQ and the SEC.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Committees of the Board of Directors and Meetings</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Meeting Attendance.</font></i><font size="2" style="font-size:10.0pt;">&#160; During the fiscal year ended December 31, 2010, there were five meetings of our Board of Directors, and the various committees of the Board of Directors met a total of seven times. No director attended fewer than 80% of the total number of meetings of the Board of Directors and of committees of the Board of Directors on which he served during fiscal year 2010. Seven of our directors attended, in person, our annual meeting of stockholders held in 2010.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Audit Committee.</font></i><font size="2" style="font-size:10.0pt;">&#160; Our Audit Committee met four times during fiscal 2010. The Audit Committee currently has three members, Daniel K. Spiegelman (Chairman), Sir John Banham and Dr. Christopher Henney. All members of the Audit Committee satisfy the current independence standards promulgated by the NASDAQ and SEC, as such standards apply specifically to members of audit committees. The Board of Directors has determined that Mr. Spiegelman is an &#147;audit committee financial expert,&#148; as the SEC has defined that term in Item 407 of Regulation S-K.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13<a name="PB_13_105410_9621"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='13',FILE='C:\JMS\C900805\11-10911-2\task4640480\10911-2-bg.htm',USER='C900805',CD='Apr 26 23:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our Audit Committee oversees and monitors the processes management has in place to maintain the reliability and integrity of our accounting policies and financial reporting processes, to ensure the adequacy of internal accounting, financial reporting and disclosure controls, and to comply with legal and regulatory requirements that may impact our financial reporting and disclosure obligations. The Audit Committee is also responsible for reviewing the qualifications, independence and performance of, and selecting or replacing, if necessary, our independent registered public accounting firm and approving all audit and non-audit services and fees related thereto. In addition, the Audit Committee is responsible for reviewing, in consultation with our management and independent registered public accounting firm, the scope and results of (1) reviews of our quarterly financial statements, (2) audits of our annual financial statements, and (3) audits of our system of internal control over financial reporting and management&#146;s assessment of the effectiveness thereof. The Audit Committee may also perform other duties and responsibilities as the Audit Committee or the Board of Directors deems appropriate or necessary, including reviewing, evaluating and approving related-party or similar transactions or relationships. Please also see the report of the Audit Committee set forth elsewhere in this proxy statement.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee maintains a written charter that outlines its responsibilities, which it reviews and reassesses annually and recommends any changes to the Board of Directors for approval. A copy of the Audit Committee&#146;s written charter is publicly available on our website at <i>www.cyclacel.com</i>.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Compensation and Organization Development Committee.</font></i><font size="2" style="font-size:10.0pt;"> Our Compensation and Organization Development Committee met three times during fiscal 2010. The Compensation and Organization Development Committee is composed entirely of directors who are not our current or former employees, all of whom qualify as independent under the definition promulgated by the NASDAQ and SEC. The Compensation and Organization Development Committee currently has three members: Dr. Christopher Henney (Chairman), Dr. Nicholas Bacopoulos and Dr. David U&#146;Prichard. Generally, our Compensation and Organization Development Committee reviews, approves and makes recommendations regarding our compensation policies, practices and procedures to ensure that legal and fiduciary responsibilities of the Board of Directors are carried out and that such policies, practices and procedures contribute to our success. The Compensation and Organization Development Committee also develops and implements policies, principles and procedures for the selection and performance review of the Company&#146;s executive officers (including our Chief Executive Officer), other officers, directors, employees, consultants, and advisors; interprets and administers our Amended and Restated 2006 Equity Incentive Plan.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A copy of the Compensation and Organization Development Committee&#146;s written charter is publicly available on our website at <i>www.cyclacel.com</i>.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Nominating and Corporate Governance Committee.</font></i><font size="2" style="font-size:10.0pt;"> Our Nominating and Corporate Governance Committee conducted its affairs during meetings of our Board of Directors, including a self-evaluation process which was undertaken by our Board of Directors, and did not meet separately. The Nominating and Corporate Governance Committee has two members, Sir John Banham (Chairman) and Mr. Daniel K. Spiegelman, both of whom qualify as independent under the definition promulgated by the NASDAQ and SEC. The functions of the Nominating and Corporate Governance Committee include making recommendations to the full Board of Directors as to particular nominees for election or appointment to the Board of Directors; making recommendations to the full Board of Directors as to the membership, structure and operations of the committees of the Board of Directors; reviewing and assessing the adequacy of our corporate governance guidelines, principles and practices and recommending changes to the full Board of Directors for approval; monitoring compliance with our Corporate Code of Conduct and Ethics; and reviewing and maintaining oversight of matters relating to the independence, operation and effectiveness of the Board of Directors and committee members.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Nominating and Corporate Governance Committee may consider candidates recommended by stockholders as well as from other sources, such as other directors or officers, third party search firms or other appropriate sources for all potential candidates. The Nominating and Corporate Governance Committee may consider all factors it deems relevant, such as a candidate&#146;s personal integrity and sound judgment, business and professional skills and experience, independence, knowledge of the industry in which we operate, possible conflicts of interest, diversity, the extent to which the candidate would fill a present need on the Board of Directors, and concern for the long-term interests of the stockholders. In general, persons recommended by stockholders will be considered on the same basis as candidates from other sources. If a stockholder wishes to nominate a candidate to be considered for election as a director at our 2011 annual meeting of stockholders, such a recommendation should be submitted in writing to the Nominating and Corporate Governance Committee, c/o Paul McBarron, Secretary, Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922. Any such written recommendation should include a minimum of the </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14<a name="PB_14_105437_8715"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='14',FILE='C:\JMS\C900805\11-10911-2\task4640480\10911-2-bg.htm',USER='C900805',CD='Apr 26 23:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">following: (a) all information relating to such person that would be required to be disclosed pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended, or the Exchange Act (including such person&#146;s consent to being named in the proxy statement as a nominee and to serving as a director, if elected); (b) the name(s) and address(es) of the stockholder(s) making the recommendation; and (c)(i) the name, age, business address and residence address of such nominee, (ii) the principal occupation or employment of such nominee, (iii) the class and number of shares of the Company which are beneficially owned by such person and (iv) any other information relating to such nominee that is required to be disclosed in solicitations of proxies for election of directors. Any such recommendation should be submitted in the time frame for stockholder proposals which are to be included in proxy materials for the annual meeting to be held in 2012 under the caption, &#147;Stockholder Proposals and Nominations for Director&#148; set forth elsewhere in this proxy statement.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have no formal policy regarding board diversity. Our </font><font size="2" style="font-size:10.0pt;">Nominating and Corporate Governance Committee </font><font size="2" style="font-size:10.0pt;">and Board of Directors may therefore consider a broad range of factors relating to the qualifications and background of nominees, which may include diversity, which is not only limited to race, gender or national origin. Our </font><font size="2" style="font-size:10.0pt;">Nominating and Corporate Governance Committee </font><font size="2" style="font-size:10.0pt;">and Board of Directors&#146; priority in selecting members is identification of persons who will further the interests of our stockholders through his or her established record of professional accomplishment, the ability to contribute positively to the collaborative culture among board members and professional and personal experiences and expertise relevant to our growth strategy.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A copy of the Nominating and Corporate Governance Committee&#146;s written charter is publicly available on the Company&#146;s website at <i>www.cyclacel.com</i>.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Board Leadership Structure</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. U&#146;Prichard serves as the Chairman of our Board of Directors and Mr. Rombotis serves as our President and Chief Executive Officer. Dr. U&#146;Prichard is an independent director under the definition promulgated by the NASDAQ and SEC and we believe that it is preferable for one of our independent directors to serve as Chairman of the Board of Directors. We also believe that this structure is the most effective structure for us and our stockholders at this time because a separate chairman (i) can provide the Chief Executive Officer with guidance and feedback on his performance, (ii) provides a more effective channel for the Board of Directors to express its views on management, and (iii) allows the Chairman to focus on stockholder interests and corporate governance while providing Mr. Rombotis with the ability to focus his attention on managing our day-to-day operations. As Dr. U&#146;Prichard has significant senior level pharmaceutical industry experience, he is particularly well-suited to serve as Chairman.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We recognize that different board leadership structures may be appropriate for companies in different situations. We will continue to re-examine our corporate governance policies and leadership structures on an ongoing basis to ensure that they continue to meet the Company&#146;s needs.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Role in Risk Oversight</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Management is responsible for managing the risks that we face. The Board of Directors is responsible for overseeing management&#146;s approach to risk management that is designed to support the achievement of organizational objectives, including strategic objectives and risks associated with our clinical trials, to improve long-term organizational performance and enhance stockholder value. The involvement of the full Board of Directors in reviewing our strategic objectives and plans, including with respect to our clinical trials, is a key part of the Board of Directors&#146; assessment of management&#146;s approach and tolerance to risk. A fundamental part of risk management is not only understanding the risks a company faces and what steps management is taking to manage those risks, but also understanding what level of risk is appropriate for us. In setting our business strategy, our Board of Directors assesses the various risks being mitigated by management and determines what constitutes an appropriate level of risk for us.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">While the Board of Directors has ultimate oversight responsibility for overseeing management&#146;s risk management process, various committees of the Board of Directors assist it in fulfilling that responsibility.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee assists the Board of Directors in its oversight of risk management in the areas of financial reporting, internal controls and compliance with legal and regulatory requirements, the Nominating and Corporate Governance Committee reviews legal and regulatory compliance risks and the Compensation and Organization Development Committee assists the Board of Directors in its oversight of the evaluation and management of risks related to our compensation policies and practices.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15<a name="PB_15_105457_563"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='15',FILE='C:\JMS\C900805\11-10911-2\task4640480\10911-2-bg.htm',USER='C900805',CD='Apr 26 23:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Stockholder Communications to the Board of Directors</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Generally, stockholders who have questions or concerns should contact our Investor Relations department at (908) 517-7330 or email at ir@cyclacel.com. However, stockholders wishing to submit written communications directly to the Board of Directors should send their communications to our Secretary, Paul McBarron, Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922. All stockholder communications will be considered by the independent members of our Board of Directors.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Executive Officers</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table sets forth certain information regarding our current executive officers who are not also members of our Board of Directors. All such executive officers are at-will employees.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="20%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:20.26%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Name</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.74%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="6%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:6.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Age</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.74%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="67%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:67.84%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Position</font></b></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:20.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.   Judy Chiao</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:6.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:67.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice   President, Clinical Development and Regulatory Affairs</font></p>    </td>   </tr>
<tr>
<td width="20%" valign="top" style="padding:0in 0in 0in 0in;width:20.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Robert   Sosnowski</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice President, Sales &amp; Marketing</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Judy Chiao, M.D.&#160; </font></i></b><font size="2" style="font-size:10.0pt;">Dr. Chiao joined Cyclacel in December 2004.&#160; From September 2002 to December 2004<b>, </b>she was at Aton Pharma, Inc., a wholly owned subsidiary of Merck &amp; Co. Inc., most recently as Vice President, Oncology Clinical Research and Development. Prior to Aton&#146;s acquisition by Merck, she was responsible for leading the clinical development of Zolinza&#174;, a histone deacetylase inhibitor, for hematologic and solid tumor indications. From July 2000<b>  </b>to December 2001, Dr. Chiao was a Senior Medical Reviewer, Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, where she was the agency&#146;s primary reviewer for a range of oncology drugs and regulatory subjects. She also presented the FDA&#146;s views in several New Drug Application reviews at Oncology Drug Advisory Committees. Dr. Chiao earned her Bachelor of Science in Chemistry (<i>summa cum laude</i>) at Columbia University, New York, and received her medical degree from Harvard Medical School. Her internship and residency in internal medicine was carried out at Columbia-Presbyterian Medical Center, New York and she held a Research Fellowship in Molecular Pharmacology at Sloan Kettering Institute for Cancer Research and a Clinical Fellowship in Hematology/Oncology at Memorial Sloan Kettering Cancer Center both in New York City. She has also been a member of a number of FDA-related working groups and has also been a Core Member of the Pharsight-FDA Cooperative Research and Development Agreement (CRADA) on clinical trial simulation and population pharmacokinetic analysis software for drug development.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Robert Sosnowski.&#160; </font></i></b><font size="2" style="font-size:10.0pt;">Mr. Sosnowski joined Cyclacel in April 2008 and has more than 28 years experience in sales and marketing roles at several pharmaceutical and major biotechnology companies. Prior to joining Cyclacel, Mr. Sosnowski was President, Chief Executive Officer and Co-Founder, Dexgen Pharmaceuticals, Inc., a specialty pharmaceutical company, and Vice President, Sales and Marketing, Algos Pharmaceutical Corporation. In addition, he has held senior sales and marketing roles with Genentech, Inc., Centocor, Inc., The Liposome Company, Inc., Amgen, Inc. and The Upjohn Company. Mr. Sosnowski earned his Bachelor of Science degree in 1980 from the University of Connecticut.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16<a name="PB_16_105720_9497"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='16',FILE='C:\JMS\C900805\11-10911-2\task4640480\10911-2-bg.htm',USER='C900805',CD='Apr 26 23:39 2011' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXECUTIVE OFFICER AND DIRECTOR COMPENSATION</font></b><a name="ExecutiveOfficerAndDirectorCompen_105135"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Summary Compensation Table</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table shows the compensation paid or accrued during the last two fiscal years ended December&nbsp;31, 2009 and 2010 to (1)&nbsp;our President and Chief Executive Officer, (2)&nbsp;our Executive Vice President, Finance, Chief Financial Officer and Chief Operating Officer, and (3)&nbsp;our next most highly compensated executive officer, other than our President and Chief Executive Officer and our Executive Vice President, Finance, Chief Financial Officer and Chief Operating Officer, who earned more than $100,000 during the year ended December&nbsp;31, 2010.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="25%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Name&nbsp;and&nbsp;Principal&nbsp;Position</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="7%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:7.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Year</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="7%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:7.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Salary<br>   ($)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Bonus<br>   ($)(1)</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="7%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:7.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Stock<br>   Awards<br>   ($)(2)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="8%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Option<br>   Awards<br>   ($)(3)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">All<br>   Other<br>   Compensation<br>   ($)(4)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="8%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Total<br>   ($)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="25%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Spiro Rombotis</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:7.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2010</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">476,100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">59,500</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">92,250</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32,506</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">660,356</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="25%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President and Chief Executive Officer</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:7.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2009</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">460,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">138,000</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32,188</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">630,188</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Paul McBarron(5)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" style="padding:0in 0in 0in 0in;width:7.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2010</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" style="padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">289,768</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36,350</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" style="padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">92,250</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17,732</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">436,100</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="25%" valign="bottom" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive Vice President, Finance, Chief Operating Officer, Chief   Financial Officer, and Secretary</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" style="padding:0in 0in 0in 0in;width:7.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2009</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" style="padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">288,297</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">86,489</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" style="padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17,903</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">392,689</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="25%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Judy Chiao, MD</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:7.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2010</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">312,570</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75,000</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">76,875</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19,624</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">484,069</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="25%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice President, Clinical Development and Regulatory Affairs</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:7.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2009</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">302,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">72,480</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:7.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20,552</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">395,032</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Bonuses earned in 2009 were paid during fiscal year 2010 and were not accrued in the Company&#146;s Financial Statements. Bonuses earned in 2010 were paid during fiscal year 2010 and were not accrued in the Company&#146;s Financial Statements.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-20.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">This column represents the dollar amount recognized for financial statement reporting purposes for the fair value of stock awards. The fair value, a non-cash expense, was estimated using the Black-Scholes option-pricing method in accordance with ASC Topic 718. See Note 13 to our Financial Statements reported in our Form&nbsp;10-K/A for our fiscal year ended December&nbsp;31, 2009 and Note 11 to our Financial Statements reported in our Form&nbsp;10-K for our fiscal year ended December&nbsp;31, 2010 for details as to the assumptions used to determine the fair value of the stock awards and stock options. See also our discussion of stock-based compensation under &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Critical Accounting Policies and Estimates.&#148;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These amounts represent the aggregate grant date fair value for option awards for fiscal years 2009 and 2010, respectively, computed in accordance with FASB ASC Topic 718. The grant date fair value of performance awards is determined based on the probable outcome of such performance conditions as of the grant date. A discussion of the assumptions used in determining grant date fair value may be found in Note 11 to our Financial Statements, included in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2010.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Consists of the following for all executive officers: Payments for private medical and health insurance, life insurance and permanent health insurance; matching contributions made under the Company&#146;s UK Group Personal Pension Plan and the U.S. 401(k)&nbsp;Plan.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Mr.&nbsp;McBarron&#146;s compensation was translated from British pound sterling to the U.S. dollar using the exchange rate of $1.59280 as of December&nbsp;31, 2009 and $1.54679 as of December&nbsp;31, 2010.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17<a name="PB_17_104442_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='17',FILE='C:\JMS\C900675\11-10911-2\task4639922\10911-2-bi.htm',USER='c900675',CD='Apr 26 20:42 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Narrative Disclosure to Summary Compensation Table</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Compensation and Organization Development Committee of our Board of Directors makes decisions regarding the compensation of our President and Chief Executive Officer. The Compensation and Organization Development Committee is composed entirely of independent directors and meets in executive session to discuss and formulate its recommendation for the Chief Executive Officer&#146;s base salary and bonus. The Compensation and Organization Development Committee does not rely solely on any predetermined formula or a limited set of criteria in evaluating the Chief Executive Officer&#146;s performance for the year. The evaluation is based on the Chief Executive Officer&#146;s success in achieving his performance goals, which include financial, strategic and leadership objectives. The Chief Executive Officer also provides the Compensation and Organization Development Committee with a self review of his performance as part of the Company&#146;s review process.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Compensation and Organization Development Committee also approves the annual compensation (including base salary, bonus, and stock-based compensation) for our other named executive officers based on:</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">the executive&#146;s scope of responsibilities;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">an informed market assessment of competitive practices for similar roles within peer group companies;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">evaluations of performance for the year, as assessed by the Chief Executive Officer, supported by the Company&#146;s performance review process and the executive&#146;s self assessment; and</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">recommendations by our Chief Executive Officer for each named executive officer with respect to base salary, cash bonus, and stock-based compensation.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Compensation and Organization Development Committee is authorized to engage and retain independent third party compensation and legal advisors to obtain advice and assistance on all matters related to executive compensation and benefit plans.&#160; During 2008, the Compensation and Organization Development Committee selected and engaged a representative of Radford Surveys and Consulting, a business unit of AON, to be the independent compensation consultant to the Committee to assess our 2007 and 2008 executive compensation program. Using this extensive analysis, the Compensation and Organization Development Committee acted on the recommendations made to determine executive compensation and implement our compensation program structures for 2009 and 2010.&#160; Although no external compensation consultant was engaged during 2009 or 2010, the Compensation and Organization Development Committee did consult independent external compensation survey data as part of the decision making process relating to such periods.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company intends to engage periodically an external consultant to provide independent verification of market position and ensure the appropriateness of executive compensation.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No stock options were granted to our named executive officers during 2009.&#160; On December&nbsp;10, 2010, our Board of Directors, at the recommendation of the Compensation and Organization Development Committee, made stock option grants under our Amended and Restated 2006 Equity Incentive Plan to our executive officers. The stock options were granted at an exercise price of $1.59 per share, and are exercisable over a four-year period, such options vesting ratably on a monthly basis over 48 months.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">During 2009, the Company granted 221,000 stock options to employees and directors of the Company with a weighted value exercise price of $0.39 per share.&#160; During 2010, the Company granted 607,300 stock options to employees and directors of the Company with a weighted value exercise price of $1.82 per share.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We currently have employment agreements with two of our named executive officers, Spiro Rombotis, our President and Chief Executive Officer, and Paul McBarron, our Executive Vice President&#151;Finance, Chief Financial Officer, Chief Operating Officer and Secretary.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On March&nbsp;20, 2008, we entered into a three-year employment agreement with Mr.&nbsp;Spiro Rombotis, effective January&nbsp;1, 2008, which agreement was renewed on substantially the same terms, effective January&nbsp;1, 2011, for an additional three years. This agreement provides for an initial annual base salary of $490,383, which salary may be increased in the future. Mr.&nbsp;Rombotis&#146;s annual base salary was $460,000 and $476,100, respectively, for 2009 and 2010. Mr.&nbsp;Rombotis is also eligible for a yearly incentive cash bonus, based on a percentage of his then current base</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18<a name="PB_18_104640_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='18',FILE='C:\JMS\C900675\11-10911-2\task4639922\10911-2-bi.htm',USER='c900675',CD='Apr 26 20:42 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">salary, if he meets certain corporate and individual performance criteria set by the Compensation and Organization Development Committee at the beginning of each year of employment, subject to the approval of our Board of Directors. The agreement had been amended effective December&nbsp;31, 2008, to make certain payments to be made under the agreement compliant with Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, and similar regulations.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On March&nbsp;31, 2008, we entered into a three-year employment agreement with Mr.&nbsp;Paul McBarron effective January&nbsp;1, 2008, which agreement was renewed on substantially the same terms, effective January&nbsp;1, 2011, for an additional three years. This agreement provides for an initial annual base salary of &#163;192,955, which salary may be increased in the future. Mr.&nbsp;McBarron&#146;s base salary was &#163;181,000 and &#163;187,278 for 2009 and 2010, respectively. Mr.&nbsp;McBarron is also eligible for a yearly incentive cash bonus, based on a percentage of his then current base salary, if he meets certain corporate and individual performance criteria set by the Compensation and Organization Development Committee at the beginning of each year of employment, subject to the approval of our Board of Directors.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Outstanding Equity Awards At Fiscal Year-End</font></b></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table shows grants of stock options and grants of unvested stock or unvested stock units outstanding on the last day of the fiscal year ended December&nbsp;31, 2010, including non-performance based awards, to each of the executive officers named in the Summary Compensation Table. The Company does not have any unearned equity incentive awards.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="23%" valign="bottom" style="padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="47%" colspan="8" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:47.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Option&nbsp;Awards</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="24%" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:24.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Stock&nbsp;Awards</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Name</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number&nbsp;of<br>   Securities<br>   Underlying<br>   Unexercised<br>   Options<br>   #<br>   Exercisable</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number&nbsp;of<br>   Securities<br>   Underlying<br>   Unexercised<br>   Options<br>   #<br>   Unexercisable</font></b></p>    </td>
<td width="3%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:3.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" colspan="2" valign="bottom" style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Option<br>   Exercise<br>   Price<br>   ($)</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Option<br>   Expiration<br>   Date</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number&nbsp;of<br>   Shares&nbsp;or<br>   Units&nbsp;of<br>   Stock&nbsp;That<br>   Have&nbsp;Not<br>   Vested<br>   #</font></b></p>    </td>
<td width="3%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:3.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Market&nbsp;Value<br>   of&nbsp;Shares&nbsp;or<br>   Units&nbsp;of&nbsp;Stock<br>   That&nbsp;Have&nbsp;Not<br>   Vested(1)<br>   $</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="23%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Spiro Rombotis</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">97,834</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.40</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">06/13/2016</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">160,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.95</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/20/2016</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">150,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50,000</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.53</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/06/2017</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29,171</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">45,829</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.44</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11/18/2018</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75,000</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.59</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/10/2020</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23,954</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6)</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">35,212</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="top" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Paul McBarron</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">63,680</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.40</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">06/13/2016</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.95</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/20/2016</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25,000</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(8)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.53</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/06/2017</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">104,171</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">45,829</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(9)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.44</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11/18/2018</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75,000</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(10)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.59</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/10/2020</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" colspan="2" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23,954</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11)</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">35,212</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="black" style="background:white;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Judy Chiao</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48,967</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.40</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">06/13/2016</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">80,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.95</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/20/2016</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25,000</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.53</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/06/2017</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52,085</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22,915</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(14)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.44</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11/18/2018</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">62,500</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(15)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.59</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/10/2020</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11,977</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(16)</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17,606</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The market value of the shares is determined by multiplying the number of shares by $1.47, the closing price of our common stock on the NASDAQ Global Market on December&nbsp;31, 2010, the last day of our fiscal year.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19<a name="PB_19_105018_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='19',FILE='C:\JMS\C900675\11-10911-2\task4639922\10911-2-bi.htm',USER='c900675',CD='Apr 26 20:42 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on December&nbsp;21, 2006, and are exercisable over a four-year period with one-fourth (1/4) of the options granted vesting on December&nbsp;21, 2007, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 36&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on December&nbsp;6, 2007, and are exercisable over a four-year period with one-fourth (1/4) of the options granted vesting on December&nbsp;6, 2008, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 36&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on November&nbsp;18, 2008, and vest over a three-year period, with one-third (1/3) of the options granted vesting on November&nbsp;18, 2009, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 24&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on December&nbsp;10, 2010, and vest over a four-year period, such options vesting ratably on a monthly basis over 48&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on December&nbsp;10, 2010, and vest over a four-year period, such options vesting ratably on a monthly basis over 48&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on December&nbsp;21, 2006, and are exercisable over a four-year period with one-fourth (1/4) of the options granted vesting on December&nbsp;21, 2007, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 36&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(8)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on December&nbsp;6, 2007, and are exercisable over a four-year period with one-fourth (1/4) of the options granted vesting on December&nbsp;6, 2008, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 36&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(9)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on November&nbsp;18, 2008, and vest over a three-year period, with one-third (1/3) of the options granted vesting on November&nbsp;18, 2009, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 24&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(10)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on December&nbsp;10, 2010, and vest over a four-year period, such options vesting ratably on a monthly basis over 48&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These shares of common stock represent restricted stock and are subject to forfeiture; the restrictions shall lapse over a four-year period, as follows: the restrictions with respect to one-fourth (1/4) of the restricted stock granted shall lapse on November&nbsp;18, 2009, the first anniversary of the grant date, and the restrictions with respect to the balance of the restricted stock granted shall lapse ratably on a monthly basis over the following 36&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on December&nbsp;21, 2006, and are exercisable over a four-year period with one-fourth (1/4) of the options granted vesting on December&nbsp;21, 2007, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 36&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on December&nbsp;6, 2007, and are exercisable over a four-year period with one-fourth (1/4) of the options granted vesting on December&nbsp;6, 2008, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 36&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(14)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on November&nbsp;18, 2008, and vest over a three-year period, with one-third (1/3) of the options granted vesting on November&nbsp;18, 2009, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 24&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(15)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These options were granted on December&nbsp;10, 2010, and vest over a four-year period, such options vesting ratably on a monthly basis over 48&nbsp;months.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(16)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The restricted stock units were granted on November&nbsp;18, 2008, and vest over a four-year period, with one-fourth (1/4) of the restricted stock units granted vesting on November&nbsp;18, 2009, the first anniversary of the grant date, and the balance of the restricted stock units granted vesting ratably on a monthly basis over the following 36&nbsp;months.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20<a name="PB_20_105038_2897"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='20',FILE='C:\JMS\C900675\11-10911-2\task4639922\10911-2-bi.htm',USER='c900675',CD='Apr 26 20:42 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Nonqualified Deferred Compensation</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We do not have any non-qualified deferred compensation plans.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Potential Payments Upon Termination or Change-in-Control</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have entered into agreements that require us to make payments and/or provide benefits to certain of our executive officers in the event of a termination of employment or change-in-control. </font><font size="2" style="font-size:10.0pt;">Our Amended and Restated 2006 Equity Incentive Plan already provides for payments to named executive officers in connection with a termination or a change-in-control of the Company.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following summarizes the potential payments to each named executive officer for which we have entered into such an agreement, assuming that one of the events identified below occurs. The discussion assumes that the event occurred on December&nbsp;31, 2010, the last business day of our fiscal year, at which time the closing price of our common stock as listed on the NASDAQ Global Market was $1.47 per share. Our change-in-control arrangements with our executive officers are currently being reviewed and assessed by our Compensation and Organization Development Committee, in consultation with our Board of Directors. The reviewing process is on-going and has not yet been finalized.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Spiro Rombotis, President and Chief Executive Officer</font></i></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On March&nbsp;20, 2008, we entered into a three-year employment agreement with Mr.&nbsp;Spiro Rombotis, effective January&nbsp;1, 2008, which agreement was renewed on substantially the same terms, effective January&nbsp;1, 2011, for an additional three years. Mr.&nbsp;Rombotis&#146;s current base salary is $490,383, which may be increased in the future. Mr.&nbsp;Rombotis is also eligible for a yearly incentive cash bonus, based on a percentage of his then current base salary, if he meets certain corporate and individual performance criteria set by the Compensation and Organization Development Committee at the beginning of each year of employment, subject to the approval of our Board of Directors. The agreement also provides for reimbursement of reasonable and necessary expenses incurred by Mr.&nbsp;Rombotis in connection with the performance of his services. In addition, Mr.&nbsp;Rombotis is entitled to certain employment benefits.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The agreement also provides for certain severance arrangements for Mr.&nbsp;Rombotis. In the event that Mr.&nbsp;Rombotis&#146;s employment is terminated &#147;without cause,&#148; other than termination for a &#147;change of control&#148; (each as defined in the Agreement), we will be required to pay Mr.&nbsp;Rombotis (i)&nbsp;all accrued but unpaid compensation up to the time of such termination; (ii)&nbsp;for a period of twelve months following such termination, severance payments in the form of continuation of his base salary as in effect immediately prior to such termination (the &#147;Severance Payments&#148;), including coverage of his medical care and life insurance pursuant to COBRA, on the same terms as applicable to other executive employees, unless Mr.&nbsp;Rombotis obtains substitute coverage; and (iii)&nbsp;a period of six months in which to exercise all vested options held by Mr.&nbsp;Rombotis. In the event that Mr.&nbsp;Rombotis&#146;s employment is terminated within six months following a &#147;change in control&#148; event, Mr.&nbsp;Rombotis will be entitled to (i)&nbsp;all accrued but unpaid compensation up to the time of such termination; (ii)&nbsp;Severance Payments for a period of 24 months; (iii)&nbsp;out-of-pocket expenses reasonably incurred by Mr.&nbsp;Rombotis in connection with his and his family&#146;s relocation to London; and (iv)&nbsp;18 months&#146; accelerated vesting of any options held by him. In the event of termination due to his death or disability, we will pay Mr.&nbsp;Rombotis (or his estate, as the case may be) (i)&nbsp;all accrued but unpaid compensation up to the time of such termination; (ii)&nbsp;Severance Payments for a period of twelve months; and (iii)&nbsp;he will be entitled to a period of twelve months in which all of his vested options can be exercised.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition</font><font size="2" style="font-size:10.0pt;">, M</font><font size="2" style="font-size:10.0pt;">r.</font><font size="2" style="font-size:10.0pt;">&nbsp;</font><font size="2" style="font-size:10.0pt;">Rombotis also agreed to certain confidentiality and assignment of inventions obligations and will be subject to certain non-competition obligations for a period of one year following termination of his employment.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Rombotis&#146;s employment agreement was amended effective December&nbsp;31, 2008, to make certain payments to be made under the agreement compliant with Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, and then amended again effective January&nbsp;1, 2011 to extend its term for an additional three years.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21<a name="PB_21_105106_3020"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='21',FILE='C:\JMS\C900675\11-10911-2\task4639922\10911-2-bi.htm',USER='c900675',CD='Apr 26 20:42 2011' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Paul McBarron, Executive Vice President&#151;Finance, Chief Financial Officer, Chief Operating Officer and Secretary</font></i></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On March&nbsp;31, 2008, we entered into a three-year employment agreement with Mr.&nbsp;Paul McBarron effective January&nbsp;1, 2008, which agreement was renewed on substantially similar terms, effective January&nbsp;1, 2011, for an additional three years. Mr.&nbsp;McBarron&#146;s current base salary is &#163;192,955, which may be increased in the future. Mr.&nbsp;McBarron is also eligible for a yearly incentive cash bonus, based on a percentage of his then current base salary, if he meets certain corporate and individual performance criteria set by the Compensation and Organization Development Committee at the beginning of each year of employment, subject to the approval of our Board of Directors. The agreement also provides for reimbursement of reasonable and necessary expenses incurred by Mr.&nbsp;McBarron in connection with the performance of his services. In addition, Mr.&nbsp;McBarron is entitled to certain employment benefits.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:21.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The agreement also provides for certain severance arrangements for Mr.&nbsp;McBarron. In the event that Mr.&nbsp;McBarron&#146;s employment is terminated &#147;without cause,&#148; other than termination for a &#147;change of control&#148; (each as defined in the Agreement), we will be required to pay Mr.&nbsp;McBarron (i)&nbsp;all accrued but unpaid compensation up to the time of such termination; (ii)&nbsp;Severance Payments for a period of twelve months following such termination; and (iii)&nbsp;a period of six months in which to exercise all vested options held by Mr.&nbsp;McBarron. In the event that Mr.&nbsp;McBarron&#146;s employment is terminated within six months following a &#147;change in control&#148; event, Mr.&nbsp;McBarron will be entitled (i)&nbsp;all accrued but unpaid compensation up to the time of such termination; (ii)&nbsp;Severance Payments for a period of 12 months; and (iii)&nbsp;18 months&#146; accelerated vesting of any options held by him and, in the event of termination due to his death or disability, we will pay Mr.&nbsp;McBarron (or his estate, as the case may be) (i)&nbsp;all accrued but unpaid compensation up to the time of such termination; (ii)&nbsp;Severance Payments for a period of twelve months; and (iii)&nbsp;he will be entitled to a period of twelve months in which all of his vested options can be exercised.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition</font><font size="2" style="font-size:10.0pt;">, M</font><font size="2" style="font-size:10.0pt;">r.</font><font size="2" style="font-size:10.0pt;">&nbsp;McBarron</font><font size="2" style="font-size:10.0pt;"> also agreed to certain confidentiality and assignment of inventions obligations and will be subject to certain non-competition obligations for a period of one year following termination of his employment.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Dr.&nbsp;Judy Chiao, Vice President, Clinical Development and Regulatory Affairs</font></i></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On December&nbsp;10, 2010, we entered into a Change in Control Agreement, or the CIC Agreement, with Dr.&nbsp;Chiao.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In the event of a Change in Control (as defined below) of the Company, and Dr.&nbsp;Chiao&#146;s employment with the continuing or surviving company, or the Controlling Company, is terminated (including if Dr.&nbsp;Chiao voluntarily terminates her employment for Good Reason, as defined below) at any time within six months following the effective date of a Change in Control, unless such termination is For Cause, death, disability or Dr.&nbsp;Chiao voluntarily leaves without Good Reason (as each such term is defined below), Dr.&nbsp;Chiao will be entitled to receive the following benefits from the Controlling Company in lieu of any further salary and bonus payments to Dr.&nbsp;Chiao for certain periods subsequent to the date of termination in consideration for Dr.&nbsp;Chiao&#146;s execution and delivery of a general release in favor of the Controlling Company:&#160; (i)&nbsp;payment by the Controlling Company of a lump sum severance payment equal to Dr.&nbsp;Chiao&#146;s annual salary for a period of twelve months from the date of termination; (ii)&nbsp;payment by the Controlling Company of all unpaid, accrued vacation through the date of termination; (iii)&nbsp;all options to purchase shares of the Company&#146;s Common Stock held by Dr.&nbsp;Chiao shall be vested and exercisable for twelve months following the effective date of the Change in Control; and (iv)&nbsp;the Controlling Company shall arrange coverage for Dr.&nbsp;Chiao and her dependents, as the case may be, under medical care and life insurance benefit plans substantially similar to those which Dr.&nbsp;Chiao and her dependents were entitled immediately prior to the effective date of the Change in Control for a period of up to twelve months after the effective date of the Change in Control, subject to certain exceptions as set forth in more detail in the CIC Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Under the terms of the CIC Agreement, a &#147;Change in Control&#148; shall be deemed to have taken place in the event of: (i)&nbsp;any consolidation or merger of the Company is consummated in which Company is not the continuing or surviving corporation or pursuant to any transaction in which shares of the Company&#146;s capital stock are converted into cash, securities or other property, or any sale, lease, exchange or other transfer in one transaction or a series of transactions contemplated or arranged by any party as a single plan of all or substantially all of the assets of the Company, or the approval of a plan of complete liquidation or dissolution of the Company adopted by the stockholders of the Company; (ii)&nbsp;any person (as such term is used in Sections&nbsp;13(d<u>)</u>&nbsp;and 14(d)(2)&nbsp;of the Exchange</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22<a name="PB_22_102443_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='22',FILE='C:\JMS\C900675\11-10911-2\task4639922\10911-2-bk.htm',USER='c900675',CD='Apr 26 20:44 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Act, shall, after the date of the CIC Agreement, become the beneficial owner (as defined in Rules&nbsp;13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of securities of the Company representing 35% or more of the voting power of all then outstanding securities of the Company having the right under ordinary circumstances to vote in an election of the board of directors; or (iii)&nbsp;individuals who, at the date of the CIC Agreement, constitute the entire Board and any new directors whose election by the Board, or whose nomination for election by the Company&#146;s stockholders, shall have been approved by a vote of at least a majority of the directors then in office who either were directors as of such date or whose election or nomination for election shall have been so approved shall cease for any reason to constitute a majority of the members of the Board.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;Chiao&#146;s employment shall have been terminated &#147;For Cause&#148; if the Controlling Company shall have terminated Dr.&nbsp;Chiao as a result of: (A)&nbsp;improper conduct, consisting of any willful act or omission with the intent of obtaining, to the material detriment of the Controlling Company, any benefit to which Dr.&nbsp;Chiao would not otherwise be entitled; (B)&nbsp;gross negligence, consisting of wanton and reckless acts or omissions in the performance of Dr.&nbsp;Chiao&#146;s duties to the material detriment of the Controlling Company; (C)&nbsp;addiction to drugs or chronic alcoholism; or (D)&nbsp;any conviction of, or plea of <i>nolo contendere </i>to, a crime (other than a traffic violation) under the laws of the United States or any political subdivision thereof, subject to certain requirements, as set forth in more detail in the CIC Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;Chiao shall be deemed to have terminated her employment for &#147;Good Reason&#148; if the Controlling Company (A)&nbsp;materially reduces Dr.&nbsp;Chiao&#146;s duties, responsibilities or authority commensurate with his or her position immediately prior to the effective date of the Change in Control; (B)&nbsp;reduces Dr.&nbsp;Chiao&#146;s base salary in effect immediately prior to the effective date of the Change of Control; (C)&nbsp;requires Dr.&nbsp;Chiao to relocate to another office more than 50 miles of her office location immediately prior to the effective date of the Change of Control, subject to certain exceptions, as more fully set forth in detail in the CIC Agreement; or (D)&nbsp;fails to offer Dr.&nbsp;Chiao all material benefits offered to all other employees of the Controlling Company, and the Controlling Company fails to correct or cure the acts giving rise to the termination of Dr.&nbsp;Chiao&#146;s employment for &#147;Good Reason,&#148; after receipt of Dr.&nbsp;Chiao&#146;s notice of such acts.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Potential payments to each named executive officer under</font></i><i><font size="2" style="font-size:10.0pt;font-style:italic;"> our Amended and Restated 2006 Equity Incentive Plan in connection with a termination or a change-in-control of the Company</font></i></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:21.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following summarizes the potential payments to each named executive officer under</font><font size="2" style="font-size:10.0pt;"> our Amended and Restated 2006 Equity Incentive Plan in connection with a termination or a change-in-control of the Company.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Termination</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Termination For Cause</font></i><font size="2" style="font-size:10.0pt;"> - If an award recipient&#146;s service relationship with the Company terminates for &#147;cause&#148; (as defined in the Amended and Restated 2006 Equity Incentive Plan, or the 2006 Plan), then any unexercised award shall terminate immediately upon his or her termination of service.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Terminatio</font></i><font size="2" style="font-size:10.0pt;">n<i> Without Cause</i> - If an award recipient&#146;s service relationship with the Company terminates for any reason other than for &#147;cause&#148; (excluding death or disability), then the recipient generally may exercise the award, to the extent vested, within 30 days of such termination to the extent that the award is vested on the date of termination (but in no event later than the expiration of the term of the award as set forth in the award agreement). If the recipient dies within three months following such a termination, the award generally may be exercised, to the extent vested, within 180 days&#146; of the recipient&#146;s death.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Death</font></i><font size="2" style="font-size:10.0pt;"> - If an award recipient&#146;s service relationship with the Company terminates due to his or her death, the award recipient&#146;s personal representative, estate, or the person who acquires the right to exercise the award by bequest or inheritance, as the case may be, generally may exercise the award, to the extent the award was vested on the date of termination, within one year from the date of the recipient&#146;s death.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Disability</font></i><font size="2" style="font-size:10.0pt;"> - If an award recipient&#146;s service relationship with the Company terminates due to his or her disability, the recipient, the recipient&#146;s personal representative, estate, or the person who acquires the right to exercise the award by bequest or inheritance, as the case may be, generally may exercise the award, to the extent the award was vested on the date of termination, within one year from the date of the recipient&#146;s termination, or if the recipient dies during such one-year period, within the later of one year from the date of the recipient&#146;s termination and 180 days from the recipient&#146;s death. In no event may an award be exercised later than the expiration of the term of the award as set forth in the award agreement.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23<a name="PB_23_102524_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='23',FILE='C:\JMS\C900675\11-10911-2\task4639922\10911-2-bk.htm',USER='c900675',CD='Apr 26 20:44 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Change in Control</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the terms of the Amended and Restated 2006 Equity Incentive Plan, in the event of a change in control (as defined in the 2006 Plan), all outstanding options, SARs and other awards granted under the 2006 Plan will be either:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">assumed by the successor corporation or a parent or subsidiary of the successor corporation; or</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">substituted with an equivalent award by the successor corporation or a parent or subsidiary of the successor corporation.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">However, in the event that the successor corporation refuses to assume or substitute an award:</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">awards consisting of options, SARs and rights to purchase restricted stock will become fully vested and immediately exercisable, including awards that would not otherwise have become vested or exercisable; and</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">all other awards will become fully earned and eligible to receive a payout.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the purposes of the Amended and Restated 2006 Equity Incentive Plan, a participant&#146;s award will be considered assumed if, following the change in control, the assumed award confers, for each share of the Company&#146;s Common Stock subject to the award immediately prior to the change in control, the right to receive the consideration (whether stock, cash, or other securities or property) received in the change in control for each share of Common Stock held on the effective date of the transaction; provided, however, that if the consideration received in the change of control is not solely common stock of the successor corporation or its parent, the committee administering the plan may, with the consent of the successor corporation, provide for the consideration per share to be received upon the exercise of the award, to be solely common stock of the successor corporation or its parent equal in fair market value to the per share consideration received by holders of the Company&#146;s Common Stock in the change of control.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Under the 2006 Plan, a change of control is the occurrence of one of the following events:</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">a person, partnership, joint venture, corporation or other entity, or two or more of any of the foregoing acting as a group (or any &#147;person&#148; within the meaning of Sections 13(d)(3)&nbsp;and 14(d)&nbsp;of the Exchange Act), other than the Company, a Subsidiary, or an employee benefit plan (or related trust) of the Company or a Subsidiary, become(s)&nbsp;the &#147;beneficial owner&#148; (as defined in Rule&nbsp;13d-3 under the Exchange Act) of 30% or more of the then-outstanding voting stock of the Company;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">during any period of two consecutive years, individuals who at the beginning of such period constitute the Board of Directors (together with any new director whose election by the Board of Directors or whose nomination for election by the Company&#146;s stockholders, was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of such period or whose election or nomination for election was previously so approved) cease for any reason to constitute a majority of the directors then in office;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">all or substantially all of the business of the Company is disposed of pursuant to a merger, consolidation or other transaction in which the Company is not the surviving corporation or the Company combines with another Company and is the surviving corporation (unless the stockholders of the Company immediately following such merger, consolidation, combination, or other transaction beneficially own, directly or indirectly, more than 50% of the aggregate voting stock or other ownership interests of (x)&nbsp;the entity or entities, if any, that succeed to the business of the Company or (y)&nbsp;the combined company);</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">the Company is a party to a merger, consolidation, sale of assets or other reorganization, or a proxy contest, as a consequence of which the Board of Directors in office immediately prior to such transaction or event constitutes less than a majority of the Board of Directors thereafter; or</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">the stockholders of the Company approve a sale of all or substantially all of the assets of the Company or a liquidation or dissolution of the Company.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24<a name="PB_24_102709_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='24',FILE='C:\JMS\C900675\11-10911-2\task4639922\10911-2-bk.htm',USER='c900675',CD='Apr 26 20:44 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Director Compensation</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table shows the total compensation paid or accrued during the fiscal year ended December&nbsp;31, 2010 to each of our non-employee directors:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="46%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Name</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Fees&nbsp;Earned&nbsp;or<br>   Paid&nbsp;in&nbsp;Cash<br>   ($)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Option<br>   Awards<br>   ($)(1)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Total<br>   ($)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:46.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">David U&#146;Prichard, Ph.D.</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">66,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">89,500</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">155,500</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sir John Banham</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37,000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,750</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">81,750</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:46.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nicholas Bacopoulos, Ph.D.</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,750</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73,750</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher S. Henney, Ph.D., D.Sc.</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">56,000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">89,500</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">145,500</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:46.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel K. Spiegelman</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">43,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">62,650</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6)</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">105,650</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These amounts represent the grant date fair value of stock awards granted to each director in 2010 computed in accordance with FASB ASC Topic 718. The grant date fair value of performance awards is determined based on the probable outcome of such performance conditions as of the grant date. A discussion of the assumptions used in determining grant date fair value may be found in Note 11 to our Financial Statements, included in our Annual Report on Form&nbsp;10-K for the year ended 2010, as amended<b>.</b></font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Fair value of the options granted on March&nbsp;29, 2010 was $1.79 per share. 250,000 options remain outstanding as of December&nbsp;31, 2010.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Fair value of the options granted on March&nbsp;29, 2010 was $1.79 per share. 125,000 options remain outstanding as of December&nbsp;31, 2010.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Fair value of the options granted on March&nbsp;29, 2010 was $1.79 per share. 75,000 options remain outstanding as of December&nbsp;31, 2010.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Fair value of the options granted on March&nbsp;29, 2010 was $1.79 per share. 271,000 options remain outstanding as of December&nbsp;31, 2010.</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Fair value of the options granted on March&nbsp;29, 2010 was $1.79 per share. 156,500 options remain outstanding as of December&nbsp;31, 2010</font></p>
<p style="margin:0in 0in .0001pt 24.0pt;text-indent:-24.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Director Compensation Program</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Since the consummation of our reverse merger with Xcyte Therapies,&nbsp;Inc. in March&nbsp;2006, our non-employee directors have been compensated for their services as members of the Board of Directors and any committee of the Board of Directors, each in the amount of an annual cash retainer of $20,000. The Chairmen of the Compensation and Organization Development Committee and the Nominating and Corporate Governance Committee have each been paid an additional annual cash retainer of $7,000. The Chairman of the Audit Committee has also been paid an additional annual cash retainer of $10,000. The Chairman of our Board of Directors has received a $54,000 annual cash retainer for his services, and the Vice Chairman has received a $34,000 annual cash retainer for his services.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition to the annual cash retainers, the non-employee members of our Board of Directors have received $2,000 for each Board of Directors meeting attended in person and $1,000 for each Board of Directors meeting attended telephonically. The non-employee directors have also been reimbursed for certain customary business expenses in connection with attending Board of Directors and committee meetings.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition to the cash compensation outlined above, the Chairman and Vice Chairman of the Board of Directors have each received annually an option to purchase 50,000 shares of our Common Stock. Each of the other non-employee directors has received annually an option to purchase 25,000 shares of our Common Stock, and the Chairman of the Audit Committee has received annually an option to purchase 10,000 shares of our Common Stock.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On April&nbsp;19, 2011, our Board of Directors unanimously approved, at the recommendation of the Compensation and Organization Committee of our Board of Directors, the adoption of a new Director Compensation Program</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25<a name="PB_25_103003_2897"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='25',FILE='C:\JMS\C900675\11-10911-2\task4639922\10911-2-bk.htm',USER='c900675',CD='Apr 26 20:44 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">pursuant to which the compensation of our non-employee directors will be changed to an annual retainer-based system.&nbsp; Effective as of July&nbsp;1, 2011, the non-employee members of our Board of Directors will be paid a fixed annual fee, payable on a quarterly basis, in arrears, on the first day of each quarter, as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="53%" style="border-collapse:collapse;margin-left:1.0in;width:53.34%;">
<tr>
<td width="70%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.94%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chairman&nbsp;of&nbsp;the&nbsp;Board</font></p>    </td>
<td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="20%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">85,000</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.9%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.94%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice Chairman of the Board</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="20%" valign="bottom" style="padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">65,000</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.9%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.94%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chairman - Audit Committee</font></p>    </td>
<td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="20%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">55,000</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.9%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.94%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other Non-Management Board Members</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="20%" valign="bottom" style="padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">45,000</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.9%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, the non-employee members of our Board of Directors would also be entitled to receive stock options on an annual basis on the date of the Company&#146;s annual meeting as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="53%" style="border-collapse:collapse;margin-left:1.0in;width:53.32%;">
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.94%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chairman and Vice Chairman</font></p>    </td>
<td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="22%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.48%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50,000</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.9%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.94%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chairman of the Audit Committee</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="22%" valign="bottom" style="padding:0in 0in 0in 0in;width:22.48%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">35,000</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.9%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.94%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other Board Members</font></p>    </td>
<td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="22%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.48%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25,000</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.9%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The non-employee directors will also be reimbursed for customary business expenses in connection with attending Board of Directors and committee meetings.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26<a name="PB_26_103327_3020"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='26',FILE='C:\JMS\C900675\11-10911-2\task4639922\10911-2-bk.htm',USER='c900675',CD='Apr 26 20:44 2011' -->


<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">REPORT OF AUDIT COMMITTEE</font></b><a name="ReportOfAuditCommittee_104426"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee of the Board of Directors, which consists entirely of directors who meet the independence and experience requirements of NASDAQ Global Market, has furnished the following report:</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee assists the Board of Directors in overseeing and monitoring the integrity of our financial reporting process, compliance with legal and regulatory requirements and the quality of internal and external audit processes. The Audit Committee&#146;s role and responsibilities are set forth in our charter adopted by the Board of Directors. The Audit Committee reviews and reassesses our charter annually and recommends any changes to the Board of Directors for approval.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In fiscal 2010, the Audit Committee met with management to consider the adequacy of the Company&#146;s internal controls and the objectivity of its financial reporting. The Audit Committee discussed these matters with the Company&#146;s independent registered public accounting firm and with appropriate Company financial personnel.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee is responsible for overseeing our overall financial reporting process, and for the appointment, retention, and oversight of the work of Ernst&nbsp;&amp; Young LLP (UK), or E&amp;Y UK.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee reviewed and discussed the audited financial statements for the fiscal year ended December&nbsp;31,&nbsp;2010 with management and E&amp;Y UK, our independent registered public accounting firm.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee discussed with E&amp;Y UK the matters required to be discussed by Statement on Auditing Standards No.&nbsp;61, as amended, as adopted by the Public Company Accounting Oversight Board in Rule&nbsp;3200T, relating to the conduct of the audit.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee received written disclosures and the letter from E&amp;Y UK regarding its independence as required by applicable requirements of the Public Company Accounting Oversight Board regarding E&amp;Y UK&#146;s communications with the Audit Committee and the Audit Committee further discussed with E&amp;Y UK their independence. The Audit Committee also considered the status of pending litigation, taxation matters and other areas of oversight relating to the financial reporting and audit process that the Audit Committee determined appropriate.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Based on the Audit Committee&#146;s review of the audited consolidated financial statements and discussions with management and E&amp;Y UK, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in our Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31,&nbsp;2010 for filing with the SEC.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Members of the Audit Committee</font></u></b></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel   K. Spiegelman (Chairman)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sir   John Banham</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;Christopher&nbsp;Henney</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27<a name="PB_27_112532_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='27',FILE='C:\JMS\kyang\11-10911-2\task4641303\10911-2-bm.htm',USER='Kyangb',CD='Apr 26 17:22 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SECTION&nbsp;16(a)&nbsp;BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</font></b><a name="Section16abeneficialOwnershipRepo_104616"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;16(a)&nbsp;of the Securities Exchange Act of 1934, as amended, requires our officers and directors, and persons who own more than 10% of a registered class of our equity securities to file reports of ownership and changes in ownership with the SEC. These persons are required by regulation to furnish us with copies of all Section&nbsp;16(a)&nbsp;reports that they file. Based on our review of the copies of these reports received by us, or written representations from the reporting persons that no other reports were required, we believe that, during fiscal year 2010, all reports to be filed pursuant to Section&nbsp;16(a)&nbsp;of the Exchange Act were filed on a timely basis, except that two reports, covering an aggregate of two transactions, were filed late by Austin W. Marxe and David M. Greenhouse, filing jointly, and an initial report of ownership was filed late by Austin W. Marxe and David M. Greenhouse, filing jointly.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28<a name="PB_28_112532_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='28',FILE='C:\JMS\kyang\11-10911-2\task4641303\10911-2-bm.htm',USER='Kyangb',CD='Apr 26 17:22 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</font></b><a name="CertainRelationshipsAndRelatedPer_104658"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our Audit Committee reviews and approves in advance all related-party transactions. There have been no transactions during our last two fiscal years with our directors and officers and beneficial owners of more than 5% of our voting securities and their affiliates.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29<a name="PB_29_112532_2897"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='29',FILE='C:\JMS\kyang\11-10911-2\task4641303\10911-2-bm.htm',USER='Kyangb',CD='Apr 26 17:22 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PROPOSALS TO BE VOTED UPON BY STOCKHOLDERS</font></b><a name="ProposalsToBeVotedUponByStockhold_104730"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PROPOSAL 1:&#160; ELECTION OF CLASS&nbsp;2 DIRECTORS<a name="Proposal1ElectionOfClass2Director_104758"></a></font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BY HOLDERS OF COMMON STOCK</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Background</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Under our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, as amended, the number of directors is fixed from time to time by the Board of Directors. We have a staggered Board of Directors comprised of three classes, and each director serves until the annual meeting in which his term expires. Spiro Rombotis and David C. U&#146;Prichard Ph.D. are Class&nbsp;2 directors, the term of which class expires at the 2011 annual meeting, and, if elected, would serve until our 2014 annual meeting.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors has voted to nominate Spiro Rombotis and David C. U&#146;Prichard Ph.D. for re-election at the 2011 annual meeting to serve as Class&nbsp;2 directors until the 2014 annual meeting of stockholders and until their respective successors have been elected and qualified.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Unless authority to vote for either of the nominees named above is withheld, the shares represented by the enclosed proxy will be voted FOR the election as directors of Spiro Rombotis and David C. U&#146;Prichard Ph.D. In the event that any nominee shall become unable or unwilling to serve, the shares represented by the enclosed proxy will be voted for the election of such other person as the Board of Directors may recommend in his place. The Board of Directors has no reason to believe that any nominee will be unable or unwilling to serve.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Unless authority to vote for either of the nominees named above is withheld, the shares of Common Stock represented by the enclosed proxy will be voted FOR the election as directors of Spiro Rombotis and David C. U&#146;Prichard Ph.D.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Required Vote</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A plurality of the votes cast at the annual meeting by the holders of our Common Stock is required to elect each nominee as a director.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Recommendation</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">THE BOARD OF DIRECTORS RECOMMENDS THE ELECTION BY HOLDERS OF COMMON STOCK OF SPIRO ROMBOTIS AND DAVID C. U&#146;PRICHARD PH.D.&#160; AS CLASS&nbsp;2 DIRECTORS, AND PROXIES SOLICITED BY THE BOARD OF DIRECTORS WILL BE VOTED IN FAVOR THEREOF UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY CARD.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30<a name="PB_30_112532_3020"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='30',FILE='C:\JMS\kyang\11-10911-2\task4641303\10911-2-bm.htm',USER='Kyangb',CD='Apr 26 17:22 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PROPOSAL 2:&#160; RATIFICATION OF APPOINTMENT<a name="Proposal2RatificationOfAppointmen_104938"></a></font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BY HOLDERS OF COMMON STOCK</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee has appointed Ernst&nbsp;&amp; Young (US) LLP, or E&amp;Y US, independent registered public accounting firm, to audit our consolidated financial statements for the fiscal year ending December&nbsp;31, 2011.&#160; The Board of Directors proposes that the stockholders ratify this appointment. We expect that representatives of E&amp;Y US will be present at the annual meeting via conference call, will be able to make a statement if they so desire, and will be available to respond to appropriate questions.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effective April&nbsp;19, 2011, Ernst&nbsp;&amp; Young LLP (UK), or E&amp;Y UK, who audited our consolidated financial statements for the fiscal year ended December&nbsp;31, 2010, resigned as our independent registered public accounting firm, which resignation was accepted by our Board of Directors as of the same date.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">E&amp;Y UK&#146;s audit reports on our financial statements for the years ended December&nbsp;31, 2010 and 2009 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">During our two most recent fiscal years and any subsequent interim period prior to the date of this Proxy Statement, there were no disagreements with E&amp;Y UK on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of E&amp;Y UK, would have caused it to make reference to the subject matter thereof in connection with its report.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">During our two most recent fiscal years and any subsequent interim period prior to the date of this Proxy Statement, none of the events described in paragraphs (A)&nbsp;through (D)&nbsp;of Item 304(a)(1)(v)&nbsp;of Regulation S-K under the Exchange Act, occurred, except that, as disclosed in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2010 and the Annual Report on Form&nbsp;10-K/A for the year ended December&nbsp;31, 2009, E&amp;Y UK advised us that we did not have an effectively-designed control in operation over the accounting for, presentation of and disclosure of cumulative preferred stock dividends to prevent or detect on a timely basis material misstatements in the computation of net loss per share and the financial statement presentation of preferred stock dividends.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">During our two most recent fiscal years and any subsequent interim period prior to the date of this Proxy Statement, neither we nor anyone acting on our behalf consulted E&amp;Y US regarding (a)&nbsp;the application of accounting principles to a specified transaction, either completed or proposed or the type of audit opinion that might be rendered on our financial statements or (b)&nbsp;any (i)&nbsp;matter that was the subject of a disagreement with E&amp;Y UK on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreement, if not resolved to the satisfaction of E&amp;Y UK, would have caused it to make reference to the subject matter thereof in connection with its report or (ii)&nbsp;events described in paragraphs (A)&nbsp;through (D)&nbsp;of Item 304(a)(1)(v)&nbsp;of Regulation S-K under the Exchange Act.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table presents fees for professional audit services rendered by E&amp;Y for the audit of Cyclacel&#146;s annual financial statements for the years ended December&nbsp;31, 2009 and 2010, and fees billed for other services rendered by E&amp;Y during those periods.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="60%" style="border-collapse:collapse;margin-left:1.5in;width:60.0%;">
<tr>
<td width="50%" valign="bottom" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:20.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2009</font></b></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:20.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2010</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Audit fees: (1)</font></p>    </td>
<td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="18%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:18.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">417,237</font></p>    </td>
<td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="18%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:18.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">500,272</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Audit related fees:</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tax fees: (2)</font></p>    </td>
<td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">72,914</font></p>    </td>
<td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31,850</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All other fees:</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total</font></p>    </td>
<td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="18%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:18.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">490,151</font></p>    </td>
<td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="18%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:18.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">532,122</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31<a name="PB_31_112532_7748"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='31',FILE='C:\JMS\kyang\11-10911-2\task4641303\10911-2-bm.htm',USER='Kyangb',CD='Apr 26 17:22 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Audit fees represent fees of E&amp;Y for the audit of the Company&#146;s annual consolidated financial statements; reviews of the Company&#146;s quarterly results of operations and reports on Form&nbsp;10-Q; the audit of management&#146;s assessment of the effectiveness of the Company&#146;s internal control over financial reporting and the audit of internal control over financial reporting; and the services that an independent auditor would customarily provide in connection with subsidiary audits, other regulatory filings, and similar engagements for each fiscal year shown, such as attest services, consents, and assistance with review of documents filed with the SEC.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Tax fees represent tax compliance and return preparation and tax planning and advice.</font></p>
<p style="margin:0in 0in .0001pt 23.75pt;text-indent:-23.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Policy on Audit Committee Pre-Approval of Audit and Permissible Non-audit Services of Independent Auditors.&#160; </font></i><font size="2" style="font-size:10.0pt;">Consistent with SEC policies regarding auditor independence, the Audit Committee has responsibility for appointing, setting compensation, and overseeing the work of the independent auditor. In recognition of this responsibility, the Audit Committee has established a policy to pre-approve all audit and permissible non-audit services provided by the independent auditor.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prior to engagement of the independent auditor for the next year&#146;s audit, management will submit an aggregate of services expected to be rendered during that year for each of four categories of services to the Audit Committee for approval.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><b><i><font size="2" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Audit </font></i></b><font size="2" style="font-size:10.0pt;">services include audit work performed in the preparation of financial statements, as well as work that generally only the independent auditor can reasonably be expected to provide, including comfort letters, statutory audits, and attest services and consultation regarding financial accounting and/or reporting standards.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><b><i><font size="2" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Audit-Related</font></i></b><font size="2" style="font-size:10.0pt;"> services are for assurance and related services that are traditionally performed by the independent auditor, including due diligence related to mergers and acquisitions, employee benefit plan audits, and special procedures required to meet certain regulatory requirements.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><b><i><font size="2" style="font-size:10.0pt;font-style:italic;font-weight:bold;">T</font></i></b><b><i><font size="2" style="font-size:10.0pt;font-style:italic;font-weight:bold;">ax</font></i></b><font size="2" style="font-size:10.0pt;"> services include all services performed by the independent auditor&#146;s tax personnel except those services specifically related to the audit of the financial statements, and includes fees in the areas of tax compliance, tax planning, and tax advice.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><b><i><font size="2" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Other Fees</font></i></b><font size="2" style="font-size:10.0pt;"> are those associated with services not captured in the other categories. The Company generally does not request such services from the independent auditor.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prior to engagement, the Audit Committee pre-approves these services by category of service. The fees are budgeted and the Audit Committee requires the independent auditor and management to report actual fees versus the budget periodically throughout the year by category of service. During the year, circumstances may arise when it may become necessary to engage the independent auditor for additional services not contemplated in the original pre-approval. In those instances, the Audit Committee requires specific pre-approval before engaging the independent auditor.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee may delegate pre-approval authority to one or more of its members. The member to whom such authority is delegated must report, for informational purposes only, any pre-approval decisions to the Audit Committee at its next scheduled meeting.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In the event the stockholders do not ratify the appointment of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm, the Audit Committee will reconsider its appointment.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Required Vote</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The affirmative vote of a majority of the votes cast by holders of our Common Stock is required to ratify the appointment of the independent registered public accounting firm.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Recommendation</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">THE BOARD OF DIRECTORS RECOMMENDS A VOTE TO RATIFY THE APPOINTMENT OF ERNST&nbsp;&amp; YOUNG, LLP OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AND PROXIES SOLICITED BY THE BOARD OF DIRECTORS WILL BE VOTED IN FAVOR OF SUCH RATIFICATION UNLESS A STOCKHOLDER INDICATES OTHERWISE ON THE PROXY CARD.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32<a name="PB_32_112532_141"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='32',FILE='C:\JMS\kyang\11-10911-2\task4641303\10911-2-bm.htm',USER='Kyangb',CD='Apr 26 17:22 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PREFERRED DIRECTOR ELECTION PROPOSAL:</font></b><a name="PreferredDirectorElectionProposal_105258"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ELECTION OF CLASS&nbsp;1 AND 2 DIRECTORS</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BY HOLDERS OF PREFERRED STOCK</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Background</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the terms of the Company&#146;s Certificate of the Powers, Designations, Preferences and Rights of the 6% Convertible Exchangeable Preferred Stock (the &#147;<b>Certificate</b>&#148;), holders of the Preferred Stock are entitled to receive, when, as and if declared by the Board of Directors, out of the funds of the Company legally available therefor, cash dividends payable in equal quarterly installments on February&nbsp;1, May&nbsp;1, August&nbsp;1 and November&nbsp;1. The Certificate further provides that, if the Company is in arrears in an aggregate amount equal to at least six quarterly dividends (whether or not consecutive), the number of members of the Company&#146;s Board of Directors will be increased by two, effective as of the time of election of such directors, and the holders of Preferred Stock, voting separately as a class, will have the right to vote and elect such two additional directors. This right accrued to the holders of our Preferred Stock as of August&nbsp;2, 2010.&#160; Although a dividend was paid on February&nbsp;1, 2011, the Company is still in arrears in an aggregate amount equal to six quarterly dividends on the Preferred Stock.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Miller has nominated Lloyd Sems and Gregory T. Hradsky as the two additional directors. We have not received any other nominations for directors by the holders of the Preferred Stock. Pursuant to the terms of the Certificate, the Board of Directors shall determine which class of directors on the Company&#146;s classified board to appoint any individuals elected by the holders of Preferred Stock. The Board of Directors has determined that Mr.&nbsp;Sems, if elected, would be appointed to Class&nbsp;2, with a term expiring at the Company&#146;s 2014 annual meeting of stockholders, and Mr.&nbsp;Hradsky, if elected, would be appointed to Class&nbsp;1, with a term expiring at the Company&#146;s 2013 annual meeting of stockholders. If elected, Messrs.&nbsp;Sems and Hradsky would serve as directors until the earlier of (a)&nbsp;the annual meeting of stockholders of the class of directors to which such individual has been appointed and his successor is duly elected and qualified, and (b)&nbsp;such time as all accrued and unpaid dividends on the Preferred Stock have been declared and paid or set apart for payment.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Unless authority to vote for either of the nominees named above is withheld, the shares of Preferred Stock represented by the enclosed proxy will be voted FOR the election as directors of Lloyd Sems and Gregory T. Hradsky.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Required Vote</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A plurality of the votes cast by the holders of our Preferred Stock at the annual meeting is required to elect each nominee as a director.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Recommendation</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">THE BOARD OF DIRECTORS DOES NOT MAKE A RECOMMENDATION IN FAVOR OF OR AGAINST THE ELECTION OF LLOYD SEMS AS A CLASS&nbsp;2 DIRECTOR OR GREGORY T. HRADSKY AS A CLASS&nbsp;1 DIRECTOR.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33<a name="PB_33_112532_7608"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='33',FILE='C:\JMS\kyang\11-10911-2\task4641303\10911-2-bm.htm',USER='Kyangb',CD='Apr 26 17:22 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CODE OF CONDUCT AND ETHICS</font></b><a name="CodeOfConductAndEthics_105331"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have adopted a code of conduct and ethics that applies to all of our employees, including our chief executive officer and chief financial and accounting officers. The text of the code of conduct and ethics is posted on our website at <i>www.cyclacel.com</i>, is filed as an exhibit to our Annual Report on Form&nbsp;10-K, and will be made available to stockholders without charge, upon request, in writing to the Corporate Secretary at 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey 07922, Attention: Paul McBarron, Executive Vice President&#151;Finance, Chief Financial Officer, Chief Operating Officer and Secretary. Disclosure regarding any amendments to, or waivers from, provisions of the code of conduct and ethics that apply to our directors, principal executive and financial officers will be included in a Current Report on Form&nbsp;8-K within four business days following the date of the amendment or waiver, unless website posting of such amendments or waivers is then permitted by the rules&nbsp;of NASDAQ.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OTHER MATTERS</font></b><a name="OtherMatters_105339"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors knows of no other business which will be presented to the annual meeting, and the Company&#146;s Amended and Restated Bylaws, as amended, provide that only such business shall be conducted at the annual meeting of stockholders as shall have been brought before the meeting pursuant to the Company&#146;s notice of meeting. If any other business is properly brought before the annual meeting, proxies in the enclosed form will be voted in accordance with the judgment of the persons voting the proxies.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">STOCKHOLDER PROPOSALS AND NOMINATIONS FOR DIRECTOR</font></b><a name="StockholderProposalsAndNomination_105344"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To be considered for inclusion in the proxy statement relating to our 2012 Annual Meeting of Stockholders, stockholder proposals must be received no later than December&nbsp;30, 2011. To be considered for presentation at the 2012 Annual Meeting of Stockholders, although not included in the proxy statement, proposals and nominations must be received no earlier than January&nbsp;20, 2012 and no later than February&nbsp;18, 2012.<b>  </b>Proposals that are not received in a timely manner will not be presented or voted on at the 2012 Annual Meeting of Stockholders. If a proposal is received on time, the proxies that management solicits for the meeting may still exercise discretionary voting authority on the proposal under circumstances consistent with the proxy rules&nbsp;of the SEC. All stockholder proposals should be marked for the attention of Secretary, Cyclacel Pharmaceuticals,&nbsp;Inc., 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey 07922.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Berkeley   Heights, New Jersey</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">April&nbsp;26,   2011</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Our Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2010, as amended, (other than exhibits thereto) filed with the SEC, which provides additional information about us, is available on the Internet at <i>www.cyclacel.com</i> and is available in paper form to beneficial owners of our stock without charge upon written request to 200 Connell Drive, Suite&nbsp;1500, Berkeley Heights, New Jersey 07922, Attention: Paul McBarron,</font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;"> Executive Vice President&#151;Finance, Chief Financial Officer, Chief Operating Officer and Secretary</font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34<a name="PB_34_112532_8146"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='34',FILE='C:\JMS\kyang\11-10911-2\task4641303\10911-2-bm.htm',USER='Kyangb',CD='Apr 26 17:22 2011' -->


<br clear="all" style="page-break-before:always;">
<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="680" height="880" src="g109112dai001.gif"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">THIS PROXY CARD
  IS VALID ONLY WHEN SIGNED AND DATED. KEEP THIS PORTION FOR YOUR RECORDS
  DETACH AND RETURN THIS PORTION ONLY TO VOTE, MARK BLOCKS BELOW IN BLUE OR
  BLACK INK AS FOLLOWS: Signature [PLEASE SIGN WITHIN BOX] Date Signature
  (Joint Owners) Date CYCLACEL PHARMACEUTICALS INC. M32070-P10284 CYCLACEL
  PHARMACEUTICALS INC. 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS, NJ 07922
  1. Election of Directors Nominees VOTE BY INTERNET - www.proxyvote.com Use
  the Internet to transmit your voting instructions and for electronic delivery
  of information up until 11:59 P.M. Eastern Time the day before the cut-off
  date or meeting date. Have your proxy card in hand when you access the web
  site and follow the instructions to obtain your records and to create an electronic
  voting instruction form. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you
  would like to reduce the costs incurred by our company in mailing proxy
  materials, you can consent to receiving all future proxy statements, proxy
  cards and annual reports electronically via e-mail or the Internet. To sign
  up for electronic delivery, please follow the instructions above to vote
  using the Internet and, when prompted, indicate that you agree to receive or
  access proxy materials electronically in future years. VOTE BY PHONE -
  1-800-690-6903 Use any touch-tone telephone to transmit your voting
  instructions up until 11:59 P.M. Eastern Time the day before the cut-off date
  or meeting date. Have your proxy card in hand when you call and then follow
  the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return
  it in the postage-paid envelope we have provided or return it to Vote
  Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. The Board of
  Directors does not have a recommendation for voting on the following: NOTE:
  The shares represented by this proxy, when properly executed, will be voted
  in the manner directed herein by the undersigned stockholder(s). If any other
  matters properly come before the meeting, the persons named in this proxy will
  vote in his discretion. Please sign exactly as your name(s) appear(s) hereon.
  When signing as attorney, executor, administrator, or other fiduciary, please
  give full title as such. Joint owners should each sign personally. All
  holders must sign. If a corporation or partnership, please sign in full
  corporate or partnership name, by authorized officer. 0 0 0 0 0 0 1a. Lloyd
  Sems 1a. Gregory T. Hradsky For Against Abstain </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\kyang\11-10911-2\task4641209\10911-2-da.htm',USER='Kyangb',CD='Apr 26 16:45 2011' -->


<br clear="all" style="page-break-before:always;">


<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="680" height="880" src="g109112dai002.gif"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">CYCLACEL
  PHARMACEUTICALS, INC. This proxy is solicited by the Board of Directors
  Annual Meeting of Stockholders May 24, 2011 The stockholder(s) hereby
  appoint(s) each of Spiro Rombotis and Paul McBarron, severally and not
  jointly, as proxies, each with the power to appoint his substitute, and
  hereby authorize(s) each of them to represent and to vote, as designated on
  the reverse side of this ballot, all of the shares of Preferred Stock of
  Cyclacel Pharmaceuticals, Inc. that the stockholder(s) is/are entitled to
  vote at the Meeting of the Stockholders to be held at 12:30 P.M. Eastern Time
  on May 24, 2011, at the company&#146;s headquarters at 200 Connell Drive, Suite
  1500, Berkeley Heights, New Jersey, 07922, and any adjournment or
  postponement thereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS
  DIRECTED BY THE STOCKHOLDER(S). PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY
  CARD PROMPTLY USING THE ENCLOSED REPLY ENVELOPE. Important Notice Regarding
  the Availability of Proxy Materials for the Special Meeting: The Notice and
  Proxy Statement is available at www.proxyvote.com. Continued and to be signed
  on reverse side M32071-P10284 </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\kyang\11-10911-2\task4641209\10911-2-da.htm',USER='Kyangb',CD='Apr 26 16:45 2011' -->


<br clear="all" style="page-break-before:always;">


<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="680" height="880" src="g109112dai003.gif"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">THIS PROXY CARD
  IS VALID ONLY WHEN SIGNED AND DATED. KEEP THIS PORTION FOR YOUR RECORDS
  DETACH AND RETURN THIS PORTION ONLY TO VOTE, MARK BLOCKS BELOW IN BLUE OR
  BLACK INK AS FOLLOWS: Signature [PLEASE SIGN WITHIN BOX] Date Signature
  (Joint Owners) Date VOTE BY INTERNET - www.proxyvote.com Use the Internet to
  transmit your voting instructions and for electronic delivery of information
  up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting
  date. Have your proxy card in hand when you access the web site and follow
  the instructions to obtain your records and to create an electronic voting
  instruction form. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would
  like to reduce the costs incurred by our company in mailing proxy materials,
  you can consent to receiving all future proxy statements, proxy cards and
  annual reports electronically via e-mail or the Internet. To sign up for
  electronic delivery, please follow the instructions above to vote using the
  Internet and, when prompted, indicate that you agree to receive or access
  proxy materials electronically in future years. VOTE BY PHONE -
  1-800-690-6903 Use any touch-tone telephone to transmit your voting
  instructions up until 11:59 P.M. Eastern Time the day before the cut-off date
  or meeting date. Have your proxy card in hand when you call and then follow
  the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return
  it in the postage-paid envelope we have provided or return it to Vote
  Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. CYCLACEL
  PHARMACEUTICALS INC. The Board of Directors recommends you vote FOR the
  following: Nominees 1. Election of Directors 01) Spiro Rombotis 02) David C.
  U' Prichard, Ph.D. 0 0 0 The Board of Directors recommends you vote FOR the
  following proposal: 2. Proposal to ratify the selection of Ernst &amp; Young
  LLP (US) as our independent registered public accounting firm for the year
  ending December 31, 2011. NOTE: The shares represented by this proxy, when
  properly executed, will be voted in the manner directed herein by the
  undersigned Stockholder(s). If no direction is made, this proxy will be voted
  FOR items 1 and 2. If any other matters properly come before the meeting, the
  person(s) named in this proxy will vote in his discretion. Please sign
  exactly as your name(s) appear(s) hereon. When signing as attorney, executor,
  administrator, or other fiduciary, please give full title as such. Joint
  owners should each sign personally. All holders must sign. If a corporation
  or partnership, please sign in full corporate or partnership name, by
  authorized officer. For Against Abstain CYCLACEL PHARMACEUTICALS INC. 200
  CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS, NJ 07922 M32072-P10284 - To withhold
  authority to vote for any individual nominee(s), mark &#147;For All Except&#148; and
  write the number(s) of the nominee(s) on the line below. For All Withhold All
  For All Except 0 0 0 </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\kyang\11-10911-2\task4641209\10911-2-da.htm',USER='Kyangb',CD='Apr 26 16:45 2011' -->


<br clear="all" style="page-break-before:always;">


<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="680" height="880" src="g109112dai004.gif"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">CYCLACEL
  PHARMACEUTICALS, INC. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF
  DIRECTORS ANNUAL MEETING OF STOCKHOLDERS May 24, 2011 The stockholder(s)
  hereby appoint(s) each of Spiro Rombotis and Paul McBarron, severally and not
  jointly, as proxies, each with the power to appoint his substitute, and
  hereby authorize(s) each of them to represent and to vote, as designated on
  the reverse side of this ballot, all of the shares of Common Stock of
  Cyclacel Pharmaceuticals, Inc. that the stockholder(s) is/are entitled to
  vote at the Annual Meeting of Stockholders to be held at 12:30 P.M. Eastern
  Time on May 24, 2011, at the company&#146;s headquarters at 200 Connell Drive,
  Suite 1500, Berkeley Heights, New Jersey, 07922, and any adjournment or
  postponement thereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS
  DIRECTED BY THE STOCKHOLDER(S). IF NO SUCH DIRECTIONS ARE MADE, THIS PROXY
  WILL BE VOTED FOR THE ELECTION OF THE NOMINEES LISTED ON THE REVERSE SIDE FOR
  THE BOARD OF DIRECTORS AND FOR PROPOSAL 2. PLEASE MARK, SIGN, DATE AND RETURN
  THIS PROXY CARD PROMPTLY USING THE ENCLOSED REPLY ENVELOPE. Continued and to
  be signed on reverse side M32073-P10284 Important Notice Regarding the
  Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy
  Statement, Form 10-K are available at www.proxyvote.com. </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\kyang\11-10911-2\task4641209\10911-2-da.htm',USER='Kyangb',CD='Apr 26 16:45 2011' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g109112dai001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g109112dai001.gif
M1TE&.#EAJ`)P`_0```````L+"Q$1$1P<'",C(RLK*S4U-3HZ.D1$1$Q,3%-3
M4UQ<7&1D9&QL;'1T='Q\?(2$A(R,C)24E)N;FZ2DI*NKJ[.SL[R\O,/#P\S,
MS-34U-O;V^3DY.WM[?3T]/[^_B'Y!```````+`````"H`G`#``7^X">.9&F>
M:*JN;.N^<"S/=&W?>*[O?.__P*!P2"P:C\BD<LEL.I_0J'1*K5JOV*QVR^UZ
MO^"P>$PNF\_HM'K-;KO?\+A\3J_;[_B\?L_O^_^`@8*#A(6&AXB)BHN,C8Z/
MD)&2DY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRMKJ^PL;*SM+6VM[BYNKN\
MO;Z_P,'"P\3%QL?(R<K+S,W.S]#1TM/4U=;7V-G:V]S=WM_@X>+CY.7FY^CI
MZNOL[>[O\/'R\_3U]O?X^?K[_/W^_P`#"AQ(L*#!@P@3*ES(L*'#AQ`C2IQ(
ML:+%BQ@S:MPXPH,(CQU#>O0`\N,'D"C^18H<:?)CRI,N39+D2+.FS9LS+$00
M,:'"APD)()!LP*#!`@H.%#3PR('!`@8>-"S8\('"3@T./D"`\$'#`ZD,PE)@
MH$"H`[(:."S`\$$"A0Y.&T@E.I5*R9(G\9+06X(OSK\F,0#H\$&`!@@",!A`
M\`$#@\04`EC`X%$P!@0&/AC(2B!#8P`>#@#@H&$TA@,&O`[(H,$#`*2K`3!.
MP&`#``L9.)P^<(&PS)$C.P`_R6'XS+S"\X(LGI<X<)3#/R#@ZH'Y7N8<7!).
M#K@[B0$4,!3X$.#"!PX!V$8@\"$#``RMVP>0FC4#@0,-1&0(\.$``008!$"8
M`@I\$,$`&K3^)ED$"F0@``%C+<#!>_$1>()B'S0PW@$2'-`!!:`Y<`!C#;!W
M``4\"9#``!XX($!6"Q"P0(8+6)``!0GTA]4"'A3@004%%*#!!``0H$$#!RB0
MG4<0#/``!P@XV9\!!D2`P(S>9=F``UQ^\-X'':2GU0"?T589``H(X-D'"XPF
M@F`?%!!!6`-DIT".$J#Y@`<!B&:!!I(A@$!M:/+X@84>>67>!P14L$`!%AC@
M00(1/`"A`A<8X"BD!V37%G\'/-!`9A.0B4!^!<S'`0&9?F`!`18P0-X%&`C`
MZ`07`""!`/EU-=\'##`V0`4&0!`9>FQEV9UX!IAG@*P3"$#8@8W^!<`2G):*
ML!Y,<!(@P80"?I!`CA"P=Q(`1R90V@</`.!`:2Q9J%\#%HC@@*X3%)`?B`UD
MRMB]$DQ`0'Z>[2K=`PSD6*IT4*7*%@("/`!F`0?XE%Z`MUH`0`005,`!:0%D
MMT".PQ8P`07L?:EL=T'J1W$!/K4UGGL')."1>Q!/((($X^G'7Y7B6LMF@43B
MYX&:'7C+XH0.3%BS1PK,R%=I%+A6KVNR2NE>!59_`%X%L@G@`5DG*7!?!PM$
M<(&`8'O*0+@"$Z!SOAHDK(`'"Q3H@(P:($!`@0500,%XB:W<W7$G;7"7;Q]3
M)0('&WAZDF^3@SF2IS-YT$'D8(K0`0?^OB77>'0M/>X1=\DE1])PA$E`0'7-
MF7X>4QT\P-A'E'\\`G-IQ0XY<9ZOWKGA@+&T%QX>69"5"7YIH&0,>.GE%_'4
M.S$]&]<'D3T8VU?OB@8B@(_"2/6B('Y(*4B//O,OW#6[7WQ-[S[LZ@-_PO8@
M*=[^"1PL6@'XV[,`_%B@.Q/TCP2ZZ0#E8)(^F%Q@4=ZKA0=T]A/A(0X#;-$9
M=#ZBP9%TL'[-F0!(1%@Z#/X&?<=)"4DHR+X6JJ\"5)'>7:)3F63%[P/_@PGB
M4M@1]XU``S[I@`1T>#^/D%"%%'Q)2TC7%9_,9`-.W(L2C]>6[D50%1/DR8\F
ML`$,3&!-#I#^V`,DP)8-4$"`)Z'`!B`@0@PDX&,4\,D%(J"!"$P`?!GXX@82
M8)X]8J`#$\"5O;)B`0ED0'"M@<"W-M`3#TB`C!5`T2$5`+X#6H"19,3A!R[@
M`0P(Y8!<*^1;%C"!#F3`DU7S``4F,,3SG+)C79%`!;IT`0EHP#P^P8`L&:`S
M`:[2)U:IER[KQ0'!>28"F1R2L3;YQJI,P`*U2U8>S5-*"TR`-!*P@(UT(Q1=
M2J`#AQ%A@AQ9RJY,8)F1_-B?WJ(;559-<!?XF'E4^4P.\/&*$J2@&KDR1ZQD
MQX0[N28$\HBB#V&@7D/4V0/RJ,VT)'0##UAC!KC&DZH4C#`8,`_^!3Q3S`H(
MT9E.#.@&;GD!#:#H)->,8\$XH#,*<*`"GIE@,3DP1-Q8`'(7^),&+%!2`R4J
MIPG2)HH>^!,-?.@G-/6(&JNBS9\PT@,EG4"RSE-(`U5E2.U!D2,W6:\SGI0#
M7QGH!4Z6@3$6!Y!7]<!.,F!356:`K3%M2WNT^<6O3&:C%YAF(=N(0?/DU*E5
MPR<MLEC%+=HR/K22Z_\&BH$EP32#/V$7!G_T,6`>YJT3!$E"/9)#HKJT?Q7P
M*(K$6;66JC.O6G65+0/[OY9VX)(BJ*4&,F">G=Z4`]H\+?A(N(&<PK&)B?TL
MBB@`1!'`$(=<W.0A&^-7G[Q4EW(E+HK^S(C2JV:U?!R`@`8H4P&WS#:)0_38
M2\'T6(MB(+#5O:4UT[(!GAY29Q'`33%72$+B*I>B@IU%:,_H`0M$<J.4R6H6
M77K0W*21MI&-0']QTP'Q^F2(X:&,?9VJ`0G44C_#Q>T%0JO*JM`*`HRLBCK_
M=,W'S2@#%@XO!ASP(\=EH%<1P(""']B_V]ZT`BL.GV]Q>\MLHNBXX<E*3W#;
MU0W$>"=#Q"`&N7)(&4=6C;0*Y$F&R($8VS**X<F`*AF9H$BV1@(_`E^*9ZM1
M#+#&D(2!J5L<F:#VWM0M64U08">PD_-$(`-<(6%^9\&:D^35S^=K37:80]OE
MS"0[G"OTY<[^\R:VD,9SX-LN";0\$UH))SN;0^.@)T>8`K)4!%W\"'PL]Q',
MQ?,DK1$.2;*S73!S.B\O)8QG4G<!QYG9`QP%$R<939*=@N24FUY27AGGN5U+
MKI..IFIV$/RQXV"`*J)[(AJAFH%.WU1SG0;)3C]GW#6=Q]A['LCT.G#G%ECQ
MAXCL"Q/.O0)V]T"7[@[W*WR(`RO&&X3J5D&\2[>7!;:PW?]NX/X";FX7W#MV
MZY-W+)8T@IY2$81,F>+X]%T"5E..<CL\I?@,_+A3D_IQ%>\IO1/.0/U@4'&^
MB=X).,YO5Y9\+W%EH,C7)[VIMIP%OS;/GQ#H;9PK7!8+W*J[^_O^\1T0/3O'
M[4JO//``MC`%`F9FJDNU%=KLL-+$)8@`3.]7OG:7]9J(2\%;<>@X%%!W?"SL
M2"M9<#4-^KS/?!$A86%"79!X_.>XB`I+480!)7WH+1/,34\JW)I5ZN:-K1E2
M;;,Y`E,V9I,G`PE;TK+WQB">[*@FX7,_H+AB@KJ@%$RRSAV09HF10,_6],Q8
M*:``JE@`\%_4I<V/&SG9>[$R=Q3!`[)2@?B>1Y"/"Z8C_X?'D1C+N5*]P//&
MZIG7-YBB?M3*%QN3>_W8TC,;6./R8GM'>YZR]8^C,]=ZL@%>FM.&7FP^>O&>
MBA^==[Y(EG-V-UDUH7P6WCO!,9CO&)[^G7Y>KA$0.2<U1"5U2/`G8K"E16\R
M3R>!3(6'6W5F1Q[E*CQ%3WB!3'U41UX1%37U/P'(%1"`6W'562A&9"]58=F5
M'4WU13O%?TX$9A>`(K@5>:WD`4+!5G=4`5*61UJA5L644:WT33;X(V.5@G96
M'3IC9@=U'KH!7S0E'&LG0C'(>17@7ZT1`33%%GFD5FS&?JOP(Z<463K32L25
M2VP17MM%`4-$@-.W4_'D>9PW6A5$6$F8()`%8:]5=GJ66'A!915P86VA9<8%
M1!B$7QYA2_]4`5SQ4I^V2I,Q7DD(0<>55V9H46I#41DE8L447SF41>WU(]GD
M13:D,R;%B<O^95^4:""AM29RUTNLM&&5L2A)EB`ZIX-408DKQ$%4B$/95&M@
MM6%(1Q6%N&]>B`EN14URE7PN-51GZ"KUM!/Y5X)8>%LG]2$<D!5W5EPX5&%O
MU8SYAULQ5$&-!A.D84;5H4KB0T*$X5+*DUDEP475`680L#G=A2)#4AW4E61.
M9UVHU1@9Y$@>H#\8`$PC1AF>XE*AA1OGU0%W,P)/DE>3$9"D^"U"H3,Y!3MM
MD1WAM87,06Z*\S^&5%R)0I&JE(LB@)!5>$I_>(8?0Q@H6)'$6(R6H'>LUA4G
MH4V]QH3MT17]M5'MD1;585^M$14C8$;FX19H=)-<HSMX!)0;0#G^YZ,[BN-.
M:39A/&F30^D9D38"7F0>HCA!YM%G>:1E6UE`5_DQE523C`1!]3*4X&--H1-'
M'PE#Y$8"YS5/UO1H7;%4\>%%XA-J6HF$7<=2GA%:A+%KB<*7B;([<ED5,'1T
M'!8^BBF3QW!N>G9SCP"6E%D0$F=T-S=%^Z9R-*!$,9EO5"1PI3,2\6&:^%8#
MQO-RL,F:!+>9NK!HK3EV)+<7CE-V^Q.3UX,_Y4,_>]%U*Y"4I6.<`T=QT.,J
M^X:;!E1PPTF;I_`2/)1%/'1S?.@1V=D7H<<2T>-#3%1$IKE$#Q<3U64\=^%V
M89<2EUD"Y62>.V1PX`F?I0-%5=1#F#G^$YDH1>$3,S*4FF@EG:2`3`.I,QWU
M>P_T1J:4`5I'$JNT=EZT4$/R%KM'?>=371442?#QECWI*0)$BR>S29]#&4T7
M/@[H%:3!2HR$6Y^T*"Q52CK(20,U01%09YUT&%.G>YED34,%2_2T)^UQ41R`
M8K[W=ZK$>#<IHMX4%>`3,W]7F'3$H#IW31L@2\.T,S-2H_7R(11%=']U8WSW
M`%(5?FTD`3RB>!\A.%W%>(`D`77VA=#I<_>3`Z6)FIB)0C-P0P`WIY&@5DAE
M1G=V,H':$UW14"1U3$RA,W\82[/%&MKU)"3@`(&4%4-*1_^34U_$8MO(4S_&
M5I$#31#J$Y'^A%"@(T(61ELF9%&3PZ!8!68?=1(X)D`U&%#%<1AA=J@^=1X>
M(Q=Y)84HEE,!`U7)<DW7-$1PU8R/DY<&ZFJKA&=QI!7>9I\SQE`6P!5M(43?
MHH;:9$@^46(,JE2^%E;),J1<,:VIM!-UFIGX(P/I>J=[.IX3IP-Z.EBFM8EF
MEEUF%F(DA5,[1T(FI5RMUJ@:*(@?`683]%IXQHL-1ESB0U.T4EL[!DVIE8FI
M%UD5!$O!JH!@:*F%E43EE40MU44,^EHCMEL@H8-`)$))R%""YX_6UU@%%6$6
MJV%?5%LQ8TR1QG<Q0UT6R;*>DD<89$O/]$>9F$._!X8"]!4!UE_^"=NSJ91V
MI5!HI#$2+)>J0UIQJSD"IW0ZM-53"8("IN1PII0HYX-K4'EKCU-M:5NVO8-`
M-P4FI]138]L5D08?&54=%WI+DC.UGD.P3+%S)3"W7PLF`&1R[8H\]3H9\@54
M3^5FE?5<RX.."T5<V8@BUX>1A$5<7"0QBG@>US<"#E`O4!<!X&1-HL4M`Z5-
MN!1)&^9%FP@3*)8@7*1=<J1-UNI^D#5EV_@M>R)>EX1CFKI)V&BYC9$!9J0!
M(9:)'E$;;5%+6G9&UCJ0#*H5\41^-&6',O9%0N&YD957)C6X'M``(R4KAY06
MGF12/\6M55H5]^JY$"579L96U7H*%7#^``M0)8+A$RZ2'1%P``P`,YK!&"@A
M&MY6O_<K,1$```FC,P&P?270``#0)M`H-`60(\L+`!3D'@E``$("+`!@>NU2
M(!Z1P++B$1LP,@J0&7D2+$/4`&(3)^/Q``4@&_FA``?P)@F@`%<2/@(@-!GR
MPB?A``,0-<<3`2]L``!`%35C7/9K`*;W"(-&$K*&1FQ5'6<E.EWQK9[S)R2!
M&S=SD[D&<HRV4]#F*>`($R4&5;ZQ7:O&E>&A:OKA&9.'L"3PB3M5')Z"09BC
M0$RQ.XS&8\JQ;'?';=@!)BYY6Y4S99*WFXW%E:<&5>`3=;A565%AG$:U)(31
M7GMK/^TE'-O^]A''97$NJV-4@<G^*#FCD"=70Q(;(Q@HL@"_LCKN0@(0L"+)
MHLJ58P`W?#,`$$4E4`"9<2=Q<L,30D$6X#=UEB>D\1I>0P"9L0$&\"*@A@#V
M^S@!8"C9H<LD0#$B,`#62B0`-,NY8JUNHP`#X!O</,(`$',FH<T.TBA>@V2W
MD<BE8%)66021]`)C]YHA`6]2X&[`=YKVH"(E9\Y24AK4D2A?DB@%L!].)P`B
M/!(!H&#9`2+P$P!#%`"R$@#\A"XG40"94F<E<BCLX2"/<BB[DBP)(`$)HWMN
M(M$4?1(3_1F+,M)=\251TA+U*QB$P2=#Q"0`,(_,,].E0AMA`C[^$!V;I*`Y
MLYF;3<V?J>F:OTFG0!!VRAF;G:G4\*K5\#-R6BT*EN&>:'*(;@(3>5(2"9`?
M"DS3#$0S_GLH/7,\..,W40$`-3,`+*(5F=$RFC$`!O`K$5`E!>!&$Q`N%V`K
M#``:C%(@7&G7;^T>QZ38C"(K/Y'$KH&N(]`HQ?P9/=<N'E("[H$B";`6"@`G
M@@%![FH(,T>XO2.:Z!-@_)/:+X<7J-S4T]/:L&D=\4IP_%QR)7&UZJ-R:KO5
M-M#;DS:O\RG&!N=O5OT)1K3.1`3.(I#8>($`XZ&='YS`,Y(G%VK1(R``)6P"
M[?*'2C48XE(@&B``1R$`XU$:H07=3I'^*7R4+3U2,4CL$6L-$M[M$?<R(#=\
MTQ0TTN[A=@:"T0##+I(]`@E,X%6AV%6B`0.0`#<LW8>;!];Y0P]TH2C0R*X6
MV^IV=RB@:4X]`LBI;DEW0`)M!/;Y`DM%=`=W0,38GA]!G"G@;RAP0-RQ"NXA
M,07T`&12WCX1'P+PI@6``#4J(^WQP>=!%2?-%"IS/`B0(S"A`-<]RV;#,=;M
M*@"@Y9XQ`$,D&XPB,1#`T1#P-H1Q`.=LDR<-$Q#,>;TL`AKC*00@*V%BP1^C
MT5N!T?TAPCKY`#X,$TV.T[/L'I0Z:!J>",I7'()3'3FE."H5R?]T$J34%IGD
M3MKV=]DQ5G7^,UJY(8SM\4REW1Y;1!7=A4>VQ'D)P!:O5W;3Q(LB1`$\4K'5
M9GCALVPO]1:.QQ8QR!02L`%Y9.I-FEP44+VR]!,Q,R3(%U@Q"*F)#GEKTDG?
MA()C]3F1!^L2.56%I'H!76'_6(3T5P'@]T4LE>R]MD6)8NN+;NT?(WMI%-"C
M$`%%#BLB`,P=H2'6O<RZ/$9EO0#_#>]^4R\$\#<&,)"RP2&^#0#Y`1(#("NE
ML5T`((NV`L$D$0`>]?!>4B\"($(SG>21C!G5'/`IW$<C@@"I)?%N3D'$<@!R
M8M-QDA4!0`#CXBK_T=`F,``S4@$!P.0>;2#QCO'4P0AU>5C7E%O^=U1'*!*Z
M<&A?(;A.07N2=;1E#R`<:C1_B55*I/N$1`A-"F9_8%5`8)9;"G:$.<A)&S5=
MAW%5^Y<H'A-)K+&,<G7JFP1#WT)'W_1:6C^$(J1-',84+#5;"%E<`0@F:R5"
M6/CI4D];B_4Y_@5_-!53I%&N(FAGC?]Z'KB%%<9YT*AA!CA<.:5`373KK,%%
M/?LM?^(Q1C:=G.,YS-VV:-F2.F0=>D<<Y;AJI%';LX-`/3UH#'>.&`DZO;]J
M;7PYOQT?:+F:L=\1F*/;`5D<^B/%NI]]CY.UN&\_Y]@1G(.1C9!%^D12_UH5
M@G-0U9=#/=L3..;T#W8>/U99F\06X;'^*'(G.&GVKTN5HYNUC<S5%4!U5;7+
MN<75X<9T4B!`:=0W?93W?9BF0=9E8>J45EKU21_^79=J8X&T9A0,D++Y>$RW
M%?#YJ7@J$UC'(JETJ(\+A:/"5"`EZ&<#N7`MDRMYV4Q;.J1J9E:CU%0J"D4&
MR4G/A>`*F<><'V.CXR-DI.0D9:7E)2;39$JF9N>G)*>CJ!\IZ"FJBFDJ:ZNK
MY=S$!4:8A05'Q6S8@MV#7Z#.2D8&E1AAS@3'1D5N!@>)AH5&Q`?$1A.'!P78
MM,?.S0:&F4X'-_5'!P2'!.ZM4IB$AZ\(2;S*!4.)+K9OGP^&-P\<.$2X9BX6
M!PL5!CY8$L'^SK`DSSRH8T)-`SL('7BP.Z&LAAT-M+SI&)AB0SQ?.S#,*)DM
M$`H.&`?NV$`BP@@,&8"8.$*A`Z<)_72M\W%(IZ$,XUXQ;>KT%"E3JQY-5=5H
M:M525+<RRIKU*=BP8L=>\J"!B2T/'39<\Y#6PXP-9U5DX?%AH(\)<S5T.*O!
MVP6U@><*RI`F$(<99\EL]*N-2I`99(P=-HSCIX_$1WCT_6!81083;BVD&`'D
MKPJ\&V15]K'0KIV%&.<^XX)W,072H/TJ\:,AV8:-H3,\/GOA)>05$Q3?-5;;
MK%D)AD/+_'L6%Y#;=B],V,CC[.@4%SH,O"Z&S8ZO9->S'UM5O5/^^.WGTZ]O
MGY+\3/GK$YQ[_S^`D6!@BW\!&K@>!Q<4J($<3!`724*49>"?6=YI(,:%J9W5
M01X*?N<'!P\Z(E*!&^3!20N>&>.!,XDAL=^!,<H8H%2LK()5)S5"LE97L/0(
M"2?RZ3C*5585^2.02`J)WR8,SO@D4REDD$`"`)C!`94$Y%#!`0@<L,H&"R2@
M@`%F&:!``?EX!D`"/```!``#J""`+Q$`(*8)`?B2@@$(/*(!FP8<`)X`!A@@
M@`4?#.#`!P(LH((#`GA@``$+*%`@E)EJFB,346EUI)%5I3@DC)N:>BJJJ8*5
M8:4?*$#`!PF4"4`$'@`@&H@!+)""0`+^Y(/!FQ\P(("?&0!00@`%7`.`804<
MH(FQ.3`!`*,]2@#`607(:6RBU'(```D**'`7N-_F4*JJZ?XGT",<3N(D953Y
MHRZ]]=I[;RN`PIE#`0A,$,":)ECU``!BI."`G`%_8$`"`VCPP+,,'&"`+`(P
M$0`U8E```(K,>N)'`[#JP'$%`'1@9Q4FNVK`!PU8O+%)^,I\8#8_B`=&`SP,
MEH9X&$1PY5T5+$&,,1DP<!X0'BBX3`N)SOPTU%$_Z0$!^4@0P$8"2(#`N!84
MW`@!X_)Z)VC8VFJT!>(J.H$$$$2P+0`'')`/FII<.U75*E`J;-P`Y+!``"DL
M@.T`0`PNJ]/^4BLN5A4^[Y1!!+A0`\$,.X3!S&_(5#.-"R-LM,$\MG#A@`<1
MD%%!!HFBNSCKK;L.)`%??O#VFA@88,8""9<"0#YCJXDP#X$S@,``.0B`P00%
M&)#S!!S[X:LF"!3P<1``[-"!GA\$T,"W)IRI`@0##*_WHZN_?OXHJ.OQ@32X
ME*#(-R.,801+AVTIAPD['!-,_?JC_S\``XB.`K0I!1*P6`*>10`(V&H0C#C`
M`$KS`0*6`%RSD],%!A``$W&,`P4(@`GJEAH`M$11YVB$U\PR`#]]RQFW^L`+
MUQ0`PW3@A>83X.NT4;\:>.,*.C!@243@`YX0Y`1@.`'^=,"69-3^`Q%GP"$4
MHP@U!;#I`#OP8`$:D()_(>`.C<```@3U*-LAH(LJ0$";OL6R!XCL@RG0%IG(
M```OZ04`?<J951K`I@0P8(L>*P#E/+:F1[%OCF.ZH12EQB*YK$`-I%D(0.["
M-H%,X"=4``(&)$`:(#B#"=GA0S9F<!KCV"61ICSEJ3C0EPPQ80D@BI<C9!(D
MU*2&$ZJ\2Y`,5IZV*"-#O82E0&C)!.=D(QNJ,.8PY>)*5#*S%8AL)C2CF:G\
MX(@^SY0F-G]DOFMFLYO>A(HV/R5.7C&IG-\\)SK3J<XH<I-32%HG/.,ISWG:
M:R<;D8D*,L0ALTR()0+I$"Q3\QFSL.3^,SQ8YD'IJ="%,K2A]-'`Q/RUL&?9
MZE$1D-0#"C#'?#`@`,,#`@H#0``I[9%1':#2`!)UTH:ISJ$N?2E,8UH)`K!L
M;(P"U`P$I8)K@8=:U!N#`#P*OF=IXE6NFIY112C3I3*UJ0JE6N'R2<*192,`
M^@N95`-S(PX$0%IH>HVM^#4]OTUP>DX]*UK3FDT/6FED&S%JM%20MPJ&D1JF
M`)9A./``"13@95AKU`1*MI$!+$6MACTL8@'H`8U^0'IR953S3F(]%6#U1K.3
ME%7LI`.XA49.P$I:8D,KVM'>"SQYVYO7#"-"KQECKI#0*3K0L<++-O99!XR5
MGT@K17**@IS^JN#M;[O26ZOT=KC#-5)PM1(DY$:EN#U2A'(UL5SI)C>YT"W%
M<7T+JN-VRKH_Y6YW=:NI!1R@`+OR`0$1,`,/B$\%#'">!@)P)@1@B@E:@]3$
MSLL!FFKQ+@3(8CO%*^![!?BG`U:76>+5%U'<<IB\ZJ4P2X',!'?E&J5`Z('_
MQX$&,"!G$0#"!CC<7PTLH`$18(`#4$P!!BQ`?QA8P`/$$`%J@.YA4EH``R33
M@`6@0`<,4,`PQG&!"`1VIQ9(L18E\&/DF4$>>^'P=41L`Q9/P!H^F#&,%R`4
MXT3`:`SP105^/(@P+P`#&^ZP&/2Z`"!<@%$;<$`%2*>#<SU`SA7^6(!A-L``
M#61``2E^P(H5P`4.]U$<X!L'Y5+#@*-E&$J6;8IZ"MSH30&K`C,@`#6`!0,>
M$&`+:W"4!A1P@`L```;@6H#%#%"P#`2`U![80*<!H8,`8$#4'ZA:8"20L`A8
M44X:2&E7@9#%YE%``,\@*J`@`(&"`2H7*2!3'EH].P(\#%P8H/7L#%#L:T.@
M`09@@0K(5($`1,H"76H4C_V&/3)[`%$:(,!&L(>M6+UP8QJI`*CCR,$+'$`!
M$Y`3>R-H0A4<H`&;GG2,AE1.A8<*N9L@DC@?KA]0@+?14IKA63"]`F:=10'E
MDRLU%)"`_4+4%XJB0,,4@('"`6P!A$S^001@54,N.4`,$A!9!`I@*X(L8`,<
MOS7E=-X`Z;6$`6UJ;`-\[@S!(6`@V(ZY9P+G`6Q#X`#_[L`!+#!TO+AJ7&%S
M&`,@0`&106!Z8S>`S0VEOPX0``&10T"G)T@!9=TZY"/G$`#T#(%_?^`!B_:%
MQA=F``PC_$#5-/`IIXL)AA\66`AXE,:!E0#(IR<%"_P`JF<;>`),X'8X)@"I
M)UCY:<MU:VWOK`J@[J\$W(!-CS*`1AGU+;%U/=Q'FZ/`.HKGIWN68[::002T
M;4>+=30!^NMHO\=]@(+=?*>P\OFXY"JRBTE@`1!X@`$D`&L.#,`$A,5\`!(@
M@KZM0TX&J`#^]NN>&@30JO`&(JA_3.1/^/N!D2HB*+BAHPJ1L&#!^<04(U%8
MB+`$AE`&7`R4+Q$'GXG$@R1(?=$%+?$%$SB)(V2`=[C(A/#*>/B&F?E&)XV6
ML7!"Y#F/L!`5R,7*`GR+!XP/JVE``;!#G(2>Q&26G)3,!A3`.4#=!65;F82@
M"G0?OIV@`440>XW?1CQ;`0E`#F34QBD"HGR``_@+K-#:CW67`B#`1@#+PA#!
MO,V-Z+E=N!70M/09MA3`!#1``+P*RUS>F(S!L61?\AA+&3$+#@X3%,**I+D?
M)@"+`@A``FQ$`53*R'E-'_[AK3%*'S;!G2#`#K@,)_!A`L08`,S^PU0Q`@$P
MBJ9AGJ.H5UBE@;B$3`X`RUGD3@<PP`#,$0,]P`"T89$TCQG`S+0TF6\<0`)0
MFPX@P+#XB09020&<!<JI6@Y00!B5&@C&S;A0B@)`0`#TFT#(S0%00QVJ#0*0
MCMP4`.!1`P((P`5("@?(#1@VSQ5Z3^P(`BI.`*S,WIJ@D>C=&@EH'*\L@/*,
M"ZL=(>9%GSG6(B<%3@D00"W^!JPX@`*@(2.&&R&Q&OO("03$S@&<3`T*0,?1
MWM1M`.T`TOFE@0!L@`%0P[!877Q-P>T<P`,<70(X0"TB`#Z4E[3H87VD0$=5
MD#*0%4L>R[6P1:D-BQ@XBR?@9`J@H2C^%(`"<(``,`HY`<I-.(]/I<#&7`.Q
MR($8H*%<$5)'P=Q4504$693(X!78C$M[E49739TO',`8*<)D`82MV%5H!=,2
MK`5?R,0RR46:I0!0V"&%X9*#>4<:9$@P<8):*H),%%,M)=-UP.5;-L(&4(:"
MV:5,>`>[:,@1ZA)YL%('**8Q329M."8ZD$(V0!=Y&&9D\HI;WD5JJ-*$J9)<
M!)-=JJ1]G,FDC`O,&-/W^"2R-(S!8`QH3IW_?(\Q*2,%-4)2NLJSZ`N[-("<
M$(S!<`+#D(NT?$\U6,E[#$#N>,`T[M37^`&PB`'O:`(M;EPVM%4*L)8F>*<>
M?@6,'-Y3*)[^.[E"J>0AQ*&F-24+I8C!>R$.#`6BSO$-,:Z)W/R*($U=VR4`
M215`0+T7&OG4M=35K2E0FUB``(P4?PYC3PD,%,;-5%3GH`2>4K'D]'P+2#7/
MAK2=`PA2?.'*!H"0>.D?J`A7)<#E;P4)K_B6CC#>=5U"7)[H>C+7=T&<IUQ7
MC#I<DG#%QYAG>9)G)*CG.@&*80@`-7Q/=Q:,'O')`L#6QI`3P72,870,KC`"
M;DY595$?#*D)F;C)#"2D"I1,E8*/#6G%V"T,JLW%)7Z,R%%5&@2`+";&S7%E
MSI0&`.#1:"E-#Z3"5/A#_?R#6:3D5014DM@$XFF%,<T+)B`3(SS^H(^\SQB`
MU(Q`*H3`A9D1*5/!G)RD%@SAR@-8S(>*)064#!!\J1]PC=V0H`J`9U=,%H?>
M6N^LB6$8P`!L!`'DS-T(G@JH8FA6@[&QDA^\Z46-E`\(4E'YR0#@T7/21?#L
M@`8$I6]DCVYI0R6IPCW=Q6<<(:_<4PJ(P3YI@ACP$`ZTQ"SP`#3P@(@,@4`Q
M`C[EGP:P06QY1R>!6Z\FRG(4C4%I*SI$4CA01*),"';9'XLH@HK*TE\H#89D
M@#VLP`W<4HQVDF;>A7^$ZZBT`(NH@L#&*[AV$K@N5XCT5HM\QHFD0*"&+!-@
M@(4-4R3A4\%>!VHXJE,E0/@A@"]X31G^'>/T&$N"S-L`?`D<&0`0!,`JCHL"
MI.$SNA>K^H&G8E5\,<Q"H@P/&-W$+(%CV:8**,^8]@NUX1LL#8`OD%K."&=A
M`=4!"%FP/!OLG0L!`("H)8I&O6VBHI6UG@,'F(!>:%+^3,$2W&W?!48-K('V
MD0#>=@$&/$!+L(0TY(+*6IK3'!D/1(`;^($#[,2`B,20<4$351(2Q`!XP%DU
M,`.+_$!+3(."?!@[F,[#_,!R\$H@O$#EW$`>!(,#C$"MR`#NMAEU(BX%4$,R
MT(`%%,3L-F)+$,0M@,$$$(,FY09I0$`%P`!+F(#S+@3>&H->.$`,^('8,0/J
MN$4,Z$0>W`#^]B:*I2'N&/"N!U1N.G"'7FQ#$Z55>>12"Z2E+BF"A:V%0%3'
MM[)E<[3`BA@J>>PO8"9LO,C2KPJ$7AHF:KBCA('(YQAJ<XAK`=-2_K;`/>DO
M:>$!:&V#!80!(9!`;Y1`:-C"3BR&#UE.(21N'"R`+WI:$.2`/0C1'#Q`\)8J
M#[C#!S,!#4>`M`C-&1A");$-#6S$$\0`ZG@$#BBFI1G!3MS#^E@.0PQ9S4DJ
M&@1O:*0&">!"$]<`KCS!(H#2,P0##S%1/P@###B0""`#)ZQ$Y7C&&PQ#^/9`
M^_[#I.:P$%D`Y"`#&<RM3&DJ6""2TNR''U?K$5#J!7#/$R3##DS^@"MA0.V6
M@=)$@4+,#B&8P,$9@C0XP":=2SX1[EE(P!&:0$&@`[1R0?[X[>PT""'P#S&L
M%PV<Q:8)$0>#1T5H<`ZCP0Y\0S;4RBKS\@HD2FY\06I`*QX#02XS+4C%0VP,
M1!/9`Z!5PP\[`_9J`CW\$`TXD0C<PG(,P^4B@_S(P#T`\V^P3Q2`00ZTF:4N
M%>/-[3HG7)2PYR9(@T&5HB1IDAM7Q%V8`7>@PQN0P`6TS10H!P20;`D#[C/X
M$!/$PSK8,Q/D0&@DPV](;EZ80?`JB`3H!6B0@$,3QT5_QCHHP1MP@=@U3>;R
M"AX;1C!*P`Q4`)&=`/LL@1N\0Y7YQ@/^L`;W?"?;B`%+.T$IL(U<2(`$B,1`
M`//L2``]4,`K>H9AW'2K1L,4<`()#,,4W*U1MT`+*$@4L`A2)RZ@10$3L$T%
ML$/WJ@D\$UA9U\>`=(IS#>EUG>9ELO5;API6>,>,J@5VA1>/,L&,ZK5:AQ=<
MBF>+`DFW7L7G0*AU545<[B@C),-@-\(XYXAX,H@4O$AS>0*+$.I99[8W382!
M55/%_7&D2ER-#O(HA##%18*(4(4//P5W&!1>/-I=])AFSS9MXTM4N#4XH:<U
M?0)IU[9OTTM@CXB[)@Y7+,EZ>HJ/,A=\5(6%"28L2$-+6-I5O$=H#ZE;*S8L
M:)>?3H+[_+;^=[-3-D1F*VV$=$1P7YO%8=S%:8(L<M=2_OYE`].E'48PC\@E
M/C-#:ISF$:[L9!8G<<EW`(-(6UA:TCR$5I0W9CJ8=!F37;-+MVI7-C#L,.GT
MN3!X>%^@,9"'"*-#0'&=71L3MVJ7>,?,AQ.#>G\WBO]/32M$=[!!&#``"F!.
M!S1`$C^O-$C#%HB"!<@%ZSZ$5#O0&Q-#&(`U)T@D"K@!.SQ,&*S##2@$7P":
M,ZA<K_I")BW'F#(0&22*%BB(Z&:2,NC$;VS!80!U:C!#$C1QF!@!^VA``RR$
MYERTTDBW9P!:HGQ!#U&`6#_O"92&)D5`S@@Y!RB;6TCWWK%X7XC^[A`L!(Q[
M@Q380`0$0@?4+I)C1`<$%G$,0B8M1*D"`?8*@O-F3F^GN*A;TR(7)@D<KEMT
M@4HW!.&J1?#&*RTT0NH,"`DL0Q/KCXF7QD"CP+F60)J9``YL\32<@$H3P=X"
M:N4H0A\L>>4Z[QT@+@^3P>7F@3^/!$F<!$N?0!._#TG4`C,'PTH,]!1GKP@X
MP4IC1*($]2!@!+HZ"!$,@PMD0.V6^C.8CN3NN!!<P#5$#F^>A5Y0`;22@`,$
M1R"H3CQ@.S7$`S''^J@WO"+U!#/?PD,L!!AD`Z(FPT($=0X01&\1F?QH,4_4
M\12,P%%LZ#V9@!:WL3;PL,7#,!6?J_[^Q'`VJ(,RW`$1Z/0(L/&I"X*RYQ..
M:_N&PH]'W$(8+[)GL(,Q(<'(:[1Q_#,)#(%!-8&\"DT@P#O2S\&2X[F3+$1"
M2,,?E-`J9[/?/D,'F.\$\/LB1`.[[^W'^[+#OSV!03PN;`/I#`A@-*ZORP(1
MR``@=#`U+S*>7X,5+$55Y\)`AV+I2JXV].X`5O)RY`;>?T/IF@#[@M03,,,C
M)2\MW,(MB+DA[/PS]&XG9_L2TX!XQ!E<:'F<2>H5!,8*T#`5H#P/L\UO_`4A
M\<`;((\V7,!`%T7K5_I4)X0@W`+7XS%I7'3G_H'DFADR:+WVU8J\:\(_LT!N
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MO\\/R+M1@9,N7BPFP(N&<-01="U2&!2XQ1M!>#[H*;/C0Y5&:U,>Y<&`X0.%
M(#;@>4S!8PHU%0OC=+``JEFU/9@\D%#7+Z?.G3Q[(NI@J9X$"2$U3(#0$B@%
MH40_7(@04-RS"A3,/"SQE(.%"40B3+#P`8,$@QJ\)@AG"4ZED"2,AJ0@00,#
M"2*YP@TY-"2'4A(J=*"PU`,]"R%+E=C[P4('#)7\QJET40,$>DVW!OS2,NQ8
M(!!(?G#@8,MDE%Q+DI`0X<T"$A8H$(&080.$"3`<;<"0P',-@)I+F^CKP8P%
MU!XPC"X)]L+BH9XOG!4I`2R%JSZK6[_^CMUGL@@?((@T2B;S]NX?:%?0L,&"
MD0^IW'BGSG6K9/`6'(6UD"$@W0D!;7!X(%L&%LPG`01F""9#!(+A]8E(X5!%
M1!%/B002!4#]P!4))&S0%!4`&GC"!6!Y1T$/DKW$#A+<"8A!?SI8A9Z($VCP
M`(8?<&>08JUE``&'3CTS4@0;/)#B.@&M>$0*[;2Q%%@2='`>;RW092$]Y?U`
MEXCL<2"!.=E]"6:88LJBU05TT77>$;Q14=]^#JJGU7HY&G=E#7Y5,$$&.!R!
M`05@09D!7B:TQ`%L&'@P$FR5-%&!#!JFD*:#?_7WDIDB9:"G!,J05L]28H5T
MF*'!E2&H:XS^0>#!@"UI$!"B@4:#@1D5A&/!5GJ:QIZ#L^*IYP9\OL4CIC;1
M$6>2'MUPB45O/H@$"18.6*<*S@9Q07XXC8EMMMIN2T>?&7!'I5:5W!06/>`N
MRT%`2SW`Y0:A/00I!T"=\!\[0)FIP:L*!@J*#7F^X:R>9;U1:WED3"!6KJYI
MM=5>])`8ZP<+D)1"!@VP-*.F<2REA5."GM=EC:J>H6E<93Q&PJSI>M!E/2V<
MYN`%I4RP`7I'R&RPR2QWP(T)1XI53\7&L6J$!@X(%DZ2)=!S-%7YX;I!:N]=
MRVW55E]=7:QC1"@S##;LL+406`@!K0;0FD.$$"IK2I(V;<"`0[K^YA1G!M=U
MJT>&V#<H,T819("EM=@IT-6)#$6D^D8V%W4`P];XB>VEVXS+44^$0YP7Q]9+
MJ$U$#I-[_C@./'?2A-LVL-JX$]_*>TTV]510P061-*$5%5C?CGONNAN2'D.B
M4/TR6+L+8H07>*#DY?#*+\]\/QL5`GPGD)0D2,\E>,T'U3)AI$?TU!MR.$W-
MCT]^^;2DL($WWR<TT^ASU!S-&]@GM#Y"Z:-3T^D'UH"#RY`$32S\'2]S^4M'
M&W3#B%.,@R.'$2!".I80K_GB!\PPGP4OB$$_@,0>AP'5'=Q'O0WZRP/STZ`'
M]9`*.40*#YLXEAQ*V$'?G:X>(-0#JV3^")%RK.0P%\$###LAG>1)"XA]F$8&
MCXA$"V:@2QN$71'R1($%%.<2;DG,C&X`A"LB"S8B45<5@L"!FET13T%(G`XL
M$9:9U6,X*.!/6*ZX`044!6%;8$>JN/*&XJ#A`P]X0'>N:`3A)2$M6ZB`!*38
M)P_4(P,\\U,?L5A%HX!EB2213P<>0`&]?(4#]<#!!5RC`@9LR$\5$T(/VH&H
M!3@A3]<K8_&@@,HW<B$L"7A)!(3G"!@,:RNW48`,MI+%XM!1,`.28Q*/B<SA
M+4H"(XF=6&94!1)$``4*0E@U4R66<`A!0_F1&7\$I)[6N`84H("9"X1DMOS0
M3`),,$I?#E;^J!PHZ!,L2P\XU?,5/4D1<P6KD6OBLB1`N88PW!G!C5`0KDP2
M<PMBJ6?LS`8!;7J@9G'Q#F7*E"S8E:4$5P2%.\HCMZ5D8"0&`04[D;4%X*2K
M3^FZ842%@"/&@.0\WAF6/S5`%PN<9P)?Z8Y66"6SL0@QF40MJIB,4ZL!6<(R
M)?"5P3:X`3=::`0`Y$VU+$&/\Y3C*\:Y@%]8D\DS&`11[+BE:_+C1VU\2Z>#
M"XL9S%8MJL`@JUY84AIS=1ZS6H$>@BI#BL::LB)%K#5%J0^S0%FNSES&3RR!
MS'`*YJ#U#,LH7'C$2!3S@$_F@#<&`8E@7K44,Y1(!>%B6'3`,JS^P#HK.EYU
M5%@:LQ3J&'6VM,5.!U*!N!T4(2Y/9,\*('#;D8*T6EU*P878J=N_/(T!ATJ%
MO-HB14Z6H#,:J)9F%6F0SORG$N$;:P1N*Z[Z-`I<"FJ`,EJDL'2](0I>8$L'
M.(#5.G$%N%4IUQ:6^`FY&8&3?O31-%$%,H"48P%A)$':K`0*QGK`O.69*7RW
ME+;]:I=(A&&+KSSP4@]P9V'X=,(0J8139*T`<W21Z3-L,M3:JGC%^C!*.7)@
MF[\DIPJ:"$PG@="!J(**';-RB@1JU@%JP:VGE>/.1]GCQG!,2IB,B<L->HI%
M9'6R"DX!Y:V4TX)GI&$%#9N!-G$0@9#^E(,&@1SQ)<"B@1PO!8M`H(H+'"$[
MP@JA*BE0QA)!I94YRPXKNG1'G9-V"1/\R\EQRYO9^D4&'*R@C$VY@:$5&02@
M]2!OVC13^D[(XDQK&HDLJ]L(<<AB[_FG/D:4A*@WC>I4MX(@]!M@22:8#L]0
M<('9DQZH$5)!6^^PU3(\R/H*6&OQT2%?K%:UL8_])7!,4!X[?)ZN1^&W5^,O
M0@RT`P*_T1#NT2_7U>XVK>LW$VX_VX#?/L-,LNT","![W>R&!:34MPP7*D*1
MUI#2853!*NO9X'YRN!^Y2N(_4821>.7&1Y")-3_9MGOA#/>'5U=P@3T?.A1I
M,QQ.\;:@&_3^V`2$(5L1'&.V$_RI155@`!&,%YPEN8`(1&M#:TX,I?>&-0+>
M:?F-N'/++(Q$`P060N.`,`T91!CE(I)!H#+^V>EZYZXE>%6+ZER4'HO!#;/4
M04B*0\-:48$+2/N1QHL`2D5BKKI`#XN\9OD$<:ULH16X6-%N4`I%CG9.#:^[
MW?/`R19A(#7E<(T#3$&/#>PS6)=HY@5@$V@/4)A5L_IO=UK4WM6-I$:#V0$[
ME%;'SB2+Q\3%P`E\Q2K7D%1)1W"`'4^`L!JU83\C2!B59(!Z$8#$.Z8_CQ<J
M7YXC^*DU*F!7?D)_'E89!;ZIV'TE2K![O_S="693S#0'5MV@/A_^-F!DUS@#
MA;`\Q6X"6^6H%[1?A?J4Q2;L^$2@M+%1/)WGU'=O_Z:?"=J3-<H_NV\-4.H(
ME>BHRW!M,2RT9'89;Q$Q(W$$#V!(O'=#79`B!'@#^,%**F`!1((IDF$!+X4S
MI54!1-(2[?!)<P4>\R<8#S!2*V`0!6A(3U$!$6`&%U@"N+5:*?@(2`4*I*93
M?4$7P_(=_1$<$"!^'E,"$3`=7F`&`D(%-Y-(#V$A%/`>5K(%2>-;A[<KEU2!
M3@42\.5'KH$Y[J>%=Z=;R)6#-](Y+0@*#N`D#C):#S9:&$8&(L))1]`E?"):
MPC4CIR$#]S>"C`(>)%4NL1)H"H(?@7+^6RK!@B-Q)BE2,0P`)<W%,NR1()^U
M-KGR8])B.&X%83=(`NC%,D'@(R0T$@UP`D?@-5T"7^F"?"<0*3["4$*P!9=8
M<VB2(E[`,D:0+$>#?$XX'34S*T>@(`X1'D?P'D3`+ELHC`SW%]$!/V`Q'*Q7
M`H\#2H"#%C-B!H;!1VAD&,,A'#<0:1GP`*PT(,07#JC!#J!2"M&X6^S$!'N7
M*4*"*,'Q3DP2'&'1`6:2"M#2!J'Q%ZP454]R,)$(&%GB!'"!%I%X?_!%,RIP
M("FX59<('%8!*1JS2ERQ&(<Q`4V1@B(09HBB*5#!)8#D`-SG%)SX8P,2<C4%
MCQ&I#1/Y%D'^MAEO939C\3<JR'[#*).:%G!_@(/3$S'0<&VOL%`XD2\XPS[D
MYFVV8&\8\8`SB91).3W=\PW),T$_)&S!Q@BE5FUL<BBFID#U,Y324Q/,)CVW
M,0DQJ91C63[IYB7GAFLEH4OV$P[PU@;;1I7@QFO?PPQB299WB9=&A3/@<'74
M\$.,45WH($01DSD]E)>'B9A*B5\;A$KP-5*J!%]B-$>HA0*DA"=[@7JE]`*7
M:0./E&9!%D7TM@'/)49I5T;8)0-DM`7:X&2)Z9JOF4PX!5^V!Q)CT3^76%*Q
MF$EEH!5>T)9]`IB:\F!*,GX>H5.1Q0,PPQ@C)9O]DEK#-TV<1!?^P,4N*0:;
MUXF=RH-4M5()?@)E3H5^;V58M>-&6,%3F%(&K>$9S>1;+X*<?Y$KGB<P9N4"
MML(C'>@(.-(&&Y>=_>F?N\,E$!<H8/$)*,`E'J-AX*4RLZ)3R8%/Z!DH#+`Q
M-W05$><497`)X?(OBI@V-R!%+`-QSI<K^4*2_VFB)\HM+J9-EL18+P9[884"
M008$@G%F>1(.\@(>84!E9J1-B3$23I$#<O5E/44%W/%D8,$K>0,816"=*.JD
M3WI!!9H+&F.74&JE5YH3XA9LL[.3NZ:5RT`#WU:E6$JF96JF9XJF::JF:\JF
M;>JF;PJG<2JG<TJG=6JG=XJG>:JG>\K^IWWJIW\*J(&::;[6:W.II4$Y;@4'
M$8:J:\Y&J((*J9$JJ9-ZITIR,=U1@`=@<AZ@``B0``@@`9^J`"[0``A@`#1S
M`$%`<R50J@@@.PGP.JJ4`0IP`#>(`$9F7@>``)=*!PQ@I%BAJ?*$`)I@`,)C
M`Q9P`#ARJB7``!*:.0R0`$Z``":7&`:0!J9JF)2JK:J6`0!`!`*@`0U``!R@
M``4@!`XP`%H!`!N`/0,`&^NZ``1&`"1!``^``0"``0$0$A%``!X0`)T1`'0!
M``%P(Z<Z`-'&"1UP```@H3Z`KPH@@@?@`*ID`!!@`*:``1=;!`1@`?T:`0N@
M`#65`@C08Q#^RP"H4@`0<`!D\`D`,*;;"K/F0P!58:X`0$/Z>B,$0`8`P!\N
M4``G&ZT:0``%X$<I0`!/`@`7,``-8`&?.@$ZF[,?,``&,!<&0`$"$#OIP*D*
M<`8/4`##&J\;(``70+`%P!TI\`!4ZWD`T`$",`%62P$#<#H#P`!^-``3\``'
M\+0?8+-AH0"\&K.!NV)HVP`GR[=7AZ]1>Z\-H'H?\+4)X*P,X+(V4`!3JR`!
M$+(&`*I0RZ\?$``7T*D(0`$`X`"$XP&@(04*P+40L`!`,;2"-S$"8`$$2P`T
MHP`7P``&4`$N^P`)@+6G2@$ZR[CWJK0S<@`&H``2H+,X^[2A\;+^@@N]NI,!
M!5``]7``T?H`!WLC<GNOD7"T'9"XG>L"!&"D'I"X$%``'```7%"O?%M=`)``
MRFMN2UH#JKL%)0(`/,<`34L!"."X%E``8#8DN2&W0E``IPL:%],.&A``'&"U
MS-HE!7`!!QP$H_N\T8O!MX,`_NL$"F``!P`J$["R&C``U^L""4"]ERK"<8``
M-^$!!<`6*TL!!F``#;`"!&"]"U`!4^NL=-``%^,";XL`02"NU"(`A',8"E"[
M'\``!]`J&QP)RJM*`.P`,"`!`V`&7JN[&<S%@XL1%#$(V\,(T*`1`_%KOG;!
M7:S&6(.6">3&T//&<RG':TS'Q^9L0FG^:Y/VI4Q)0`+T7D-9;(U:J-LVQ]&#
MQE_:QFU,R#C$?N&&L'4LIXB"?'9);WJ@<!"D;0<D!PI7`X2YE*9T"C7I!SE@
M1C\!1NK@E#<`E?LF='=<"`/GA)`\ISC8%ES'A$T'2AN@#7[3H1E`K5H!`X:3
M!6#Q%;+F`%'A&.EA!19J`VVG-D%@8)B3'M%(1RXW!$!I+3:PJDS7="87CW*W
M6=`B&&6D&&X3#@S@/\)\5WX#>WOF87[31&Y'-FV3$OZA2--@-AUPS'!7<=:,
M&H*#-\G@,AWG'V]3'/S)SO/<'=S!./(FRVV*@XF"'KBG`I[''1#0(C[B&T-2
M!(YWB9C"3AC^UEHU@-$%ZAT&,BL1AUY8@2H$N%\NK8(@\2T[T!V2@2A588K@
M@7S.X@Y*XRXB<0EZ<M$DIX+I0R3LE(O_,8GF83;ND(NY8B`UP-0-^C`&@]+)
M$"LE.GE$0R2?D,7G=R5AQBJ!55$WK0U400.\6"T\<F%-Y8;=X57I,BV8]]!N
M2LO!(3N3X9#(XD<?O0,M,2P_6BU\DLU/Y7D1%4[4\C2,80EHA#[/\`!3.""1
MW2.7\%G`(IYP4BO,A,0;1#A7,2SS9Q1]G48KLQXE]G34T2*78%D4*A)J87^M
MK1]/-8(W^86I8*'S=XDAH2R4:"L-""=<,'\V4&(A\AU-%1`:\EK^\E<D=0VG
MHD@XL(,YZ48"WH':'H#.)5%B;@A?G\7,J-W,5<#=-U,&^X/<-U(0M\4"HJ@L
M__0=FFV(-6"AT*W=D36=ABT$`/+6C%%9S.``W#V*U1TMYZH?!7;:M#TK'?"K
MMPTI#Y4K91"+A!,QV_?>S*)XH9`CF'($OO%@[Q$6/UE'F>'<;1I57(%A"S.1
MW@`7),"2']``YH`Y)\@2ZCB1[[@-&I=2UZ@&%)`:&U,%*WDP!C$4;1$$R?%.
M&/!>O!T=-@"?):X^`\($*<4:-P`0T1D2:"8"E*C-<U202\3BD0!*1E&0KK&"
MV%@7-Z@#8%D.2.&$>X:"/G8HE[@71R[^+X%B(,PP`:"@C4=)!BZ)Y<,RCB,^
MRX!@4(%<"YR,#QRR!HEP`IZ<"7\@0H(NJ+`F;JFRRN.@#H'<,[[0H;^FJ.:6
MJ#89!Q?@EGN,$UOGSHC<;-73!DT:ZI*NK8<*Z[-^HI[1HP9)=+J1*D;D&7_<
M;[%S+8GLU.&PZ'(L#GB`&'>P"=(SW9X^!ZD>QBCEZ,LH:H9<$EY9!W%)ZW**
M`9=ZNGW9+CU`%,U>H/V1W3>"Q#:PP&E)!IB&$31R*/IV"FKB(C*T)@:T02;A
M0-*3$M2!$WFF"IC#R;(5:+?&QTC0*E0#+Y.\[7#:W2J`<K&\)A[A5"DT&T+`
M@Z`^W%MAY-K^&!HCH*K/X!7P]A"'LE;?\DN^X11GH<]75$7[=A1?Q14MK@/;
M6`]B<1MG4>*OD2D>Y`$+0!<1H((07_`0WS+O-5*C>JQ]T0$+X!H)T$-PX4>-
M,:O4K!M>SAF>419!4@^.$&DT@QMU_BVSM$33M#%'(1@(PP$)<"ANUO!L>A4Y
M25J\-2,IZ!\=&32`P4E0MC%(L6B@$(R`*20`0A<^DD+^`@-8B![.`AC::",:
M72BR`2K#(ER!=-:3Z%6%]&,:"&$TDUV%TI>8HR!7%7%G:U](DRY-GB\I(R".
M`@>BCP7L=`2K$XPJ4%!Q)8@CHOF284A#`A[5%27/D#+[8R6HXA[^.5/Z!O_V
M)^H0+A#IQ+T"L4(NW>T#S61[S$X2LQ>D(H`IJ1'G3I#<D8"$+V&+0>$_D[7A
MD@'A+Z-Q+]$.0%'O@S611[?AI0C9Z[\TKG557F`%$;$TM`("'?5E%H5]FG5I
MW^1]<-6^V15E(X9C\+>-/)0,ZF/$H"0?DR2CN64RGDEJQ>%41)]+\3-S>5:0
MCS)BP;2,ZC6[[7[#X_(YO6Z_X_/Z/;_O_P,&"@[>P;P<H7AX:&!D5"QR4&RH
M;53$*%(Y7&!]<*Q16&QX1'!`<&!<2&B,J&IT4&E8'L:`?5!T6%R-3&A,<*3%
M2'A$DDUIN*K-3%1P661:&,%@0*R^;KC^4E%45.3N.G4D7Y!]-,;^JG'@>-A0
M4'@H15-#X-+`P#AJ.)!M-'VU^I#!H,I&-'))O/0Z]N[:NV$6<G'B%:%+B0P/
M.$C@\,`%AQR_%!$**7(DR9(F3Z),J7+E&T]&.H#ST"&,!1@/74;S-.Q')T4<
M=J)CUJE"ABT7[BDBRG/GSS5-?_YD.A18"JB=8EPXJB;,IB5=,Z[Q@"'7APY*
M71*)H7-%6!2>.G@RY[2")U2>,NB,0?8I0!(66GBHT*-#4;-%M_XM"TX-3)Y1
MSY057'78S)V$)R0ZDCA6BW/F0+(,+7HTZ=*F3Z-.K;J0&V>K7^,)S*TO[-JV
M;^/.K7MTW][^?P#Z`$Z(-AS:OF>Z$1XV.1WCM.(0#^M\>)UAT;=B?[Y[._?N
MWK^S/'R8.721UY/YH*HF[7D8'*"]<<>ZD`7VQ9>X!"E_#@5@,$8\<M\E0K01
MW"3D%9B=>N`QV*"##T(XQQ1&O&`=2/;@9`\,R!487%.77'5A<%NY]V%,KXQ8
MECWDB+/AAQ^N8XF(M/CB`UPY98<A',A=$8-@7?08PV**2$)A434:$:1,Z$00
MS6)*'*+3BL\]5(P/'"Q6$(=0C2$D&SN10LN20F)X7H1GHIFFFBE-Z()9W$01
MF&QIN(.&!A*H\IXM9%!A!`034&&!*1(L@X$D$CS2R!&(1B+4`S7^34"!`SZP
M@J@/&#A``9;:B/.G.#E`,((7ZS29102(#D67!@\4B1\'FQ`*S0ADD<,HI[80
M1$X[':Q:9`62ZL0`%1"@BH6JK*:!@0(_$4K%"YH"2A0*INCYP0,;.3"!.+'4
M9,0&J(2ZC@0K+.N!`[&0@)<$0RR``EVQ?N"I+2>L6:^]]^+;A[D32*#/JZ1(
M6P%FDWKA"`<53@#$.!(,J80*H61ERS$;_:6I$<*X5T$9$A=#X3A<&!&Q$E@T
MV61_L(@Z@Z`'?YP!HAH3!`\J+'R1,!5?6#F4$B=TH0$U-@A1@@L'^K.%RQ;`
M+`X\$[(UPR/:N(OT!@]4A,@XO#P@4)_^3X2RP1E!4+$!%4HTDA@80OB#T="J
MY-NVVV^[W:8O=(U!002X:.I2.I;`TQ\KM<0`RP6Y)%8?!ANE(VJ;*MPY3LT^
MO$`%*E;[\I<2.Z^2@B6=C*N!&2U3<,$D2(P3#)3@^&W+).]X:[DMDR^14%I#
MB-.?$45?D(&V/Y'>)^M?Y.[.KRWD;H$J%`@3\D$5;!"!!J)X.[@N/V04]M_!
M+U;AKA)GTP+2<(,?OO@,MGDHIDLTV8$$$1OQZ!*`BK.-/K-\X(`)6/QDQ@2Z
M-ZX)+:DT`A1C<!@W".:"`Y)N"R@XF:#&H:G!12`(UNI!`\`A.;QHBQ$HZ),M
MFN0Y@2W!`@[^<$DJHB!`7!7A!#_;H!`N,,*00>."!V,!Z99&A718H$G/PF&3
M#O>!"&PN!9&S14="EP85B.X]CKB;+X@Q%JKA,&A":-ZO'%>)7P%E?%K<(A=1
M,Z*.Q"0X&8B)F[QUH$60,1J\6)T].O.3>CBE*`IY3D>$HZ%HK&B.4YIC0<9T
MQU,H8D4R2,,YC*`!G/Q`CAK04'`P("5:="1#@`$180*I'3$*,@:'`0F'O#6C
MCI"(D3WH1%XF4Q8I[,0]:<@C8,S4Q5?",I:BX88=/"".+[5A&PW"``>K(\M?
M`C.8PER)*\LSS&,B,YG*7"8SF^G,9T(SFM*<)C6K:<UK8C.;VMS^)C>[Z<UO
M@C.<XAPG.<MISG.B,YWJ7"<[V^G.=\*S),4LB#&7$\][XC.?MTF1/OOISW_>
M)D@]6L=;\'(,7N'E)1H8XR+:F"27\.I*>J,,0"MJT8NJ@0($,,(!9C"`!`S@
M!`<(``$<H``!(``>#$`I`39@@`;4;P%E"4``/-$``/2I``4P`@$F8(`FS1.C
M0ATJ.3D@@#$2@`,&T$<%!.`)`C0I`0H`D0*F&H`A#,`"22W+``9@B0,`0`D6
M,(`!Q#$`GP*5J&I=:SH/0($)(.`#`4!!!^;Z@0&,80$!2*D1%B```R3`"`H`
MP$;*(H`&-*`""C#`&!+0K\">]0!=8BO^92OK31A(``%\#0`T-A"`HD#U`PI(
M`%!&RP$"B.,"`,@/9Q7@5@,H(0`,2(``/%"`"1P@K9;=+6^MR8$!.-5:`:A`
M`0)[UR8MMCY]-8`%`*`#``0'`!JXZ0=Z2H&K-E4"L#V``G#6V^^"MYF`2L8"
M9C$1+S2``9NS0'I%I9'@/(!7(\`!*(S`A!RDMRA!#2]_^^M???TWP`(V3X(Z
ME!T!*><Y=QPP@QN,+_\@,DE=:`.,\*`5-5RXEGK8[Y=N"1T/[R&+/6E)9HB9
M'Q#3P9$.7C&:&'"84VGG!Z)"$&OH![A.P$<0_"SP&]K4GEZN(0HQ9@ZMB$.@
M2@QY#FD!<.#^-,P\%D/901[X4R<>L`E`=4`@)5`8AIO0`XW=+`*W#`QFWI$P
M+TP``I2:P`/(;*@%+$("18#&,01B"0S`)0IW*PN>CC(1(6`&2K!(0PF=$;\)
MO$("32)!I,(@YK+P:]$^VX#+5J6/U(I%`OS0]$LN(*PC'*P)(4O`%;+E"6>X
M9`<9P4@3$>6`-@-JD?RRQ`5XH494U;HF/8AT-+3AZ*-`PY&I",.W4"6054^@
M6XXDT#$J'>5GBR8PFLH!-"*!-+Q`0+]J&*&T6S"&"-BR"+]PWLZ4HN:"Q6L8
MGHO%E)NWP/?46F*YV,#@BL"/+;3#"TE8-UV^<.\K^.R'0H#+HH?^T807Y"X+
M:MO"7R+0O"$XT"R'A!(,'I:&&>Q,)S?<63M6]9\CK;H=(P#9JR(%%XE,S0GI
MT%P*G/>K*RQZ?:D0!O9^U1\@QKL_DI'``U8Q<A8TX#W(TTB$H6UTD@3MVA;`
MFQ4\D(`%J<S6SC*(7FZ`KK=.XA"/RXKS:D*U"X!#;&?8UDW@G0:%\1(:R9O!
MN0XF*M)Q90S.PH01;-"$D3N"[N0XQD1L<)!;0(1O,*"WZ&Z7N2)-Z.J14A1"
MR+#H&F0%!0]9%Y$RP`-\C"`6-J`&%@_XPQ6(C1Q.D+/`T%!K.3ZD!?VR2PRT
MT8O<36241Y\]TC.QB16,A1FZ0$+N8H#^"C,,+@/Z()LX^%&*PX\E'_?XRP.,
M/R@7.,$']HN7YSIR`4X1T@%>P\"=`QUH:\%G%(SPQ?P4.(V+\<-0HI]9EVJX
M@5,`2/ET(<8AGL"^&8P`\<*@?R\^,B\5@`(W+!2B!(_GS$R3:-HBQ4#/G4%&
M<%Y67$#[:4KH-8('+`!<K-H,.,_==!S2)!&%-$D#%$4"<ACMF:`=3$)4G-K2
MJ2`)F()]%5\*G-];+`9G[,0DE``P))_FM,`A>84/@(59I!K8O<CZ+!):@)TX
M[-J!1,8Q^!M6L$`T"(9E>,+@',B-8`$*]$`8%$4+-H5UB%L'I&!Z6$4*VHX7
M@((TH,`JU(7^6(2"7XR,9"B"&;@%4>Q$5C"A.7@"EJ1`DO3'8TS"KV@%]_G`
M^Z7`ADC&"2JB:!2=YBA%<_"!:]"!UR1908!0O;QA'7#?DWW)YI0@)&;B)R[B
M*`+"CM%8D/`!</A&DEQ'=+@2:!P8+MF3+$K(2+0'/7T)*LY'+/*8'-PB*0+C
MAHV'*WX),>)1W4V)(1DC+LYB)8H8+8X8B$#',=!3@E4CB*QB2V0).HP1,^+B
M.M`"<BQ"C!G90H51,TX'B:!#*4G'2QRC*`9C/#99*KH!A]B8(93@*50'0:D!
M-;:!PP7.E928&DS#(\;&-OKB#Q5=!&6!A'#0%P)9@B`/663-&D#^P"UA`$P5
MDS2@&#J,0`=4T(W)XTC>0:BTP/#TX##L3U#X@@AL@-A$'R2\BMW\P$J:`+A%
MP_6=VI@1Q<&L`@.`XQ6(P/CYQW1QT+4(T7B@R^#T'P4`I6SX`,@@6G_HI!"]
MW_X(`33<SR_45R2<H4<>$H`$B,=P0=[II+1YPEM%SOMA`;^0PS*LPYFM`2=&
M0B)@5I=(P!CHSB0\A-B<I"4`0;8=3%'PDDZ(E3I@!B_TR'B09&-^R3Q(PK<`
MRA08GZAMP0ML@SMPH/,00<J5`D9$`@YT0)O9%UTTR44D"2EH&J#\32.XC+6(
M@$L`H+8]Q)2]PRKMC#.,0LXA09_LP%_^&,H%F&8'D(++5$(#U(3QB(5P%D\6
MF(!V.,][K$)OT@($4)DI"&?S>(!D_L6=O.;*N`P6C,+]A,G_/$"`)-#MS,#!
M_(4OD,(&[EX&0,`C+(,D)!NU&(&F$$7Q_((JY`(5P*-C&MV$2`(O808HC&:M
M'<CD.,-"%=^XO,!TI:7/($V8S(+694[K)&CH\,W>I44VR"93_L\Q;(N,O,XV
MM(#N0$,$A<ZB3$+PV,1*3DVMO0IAFMXFN-T/F"C+-42?7*C1T.<@\1+E!09!
M6,!&%*DX,($)$$?F@$Q&/<Q8R.?]U,<M,>0RZ(J8-=%8]L+3Y,(JJ%G'">B8
M1H-8:0MQ<@#^`ZA>5(3,S=@AN*D"C%G$(JE91@1&#YQ;"*7#A`P>W[P1B/+"
M$SC0@7B-<FF&;:ZD(3E`!O##.^B.5UP%U1D-]X'FW;S#&XVF%`#*6.B"<^J`
M&I`"]Y%!%'!01E3,$M`%9N1"YW@G-%2`*=R)PN#`"_R$%"CC6"A00;P`GHB`
M^LC$%*"I4:3`+IPEEERB!;I+SRD!Q3@`89#IF,I16TK>X+7#I41`PG#`)/2"
M%K;`2^9:)S2:,^18&/@""3!&40"!.W1%.US!Z*3`8D34N-;$MH:%LMD:61@/
M(1'JJ5F,=QX,,ZA"\^`%0\1KLMV;>]A-"FX#&0$0"2@"C:+9`NW^3[961>GY
M!2G<R=)-ED#`AR&N1PJD:`J,"SC>B>0%;*1<P3)$$8:Y1U%\:PX(Y[/*+!T\
MZ;T$Z!UP`5UT4DJ\QU@`1&.8AI%QC@_.[+,:F2I"(SK6T]*&6$(F;2]>XY"Y
M!P8PH8`T(S.:(CTQ0M9ZH]/R6#9>+20M2-'&HW7@R"?VQ8<4&"PF!YMN!4S<
M+-G*;4412Q&T"3URHA$T*_H03Q"]H!=T'YYTPAB\0@7L[=PB;F_=[5A0`1Y6
M@2'RX1MIA:"F0"H@$G)*S"ZDQPL6[O^X+$YVPHPE[NA2UI3A15;DT`%&0B]\
MFP[Q$B_ICD!@P:ID2#LHC$4@$B<B&6;^08X/L`7I`B];S><J$(D[%"D$&`^'
M<L/U@4,%D*8SN`L3"H%7TMV*Z.[F"`V%V,-^!&_W8I3<J.0M@"8\;(`#H$(%
M00:@',G@[(,X9H,^W&U^$NKFG!D^LISWXN]%1<"?S9JT-4DJ/,+(W!"_:*JH
M&4]&%%88-)D"%X2*=4*+@)BRR6;<YF\%EU.==62/N4$A67`'/QL6:(4U2JT'
MDW`)F_`)[Q8%H_`*LW`+N_`+PW`,R_`,TW`-V_`-XW`.Z_`.\W`/^_`/`W$0
M"_$0$W$1&_$1(W$2*_$2,W$3._$30W$42_$44W$56_$58W$6:_$6<W$7>_$7
M@W$8B_$8DW'^&9OQ&:-Q&JOQ&K-Q&[OQ&\-Q',OQ'--Q'=OQ'>-Q'NOQ'O-Q
M'_OQ'P-R(`OR(!-R(1OR(2-R(BOR(C-R(SOR(T-R)$OR)%-R)5OR)6-R)FOR
M)G-R)WOR)X-R*(OR*)-R*9OR*:-R*JOR*K-R*[OR*\-R+,OR+--R+=OR+>-R
M+NOR+O-R+_OR+P-S,`OS,!-S,1OS,2-S,BOS,C-S,SOS,T-S-$OS-%-S-5OS
M-6-S-FOS-G-S-WOS-X-S.(OS.)-S.9OS.:-S.JOS.K-S.[OS.\-S/,OS/--S
M/=OS/>-S/NOS/O-S/_OS/P-T0`OT0!-T01OT02-T0BOT0C-T0SO^]$-#=$1+
M]$13=$5;]$5C=$9K]$9S=$=[]$>#=$B+]$B3=$F;]$FC=$JK]$JS=$N[]$O#
M=$S+]$S3=$W;]$WC=$[K-$ZK\&_8(B3N1D_[4D('4G`DF%$/""/%1CJR[3&J
MHSW!(FA84CN&;7&\8F\@[5-;-=A:;3%F=5,78Y(A=3\?Z:,`6KF^3LC$`J!T
M!`2PRBC(V7/D`"V4)UC$R_K@QQ3L(;$<TBV)`%L+4;*-RL&$`>6EP`.4Z_XZ
MP6$<3+C^!PH(F1/TP@/;UWQ2=F#<C@M\SJ)HRQ*$2V6/@)Y\7)*PYA;\1+D"
MTA@H\)T%T62#:UR[`/("FJ8PL)"]I9S^O4H,=$ER$HI0C_/DV`[+U"2X?@'+
M[&Y$9L`%_L"RD,/G3`BBU<=8(ADO;$YP(UKRH`ZZB"J&]<#E*`^%W$7J_9`2
M?(%K`B62$5$L:`'XTD^&5DZVBHJFJ+=[11!XET7!-*2.6J"L"8$*?`)`VK7V
MHAMA^^:VQ/=<'TY1#$$0-:(]@XP2_,>!D$T5R<#TC(+'W@->VTU:BL`<$@,%
M%%:29`I>R`B`7J:VQ8OOM*@TF.0/+1+I[.[K;((VO$+(.,$V$$,'(1HQR,VH
M-@4G/DSNI-"U#L-Z80%<["@%Y.D/Y,++C0#FHD,HT)E<CNID#]+;U<Z!J`!=
M/`0:Q)"X[;/^&AZ0#!`-9TA0WL@(8C,F$D@"CIN+?+;``]2WP$R2\3$/V-""
M,VP2&>1MS)*#REA+?Q`$NOP'%FC*UZ@U$0@G?/`,7N#Y`5WK+>GNX%@GI2"!
MH[?/#LSX<]!Y/Q).+#R"F)%1ZB;P&5ZK:USY$<0/H?X%DX;.8?AY/P-W%SYD
M?4,<RQ"ZB2-'[L`YE^_GU)'WMQP&NE#W[="ZK]XW9N8%I]50Z210N<YU!(Q!
M^<)ZG9G+YM!%)6@!&6`)Q?6CJ,S-*11!MF>!#NR/0.CU?=-%[U4!,>PO&,C'
M*)"JK:J/@-_Z$+'(L%*(*##``B&I(52M/@O962-2_8+9'MX2!)S^%VE&W_^^
MRF(LW9TQPB2$R6CRPI2IPFS'!;^XJH?S2Q'TBB<HO!,@-ER\%7J"#5HT&\-5
MMB5T`+'TYTJF&31(PZ::-F9[]D<BMEWC:&D77IB<0@=LR\U0#V7_`!H0BDL$
MB,;_D/.L"J(9:!&PS5R_PGF-;9A[;3MRL#-6M31.-58G!]B_XU@_;=@[=52+
M_8&AO=2B+3E*HX$-B-<;(U@#=#JFAF]W?4C@_4[S?=_[O='.(M<*+2_6R][[
M-$T;?O@LF%0;-=W'O5/+/1ZMO55#/MV3?5@_]>2_/>-G=3?;JB8QFK9VMK"N
M`BT!`4"P)U+X"+JF(>"*$81@ML\^@*;^><#LO\IY2D,$.,`CP(<E+-U$@G92
M`';=OH,#A.HO``HT/"J]@79@*S]BZP1.0MQ;60RV:W:.30`0'7:Y.@.GU5IG
M"\HC3!E@)V_B\S(,(/;MP-08R?>K-`(2],``8D$E7(K*<$#0Q0X+_((-_`5Z
MLQGL@P"E6=]6?>7Y4=Q&H=KI2>CD55.&HJQIZ1S;Y#/9?"2>3R5#25HP&8:'
M\U)J/AW;YY?!'%&8RVP%%-:(GXL7?<ED+J@+*:FILBJ<$?5#E>_^@(&"@X2%
MAH>(B8J+C(V.CY"1DI.4E9:7C!,0'AX10U,5'6`654A*&Q97%W`?&%Y(+'M9
M,!5A%7`:$E7^F+R'#20E$AQ3$D:UKB@N'YT;'!$K&Q-7212N%R])%;D<>$2B
MUSK+%!D5%<HK8FHH'N,B<UL1G)]654,2(U='>DP<1$D\1CYHD`,EPQXKM?[U
M6LBPH<.'$"-*G$CQ484G+EYHF*"B`XLA_KYH:]6F2P,6*SC(^L3"`P,#5_"`
MK'BIDP51'!S$TLD-PIH4RQY4H/`@9"T>$#)XF*<M0@056BSD6'8#"H:+2,-X
MX;3D`81^,#XQK8."AE,:2<ZV$KHT2;:``RU`@%#"CA$_-//JW<NWK]^_>B=P
M$X$-VI8D-+Z06W'EB9M5._`$X3/$0C_!2N1:6!`0<*.V3;@EJV+^[D^,92!M
MM/P0SS`9RDN/B-*RI,D6-UX<J*!@I(,I+ACVT+%31C8'&D-&HF'1)0Z<X3RX
M<8`B.H,%3D<Z4\2^0V&@?VZ_=_<.R#MW\@K)BU]&R/RZ0>#9"T)?_OT?]?+M
M=Z]?*+S^]?[=-UY[`N:WWW_\&3B?@?0=*)YZ#3:8H((2KG<@?NQA9X,$JKF`
MP0N>!!?##T1,<Y$*K6S%6"L65'!#4AI@\`0%'7"0P28*UN=>@0CNA^&$\7UW
MP@9(/!"!!AX\4`P&`27!P7,JN)C*!/?$T20%$PAV0RLZV'9!'A)(<$)S%ZCP
M95AB?N"&$O\\N0X%'!J1`8<Q>;`!*R[^QJC!`Q.(@D.5%X0)QY<>6,;G"4%$
M\)-GC#;JZ*.01LJ+*!Y0ZH$;=+C1CP;Y@+5,/NLH)`H,_=AHD)IB[#"JI)#\
MR*HBKHX7JX-\>:!!!K?>ZH:N8%VZJQN_9C!JKL'J"BJPNN*J;*_*-@OLJ0(]
MB^RN.R0[K:;K7!OLL-H:NXZUUD+KJ[/)<OLLN-\J:RRPS`:[+0S-KHMKM>0^
MVVZWT(:+[J?JNLMLN,]R2VRQZ6J+[3+XNF&NP?G8"JZ]V?Z:[*VC;I#!!AMP
MJD$SMW8VL<7-]LJI&QGCBK$&8$V,Z\3I#ISLO](&#._`Y]*K,KL1G_MKQ3K'
M2^^T+R<#L+K^;DD<\\(/Y]-!O<W^$_.T8)EZ\YH(]^NLIPYY$```7'?M-0,H
M9.#UV%R#9`#97ANPSM9H<PVVFFUWG=C9<:N]#-MMORUVW`"8S;?=6O.M-]]]
MHT!WVX#CC?;@?/M=]]J"ATVXXXA#'C?C<5..=N*1P]VXX7];GK?DGW]P^.;K
M"-#YWIF#_OC=JT_N>N6P7TYZZZ:'7OOH'S#`=P"BL-ZVYF3;/0'A.G2@NNV]
M_QZ\[+-.PDZ6U%<OP1K'5:]]E5MPJ'V6:8KS/?77HY#]^'#F@\/X5*HP/?OE
M4\8^E>K/+P$P[X\??Q#VYR,5_/C#$ORPYSW]^:^`VW.?`/6'O?G^T0\%_]-?
M`.U'P/Y!$('6PY\#][=!_]EO@@,T'P:M=T#X*9""YNO@!0'X)A3R883D*Z$$
M6QA"^5F/2@_L'@X32$/RD6\-&,"@]W3A)!4J`894`D8NP/<]8:"&0R.,7Q";
MF"7;^,:"K\JB%K?(Q2YZ\8M@#.,6P^.6`/DH0PQZSWETA$;N"`@[01H05?[C
M'S@R*#YD9*,==91']_0Q/V2LHQ[G"*$VIC&/%)(/(M5HR/1D"(]^K&,AUVB>
M\YA15J$Z9"//2$D_MA$_>$RC(A'41S,B,HZ!5*,G%3G)4*HRDP&R8QG9<R>E
M\$$-3PI#J2A5@E3P(0D=6%6-S`=,3JS^PE,>"`,G9&2C52")4OUX0ZF*><M5
MU,A)4YB"&MS2!DYXX`)(*L&9U`#.*?2R'^9,IS&5ALUA8`QAT1.C/,.X1P`M
MR)$\HJ,AW)C(,UI(0OA<T!SAPY\@N7%'HRP00B&$H1W%<:`"O9`<+<2C64(T
MGIB(@`4"M8(<=``##K#,!R!@I@G(R`II^`F5RO*,-F@@`G,*!P=\\B6?Y,$I
M*I&!#2!PC2.TU`L<L(`#,+`44=!(#4\@:BLBH`;?7`5$I,@#GS[JBG'<HP,*
M0(T(KS*$7ZR@`Y9Q1@F>,<^RFC4B&`7CC]*J%[:^RJV1T`(4?%F#X;Q@%I&Y
M"_:PU(\*1.#^HX_1:EU*)`.2"`0;]DC)!2+0S'6DAAI/H@"*4K0"Y9CC!9`I
MC8P4.%,Q)(8W*+@L$O#@RR=TXZRHE:<%^`2!%V"&+%1P@@/"\28(@,0"3EG5
M:M>0`9!(=BAAV\4.,"`4$3:,`JVE@P1L&PBR+.4!VD%)2E'S$Q$X]E(1>``P
M`-&!W,+`B=;-;!68T!U`:6$581!'7[,[!`R(956H@:Z:4%0!/H4644-XZ5R&
ML=S6D.<"6A"($T>R6`B\P[$1@(!VW.L$U@YA`MF%@U\?0-N')$$+(\#M=8Y`
MC0Z80SC48.H#UI"*$2A!1@5AA19RDH.<A!<.)M"J`SARXB>P(C;^K)F`4&\`
MIH`0ES=-2$(;VD>-*_3V'>Y(13VP@]156,8"`>%I:J?\12$[(``,<!$`X`"!
M`;0"`+TK``2*TAT`..``624``A@@@'XHP``0((`#X.8*`'1ARQ\8P`+DTP$"
M)$`"#NB'!`#P-@\`H`$(*,`1`""!`Q!@5&DA@.D28%_V(&#/'BC`"2X```/\
M@P!D-;0&&C"`"0P@`8#(P``80&H='(\&`WA&`E!M`3SK^0\">(8"`/""`5"`
M`:CN``"\4``$0(`&OO/"L.5C@`0<FS5>SH``#A"!!NB@``"X%)@G$(`(.$#;
M$5A``"H,.A4S.L^Z)H"I4=V=`#3@`;S^7L?9X+!:0KL(R]K]0+$'3>:(R!7%
M';@P)UCKHIF@PR-K./9R%7N/YK2E!!/`99^2@`SGVN-#*0EB.'`L`8-(`*S3
M0,F'+@,6;52#-D:XBOND<1-=U``L2KY!/*`<6E!1^>9C#(`7A.V%"$@:`P'X
M``$:8"!A<PK,!*`!`.H@Z1((P`L/0,`!R-R`!%!@`)#NW0$`<>E'+V/I&@"S
M!)I^`+!A1P**CG=\*B``-06@'PQ0``'6D'04")L#<>=#J9E-Y@>H;=`'R+2N
ML_H!1%_=.PD@^@`&H'2\9[4#.A?Z,Y+@NP5H[2>&+LS834?T]QR@VV$_@J23
MD($`)*$!=AO^[@'67`,`!+X`@]?[3"Y/!`%0?/6%CKRA=9`$4+=BW!*Y1YE.
M/*K*L`()%K",#DH#&;)`@^8,X)0Y,".0$]S#!J)`ACXH``?D>-@(#5@#CFD#
M5EQ1H1_J$/!TD+,%":O".I89QQXF0.9M!!$-'+#\1OMA79S[/XN&MA4!@``-
M4`"*A@%@5FL)8'.&-@$OH6\&4`!$IP!9U7O/L`$!\'9V5P`!8'!"AQ9.0``>
M0`!T`7D)4'<1X&6B]P<I.%*$AC5AIP$0H#8;T&8*P&Z^]W4;L`#L1H'M!D1B
M9P`-,`$'0!<)0'@=P('SD!8%L`$)$`$&<`&*)FX-L&O$5@`*0`+^"K``"V`!
M3R<?$/""K"%I2\<!1_@"<I:%07<\"U`4"-@/0!<?E(:`1@`!!S"$</8!1X@"
M/@A,RP9Y7H``(P8`_<!S6#"`"W`%L88"O@=7C>!>MK01+B(0)=`F<,A]`N$D
M_;`!HU(C'"`**),%-]$=5]`,0W$%*K$.1T&)*O&)`N$I^1!.2*(2I!`0J6@^
MW$<'G'`%X92*'S(-TT!;?:"+:F(K.E:)_Y>,DD)[D`=3#/!S`(`3"&![W2$`
M!-@/0Y<`6[<`%?B!1,`UA?$`*O@'8B8?#1``%$``6P=Y8S=G/H<"$*!H[/&.
M`C$`6T>.$F``SW`\$9``U-B(AK8!>:?^AYAV-ZQP`4$7`05P`0D`>Q_0AQ\@
MCLU%``R0B`H0`0CPD`9`#LM&D1AP!0G``!.@``/`"M4R`&KSCI&'`0:P9Z7F
M``O0=A(@`.H@-MEG>M5XD84#A0SID'M(D!D2>1RP=!\0``HP:-A@9X?(5-A(
M5G7GB,H8E5(YE0]AB`$(;;]G*R6@E&ZQ;(Q8!,`3=J]`C;[V`$V'E?M!`4HY
M#`2P`!(`;W"P=%>'E6(C7.^X?-GV!X/69A^```@@`1$0`'2QB%^7?ZAV/`U3
M>)YF.F#SC@EP;GL8:=]1``8P!*I#`WL(B.C&'CXX`%R),$H@=E[6`'RYAXPW
ME&(W>G##"0+^0'3_4`&"*0$GB)6/20,^B)AEY@4'L'5LYQ0(,'K+=I6,^`RD
M27I0N0@(U1^/X"H-=9P]DD_[%)T$1974^1<>(`#)\X4*J29M]Q(%\&W5J"(%
M0`/JI@24N9$CU70D6!;R"`@^5W830(WZ-F<!@#)M5@$`<()DQ1YH]P&[.9[[
M,919%8,HP`!;YV@$>)T;\``"<(*%M0X%:`!2<`2*QFE=U:`9V9\"T@!XMFM&
MP(58\(6.=H<?P(TN""H>\)_/T)\N40`-.00`J@!!IY8)8`!Y``")]C8[4':2
M0P456CALYJ#W88\&@`#]P*,"093`UP$HJ8^FHV;H27O5.:546J7^O1!PL#1+
M4X`UF01+D#8,Q+0.O8(A-1)P6+H,Z%1,E>**Y>$6;-JFRX"EG(!.+2`*T`2F
M@G"+A"2GK0A1]P%IX/$/7]H,>UH>&Q"H.Z`2@!JG:*H2P*2GZQ!P;<()E,*G
M>#H>>HJGV3106WJGZ>&<5AJJHCJJ!`(KD>"(L0*JB:"JS]DJ"9)6SME0ITJJ
MM%JKMGJKR(FK$L&JNMJKOOJKP!JLPCJLQ%JLQGJLR$JLR=FE$\*L^110SDHK
M^.10%44K?BJM$I6M^@&MUZI/I`1*;$11W"I*.;)0#E)(Y^JMYJI/X)JN;^2M
M@/2NXFJM_&2MW9I([>I/0(*M^1JOVPK^K]Q:KP#KKNM*(?T:L/V*1A05K3TB
ML.2*'KR:K!([L11;L8T2L8F``0A@`+O9L1[[L2`;LB([LB1;LB9[LBB;LBJ[
MLBS;LB[[LC`;LS([LS1;LS9[LSB;LSJ[LSS;L[LIH1@;G?A).$1;M$9[M$B;
MM$J[M$S;M$[[M%`;M5([M51;M59[M5B;M5J[M5P+M0-`;@Y1:UQ#@`S`:F5[
MMFAKMFC;`&F[MF[;MG#[MF?+MG%;MW9[MV5+MW.+MWS;MWF;MGK;MX&KMG`;
MN(,+N'5[N'*;N'>KN'[[N'N[N)`[N7\KN7@[N(Y+N)K;MIC+N)'[N)U+N:*[
MN9D[NHV+N*#^B[J%:[F2F[F&>[F`2S<9*1&[%F\6>[NXF[NZRP?8AF<0H3R=
M!DM4`4>R5+RO5$;$^TFE1$@&Q:G#^[S+&TA::E'3*[W0VTC&^TC8NT>0]$K:
M^[W4"[[.VTG>&[[D.[[=BZB<&DKG:[[=N[Y=VK[H&[_S*[[R>[_UZ[[EF[_P
M:[^2%+_L^[[Z"[[J:TG[V[X"S+_WF\`#W,`*#$E"5C8Y,BFJDWJ[>\$8G,&_
M>IV%\[L5_!TC:0`5T`![]I!TL11O=@(*4!A*,`"@H@$.@``)8"M%>@!P<``V
M!P-%J@!7X`!SU@$X#`,#X#Y2AP!>8`$#0!<C)0#X8P!D1G$-P*/^!DJB&A!X
M$3EG4UR9'&#%&!#%G?>0A'?%[$$!J\=[U;)U2'P%*QQ:+Z'$&OS&<-Q%P#L/
M6?/!@+``+EPR=B8V7A"3*.,%A(D""'!HYH-ER60K`-`,G."5[R$VA@G&6."5
M#N!ZZ[!E:OF-(CB"Y_:-`_`/"(@$<$``10&'&AB9M:8#8O-EH/P\2@G)<',Q
MY(:`*P``+OD,$;!ETQ''NKS+DC+'$0&\:J,0&E"??Q!U"#!GPZP=C:@FZM;)
MA9>13D.(;A%Y^Y'*$N!E-R@0NN=K7_MUY*!H"FD`+7(`#FDZ4)@8!S!G.[">
M%!>-K@QTS^.?ZKP#K*8`;^.#?```;OS^![)\S1OII`(P6;P\T`3M%[X<M($`
MS(`0AVJT>!2'D]BQS"8:`+99@:3G>@BPR"JR`V*#QR\@;@IP`,OVCBW)!P%P
M-B=@ATX!`5#X#*E<@(P(@J:#DB<`SZYLDU^F;Y,WS3&0E]E,#0+0S8T,9A%`
M;3/X#%QY206]U$S=$!R<&%5IQXGZA>^!SQP`?)\6:HLGHQGI=_R,DW<#MG69
M#SZHF8-,DEXF:MG,DP80A4XZR35*E"'Y!T\)-VY&>`P-=`^IHZ&Y>O$&D2A0
MHPLM=@7``08@`.2)%DV]V(S-$!Q,QTXMU>SQ``%P$<``D?!V"R0P=!_IA7_<
MD0C06S8"`/O^9V@2`$Y_(#;A4=9E&``7T`$8J'2W0M22-@!MYWN,%TQ8J,T,
MT%N9Q@#(H#7A9[LXC8!V<FB^'9(!QP!>M@`;B2L.H`$;FQ_6[&63G!R,]B$>
MD(B-W=W>_1DAVL$6MC7!#`@60(''!]5*@-XC18''ILXN00(=\`")-P5<F`!>
M4)$)8'`:,*%E@18,\"0E_`$.@&Q7T``;`%*L00-#M0$*`!83H,X;4'5T`0$4
M2&91D``H(I!)P.%\0.$>H`!K<`&61P$4&.!5]P#D(9!I,&=FR%L\^`(\_-TT
M7N.&<-!1';Q5MIRM:@D8B]`V'N1O_-B_+-G0N4I:BJW.*K`1`J_^HO10\AI+
M#RM'X`KE]%I00I[E08[C=:SC6O[E8![D1.[!7A[F9G[F33WF.6[!:-[F;@['
M7-X0"OWF=%[G-Q=0>$ZPCQ#GCOW!0&[G@![H4:GF7<[F@G[HB`XI%E##NREU
MC?ZQCMZQD;YZCYYH^WD(?+X0<Y[HG-[I?G%A66MVB$#H"P%,1N[IJ)[J$$%Q
M]FRZ%3FWCTEHL*(Z'MCGP?OGJI[KNHX)%RWKJ1K>D.W8Y+WKQ%[L/@[`K)3L
M?X2`OHX(F7ZEIV[LTC[M%;$W?+U/M(Y6T4[MW-[M"V'M$YS0V8[K=N?GWG[N
MZ'X)X+ZJV;[JVY[N\![OB`#NT4/DY![^WH8N[_J^[X'`[-=>"+Y,YOG.[P2O
M[^ON[./NU,OP[@7?\-W>ZZ)^"*1NZP/O\!;/[0>/Z0GO$)M^\1[?[?0^ZI=9
MY&7^\29/[!`_ZX5S[QQ<WB?_\KL>\AHOWH4.\S:OZBD?/0&O\!U_\SZ?Z!F/
M[2MO80S_\T;OYC)_XQLOY^9^]$Y?YT'?'^V^YD]?]72>]`"_]!1O]5R/YOZN
M\K7."Z9>\EU?]D$>]82P\S5_[V;?]L::\R(_]#7O]G3_W6@_"&K/]&1?]WP_
MT'`O\5JOZ47?]X2OP7<O",]>$PN_]X7?^(;O-N%>'E,_]XY?^1G\]THO]WI?
M\9;?^15[^-_^,?F;[_FDK[M[\\4S'_:]T/*17_JN/ZQ8?T^!O_K#_OJVGZP[
MJ`"J/Q^S3\&,?_O`G[MYSQ`]'_S&[ZL.F_:]S^N#_R!NQ?;ZVOIM#OW*:9W'
M[O@3+_BW/JM9DZI<6BNE_AW47Q$."Y65,OZ4@%&7JJW'G_W0_ON#D'\-4(4>
M0,*$-`@14+:)*?'+(-39^A(@L'VC]S#+-6J--Y(N/&YM7-MM-K3T^_$VD,;Y
M?22&'A!&3,9VM:4/&54V79X6@S$E<483R10:8QA$4B9-N&N8J<SW:/C)")S6
M6H20<M(_DV-:D@<;7*'A(6*BXB)CH^,C9$R'`,#$5B30),`18L?^Q<%!BH+"
M5L<2`8,$@$8<CRG)U4X'`$:-W,<%0)<50`0%`,0'1X5/K$^'51>&@)G';G%+
MQ_,=!H":%7)<MI7Q2$=VQX#%7=Z6W!5LG,UKDQ,ZR?;M%?*[\;LZ+$_+J,\M
M0\((#+6$Z6,'(Y>9;R_NU=NQBX.`<1XHT#-X+X:\;BZ6L<H`P.(V%QP`C#L6
M$$`1`ER\[4@SD1[#;F(PT:QI\R;.G(8T69I)TP,E3H?VD?JP@,""`BTF(%#`
M"@8!"1X`9/CPX`""<1,.%*#@!RD%"04<4`WS``&"%`<`'&"U(T"M"P$\:"CP
M@<*`!10R($@P+@-2#@@V<="@X,`"4WG^&U0PD*#-"`:(YW:0G("5A01^/T`P
ML"!0`P('#""3@.``&`8`")0<H<K!`%97#6C04-9`!@^2(?S8:L`KCPEY*6#H
M^[>``F0.T%KP,"#!@`<1(GX8@"#Z=&(E$#`P12"!@&`9"C3(:Q4![6H!&GQH
MP'YYUCD"P!.SLO;`!@I8P0A?T/-N`!]L8`!=AS$PR&HI$,"!`Z*1-L=8`OPG
MC&0*5#7!?+%%X<%:!A0&0'G$&(:`)3"H1H!`ISDP!TH1#/"!!@D@L,`'#AS1
M`$H7+%A`;?,)4-\H"1SP@0(T^J03DDDJN:22.U!2HI*:"&4(42,H<$0`$VP@
M0`=&W&$``03^V.6``!]8H,L%'&!8Q%P8!,#!F55%0::9NMAFQU2U=!!`;2A)
M$$`'&Z"(P8+1C9#!7!\(\,`'6'T`@%<#:#%-!64^@-)I-0[0P:`#C&1)-OL,
MF64U'(PT#BTQ_-DH*13HAH"B$&CPX@D?&``&.A5T(%P@$<PEJ$">#A",567&
M25*I#ZA$4BX<//#B!'8MP!ZS*!VP8@`T>D4&D44ED$J`9W[(`00J\5!-G:;2
M0L&;SXQT@6F*,NHH7!_,LH%D'P0`QH^/XCJ"HW2N>@`IZ'B$@R[/-AI!.`,5
M0]4LXP0@JY\J";#B`0E<X.EU\,*ZBFW.OMC`D`RHE(&<3*J\,LO^+3_"TR4Y
M2;D(/]U61T$%`"QP6D@$S#L!`Z3,DH$%6`4H@4IN7I&J"_S,TF=(>]:R@9T5
M?U"-`@D8L,Q`U2Q=2P1VE37K`;W:A2X!$5PM0"Y9%[!!-5K`P,\`%%"@T@=1
M/9IR"^44R=EH=DF6Q0<%(&<`HRXTAD`=,"#-8M9;"S"0TP%<($"?18B=^>,+
MY(785)D7H#8_$`1N,Y'N`12Z;2G%X)'K-]]=@P$,D/@HV&+7X@&?_U0'1JIZ
MTY#VU5;7'!"@+&K.>U._A<&G;<@HP,!('Y135CD#2."`!#M;`K+QI)3C,OGE
MFW\^"4\R.3,B5=H\P`1T<-#!4RX0$$S^`1!,8,W^&@1`P?ZL]Z(-!`!E98F"
MKSRP/P\<3`DD<0XIT"6!%T'D`@S,&PLXX!$1H*)PI$B5!GCW+S-Q215&D58!
M*D@74]DF9>^;0`L]D@*2Q,!%'TC``D:B`9-=+0`%2`$.8?2,J51@@2^PX98L
M6!4"9#"!$^`3]%JTK,S9\`%*V<`,P$<D&J&":CM\4=:LQ(`%+A!V$Z1&CJCB
MD0P(API_.D`7).7!1TD$`/@"R`#4-H`&S`(,31/<BVS(#QH@2@025`GQ<@.#
MH<UB`B)LW>.08BN`X(@"'`B`#ECGIQ=!8"Y',5,*T"?*49(2$T"I!)-."8A$
M.(`]-6+/[3+^XSP>7,DS2R$8*R:0`!O=!2!^,(`">+2%K5AH#@12`E8,X(`6
MU*67A[H2HS:`GJI8<7Z[N0)NK&*`"!#A`<`L6PD.T(`N9.!*P5C``;SR@E9^
M();,&<'=2M(""L"J`2MRP`(6X"U?AC,!TZ"GC7KCRW(B3D#3+`(N/4";9E(`
M(&_;@%T:ZH735.6A5^S+`1B%SP4`A`,'T()[_$"PJC#4ER[(P#$M8!P_F-0%
MG%J1,$CV@'GJH7#.@J57^`(!`8S0`Z8C!#W;`U,75).AL.(`R0ZD!-K,X3!@
M,&I,,]J"2K&"B3XH`T3O`JM!Z%,EA#M2*<,JUK#"#*R08!_+S#K^5D>H=:UN
M3>M0KO:AUE3A?&V-0RWZ$K.W\K6OY"MKE(*2$[/^X*YG@,,2U`J%Q";B2(;=
M*V(+(89`-#:RDJTK&AYQI&AM!K-OF&Q<;\`(#AA`JGX]+6I;=DHH)0FMJ7TM
M;&,KV]G2MK:V701@DZ3*V_*VM[XUY6\/&]SAPG:UZQ/L8XFKW.4RM[G.?:Y.
M<HLDUT*WNM:]+G:SJUWC+FFWVOTN>,,KWO'VU;C)301UR:O>];*WO>Y5A)-0
MN:29G?>]]KTO?O/[6YAU5["I)-]%]"O@`1-XO-*-KG]75M]"2*/`#GXPA+5[
MX,$F&!$8J)\APN(5"T!&$C[`\&45Z$+^"TB``F8((1Q"$N$5L[C%Z.-NDRIL
M"&<Y3+)2Z4(%6-%@'\S`>F[1AD@2*P<VJLI4%/AQ,0C"A19`0`3.X$$73.7B
M*5.YRF=5WX(CF]Y"7*#&B(62)7=E23--($T+J,!$<`'`^4&@`FA6`@#'00&E
MNL"1/K"$5R00`0Y@0`(EL4"9.:"7B4Q@'`RR@`:*J&(K,[K1CDZ??&.\B<I>
M()14>D`%QE&!872!`A:HRE*N<&3M'%EM%AC(/$60@32IL\XTX$\1G$$,#'1Y
M=WZXBZHOL*N[@/C1OOYUBV'<6AD;0B"0O4$$:O.!'/M"`A*H@)/]<(4*K!J>
MB<9%C>VL`0O^=``XKG:-M"V!`0A0``*T_K%4M,UMX-@MR\!^-[RS.V&<T#<1
M76[??Z`]9FQ'P9$3N7:W\\-OQ;&BR\,89@LJ781;:\#;]U[*LEDAD(,CX]3Q
MOCC&[3OOFW@W$2A3@2'TM^$AQ-E,>L:%(XF1@1([XR^@)D$%))`".-W!V64>
M`3'>S$88FEQM%TBYS(4Q#@Q$H#D9/SK2Q2OLP=J+V)65K$&.08-77"3J-[#Z
M(F?B@6VPHR)$P'K2PRYVYF[<)AUGKKL9G5RPUM>P:1\[W)^@OOY..NYV/_;=
M\VX3_@:V[GIG;@1.8.L9+\#+31@G9`-LA09X)1R@UD=O1OCWR2/^%LM]GQ+E
M@XN*"R<9&DG(&:-:$HTN3(3TH2+GVX!@FZU:CAL=,,#,E;&'16>^]DU'Y=N#
MX`/DVOZW!'``.<%$C/(,E7842+W)@%F<!+``]@5`P.@^()D8`4!N-4A`!.(3
M`,;!$'$XPKZ,)O"`!1@`/6KK?>^7KI.SH_^V8-)"1D=2&<S#`#`<&,"F$T8`
M#U0``@"XG%SD&)](2`\M%@'$"+58@`7XS(+P#@9P``6$AF;\R)VT7^V574UL
MF07*5AZ-0/3I`D>)U@($@`*(AO^4@`$TP"[]GSA@SIW,B@-4(!5$``!H#>;`
MA9MTV_]-#O-!AXP,0`9$SP92GOK)C-/^#2%L11\N%(!5Z=->.<<X:``S-(`!
ME)81-,C&7$Z/7,!II,",V$!&^4`!(`T"[$L$`%-[<`=W8$4)UD:B(*'>\9UN
M'>%-;(!;U`]#A($*X*$;W($?3MXM",,N@%T_!%FF?900S</6F80&[((S/,$S
M2(,T=`'][,`,:(`I?`/I30,<VIUY(<E;3%KNB58!E$D#1=8$L%8G9E9EZ9(#
MA,IGX9WNB=8J7N#<71Z3K,6168,P.`#P7<T#.,`#=,`#^)&;64\$+(`\/<!,
MJ0`#E(0N#5XM3B,UII7E#9O?)4D!!$TN>,"61(`30<H`I!,`$$,"D`(!(``-
MLD("2(`N&1/^7RC@Y%A:-=)B/=[CRUPC*-*A3<`/`P@,WM0-7KR/VISC[SQ*
MG[22'97'&;8%B(PB/D9D1!8AO?%>DA!`_`1`F3Q1"Y3C0-(-Z9!"!X+/7HQ#
M4JQ:570`*,BB1+:D2R8!!OX$/]8$\:Q%"YRC`L"*(.%1,!BD]NQ-C2S``P3#
M!B2`":Q:T!3?2RXE4P;!+6(C_>4$!HB`!EC0""B<,-2"LCT@C%0%5UKE'/"<
M#[C9/+E04YXE6LKA/F9C^3P61*(E7,)A?$T(*`8`6W;7+/:`UCU!7/9E6C[E
M=,VD7PXF8:[5)T)E82:F8KZ56JZ?8"XF9$;F?.DC@HFB9%XF9A[^%^[A8F;>
MEKN]96>V%T7>A`;R%FA:F>*Q%<>Q9&A"V&&N952VIDW0H`#8Y8,X@O\%@&UF
MF?\)0%"<IFQ>5S0`9F7&)DYL`">^01L871^Z`%T)2(Y17LY0P`6<FJ,LPE1!
M2G5B0/DY0LY4P'9>9W"V6$QB0FGNG0/P#1S8F;1E%GM>S9')26'I)<;U#=[8
MIR.,SPB4PWF-#WZ.9[`1IQ'>Y6!9W!P4W1NPIR,1'3&DB9G0Q;-Q4Q1\6A00
M'2LDV@306@2(0`5L:+RUP!G1@'XN`G_^)WS%#GX")X`^5WE&PFZIJ`L\7`L8
M*!"P)WBF0%6N6ND1`X/$@`6DP`:,@P7^\)G:9.A=4)N]8)Q_"A!K\N6(CJ@B
MV!`"X<V*1MAH[MUC0D(+&!N,3(`#&!X,V*B)W=E$8`#*A-)[CL"IQ=P%R$JU
M'9FT54"KQ=N34FEE+2F4)@*>VFF5.MB59F"61@*M"8//2>,=L*?=L(*:+-N*
M$,T(\$8-R.FF&5(*C*E4P&>3!IOUW.>FYB>G\N>)CNCC]"F$M>B5$:A4SEP$
M8,`#U$(@PH`OH)FKN)FKA.55NEGBJ(#=I(`"-D>U0=M=9(";=9BO@6CCM$!H
M,(*Q.D&R8B>;,"N?DNJ`F:IF!:J6ID$CML0Z!"$ZT$4V7)L*O*H0D8`&.!F>
MC"O&=4`!`(#^;MJEM^'6NK8KI&1J#:@KN^KFO,*HM`[7G\HDJO*5!TA`<@ZA
M!_0JHFFIP?8:?/5J=.ZK@U&K(YRG6SVBPU8LO/6KEMZ><0)L/=J!B])K+%KL
M@V&LBUJDR)ZL8@[G9NJ6;:*LRT(FQ#:"Q+XLS2XER6JIM=:LSE9CS#)"O>TL
MT-JL@.($^P6MT>+C:Q;GT2YM1#;F@&XLTT:M!?9L916MU)Z6OEXMU@XMQ^6L
MUGXMW%&M(LPL<5$6TM%%;32BEJ:MVFH6VPXLV#K7*?D19X*M:@``WFJ((]QM
MWA)K(O`M``R`W\8MVE$FA5EFDSP6W/0:$3!6$*`,RGR='XI!8;S^0-OJUQ,A
MYQ"0'\B&:0!L0*!X0%(X0N::BNC:!>%6E],2K=<V0JLF@@50YZ9E(-&M:D@H
M$`G0)15L0'W@G,*^5YTJ:Z=.J?`&;^I"U^K6A,I"+4U`X$!HP*H*`B[0XS#@
MJ,#Z@-T8'8DI`WB*0.6^P+TU08G@[@7HR@9$[]44FJ9)Q:9U`)+.@7N!Z(L@
MT/PRPJB:*(E^:K0>KW(E[>$R+TT,JC"8R>]Z00M(V;@)`S$,:?L^``=<0&ZX
MRJH&+*_%@,(5EL`6!AC$X``C6E7Z004(Q+25[UV8BBJ2%_[F*2($;W_J;^?R
M;VR)+7J9+)*$+YQ\Z;'9V04\@`:\J27^E5S$J1,$U^J1L=:6@JD#V,T$%&D<
M6$!ZOAGO*E`MB)\**&`!BU>)#F^HSB_^M@^3$B\,-]?-YN._WL2]<0`8A"\0
M&.@%U$8*I"+*-)RUJ=.GZ0J,/``]!H3AX>Z=+1P:XT(&4`2,T#$&6,">N<:E
MBF;L[*>YA&HC+W+^.L[^AO%^&2[KEK%-#"JYD$L*@-U$(!H,59LG]+`'5&<&
MC-.V"6M[EL`T))RK*L'X6@(8;#($9(#[0N^F%?*V)5JESFE[_4(0-N*5.`*[
M!#,':(WP`G-M<,`P9RTE`QC7_H3&JHQ"")TBB6O](6DUP\E`!.&8$LT!?YLD
M(`,GNLL`6S/^,B3:$!1L5<A!P>4Q>WE``N"M74X.6\TSNP*`/9^7/.,MWMKS
M,RM7\IH=#:<6__4P/,>H=JQ,ES@S;3F#J<R/ED:T1$,"13MT0+N,_UXR`-N5
M[L$)/1*!(JUF$MAA1I_T.D0SH&+RTK[E*&(T2JN6)9-FZX853%-)3.>T-\RT
M-%NM3O\TBXTQ6]4T4!=U>\EP)Q"U42_U>`FUS"HU4T>UA*FTOZZ25%^U?<WE
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M=UN/MWLW-WS_M7S/]W&O]QOD-G[WMWX+]WWW-W#7=RRVMX!+]W\+`GH?N&<3
M>.4%.(/3=G)C*81'^&N?-4T8N(4'=X+SY8MN>'H[^&<M.(@SMH@S@8:7>&UW
MN':/M66I.&.SN-PM-UT<\#8HFPIDP`;^9$`7U`:/7T(/]W!A.-:AS*=G7=8?
M)CEHV<!(7Y!/X`"422\2+-A("Y>4ZP-FM0!RYN73Q<SWO@$YS4$:F"61)[D5
MN!#<GKDL8KD4\',["U?CQL"6,Q/MM?DV_`#]L*23>S$,S#E?GO.Q$<&6VV,[
MO-SE*H$+H=@28$`:@"DZ_.B1"^^)BQ;O1#<3[`\Q=*`\5Z$"M("-L,4NR@@\
M8T`%,$;#J56:CA)8U@![\G$2<.5[IOF+'T*J)XD:8P*?[17OLF076$*KGS"5
M[,$3L!8A*ANPJPSNRKJ:,I:QI1IK+J(-7-M,2,2Q6UA"PX"R5\'#Q0!7!L%_
MC.FP3T&M"P/^:TU`<FX:!!(Z=8<W:E_6_L`*\>3D"'PABR"#UY"``T`&'U-G
MK:(QADV$5WA:K?;9A89P^FZI!-1/HEV(JP:R5B*ID0*\J#4\SVF`7AR\,,A<
MJQ<=FJEMVPX";_`[#APH'@JKH8$GF9'3%7#>!9T4#O1XMUU`OU<\!NR;"F``
MSX'TKI1$!N!\E%5\CA&-DV&8!8B(,L#(]0(\_%X0!2Q`51!'0*AO#*#8CS=B
M+MU%&OB9'9<I#%"]@$A`+6"``J1`IJE`F;'6A<K\#P1CPRE@[M98!PCKA?$<
MP<.(SPL#&SU%T=M+=?*`!I295Q3<D.X]TO.X?]B+6!:]P:NIS)/^'G4*G07M
M?>C*/;;[611"N0PH@*M(/=)/`R;"KP;!J9G@S-//',H#6N6J":17Y<SKO9LY
MC.KK!F]L`-C'09F1[P/'KN.C6;*?_5*X*K4A*8G11>^ZP`_3&;E+A,.+.?/'
M=[53N(N'C3)^H)PH3?'8.P"P'(?\>XF8VZZ[R@6T@8EU`02$/X]B/0#!B`5!
M,#%$6_IO6A!FP#))`.]:PI`&(;0-P?WW\$R9N_44!@A<GL55G=9\ZN=L6,51
MG^2M4_9!5_Q16O79K#@-3P6C@8PR'HHG<[ED)A_,Y5/[6#`LH"1WV<B<EPZ%
M1L5^)A-/Q(.)Q#H9R^>Q>U<\NPH5@R'^$Z5VH;'1IV%AI%6RL>'1!ODQ]0&3
MH0$U0Y6EQ=7@!1G:MN*`267)I3+!$5/"QP3Q4<@1IF@1:P,FIJ9EU^!B!X,Y
M5&311L':T]3V]Q"*Q('!\<"Q\C,22^5`JQ&]87'R(:<<)N6!I\8F:8D9.RN]
MU]!1H3'D8`1X];4RWF*U"&X%O1E5G$WH8.X!%`Z7,L3:XD&#$PHG'-SI0XX6
MDP>I9G@0,L&0(G,P-IC!8(?"P385-I0PT^1$"G8.)5W`X(&#I!4UD&W8I$)G
M!@P=BL``1'"%TJ5*/0@`D(:IU*E4F3H%8*!J4W$&*#`P$.$#`!R3`'2H$N!L
M!@`,[DG=&8G^0@8)'"P`J2&Q7B0J/^Y9J"<A3R(1*Y!UD(/A!I?!'#I`<$%W
M%0<(T6Y<H0!R1I@)<E5E@0M)HHH:`_>NZ4%8Q:XF2--8Z1'60@882LW4H4<E
M4H6Y)2P46L-IH)0,EZZ<'F5W507?]:0`HJT"@H8DDU)0@*'R2D\/DJX]QB#!
M21`@2F-`H2<C-_#1:3!'@*Q&PP42?[&HEZXAO!!)68YQCRH+%U1LL,=C&815
MPRZ#(%."7X!5P84/$EP2P0^\M&0?<%1`<(E^*WS!FS'D(:7"0#X@IE@.'29B
M1H!JK'9,)NG\]\%@R$R@7269O8:>"H%(H$%B0WU@'CZIY,:=A'7^33`B%S5D
M@$P/'=1GA(P?+$"6B196\H.,)U8VY!?F>;84#"4T=0$$)@B"DUQV:+54!T\!
M!6>=5<F)%2]P1D#`!P@`\,4!*7S0``(^IH46)YRPYQD^'.ZP5$A[-*$!%<C4
M%T$%-ST9E9D.H!3-%8Q-8T4]/=QB!4-78/A%IH4,XM%H^WQQP0.FDJ87C6E0
MHIH,)62RSTUK4#&9#$M1X,,%F@)7)8>*E,:)#[(01]R;7QRD!041U&%$/8!X
M`(&Q*C@0!0X5Z"$!(*(U^L4U#M3!`;9;*G5=(LLB*1X6^X3$41A#(-OM!QU0
M\04>%A!83P?[J,(L@*W5",Z[_JH&Q"#^RXTQCUY5K)I$%-T8BVN&S-R!$L+I
M5.'L3RH(&[(/"NV`%!ZS@,/FBS(,W`-E2ID6I`7I$M;3@SQ6ZJ.VJ;ZF@EU;
M6,OL;H_&N[*3LAI15\)R&<<"85H:Z\,6QO&[4)@"Z;,5@^3IRP&+-5.@LYTJ
MX$FGVW+S]%16==80P0!K0%5C`0HH4("I:]6``5M8?B``68PV+,MTU:AP"7;<
M[4:77T(<DC9#=:B!(1(N86!K!%-ZZ_@E!U_R^64@94!+VDM<8!$I+P"A@3-*
M66"':6U@L'E0#>2'R14HS;;&=%1L.PSG*63`0#6F_:5!P*/T!&0L2.TF;+C@
M:3'=",UQ`4'^1S5*0V`9=.V@`4*IWE1!+!Q(T`'OCC22:?*D6:1!\QJNA\6G
M%0#!N^DH)0)AR1BK-A"DM&6,;4KY@A-VPBF<$:AQ`NR5+*Y@`61QP'($>0TR
M$CB=LPD,/=DXS5`42(_<X:`0W:B#!C[%N5P%,!I<&`H"O\$#8?DN/US``"YL
MP`2^[($$Z5M!'3"0`@^F[2^?(L[G%C.4"\@`>REX7NF8V!$DR,`W)?B!$'9#
M`LS0`%HW^<<IH&`1SX5*1ZJ:CJ^48B899($RUVG1("X0EKE=!4!SFQN>[&:G
M0XSP<4W(E\`4<<@SU,,$37F<3HB$!=QQHHM!"`K$</#(&NWF@I/^K`$?]H`2
M#`CAD9]LS$!*F1,BU6!*->I,E1Z'!8:D8B<\480C(0FK!.T&!QTXRR04P8>5
M]8"2/*E&*BL)R1'8L@:DK,0_!':6):C@:IZ4)"FK,1"E!,(%A.NEI@A'FUE`
M;H6T\6)H&AE+2XYRDD-:&72"XDMBRJ<*`^DB+"OYR'O*PB7IE,4[4]F!:NB$
M0)AD)C15.0G,0+(\]*C&Y2`GK1)<@97*?!()?(G0QRFKEX^;33UT(E!%<4,%
M%E*4+=,IT:6<\*"/!%4-E`722'+!F(5HPRTK^LO&6(,V(_!`QD8C22$$-)\K
M,\Y^=D-3&*0R7B,0D$#+8]!:2@.@#KW^B]S@IJ<^NNTJ@-2J5^_V5:\B+:QO
M@=,1[+0H"]J):(HCJT#VLY49P8EH;EUK7>^*U[SJ=:]RFX`0^.JVNM!P*8M*
M*UKA9-@Z,6$TXONJ7_NX1\!:)0!YDMMGU)#)N&)!458935P+ZUG-<C:KH8V/
M/GE2VLOJ2;6I3.N3>$?:Q&X6EL<DK&HG05O4CG:UA%5E9A/["-2&%B^G54-B
M;SM:SC(3M*0=36VY(]RR,G>W9>UE:V/K6JO(MK:\,"QW=)+=X>K6D\R-KF:U
MPDQ3@=6R55F41-K:V_5V%KWMI8ILZ;L4AF@5J_?%ZQ_#:JYZ]'>M:BFM9,G$
M7CCM0BI,E1O^#OAS7O.>ERS%K8JY_OK5`6=8*PJ%)U6B=R9/5GBO.D%".[52
MQ+<8DRDE[>=40H'1YM8F83$^L(UOC.,<DS6R./ZO@Q')O$0\DP\"3EY0AD+D
ME=G!`P[P*P.63`(B3>>GHY'ED76R22DC<@0"O01FELO0CPXDH"2H"S,1N0(Q
M7(*D6HL=K%QPEOI@M@&*D$LJS-S(0G`9"]!!"@>>O-1V=A'#1F2`D%.3B/S*
M)PM(B0@3!L$'P@R62-F,93MGDUX1P);269`"AM[&'1PVQ0$^.$+"7HHU(GWC
M+"?``::1B1,B8?2O^:P&[ZSTN%&>LLDYV0,Z1YIFN9BJ&C^X9UW^H.33"Q:5
M2*RC6B4:H).SP(H#W]"PCJ^-[6R[-;+6WG'=?DR\%T*B0EN$5P9:H!1RX7$V
MC3&=.,"AD$H03UL2<4&Z7R"#<,T#"N`[@@,MQ#9\R(`N*]AW!@S($%LA"]-=
MF^3O)O2K*Z2I$RC)6B<FAH5X-P`ET7-3>7Y7`2`Y`8Q/N,E&@DBHX76+@4MY
MH1G(K4D9U4!-V[,"-'XGFX.7\0J?^DL3[+V"C<NF"A,,UUQ4WK4+9@#:A+A$
M*<0SQQW\CB*\,_F*Z6V];=2!>":/@!W@9P.=&'H-MRY..E@Q<B^^.V-H'H\'
MIHYA(A2["8U07!?/0!RKE]$-+.&6#^'^``A`I*1"(M2VX0^/^,/R^,;_M;8'
M]K$%@D@+&6*R3%.^H"`N$"@L&.*+#%#BKTKK2P77VACIUW"6_P&0.:A?!8"D
MQ24L>'SRRZ)`1W9AAL[0Q<SM$<W[B)1'=M7H)L&0FH(P^+\J:-`-S))!6.1#
M)3Z.7EJ6P@'!27\6S*SB\1:J^()],"`@P%Y6XR$2Z!@GGXJ+:)IP+<3F.DP:
MM$]K*(E8E+2&PX5@7>8+D?$L%&;S%\-!'//T6DA`)0X4#<7W(N!`!;`2!`TH
M('3G66-F>]42!')T&D3S`BT2".3!$KF2>"$H@B-8<'.28SYV-ZZ1?['G,GZ0
M=TTA1-,R/`[^)`1?`#I^4#58($4\D0;J02+,4`,9E"ET41]4X#.SI",ELA]7
MDX1^(`$X^")W<0:<(0,$P@-<XBL/8`RI1@/=,1^9L@K!YB)"Z`=)X`>YDR09
MZ#$90EA?4!KB0(6>A'I<HB8X<B8/J"PE(AHEM8.,D@B5L@%AP3-?6`&V]R;O
MQ$*K0F@,(@B8H'D$%S+N=P4JN`9NF"Y*\0/TH"G40BT=D8EUL1\.-`]/&(:J
M03,N0C$N\@7S\"9)6"6B0@%YR#`^Y`<N\7DX,DTY.`HDR(N]>&W\Q7C?YC:R
M,0]XTP,@P67<T6B,HB!3X!*Q8'LSH!.*T`%&(`31$Q5O%R0$,T+^=&`'>/`^
M4Y(3`=,N\J`4JQ9"1.9!>C%/F44$1E`(,U5^/J$(FT`"W$47W0$#5Y!9QR=O
M(N!3OU$-^<B-Q39$2M!6C]<##T(<"!4=>=`X`K.'2T`"U1:#()@A\G%6T$@C
MB5`7`F.-1+!BMZ8ZGN4#"N*(T_A@P^(&@*<%!^<$6V`%&U`$2T%`E9!&#6$E
MXO!\>R`L<G$(XYAF800A-N,B-L4#>#%$VS)5LG$PV,@=U)@3?^`Q9Z)0N^B+
M6:F5>P6,-L95<V,,CU,JU?!@(><2A/8$$EDC.H$L7#`P4TDDZE!$%W!]LK=1
MD\!,$_`F%)!!`J4.)C$);(B)X5$CETC^;3528/GA:Z,Q&X0!'G80#H7$'61A
M!$!RCD[P8/6@F)P0#HY0(U,9AD=X@6F9F0_X`B^P%*6B%H0C`:VX!E+T.#[#
M!)IYB9*9EN$0ECS!2XNDEW@9F.&0'P]T'8L5%*QPC3'V<_7@$L9YB2N`.]+"
M3UIP$$U0(CCC7J.$`\MIG.=H*ALP(6_3!MYI2"<0$4&`8>&0#$P`,)@X`=#`
M"K5Y+JX3EV&(5-6PGD6$22.VE?O)GXAE@CTFC/UI7]*W%5A)%?.Q80+J-@A4
M!<2AGP9F`]VFH/85>XA5!:XYH1FJH1L*H'PCH5^%@EIU7)`U7UGE6BM)%<0I
M84:P76&E*"/^FJ#K55ZU(9H`YEWQ)6,Y&F$E^J'UA8DU!J%\IF$2VJ/R]6(X
MNJ-!RJ%+.J&+9V,ARJ11*J532J55:J57.H).>F!?6:18ZJ5WU:5?*J9C2J9E
M.A5=>6!0:J9KRJ9MZJ9O"J=>A::2I:9Q:J=WBJ=YJJ<<JJ5T&J!["JB!*JB#
M2JAI:H)A:EE_6JB+RJB-ZJB,VJ>`]96/2JF5:JF76J98U:%=A:F=ZJF?"JI9
MR6U;*C"*&JJGBJJIJJIZ-:>2^FV(NJJQ*JNSBJF1RE<>0%F<2JN[RJN]ZJFM
MRE=UZJO#2JS%NJ>VNE>3:JS+RJS-RJ::&HQY`JO.2JW5:JTA.*K^7FFJU\JM
MW>JM(PBM3[JMWTJNY6JNDI6MAEI9Y\JN[>JN806L>>5)X_JN]6JO]XJL>J6L
M]\JO_>JN\<JJ].JO`TNPSIJO>26L!:NP"^NKX;JEK\JP$2NQLSJO'GIC^SJQ
M&:NQH.JPMUJJZ[JQ(2NRE)JNZ"JP(XNR*7NG'0M8C:>R+PNS=@JP"'NR,6NS
M-UNE,XM7&(NS/>NS4GJP=;5*-?NS16NTHGJH%PNQ1\NT3=N+0\LW.,:S3DNU
M5:MM.GM7"6NU6\NUM_J?T:JK72NV8UM76+MC6$"T9*NV:VM?7ZNM(,NV<2NW
M;1NU8#NW=XNWM9&TX@JW>>NW:FNVV[;^M']+N&(;M&":JX6KN&(;N&2EM8L+
MN3Y[N&6;MI%KN2H[N8+;MY?+N3`+M7'CI]+:N:-KLXT+KY5+NJF[L)GKN*BK
MNJ_KKZ:;8:X+N[5;KZQ[NIMKN[L[L"7;LK3+N\'[K2P;K,`KO,=KK;+K55R*
MO,W[KK@+HL;KO--+K,J[7])+O=F[JU>Q,'P;MMH+OLWJNUZKN^%KOM7KMNJ:
M%=-ZONU[J<3+E=CKOO-KJ>.;K/)+O_G;J-;;1X^KO__;J=`KIX,+P`7\J?RK
M1_AKP`M\IP)\O>7+P!&\J/"KKPHLP1=LIO9;P1",P1V<IQ0,IA_[O1Y,P@V\
MMP_+P26LPL_^>L*A.\(K#,,9G+XNK*,Q;,->BL")FL(WS,-4ZL#LY;\]+,1,
M"L([:\%#C,0B6+&@ZZH[G,1/W)\:3+-.#,55G)5%G+5';,5;?((MG*QH*[I<
M+,;[^<,)3,5CC,;95L97I<5I[,:4:['>^\9S+((YO%5M3,=YK'@S_,6X&L9Z
M#,@=RL3%>\:!;,BS6[=R?,B+W,0$2KXOS,B1_,"#'+]_+,F7/,!QC,*0C,F=
MW%Y\3,B<[,FC'"=>_,BDC,IW`\K)FKBI[,IG:LJ5+,JOW,EK[#9!3,N8+,5&
M7,BY;,A+W,66[,NHC,5P/,O#S,AV;">XC,R+K,RJW,O-K,>VO,S^>"S-5?S,
M<,+,UPS(U%PGV\S->>S-_BG,X1S)V:P5X&S.;XS.=V+-ZRS$XYS.[PS//-S.
M='O,]>S&\OS)T:S/7'S/L.S/_VS%Q>RB(DS0YQS+&[R^"7W(_&Q?K>S0AAS0
M4J'.$PW%W)MC4XO1;[S+65S.'9W&!NUM`RW2/5S13''1)QW/JQRP)LW2-IS2
MND7/,1W!$/UB-6W3"XS3%JW3.UW`,ZVW,`W4)2S4=!/218W$P"RU/ZW42\J^
M_7K44)O/)4K&$XJ<DOJB2'JQ40VJT+6A'QH]7*VO9RLWR=!;0XJNL-K35D&[
M$D"8GT;651%<7$DC7OW%02$N4'-8;M/^.[\$@S6L56%8C+^TF'H$5V]!:&!J
M3`^*7Q)F68Z-I,O8%(M=GL5$%9F55\;DR+T5"&@MF%:QV()]CE:U875])Y9Y
MCN`@0H\D8-@DV5HEUR+JTE/<T&@%(J5")(ZD7H:@&OJ4-ILE9>0UUBVW2L+=
M#6DF!`"SBV"M&G]%GCQ!7N8I7CZ%4=Q1W,$=%*-$2&,M+;X]?EA01-C-"8"I
MEB1E3!\QA\E-`SP84*,QUM^UV_#M2SE17-*R=-4@&R4Q!(1DWCPQWN(-7?8M
MW%)F#9J]EHP98]$=!SE!#08^6U@0G9\YX(8%F-'D2]DM8)ZU`3HCG_)-6-E-
M"V[Y4>D=2_7^+3"8].#OS:#O]MS.=5K:+6LSYDG2`0EH?=G6/4`K&1%0<UD1
M$4WB7=\Z)3!6D0Q;8M[:'=V'&>+DY4O15-P^\@4#'@1$F041D",J$7N@?>!!
MH5XDM>&\$-P-%:9'_3:NZX4'$R_(8`21-QN8R22<\`.7@G87\#NU@SM+(47B
M1V0$0AM08@(18"N;>!I#\#_1\S]2LSD'(1%R(0E%-PY/HH5W@3M<$`'7@>G8
M%(L$\>9/($*S,PDZ\`;38`$54D@X\(E%L0,-F'Q#MP(/4(B:?@5+=PF<@4V%
M6`.P'B4M!P0A,7#BL'"MQ"!::$@CH"EG\C\2$!:Z'E!`<.GW5XC^L4-2RZ'?
MRW$[UEX!S9,!6!(#RX)$K$/L0<B7N^#J1@0PT&,'&00$,7`I&K/MK(,LP@-#
M2X$[=A`#%J`0;/`_R$)FYX#K36`$NZ$!"_`#ML**]>``--#H.$`!MI)?UW$%
M$#`.HW$=Z\X`!1+KE;#I$D];GX#L?B"(Y5>(TB`(UD[KAB$NHP$!1\@#@>`$
MO8'H1W#J3<&7*[\#%-$BA9AJV6YZ9D("5L5D-.`$@DXU:TY(FF0FAVY$N"Z<
M%X@,YW)6DTS:FEO5+*`25$,1!)$3G"=@Q!(52(,>+X4)8[#AN\`M3S@:R@)A
M2%%J?`W@?I7R`L,,5X@9,B`:[;T".RC^+3D1"^/0+G^1[GQ9H;3$'L3Q>640
M%C"_!DEE1Y.8:T#_?(#/)8N>?9O$`[&P&K5Q###1*CIA*6<1$F'A@*$P?+"%
M,['@D<['EEN"]VG?ZZ[U>*QP%P03A,$3!*)/%#+0Z:7(*%"#+$2B^^N9A+I3
M^SLIW1+P$STQ!3J!>3_/`;A_C"!#@_`=%HSH&:)G'[B2]6$'V.V-^I*_&X:4
MBW4!6\]/$$)&%BTF%YF0<Q@*+K)G(5XOWG"OAXM_=A!#`K=F@)U@E$KT$BD/
M`M3V21]V?117<:3WP9]W69D5PU4&3YXW?7HP"L:%.R)Q'@$`F'Q"H[)/AVF0
M(CT2SJNBB4S^)-M)Y2&S4#00"GCZN4@\7@KLDLF@5#',&H)Z5+Q12%1TT+U<
M%`%1Z.!H3+!]:$AHX%!87'#0?<Q];`0*[>5Q=)!!I/@`:="`15C<>%CT_.!8
M5$!HX$E:&%(-2DQ`=&`,\M)=H'@P2@;"T*Y:]&UD%#T,0E;2EF@T'Q$%$MW,
M`CV$37R^%<5P3&1LO&8#J1H'^51@J(<*2M!Q2*`X8_2@@R8J/9S86>4I4,(^
M>-`<X6"-'XD()M:X.L2ITCA:;^X`5")0PR8,&2JDVM7!0L%$0211TI)BQ*,)
M%E6L&,+!P@@E"$^^F")D`YUQDE@%(QHT!DX:\9XYA9&SPJU<*(C^ZO$Y1`,O
M:Q%$3+`)<Q(P""UXO(#&82=+"U]QQ2#Z!@6+%;VF>'EY8B,8"19C7!C$<$NM
M'A12T>HR0A\6'%6:N&DL.<D2`%>68DG,2=-9"COBO'B%,G*'#S8N<&L1P>K,
M*7(176!AD=O+%_A(<'(0XX6$#C(]="@1-`,#'X=3L.,$)(XS$WDZ-+)HE"M7
MJ4!:U*C^8D,)"[DLWNN@^Z0=&1YFLZ!#NT7O&KOG:3>AZ.S>ZML"83;=H!(&
M!RV,9B672R\`1P)U*&1P2@GO%`2:"G2(M]ML$!IA`BAK';)("RSH0M)'!;W`
M`0,:^/`>@5QY!Z(R9WGA@1FTZ,$A"ES^`'8A"Q]$@`%*S[!4R#&*R!`<;GE%
MX%L)*BCS`A`L%,A4"P]BEI=+TWD'2SV[;;:30@D.Z44R7/G#208*X5@"C3$X
MX`$[.842@0_"E5)>E)50A5I%)L"RE%P8W/#`6O3$4,$()>PEPHU+G2?))AZ&
M^$$-AZF!7`X<Y2=994Y,END1E5V1:2R`<3%()F)8E($K'[`CP0XP<'?,?Q1,
MH,$T;YP%PR037``$=QA(X(<G%."B18>;Q)"!38<!4ZL,3K`S00N3$,$)9G>\
M05!8W?EP`P<HP+&D!E_<D)4,%03#`;3714#NAA3!$<$%,Z!U002?(:HMM\!X
MD(L,Q9A`R!G^J*)`(@Z:A'B<!=GN^\^VIJTZQ!8+8^`*$-IB`._!GX++7!TV
MY2%!3P8%4]H$15"E#"4,`XQR3964$(&RJ?+JPVS)*N,K),>5/$@E8WY@1@R&
MA*P,!6F\^RD'&`P#+\\'A[6A!1BT8"PP,*G9]!O*J`.#(:HZFI\%_\"`00_V
MOH'OP5A>0-"]5$D"21%P;)%'4K,ZU[,2Z7K<P8QA?'OL#Q.4]O5Q@4)BQPC(
MA`U,:5(!),MA1\,;PQ>?=N`RU":'](9-4'^UE*DHE+*,'!"8A)V:RC9V:62:
M9OI8IZQO&A1FB.97HE2A50)%I:O;OM1>LT?AH3.(3F:[[@5/`:+^$K:%A`[Q
MS1UAPQ2Z1+%[[[!7+\52'916G?8MW+7;\TI@:1[TU1-H6!;G#U\^[^SG1+OX
ML,L_/_3&<[(X^4_@7_OJVN^/0+$[@A>@HY4LR,Y^\+--UB*SN^*A;U/NL]_L
M'@C!QV`*>Y-QG08[F(1<G<R#2?"'!=WW`]1YL(3LLR"U0I0,2PE0A1(4(0W7
M$89N1,$0G=M?#2D3J&ST,(*>6E\0S5=$REA0ADE@U.RLA$#^(<%8N.)AZJ@X
MP\P<<8-,`((2-4@@*["N`[ESA`^':+T)XF`T6,C$]!I&1+2UX($>&$$7WPB[
M,>E+"B$)A!I3YK\^LN1_`"PC^P96*P'^"E(&E?@""NUX/ROJSE;_0R04+85&
M1[80577,01(ELY9+&E)W(SO"P=A(/T<:$7LEDN/X$BDMR76PBSMQI:6VF$7*
M@%%3SKN>$6F`!-^X078$$B;Y\!>D>M`.>"*8PFV6YPS]J6DC3P`F,=OWQ%26
MB)K&ZUU0[$"]1/8G=P=9"J/L)X0N`!%+QC3?.LV'.&>NLGY9D,<8K3G`5$YA
MF_*S'6&JB4\%5@J8V%24/;=YS-L,TY[7/&<UF[3.Z_6O4OZT%;&<Q)-[ZA.;
M!O7!"]*@T.&U4J-8\JA(FU.B6=SOC,^<GT&7J)$$MLZ6F\0>!W49B*_A!Q2P
M>L$#&D!'&&3^@!^QD-F&?C`T1.3(-`]`C5!W\S5CP:H%FN`:M0[&)$@D-2C<
M&<W7BK"UG0"CGOW*!`ID,;6;8<8?@UA7)=Q"#0G<``X[0FL*3H8:%!TE"2/;
MQ"*6PH&O-".H%!#9'/EA%G"A"@)S<%8:824V(+`1):GJ0$]_.H/5Z`M6.7JL
M6)W1`P9D4!FQ.@)W`+>!L+05%Q40%:K"L`.;K$6H'%#`86X05,:NEK$XN"UP
M`"'`<W6T'4%P&046P(VH@@PXBHW%:DQ%`6YQ@1^$V109N-:#K5:-L5WE1`B=
M\=3,<DP+RV@.'L/2P"`L8*C*2,%*/M9:C_W`NI8+RR$J`+9H9,#^J%Q@``34
M1(C9V;>L$'#CT,`&+1\`H@,,6`TD`@M71PTX57_#+0GLZT:U<E4";S,O<DUU
M`R1PP`'V'0:=-EF9$MSR"#7-%%>HP8R7Z,9#"+55(';BA1!7#`AI`M,-6'(2
M%TRK&<$J`>`VHPL5>.=&8&,*JO`3!$TL[A(5:JVM:G"5$L18(Z@RPTFH=1C/
M>,0EM-FQDRUBDCN@Y&D@+HJ2?N!7,]2@(*5`SB94:QJD$?FG,0C6*;ABIT7T
M9"_%:H9)O(,GMFE,*X*2H)M^=HB"O.0>'X!+;P;+B=/^-`-L5@8ZYCSDYJQ'
M!1DLFZ->:!'"R.733!)4"7Y,:L"QA`/^?:YH#![@WWKTHQGL$%YY+)T60N.!
M/X6`<P/OFF<<R`4TBVBO)0AD:4&=(PCBT)();+"#$!UI,4U.(W]LD+474+I$
M)Q$2<B3BJ(K1H=#S@4&PY-$SX*!8*L2>0F\J<`.7N9D.WUQ'J[W`-$VI;J;T
M`^,FH1&/EZCB&)EKIF>0X6T@02-=#_C6C#1\!%X9(B4_J<Y@O5.2(H0($&*1
MA0/*F1?&,'(#44F2KG#8Z6N4(1:+=)FAUZL*<$A`-]X$R>!J,=B3R4-/QV`-
MKFGC*#94P!4@FL"'A9(2@R.3#'7#0<SP,9I5_%FBV19)SI&]"72PU]!"Z,1'
MKCX!:P!9!P#^Z:M'PJ:.-#C9[2\>A&Z&LFERK'8UA(Y#H7:RED#,>79..)(:
MR!4'FY@Y#L`H@[+@X`%\'(=!"L>!-_/@7KD`B-J>-<]/1B,E8J0%'@:)P"E4
M0%ER620H0D"16(6`DV#X*`<8^DCA76&G'X#"./5P@CYHXQ)9-$#F0/:,8M.U
M.MKDVR4QA4R*E1``R[".*[?!/&Y\W\`?NSD,G,#W/'04S1E[#$MJU;AB="$,
MCRLI)'_]/AW2,#B/)IK>TB_"!D[]8M>@APC17/2;&E$05=!`$91`0A2!B"7!
M5WS-<B1)7!R#.^!'MFT"7#W.MG5!Y@@!`!I:?W4!2`13:]W!1<7^1M9EP=9-
M0;0D&J1!6@\0R6*P`SH=1J)@GG$@7]"UG6G``MP=0:ZD@YH1V7;0`7,`@<OX
MAO*PPY&MQ%J<PFLHP8L<R?JQ1W19A_[I3_*TPTD<#DK\".7E0KA<W@^J2>GM
MQ,>X&5ILA*5-41I<%#X8FLO@!I*XB4`-P0BHH5A%``O.!J#@1`-RQ_X!T3W,
M%2W8FDPPX$=H&G*<G#T\`G!4RE]YPI+8FJ9@$"WUT(I)AK%@!R/HWG4$0OVY
M%S$P%JR\0>K1P3N\0<FX&+ED#M"L@.YIPG/M2\RQ1"DDG1L=EP;X0P4X`/>P
M`1Z,0,^)EBW>P&H-0@HLQ,``0AUR`MO^!-)J[8#CZ-XJ0(MN8`#%!<$B[9:I
MY43/H<-M!(8>J((I<,!)X$0@B,W9,(7NO0/NG8*QU!@;:@TDA&,1%!@R5$+D
MB82CN!=4^8SDL,$&K,REX0BLU)ACH4(0W`(=H,%ZB8T>O""M+21!Q-U%N(4'
M")89'(<6<`,K,D(F#*0*N)@*9,+IN4PAXH!B65P/D(277(M1C0!5]%$KQF,*
M%$-!S)@)?`O)*`LZD(3V%4(@K8.HA(X\=D&Z<-'0!&-+#D*IQ`%12-INP$HP
M'E)`2ITI\$)@Q<H-W(:.(%D+B`TXZ!X=F&0#;:,M$D*:7$`OZAXQ#%8%O%!B
MV=<BC5IC1&+^\_U,+DT&*3C#!@"/&YQ)7"Q./#W2',517N;')\'4)SG#600%
M02RB7LJ`8U(!9"8!09B4FF@9:>T(8?*E8IY)`JT%\#!6!2G0%4G%7TI%K2"F
M5LE1<^#E8P9%7Z+*8'*4]#P2*GTFB-$(8L:`LZ`F"J6F;+:F!04GEN"#[3`F
M:41E9*85"FT'2@2.&[D9ZG"`8R)F:DKF:>:3#RB$2A72P$SA9%)G5!:0[%QG
M;*Y#B)3G'#T0;ZZ#8I[G^>BF#,"FB32225UG8?:B;PY'TVD19`@<ZW`*79*F
M@!)H\)!!SX%81`81,?20"JWF+94C?Q8H@F91"=4D#>W.+(7([%S^9@\1`]L4
M:!0LVA!A#X56**V)4'V^0.4(G.H0*`?])Q2$HRMMJ"/-J(SV!D;"(2B]:'F&
MJ";]:)!*A8\*:(P**88>*:H0:9(R:8H9*?U\IV1$XI-*J5V*D!S\"A9A`=BM
M3UX@U(,V:9B*Z9B2:9F:Z9FB:9K^Z(D5*"5*AKSL0`:T``I@0`*,BI1YPG\Y
MRCF0"%FTVFK4`2'@D&FXBPPL@(YQV;I$#:"2A(2JZ:-":J1*ZJ12:J56:L`5
MJ95Z4CV(W9N@BFYX1R^@P[Q(TUQ@*2^X!"CNIPVF0"4@#I+II9K<U./%FZ7:
MZJWB:J[JZJ[RJM;8THMJ:F,82_!U*BW^"`C1!9TTA0FL3`)09&F)\!^@S449
MEF"L-!?(]6JV:NNV<FNW>FL8R92`NFGV%"*LXLBR9&E"P$(/`J2=K):^,!9)
M3@J5>13B>`&F#(T_3MVW\FN_^NN_`BR:NJBX!JL4!%4&Y.(G6$":&(B`E%5L
ML$Q'F8L#%*<=O,L*1$Q%R4%L/`E_C,(*2)J5/=Z,!&S)FNS)HFS*@JM_9BKT
M;=+1],2WO.:U&=$T:LW-#H/-ZLVJ',V.RH`I`28PK0+XR$FCJ.S1(FW2*FVW
M#BQ=CFLLA6@G+>W44FW56JVE-FWS/2W`:6G72N+5@FW8BNW8ENF4$BSTD6W:
MJNW:LBW2FBW^709HV\KMW-)MW=[J%S'?V5Z&W?)MW_KMWPKIVVIMP0)NX1KN
MX2)N9OQJR[Y.XCKNXT(NX&9MBFWM*7EM)&5/\SDHW`X2(6$NB69NY%;2Y][2
MYHXNZ5I2YT*0ZJ8NV0HNY1*<Z,KN[-(NV+YNZ1*N[GS+M_@C[^ZNK``O\/:N
M/Q)O\/:NK!2O\/IN\1YO\@ZO\2XO]/*N\T(O\^XN]2IO]4HO\FJO\F(O]_:N
MN33O[U+O^$YO]_(NE0:L&&%O^V9O\Y9O]";O^T:O]C[O^3YO_M(O_M9O\-;O
M_,(O^AXO_8[O!EAO]OHO`5_O]2:O^C+MXCIM[CX!8+ED!5OP!6/^<`9K\`9S
M<`=[\`>#<`B+L`930`/8P@B+\`4X``.H+1B<,`K#<`S+\`S3<`V[Y,+"E0UO
ML%A8[>U6J`3KE0/7;@TVWP4LP-<J+6/4;@>-*-S&I=).+NZB[62<T_MT($S%
MT!77)C%E<3YM<?MT,2)A,1A[<1F/,3N9<0>J\2J5\1JCZUXF$$Q]\1A;P!&G
M;16[,1J+<1YS<1J?<1_O\1^3,26-L1R[L2$7\@H%YOF@TQ>73QPK\A4_<=)B
MJI-2`1`C0?PML2IQD8`:,1(GK1)O,M<VL>9V\M*N*`1K+B8?@2B/LJ=,<A"%
MAAV3K2N_\F2(BRE?K0\?4>4^@2W?<F;^Q'(1?;(0\RLP!W,DY461#K/*1G$6
MP6@5(7,R\\\I%_$1&_.W3C,U)\$R.S$HERPO%U'<4G$VRRX1IU@=DVV;<3,$
M+1,S7RV;<JXO!W$[%T\S(^DGW[$Y1ZYB$"@Z0W&XPBTKX\`VV_/F$:@Z\S.W
M&O1!`R0\][`J.RE![^9"0RY`9Y$^U[)%0ZXWZW)$LVP$3[%D-+0]8[0L.PHV
M;[1#`]"-0'35SJ7>:DI)M_-)%Y%"KS1+2\$[?S-(6W.%RD#LDC1'.ZYFT*5&
MCZTFZS3YE+*3_G1`Y^U`CS0`T30WVW00(378LO-2^U!3ERX^HZPX!Q$](T%5
M4_-5(RE.CZW^65.S5U?H4U,R$]3JX$XU%K!U,!MU\ZGS/G,U%/#T1U=M):]R
M74O!7=\R6E_I&ZCT6A,UXOKS2U-M3%NR!SS?W@YU7U,&6--05H>M8=_R7SLU
M.*^O0--UXS:&4F,V8M.06HNM9V_R8_=T8$OT+9%U*[?27AI11$U0_>CV(_MV
M;UMQ;HNF;P?F<`<W-SG3"J5/<#O0&3,R,>WU2C]/'!LW;B/W:':Q%@,4#UUW
M07&W<S=W;3ZW>(>W%WO4<",R!46R(,(T:4\T84>!:[^V9HM0,><T9A-0?8XS
M?0,LWO)W!T4S%OW#'1!X@1OX@2-X@BOX@C-X@SOX@T-XA$MX@F/^P`-,^(5/
M`BTG-6I<>(=[^(>#>(B+N(&#2RZ<V8@?.!S$\VS_,'SSSP``0(S+^(S3>(W;
M^(WC>([K^([S>(_[^(\#>9`+^8ZS<&/KZ@LPP)`K^9(S>9,[^9-#>8\/@)%;
MJEA/(D4O"R30EY;#RM!LN9;?#)AW.:R(^9>3^9C3UYES.9BS.9J7.9>K>9E[
M>9BO>9>'19O3>9R[N9[GN9KO>9[7.9\#^IS_>9B?5]@^UIW'.9R;^983^J*+
MN9\K.IX+NI]7>I\[.J#+.:._.:%KNJ07^ID+^J37^:=G^I]W.957JI77$#GC
M]ZO#>JQO"HL?$66[^.AF,41A,20#9F7^)G<237<QB?<9&=-M![L>>W%#F52R
M,SLES;$9YWH:M_$ZVV!^Q1%@<E2SQQ`;7TYI#!,7L'%V%J=YQ!-$D;LGT&Q"
M1?NZ+_(>!Q.[)[*[`S(-7'NR!W*SX[NJ5[E[TS:6`Q73M2;K0L$__("VT,<4
MH0K/YFNN-(RF'4SNI"2J9$/,VLH(B%$X0D*LN:9>7ML8R4+,1HNY*%*D%&@Y
M#F9WBF[H36,[(8$Y:L\`8NO-[D8W_``RH/9IZ[N01DRS\F7F).XS][*_@PFX
M#Q0[S34[+040Z,@JN)B!G(5?Z`19;L!9##TMV$(X/AX+&]UHE4,*@%[$S$#`
M](@')$!*R,#^X3U>Q^4>;<BW9%#")*QH1^6.ST(N)DB%+;K6WVQ(.W!``D"-
MJTK;GI[%C[D$N>S,^-5I3RB?IKGJ"-R!O^RID;C#O!@:OPZ(J`U6<1F'B?HM
MT!=1;3N"$(Q)?`6AAAF"9]0I*?281&0`=+@TH:!;TX<"-YS<P4G..3W(;FD8
MI-E!Z-!9,4Y?56H!2CC!>4!'*:B>M31#VS>&Z#\-&2@8$&B:ST=NKEAFNAV&
M=*A)I,#^2YR"+:B!W+\!-&@!='@?LC!%[IQ6(#A`6^@`UJ5!'5K$@.7+H&HK
M\_#`G[#$<N##T?LMJX/`)XYD:9*>`!B?=[X?-VE91GF>]$7?Q'7^%M[DHZ'T
M-$.(Q0(1#3&-&^8B@D`J'TK-Z+$8'1&J:"/)>"H9JN;1R6`L%VRL<M%8BA\=
M'EIY5#@6@!<81BT/%!4>0RX5&A]*3BXPDY0G$RX:6!D073\.:QB5HJ.DI::G
MJ)0<%1N(1!8=1I<73'D?&*&70Q03@R*-'X,4'1^-%K@]BBT?%ADBN!@3;SZ!
M@!:]&*N_&=J2J=_@H\B*@!,5L3L5S>'L[>[O*0"+[S`=*BRH%5HWBLH54QAT
MZ&B5)=...AQ$Z)CR+%2R%A`F3.`DHHB<$A0RX;E5(QLD%Q,B>,@0(=1`(Q?4
MP(*%)<*0%KLXW'!23&,>;_0LN1A4)T+^AS\<(&C0@#.GT:-(3VS@UJA"TW.R
M-$CP\*`'APUH>.BYY.A#!@M9.!#2(%)+KAV2<@R=NF&!!PI5@0::R@%/!@U7
MG"7=2\D%H0V7S-Y8F*@KW\.(2=F3EW@Q/E*":-UU*H294PP\(B2D<.&!P0PS
M]#YQB!E##E89Y*!)D[6."$`8SNU",V$I%9?+^L1HX&B(MI2O?J+3#?&"$:G1
M<&'Q4+;H41<1+-#9L:8#K2RXB"7>SEVQ4QP;@KERY,A&*+%>@75%HE<1C6>)
M/FS@D)"\82#G6CBK2P0\D1D>.&)<!Y=TQYU,@;3@5'C9W%*;@1!R%\\\?,7#
M@G,G2))&!SC^$'&!;S&,U"!]'W20C0?:;7"!=A%LT&$+4WC`01T<BH#BC.1=
M$)X(&Y98T07.=(CB"!UHEU`,+20D)(=,)CF"!BN*8%UX&FBG`0<BO>`-ABB(
M`LB1,X878$,C<%EFA&A.8J8)7"[Q1SO<G++EF:-P$*2:?:&RYC)RIIG4GEV6
M`&A.+G"@PDN'>4````2$8T."X6"@EY^);0`6I9AFFJ8'&VBGZ:>@ABHJ/1$`
MP-B@X+C0@*D)$%4DDZ\RB2*'],TJ(P>SQJKKC;#JRF&NN_[@JZ["XB!LD;GB
MNNNRO0X;*[#+UJHLLB6^"JVMSPZ;*XK7=E"LM[-.JVRWT")KK;/^S9YKZ[39
M.LOMLNN66^ZYK[)KKJ\R=HLOLSC<F^V\VZ+[;KO8,MMNL/H:/+#"`J>[\,'S
M^ONOMO123"ZR/Q0<<;/VIHMQPA#?N_'`^>[KKK44F!K`D8AU8(#*`@00\\PQ
MRVPSS3;+/+/./-\LP,\!Z+PSS3@+S?//0"<]=,]"+XUTSS@3[7324!.=\]`U
M/PVTT4A'G?7-1Q^===0^!XVUT653+?763HOM-MME@WVVTF&OK;748M/=]=MP
M;XWVW'UC_?7<9K_-M]Z'>UVXUX,K+O?@>2].MMV+1YYVT6?+'?;ECW>M]]U-
MYSWYSISW_3C?G<ML*@!5H=J.RZO'+OO^[+37;OOMN.>N^^Z\]^[[[\`'+_SP
MQ!=O_/'()Z_\\LPW[_SST-,>P`.NN\/(!`D8<(#VVF]_P/;=>_]]]P:$;_[W
MWG.?OOCDKZ_^^^ESWW[YZ,-?_OGCY_\^_?:#K[_[_0N@^_PW/_;ACWT`[)\!
MZ\=`_^7O@0-TH/@6",$"4G""Y#O@^?BG/_7%#X$<C.`%\4>_"HY/@R=DX/X`
M^$#Y@;"%!/Q?!ALXP@9Z<(8FE"`*;XA"'=H0@3[<7P\_.+\;QI"(,DP@#7&(
MP13F\'L%8$`O1D7%*EKQBEC,HA:WR,4NPJ!Z]'`!3L9()SZ9<4XV,F,:TU@4
M-)ZQC&N$HW/FW)@6-@7JCFJ\(QW+6$<^^G&-<\3C'N.XQS;^\8V$C",B%UE(
M02JRCX#4XR$'R<A)XC&/C\RD&B%9R41ZDD]D_"0EQ2@H2XI2DYNT8R)#&4DZ
MA9*5F!RE*=_H1B_:\I:XS*4N=\G+7OKRE\`,IC"'2<QB&O.8R$RF,I?)S&8Z
M\YG0C*8TITG-:EKSFMC,IC:WR<UN>O.;X`RG.,=)SG*:\YSH3*<ZU\G.=KKS
MG?",ISSG2<]ZVO.>^,RG/O?)SW[Z\Y\`#:A`!TK0@AKTH`A-J$(7RM"&.O2A
0$(VH1"=*T8I:]*+1#`$`.S\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g109112dai002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g109112dai002.gif
M1TE&.#EAJ`)P`_0```````L+"Q(2$AL;&R0D)"LK*S0T-#HZ.D-#0TM+2U14
M5%Q<7&1D9&QL;'-S<WQ\?(2$A(N+BY24E)J:FJ.CHZRLK+2TM+N[N\3$Q,S,
MS-34U-S<W./CX^WM[?3T]/[^_B'Y!```````+`````"H`G`#``7^X">.9&F>
M:*JN;.N^<"S/=&W?>*[O?.__P*!P2"P:C\BD<LEL.I_0J'1*K5JOV*QVR^UZ
MO^"P>$PNF\_HM'K-;KO?\+A\3J_;[_B\?L_O^_^`@8*#A(6&AXB)BHN,C8Z/
MD)&2DY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRMKJ^PL;*SM+6VM[BYNKN\
MO;Z_P,'"P\3%QL?(R<K+S,W.S]#1TM/4U=;7V-G:V]S=WM_@X>+CY.7FY^CI
MZNOL[>[O\/'R\_3U]O?X^?K[_/W^_P`#"AQ(L*#!@P@3*ES(L*'#AQ`C2IQ(
ML:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRC^4ZI<R;*ERY<P8\J<2;.FS9LX<^K<
MR;.GSY]`@PH=2K2HT:-(DRI=RK2ITZ=0HTJ=2K6JU:M8LVK=RK6KUZ]@PXH=
M2[:LV;-HTZI=R[:MV[=PX\J=2[>NW;MX\^K=R[>OW[^``PL>3+BPX<.($RM>
MS+BQX\>0(TN>3+FRY<N8,VO>S+FSY\^@0XL>3;JTZ=.H4ZM>S;JUZ]>P8\N>
M3;NV[=NX<^O>S;NW[]_`@PL?3KRX\>/(DRM?SKRY\^?0HTN?3KVZ]>O8LVO?
MSKV[]^_@PXL?3[Z\^?/HTZM?S[Z]^_?PX\N?3[^^_?OX\^O?S[^___\`!BC@
M@`06:."!"";^J.""##;HX(,01BCAA!16:.&%&&:HX88<=NCAAR"&*.*())9H
MXHDHIJCBBBRVZ.*+,,8HXXPTUFCCC3CFJ...//;HXX]`!BGDD$06V8\'82!I
M@Y+8,(F$DP)"^=L&'$`AI0<;="`"EBUPX$`&+V#)P092YO!`!1]$$,$-$*!9
M)@IDPI!!`QUT\.4)'30`Y@AS5BG!FA4\<$,'#SC`Y)A9EO!FF!O$^0&6CLZ`
M9*`C.$EI"ALT`,$,7N[I0J.2?G"I"6>2T&B5(IPZPZ@`%5#`"6\N6L*?,-#*
M)P`!;/"!!`!XNN4(#J"9`0`2O#`L```0@(&B-2#I`0`+?.#J#!+^;-H!M#!`
M`(`"+B#):Z/$/EKI!\,6*RZO8!)`P`<,`("D!G1V.\(#VRK9@0#("C"!#DA.
M@*RYO(8K904.M+"`N\RVNV@"`!0L*PFEEBON"AL<@*R@3CXL@L(3;XFM"/<"
M<`#(^([L@@8,:'FPQO9,BV4'8Z9:)98>P$S"RR-PX`&6&D"K),Z/DFGS!STK
MP.2Q#.S:ZPA4CE`!`)MZ8`&J8C*-ZJT0=%!``$HVG;/.&MCKJ,U49PE`TAGL
M228'5W_`00<>:$!"T1]<F[2N(W00M@D>#(`LF!W@_8'7@=MK`=$`[!NTEHA/
MP&7=%B`Y[087(*D``!H4+@+;)<0,,@'^KU:Z[0<*!`!WE7B/J:3G'&C@^>!7
M!]S`QO]NF6C-ZC*N>:IU8[GLYH)SO+L(/4=K.^-NPXW\TYL.2X$';;\^P@*Y
M:G`XEXGF+'C=36OP.]#/)HUD!P$`,$"5&)1O`-/;!\ZX!Y?+O<'O609N:IVI
M(^^.NN1NZS<#"$"6W@!@`'P)Z@,8(```!&`N`D"`8<@2&='\)H`+(!``!<`7
M!7J&+)/U#P$"^``%EE8Q9!7,7^5S``<2]RB++:U=#2.!Q%;V@09<3`3T$D`!
MEE:!\A5`5Q`P`*\TD`$%'BQ:T\(`!O%EKASN<$_'DJ#(#`"`V;G-;P.P().>
M]C1!]<R+`*#^@*A\J"M_@:M8&E"@``ZGQ`7X35`C3->ZVO4!%X81`&`4X[S*
M=P`RE0]7[\,6KSBP@`4X```BQ)>R$#<[`2#@BXASD](8,(!'#:!=:%2C!?_(
M-0Y@T8+DHT``'$`O)&D+``A`TL$0B*\$B$N)R%K?!=2H.`<>8%U*2^$&_!>N
M"Q)P>P6HY`AX93%]B2!@"4#2!K!80X2YL%CA$YT"!B#&!A3@EL=$EM$&]\D/
M4!%9&SCDS@(@``7.S@,'(\``N!9->!1@7<,RVN4JL,L'[+(`'F@7F$:G+3"]
MDP$2*)HRE[6`5\53:P*(6[W$Y;P#3.!I_B2`U,+%O/X5JUU34UK^Y@(`S0\^
M@`#%&N*UBH6MRX$I`[HJ0-(B`"T56JP#VDH:_PYJ@`#4K:1+$T$\;UJ`#AQ,
M;M=,D^E(X$9IK>\#"5@72[6$T@\0(&G?VN6^-@"F@O8/G^W:`$2=NJZ5P0]S
MWGR5MI#'J\@18'T=4)?./,:MR[$K``N0@!(W=3DMM:M=RYK66(<)``L$``/I
MLP`+J?J!!:R/`VJ5UL@BP,X`'(`!&+`ADC``,XX6%I$'&$"=9#BZ:W&KG])Z
MJN)$!;7^*0"A-YV=5<6%P@AHR5_<HF+_Q%B`:!E@`*Z[;-V6Q=A'G4UT#@#@
M!P80`6PJ48Q/5:Q0M10_W3ZKIP?CP+#^7*M`)`4K'N^TJ'.KN,)B#:L"6WU6
MM$#G,>.E20'3FB'"?JND[UJ@`"P%E^*R*S'G?>"W(K#8`1AVU/ZIBP"ZHN)^
M41E'I8')`PY0@`"B-43?)LUN7-7N*OT%I@9[[,&__5;/"(``BYEK</P$`)J>
MU@$%(&!+"5ZPTLXH`@B@UZ#A^NY6^=<NNP)`2_3B@`%./`+R?H#"3@T=R/[(
M0';=^+),%9@""_8!;>F8QR(P(P(:T``$[-)<+IY6:/W;81;BEV.$/%BQ5LDK
M!/A*O`;V[7B%K-,8AVO"(D/`$^=V.5>B2VE>$ED"!"``)7:48Q5(0`+8B2UG
M-<RO@N4`-MO^M5\^"Y;#'D:RD9$D2`!P0+*3ID=ZW^RN9S5@A6M28@4$NZQK
MS<['[3P`/C\J842VL\W[&@`570>`-3EU9/7ULGD/(``(^%J/_:-G#'D-@0=`
MP`(C7-80/2``;B&`6W=&,X3)J]X?`\""T5:SMJ.Z+5]#P%.\XK/?9L>!40Z@
M6!QH]@>>O6*IUG'5\*SU!RX@XJUFEX8T[!D#`F#!$6`S36#U,5LW:V0MV5!+
MQQ4ALHRG;WY/S(STPN,*]Z5J#SP@=-/J60*\+;<O(W)8FQ+`FFAX@0#*K;P*
M+W45@]RQ7(\9D4_3E*_;1KN4`YP#]'J`L2F@Q#4AB8XVU"JAQ>?^VT\O,(39
MM:'.(4"!>!;[VY?]^7H9;.F#9WH>].6T"+B;K)(#0%<#.$`&#J8K@<L:3([4
MP*9?CJ2P>TIB$0?3GC&@+33M<@$#W%>[SM0!+FJ@30P-%Z])6X&_6^!:","`
MQ6CM@/11?4\,JX`-91KOEX,8`1=8/`G"'K9*@ZG#&<"``Y"'@`%4@`(5&$!"
M28?!5#7,\>UF80`>N6D">+T#!>8?#;5%`2U9#)?B$BP$,.!($617=$2/.H@A
MFUD1-%NPMK:8D+WU=0ZB5/:T#]V>#]=A[S5@9QXG[4/EO;((9."0NC*T^,*.
M@:QNV530:AVGV\X`K1Y0!!600`6*7V;^XE=REQ&P`1.P)AZ&)G2T9QI`0_BE
M;18C4Z\"@`*X)MT765JB+7K7:97&`8+5`!;@-TB"`+;V#AV&.-542<P&`;N4
M5*:7*OSU.P@`967V`1TX`!`0+3U3@EHR0E!V@VZ307+3`>U"`&@B`H?T`"ND
M1_L6+A3@-XOT+F%D;6A"`8I4801T2+SE6!!0,"-T<AMP.914,`<P,CS8``-`
M?0=P2+X2@P*@A6#E4PLW`AH0`/O2+T\X0O?'6`=0*`H'+F*4>C08+1FP8.H4
MA6`5AA_@`&78@TOC+TQ&`DM814KR@C<S`$QF78F(0%24`$`T`+I"23D80XY8
MB&+XA!W8:TG^PTIEB$ZX$BU]PV2(:%W;X@#%T@`A9$-%5BF4R((BXX)0!BP2
M]X1DJ$P6$P";XHL!H(E*LP`"8`"_@P$[1$UU$T"Y\@`A5$(/H`!5DHM;DHN\
MLBR2B$`[)`!BY(9PM3D[A'.)F(M;>(@`D``*:$7\,"RCI0>HLF<_P#A[QC(J
ML#-\$P5/LSU!`"63\G4=0PC^<G)E@"H#T(O^(#$%"0=08HMK=#,KH(^V&`"'
M<P3ZV(\QD%:@J`0>L&0]L)%;0'V^\B0Z<``!$``$@)#_@'LTAP>XUWM`T'<T
M&0?@I9&*DI.*P`$W608".(0.0I+H`3U:4B<>\#LCZ0.@4BEKE0/^T!,%1)D"
MTG4"&>`D2ND?&R`!$H``$[!!K@0K)-``YK4`,4DT56(G*3"5IA0UY)(`%1`!
M&<DL+W`!$3`!NM(!64D">]DLQ+,]=/>0%+D"*(@!W%*0"-`VB?D"&@"00Q`K
M83(WCLD"5_(8',!CEUDW-Q.18+5N5*,EEJ-'3,*/CZ(_>>,D<$,"%5B,,F@\
M"7!R_)B:=/DK.G682$(!A]D[.G4`/Z,_-0,RJ+F9(Z``P%8"LEDI[S,N;O,S
MK7F:(I"8I+F8FLDWR$.<@ZDH93*::XF=NLF1I:F<ORD"UKDE97*<Q_DH]C*5
M>I&9;G,`%3"`2)(!$:!_8]D`3+:8\OG^E0AT`)_F4X_"E6+$`7?Y82*`;`P@
M1A/0`&J")AP``5^I`"%H`<:S`'37)GWW)V`R`4E#,!'P+JQY`?V5*0=@00:*
M)A!0``$ZH`BT`/EW>A+@`'+C`1(P@"*D*1&`)IGW:2-P`07SHA#`)`((`;,#
M`3'Z`![PG@L`)@W@/='BDQ&0,NLF`100`7*SF!3P)RX9I`63>0Z`-QZ0-2+$
M8Q0``>;B`%;D8E62`?@T;_>W`!0PI7(S`0Y``1Q@E_29`:Z4*2CX*`Z:D1#0
M.G<I1CF:I@XJE/^IGR(T@!46+/HWI2JT&.S9`0.P+`R`)CJJ``=66!APHY[)
M+E52*BSJ-B?^-I_B<B=S6BD_.*HCLP$G]@"SHS4=90'<<@'1L@"`(B@<P`"6
M8P&M>CBD.@(0P)L%RHH_Z$H=P&-WT@"%IUGL4C`)V&1H\B<3L*H)H#)S*8-Z
MXDI.DB@<6`&;0BER8YB:B@'1TC0O*BW%(JOK)C6;0J[W4T/[L@#7*J^[P@!R
M8Y8)4"5"6C,.X&NB4JD?\`!S60#IZDHU2#16M*3L0@%)ZJVB@H*SLP'1P@"?
MBB;TFB?,Y2ED*BZ40DAI8C)>*2KWAQCLR9YD2C!LTZ_B0J$=X$HC4RV;XTJA
MR@'5FIOD.B83P(I,HP&+58P(T+*HXJ](DGG>JBOTBHTBH"9N0P#^AV,!!6.6
M)>",%E0!.JL!/,LV)W:S6ZDGQL,`A[,!U:J)&D"K$>"S54*O(R"AA_@`IIFR
M:\(M#I"1WG-B%.JN02,!27,`J/*S-8L!C2F=P*.RH>HTQ6)^%W!I388!/FD!
M&V`!KE4P5"I&NCH"TGEB_NJU!6I%![`I'ML`%L1@IU>,-%M8T6J$7E*,+4L"
M2`NM,-NI:JL8)<MC#LJP&`!>5Q.J#8";'E"VFW-BF`NVQYJV"5"[%>`K;VH!
M/?N<-!NTK*FV2D*OTNFOSJA'GMN(OR*N%G"*IX>\=7)BO)H!MGL!ATFO--L!
M(PI>&^"OG3JXP\JG/\0G<F6K3=:@_WG^>B.#J1G`+5MY`0^0-)6[O`E``18`
M7D<3OYO"OFXC`1D@1CQ7,`-<`92%;/M"I&N"E\E7N6DB*&BKMJQZ0'%K10HL
M`;LKNKYKHI!U>JB2F9$8M%_IL[KBO(D1NRVFP.9%5(=S:0<`,U9$HPIPPR,#
ML(.33":@OLF[K@U@+B"8MC4<JA%`O;KR2*_Y8PAPK7#HO=%"Q'5"K4SRNO3*
MJD@5HTWFPH5UK3!L;#&+0YMB`4S'+H?#L^,:+8M9`=Q2`%_K2C^KK"8PN@%[
MP%0<`0\`)A4`67S*MAZ@H55"`:5B`;E+`@6`)AI@L-]:C,<VQGC,JXKS=\62
M*5$V<DU;P]/^(Y1-O#$CK+S-";N8*;N;HB86X#C3DY$CI"5Q>2F2I[@G9B<.
M&R@7(`'(`R]?^2J\6T<P$RP38``^5\JJ=#UG`GB\*WGDLJ9Y,P$8\``_6*F1
M):4&H"4.$`$<$"@6(,)<?,,G=G[=W`&_',<-L"Q(HK9?J;!H;`$;-S@"(#?9
MZZWW&WK0%BP-D+?'5BHY["7@=:W%YLZ`<LZ_(@$F4P%0Q@"GV+\Z10!:H@$&
M4"7F5T?[;*+%V,0T&LA$LP"2XRD$H$>Q7(RSG"9RN2^$4C?)W&+>:M&DK+9L
M&\,Y`S*Z@P&H^3."HS=SHR6"TY1)27,=`"9IR3A7DSGA^9W.23S^J(*0<J/'
MJDG3.?.#0+TE>Y*4H*D[JP.'>2G4<(@\OZF74$+46KTY2]T[X4DE48DZ5TT\
M+JE3RD,\^F,_FY,S[U,V,;V<GGDUQ\DZ78,DU7K4=>.2F0,RGH*034DT[Y/6
MFADIXW&@FJ`!37RE7#D!7#FCD#T!EDW9DRW9,VK9!=`FF0W9F"VE7!FH"!#`
MF3W9F*W9%*#94JK:D_VFKZW9ERW:\QE0Y['*GJ">#\G*,>#8ZJF/NFTDPCW<
MQ%W<QGW<R)W<RKW<S-W<SOW<T!W=TCW=U%W=UGW=V)W=VKW=W-W=WOW=X!W>
MXCW>Y%W>YGW>Z)W>ZKW>[-W>[OW>\!W^W_(]W_1=W_9]W_B=W_J]W_S=W_[]
MWP`>X`(^X`1>X`9^X`B>X`J^X`S>X`[^X!`>X1(^X11>X19^X1B>X1J^X1S>
MX1[^X2`>XB(^XB1>XB9^XBB>XBJ^XBS>XB[^XC`>XS(^XS1>XS9^XSB>XSJ^
MXSS>XS[^XT`>Y$(^Y$1>Y$9^Y$B>Y$J^Y$S>Y$[^Y%`>Y5(^Y51>Y59^Y5B>
MY5J^Y5S>Y5[^Y6`>YF(^YF1>YF9^YFB>YFJ^YFS>YF[^YG`>YW(^YW1>YW9^
MYWB>YWJ^YWS>YW[^YX`>Z((^Z(1>Z+&Q*,'MEY0I+SOPVT8@D/RRG8T>*M[9
M`HX.E3&`Z#_^D.B"R>BSN93*69%6$-RZK>EQ_M-ID^JJ?I6;L^JKKM090$2N
MWE1U,^NJOCH8,.NR#H>N+NNQ+MB^[NI=$^NV/MC%[K>"W>NIOCJI'NRISNO.
MWNS)7NS#'NUI`^O*_NN[1>RSSNRO?NNIPNV]/NVV/NS%[BE4I>J^CNRUGNVL
M[C;-/NO0;NLG)UW7WNVM7NRP;NVTKI?G[NWWONKSKNODCN^#<^[8+N[2ONW4
MGN_9SC39WI@@D^L-3R[JKNJ*NSD4;^M2'>^KSCA$Y.OK?G*HSN_M=?&JGL+N
MOM9`0'T1]/(1M"<P!/,1Q#7Y1?,O?U0!@_-_0SL\#T@W__,Z__/^R/([,X_S
MJU='1&\R.\_S1D_T-N]-1#_T1"_S4*\D=H3S3$_T.77T-!_UW\3S6U_U/L_S
M21_V6I]-1/_T/P_V2Z_V/V_U;8_U4P_W/"_W/!_U64_S8Q_W98_T=/_S?7_W
M?__U@2_V=H_S@/-'/'^*7@_S`H!P7*\X>P_S@Z_X=</X.&]%C__R44\$6[G9
MECWZ7,DXFRK9HT_ZHY5_,RKZ7TF?1+/9LM_Z$H`JI^_ZLDVXK8_ZESV$&M#:
MD<W[NBP"IY_ZD2VE2L+ZLSW;0[@!\[G:J"_[IC^@O'_9P*;\ESWZG#HXP9_Z
MFCW]U:_ZA)O]QN_[&"W;I`_^Y)_]NB_^^]KO^ZY__%=J^QC=_0"J^ZJOV<W_
M_-DO_<1/_2`@3>,D?F<EJ:,X1M6IM:PH41)W8E%)DB9J-9O<8!]-A$+S23JZ
MR&PUHIP^J1YV\HH-A;?<9Z>4EFS5Z^]GE+'2*F>8UZ91/,$R4[*V";'-C\=-
M3Y0$QI-25DG=1P<9%D7$1I!CC=$&SU@>G&!4F6&<C]^$756IZ2EJJNHJ:ZOK
M*VRL["QMK>TM;J[N+F^O[R]PL/`P<;$Q+2E@5;(I*?.IG;/J<^HS=?/U"7.V
MLG8UZO4V:[1W\_+T>;FY.KAV=K(T.C?\=WK[^CR[?;<\NOX^MW0!R?$K1:^@
M08$)%T)CV!#^'\.#T,35&[ANFD5]TN(9W,@N'L=N'L@1/$=Q'\)C*E>R;.GR
M)<R8,F?2K&GS)LZ<.G?R[.GS)]"@PBJ`X0#C`@0-'RYL^4"!R@85$CX8+<4!
M`@4G%9QXD&#A2!([)4AU,"+T+-JT:M>R;>O6%H0()R@TH/IA`@<G&2Q<V+#!
MT@2G<I5=N-"!P@8'.>IDP-#!`X>G'3H$_B`!PMO,FC=S[NSY\RU(([%2Q5"!
M5&$J=^U04,JAL@X,79URJ#K[B(6H#PQI>`KZ-_#@PH<3AUG!@H7>5#A8L%2G
ML@2QI*9Z.(ZA05;:D0%-I3S2P8(,JZ<6+V_^//KTY2<<EK!!M=/^#1V^6CXQ
M%0/]V_(O?*)]F"H5IWT0@1,45`#!!`HHI1Z##3KX((0V!>9;:Q!4`,,#>LA'
MA"39`0);&/U5($D&1#CU0`4:;$"$$8U$^"*,,<HX(S+)J'A"!WXYD=<_*%4A
M'R`;:."$7S0:>22222JY))--.ODDE%%*.26555IY)999:KDEEUUZ^26888HY
M)IEEFAE,0!?5DF9*O;#)YBUOK@)GC_6X0J<_<PXCIS!\VMD*GH'BXB<PA/YB
MJ(\5S0(GGO><^2BDD4IJBP<0''`IIIEJNBFGG7KZ*:BABCHJJ:6:>BJJJ:JZ
M*JNMNOHJK+'*.BNMM=IZ*ZZ98M:2`@#^^/HKL,$*.RRQQ1I[+++)*KLLL\TZ
M^RRTT4H[+;756GLMMMEJNRVWW7K[K;`*L/2`KP(P<"ZZYS:0+KOHKLO`N^W*
M.V^\],Y[+[[VXEMOOOWJ>R^_[08LL+K^%ISONP,;?##`"SN<KL+N/CQQQ`S_
MVS"\"U=\\,;];MSQQ.Q^'++#(^_KL<4(HYPQR2F?*X"O#JCD`<P#@#$ISCGK
M/!,'`P`@0*.W=`#SK@1)9+0Z(/$C#D4>*:-T.5!;$[5("CUMM=3F-.V-TR'1
M`W755R=M$M5EE\3T0EV'?5#6:7,]=M5LFZU104JK73?98:^]M#U(\QTW0'@#
M+C9';4\]N-S^8N^]>-YSWWV2WXF?W3?C=@>.]D@?0`#``$';(H&OY.T\.NFE
M#P.Z`'`4,T'HIKO^.NR+WO6SZL2P#H#HL>N^.^^6T7X,Z+BWV3OQQ4?*.M#%
MV!$\B,8[_SR9R_]NS.W-0W\]]ERB7OOIK7N>/?CAQRC6S]_3PKSXZ:O_)/+F
MQR*]\.O+/S^-VQ]S.W7TZ[^_>N2G?K^OK,>_`1(0.*`;`/>$$;S<%;"!#MP,
MZMP'"_@%1H(/O"`&7^(_"\("?QG\(`B!@KP$!F.!(3PA"F\20>"U+H4N?&%+
M1LA"``@0AC:\H2ZD]S]CF)"#./SA#^U'O0`"L8A&E,4&9UC#(S+^L8DG:)_R
M?!<_)U*1BD+<T^R$Y\,J<G%_2>0A$;LH1B`>D(3`\.`8TVC#%0Z1AL-3(QP;
M^$4LHB^.=@2A#,&HQ3OR\8%LI&,+^RA(_OG/C+^HXR`3J;\K$J.'BGSD^A@Y
M##1"LI+A@R(QX,=`2W+2>9@L!B([*<KB?;*1WALE*G6G0T/ZHGJI?*7N\@C*
M,,*REJ6399^DN$E;\A)2A8RB![?8RV%&Z8^F=",QD_DH20J#DLI\IIA*.4DB
M"A.:UAS?[)*722DN\9K>I!(S2WC*;Y*32K_<I@G+J4XJX;)[R%PG/-E7OAGF
M+Y[V1-(J`3C%>_+32.U4("W[*=`8&1/^3;H<*$(CE,\V[C*A#CW//X/ARFH^
MM*)"B2@PTFG1C1:GH(7B)D=#&IPYVHZ:(CWI9S!ZR$"BM*5OT2%%51%*E]*4
M+2KEA29KJE.VA/.,X]PI4'VRT-4%-*A&Y8DT`;K/HS(5)TD]%$ACVM2I(L-W
M.R3J4JFJU9<\-:,LW>I'P9J*,BKQC6*,QC9JE[E_K/4BF9-(1QQR.)2<K:V`
M",<R)M<WN")DK@YYR$GJI,:N_L*9<.R``P(```)8```,.,$&!+"K"A!`L9BY
ME"DX0``"W,P#$1"`8B_P@<HJ=BH-"``]'/`S`#S@"`!0#04`L*`/J%9T"%"L
M`*A#```@0!O^N^WM"33+V5)@X`"^6L!H`U#:#S1`FYBM&<P4@TS*^FI7S'6C
M'3!;A0OL=@"2.`5F55N7#VAW`[T"P`'X.-1C=K.*'AC``"R``?>H5CP'&,`)
MR!4!TU!ALZ8@%VN5D0``5``#%!`M;S,PH@\P``#/:#!3"+R!^(%./*Y=+"D*
M,(`,-```7U%LYSZ0`<6F-[^^:JT=*@"`!BBX#KPU30X6X.`3$*``2U%Q`C`@
M).'IUS1K4"P!,DR`90@``1F0P&R]X=\&!T`I_M7`BRWP!S[>=!<YE2H&69=D
M#P3@`!C`[HI-X=]2$&`!"1BR:T'D`<>6HL'T:#`@`"!=Z`#`PA#^D"P`/N'?
M#+@1``H8`(8*8``TC];,A#:``0S"YBJX^00%L'&<'ROBUWX@S*:(0``V]XE'
M*X//#77TD&5,@,<N&;6#/"=6/\W%`]B8&:P+`'!5;.$JU+@44)ZO;&D[8V<H
MUP`"H(*,'^Q@*$>"<X_VF84/D(`UR^P#!1!`!110`">L6`$)^,``+(7F6X-.
M*1/.'9<#\&Q@SWBTD%XS<B==X#J?P@#+EK.C6^UH`"S@NZ<H0*@#,`'\<EH`
MR,4R"CTJT:^FD=,%00"[?2>>9'":%#*N#;T97&X<`<``$&B`(8)]#B:CU[4*
M@``$>B6>"P3XMCDP`.?TS0@Y5T``7];^P*!/\/`.1)S/%=0&``H0`0<8HM'.
M/O>B^7PA=I/CRZT=<`[&C*,'A!8A_I4Q>2/`ZDH_%N`G)"Q.HZI&.Y#K9HPN
M]X1;6PI\+V.WCPX`?AMKEDBW>>(G:+!\[0!E\K!./*JML<_Z:V,"X'?-#9CP
MLW_."+,7@'-V*+*B)6T'GQM\S9+FLXM17(6[:YC2M38%S25M"K+#60+PM3$"
M\'OJ;+*R%X9-(Y0+H`$-Y$;F$^\58O`S6@)L0#:-90#(>R7:RO;E`N(!0`)J
MKY0&8V#U7T^&I^W#[LV"?'/B\B_K#,'FPB/7O[>/2Z^^0JX';&`O:PY^!I2B
MX@5<)<!LGW3^8`:,F`SLO@`0>(#SG>W=#$@B12H.#`88H#JR!_N]%;>"GPG)
M:60`^=F1P/E"3MT1!B"<KUB8SP%"`_@,FZ&<KS3``A#:A%W;!BR`8KD1S/A*
MHG%<>BW>Q$%99<36!C26:-E!KW#`U$V8N+`9N<``IR$`!@+?"4#`;G7<!W:<
MKOF*`CA#T+E1!S17S)`<?7Q`"R*<8M6%!#:`'=C@V-E8HT6`#U(`!0;`[,S:
M8$W/++W3'4U&9R50!]2&'4P&&G(`6C&"&N+(9)PA&G)%7O"(&QI$&P)"#M2&
M06R`!TQ&'?IA']8A'9[A&/IA&1YB%92AUS%",MPA(+QA&7)-7AS^8ALB(E4`
MP&`$EQQ6`1WB"(\$(ARMESNI6A=9G=6AQWPL8BWU5&&9E%@95&:<(A[-DQZU
MURNZA"P"2B61E$$Y4@AE`/<,R4MT0)+-PHUX@`90@P:HXC0LHT$(HS$R8S$4
M22L8WS@DXR"QHB]HE!RQ&@(<@`!$``?$3S2PV3O\26`-C\:9%=6@F^_,5CE*
M6NTEBN-U@\W=E6!=0`ZXHUVA0@0@&@%85^!@S>P]Q!EXH09<"@$@@(`DW]1D
MPWRHB6`5$-;UPDP14*6HE@$\0'*`H66(EDO,E_FX(Q(D4"$`0@!H7C5$7!4D
MGRO$EB'4XSA(W`/(6#W1@L%]`]F5`I_^)4`$(!QR=4`$%*,K3%T1D15#99!,
M\AD$)("1`8("R$4%'``!<&$%6%P!%"#\78`!+`\!'("%+<!C54`!6,"ZY%>Z
MV<>U<0`#9)LI2,!7P@%<@B7;60`"2$)"#H!<)`!>^$P`!&4"9%LT/,``3$!*
M\B0`-"5=/@`"I-@!P`$$X!8,T%L#E&45-!<4E@+4+255B@X%/)H1+(`%1("X
M>!X$Q)Q!.,``D)\'&!=O(1\R;<Z0'(#V08`%I-<&@.89X%L%#%B7>25=?@#\
M68`!=`!AIJ4#520ON!(&N>.D'<#F))K?5=H"0,`GD,\!?-:0*<`!Q!P#!$`$
M$)_O2`!57E?^#H19YL"9`H!G[C26`T"`)'PG!#38[R%7M]$,`3P`@CU6AQ4`
M%1A``5`6<LE8R)FC#G#./P(``'Y%`9384@"E)`2`9%56#GQG!7QCVS$`@-K!
ME^'>8=*6!#17#A1``O@;Z#2`:HU@%;":!""``'"`!`A`.,(F>=#<`XSC5'#G
MHT66`DQ`.(8!>D%`!GR69#$8>(HG=QK``9`+R.7B+=$B(&'7!2VE\/3?BJW9
M`=@;^<#`YG"`:DE"V`'"``!7KP2`:$'>EW&A>A*8*:B8_GW`A.V*`%Q;Q(%.
M^7U7/=(<<JD8B\G8B/76A*DDE+66BE'!E9+C%L:9?<H6S2$`!FS^#@R0(`(@
M@&6&7@X"P#Y*&;MIF*.)G@!`&@JP:9@JW0G<X\HU`(Y*G"3T&#A^0(F.W9"%
MZ7OU5H-)PN8(9`&)HE*1HOXX9_)M9L1AP&Z-UQ.QFYUVF%X@D\$U6`&0PD(R
M`*B^W8SURG!5`07`#&(HJXW5*:9VF!`^EI[Z#@$(P%=BP&%FGC<D7_(I@&0%
M0.U4F*+ZSH[!5XU1`0DZ`=3MI);U3`)H6D$*GK,16J*BZ^4I@PD>Z(A4*0`X
M08.-:X,*GI"A'ZA]P#HR70#T1P-560X=5',.X52XF>-!1L"60FS)#,)Y@+>>
MP`"D%Y1A1FQ%9K,!F.B0H`=(@I8I`Q_^4N<'"`#+)J;.@DY48"+.55W$39B]
M?@7?`6!=D`*?]1:Y?(6*+9HRU!W;==O.CI<%)(.,.8&+:DZNM2J<39@A&%P+
M3IB#PBF\J1B#1NND344&%("[SAW%SIB*N88A9%\5&-S*NE9K:9Q2R.T#:>PN
MH(^3D@Z53@7451JJ`H!BJ8;TC&N`K2,&#(!BB4L'C*EP>AB0OJ@I0!T#7INU
M,JX`B,?D5FZ\PJMJ\9;.ZEIZ&:9B]18%*-=NJ22?P1=+7BX`@&0BYMW/LAL&
M@!:&?9UR!8"]END`G"G,#-KNH5D&^,QN)5HIN*[YD>JD*1?G&,*OEANY*);,
M>,"`L=D!>4#^\U;NO5Y7SI7>^J#:,?&J_K0>(%A`#K#>"?1%&"Q8]-99\4&6
M[C)"@067@"S%@BSD*:0@553`_LXO42Q#_\ZO:V0M(."'(=#O^UJ84>BN471`
M_BZ#!6`PQOX9*OQ%#B0'53CP^_XO9"$'_!(7"1<PG#H!!LQ:=7!`8YR"4<S6
M#!O$!2`'#*>P!NRO!BPP(%R`_>8PCE3`K/6P-B!'X9+.`;9B5C'1S=H"!:PG
M%ZH%AW(@^]YB%6BC1;KB#U&#7=H;$@U(`=BBH_S53-)-HM@#6>+J&>MB+F2$
MCRPQ"BEG''/L1M$Q'.?2'C\3+RJ5&2>2'FNQ"GGA^K)C'"$C^M+^`G:4@I#@
MZ2,O2B-[#C,@%@-4<OBA,4.`G#?DGS16@2>70@40JRVI[S0]<1]QG9\="DLR
M`LR4&,W\WRMPLDSB@FHM0#)8@`3"0!&NW2KD9**N`M4>GT2*DN#JPNF=&N4F
MG")3(S(B(Q@H,E58F/A&LX$.#>=(@@4H%O0>09+),!Q\60(X`?WJ"#;B2`9`
M,^9EP#YNP``TZ]@=@/@J16P]`"F`LR.SL^!Q@"'$%OUYG0;,&M6*+\J"73H'
M5PY(@OB*<2+9\:!HW2.IF(J)'9]!+F:`#LH%``QD[TBX)F;48SG^66`P@$)>
M*F\1B5\6WZ^DUP3FW&M^@"Y7G-3"M%_^3D4'NBO.@:[O*-9C81KGT,<VJVZM
M#8``^$Z9\O+WCO,[NFK.&5>**9;JN:H"T&?A!9DBZ>K`H7(?>3"`EFK$&=?L
M$$B7M>W<`H)X2(`6UC*S,4!OA6-Y?AD-/E]Z@4Z.K'*X%AZ,4EJOS,<U1YP5
M&L)F,0.YY)8=-!9F?)E<!%NC^N&C16`.L(Y8I]?#C2-RL<Y[T%`'*%8?PAL#
M#-EW,D`%R!A#-[0ANU,@H]XJ0RI90YT_CRQ'6\:DFIK4^MT%!$!C=0#G-;6,
MDMS*HEQ@L%FX[EF?$6W5*5R\%BPH(UQKO;;0R9HRN";=+5^B+1J<L0X'I"S4
ML4Z#[M8&(&O^&*`=?"A2$V<=-R82ZECO8V5OHM::>G_G?*`6/\99`]`<VHVL
M:D4`%*2(GTD`%$B".;*9<!NJY1JHBHG6.,H,,,,J6:M6#I"<:>19WKXSI%%M
MK06`N"BA%L;6=6.J$BJHBCD`%,A%RL*I:ITV%\&4/F5Q&MU7#D]N4<LM:R_?
MD(VC`5"`S[CJ\?;*2,SV5P/XC"=F!G!R`AQ`#K]IC<F&CY/U@$T`N9`R`1B`
M!?2*)%!OB`<8#"XCO1'GC!/U"(R6EW&K>/C7YI2`SP)MA[Z:'1"``F#`!-1%
M%5:`%?JR(!US+DR4(FG``-BK4V@T!V@T;0U9!329JX+NM29`9<+^J8M&P`(X
M07Z676OYJ'@D`.AF@'$10*0F5@!D9NQ>&P'(C*0?@9^[8+LB)P=PX`$LR*>7
MPGH*@`.0PN;(#*7_95$<0``,F5/25@`PAZ`C`.AZGEZB@*!['@)(FQUPP*IC
MA@-8-?*XL2"-=Q=KM2`-<C';@A]*-"(3<A70.:6`U"X"1:/P&??F";9[`Q<O
MIQ>/NRF8QFBC^RJ4^^`2'+MGG;BWU!^+DT>B5$E,I+RG\5$Y=)S@,;U7%NAZ
MP&[IM"MH0`)8%KFK[BE<@''Y.2,8UP`LB`<TF%*D&+S5E+LC\T^=5"R'&)]U
MW#,\QD)<1?YI+B#LUMFVY'XAG"2XJ`;^=*T[-Z#KS;3'DYX^F?A`?1^@":>@
M01K3^:R*&<(V%R/@+@`"H&9#W*S/DAS]00"\"N>7(6=+(>47JCA"^9T"B,L`
M/$!Y6H8&6#?-U<4"%/4YB#;:%I?`WAM^R:VI#G.\2CLJ.?O&$JY+,5OL\EE"
MHIEQ=IA]#5G&'^1X*4!=4&\I;([;"H]+1OWYT7LV.6DRAY3?`5Y1DYUA-Y8A
M@`[3B3$,XDBM&X#"/X.*[<HXRL67T<?-QN.U)Y2VWT)Y>_ST1=R2+6QCB4>?
M,SR.&!?]24($/,`#@-970'T5:`"Y<H`S4J4'K&>V)USCNQ3=OSNT6Y0[JC:G
M<4#A#?DGV&3^*8!.!W:SX$V87)!@!SZ69C%N?\!]+;M4ZW].4:%4&T(&'&K#
M/KJZJ2U#;5@B(7JMZD"&(L)!CJ@5"'#?.'(=B:;JRK;N"\?R3-?VC>?ZSGJ?
M!!"<>#$@0/+Q$9?,IO,)C4J?RI&F`(`D:1K+]`L.B\?D\@LH%$\`@(GY#8_+
MYU&.`TG/Z_?\_M*W)E#U9>3F=XB8J+C(V.CX2!<X&.5CA`>)F:D)-KGI^0FJ
MAS8T!<B&U!FJNLK:ZOH*BV,J*%88>XN;J[O+VP<T0/JU=M1;;'R,G*R,@I8*
M->SFO#Q-76U]_38KS53)9H@-'BX^3EX3&#QEN57.WN[^CMS,^7/^"F]_CY^O
M.8LN9:L/,*#`@6]&U:JWC:#"A0P;KC`89M@EAQ0K6B0H:9ZZBQP[>F27,<R_
MCR1+FCP6$HRZA"<_LFSIY"5,&-W21/168P.&#!HP;-!0`<J%"\RV82!*HL/$
M%1TRH,@0K((&&QHH@-'03P4&%!HVX+C@)4:%H"0X8$CE82H,#AF@UO"PU(7:
M'%5);&C[DH+7$1O0:>C4<^XBN!\J[,VA-(>'PURW#7W3%PKA&7^9924A02:,
M<P?;U-!P`0*"G146F+N,`H(6$@A$K/"A&@4'!"\J."61P2J)!6%3;+-@FI!@
MW&0QD"T15T9L&`YTC[``P<)6%1U6OUC^\""#@Z`R9]=V6GT'<!('*%QXX-H%
M;Q($&'`%<+OL`0L5K"O:0'N]#N\S)I#2$,$*$&1EVP?+E1%!?$WPIUPE([3V
MT(/I*?8!9U]T0XP-XWU@@7N"189"!Q@T9<!Q&S#F@5.Q=>!5:QL,XI:!JW&`
M%6U6C-!!!R9HT,`(;8W@P%0^,&!!CER5E985/HRW%P=*F)#4625\H)8'3C+V
M009*G."!CGMYP``#'H#IPUTC1'"<DG8I^).,'TR(XVT<)'`)@Q_DR$%Z)X@0
MF0;I^;">!@G@-@2?0[@U)Y4ARIE`!#X,H<%P&329XB!^7A#<!Q!6X-X'/DUY
MIP@,(/5!`@O^'%;!`4BE^*:-#ZS&$XY6YOG!7FTFP2*63\T5&92A_IK$E6]*
MZ=T"%0QA)5>WY>BG;!LPZ&2,(XSHXP''C3F"!]/=>6<'6)6`@!:Q*:&KF25(
MB2.>LM+**K!>5?$B;L.5]2<&$T+5`6V"&5GK$.]Z4($!4R7`0;S9ICIPP8,8
M3(.%I52(4`VEC7"!`19(T.,'$5``08`^5.``FAD80($/&U,0H(%H>A"!%D1^
M<,`#%S!PVP/U617;`A%T2)L=%33`@00)!+6QC!!X-8'''X2)07-O.F!!`W\=
M(,%6-LL\\E@]4H!'`T-@,,$$@W90@`06!.E!`1.<[=0&#IRWE0+^.Y6-\9L+
M+.#!!0[\\.I6&/2HA,W;%5:?:3X3C4!H]M57P0.+Q8PLR5M$@(`%$SSPY@$?
M+-!`D1!4@"8*Z^'W--R;$RE!QQ0XT*7:9V^%L@68:Q!NE[2I!H%K2EF@0%`+
M*+!Z4!T`7P$"[OFPJ6EF]^Z!C;$IT!OPAFPP00-!=6Q8OB,T8!4%G(K;>[[1
M:4S!!%I4'($$>ZOP:NX:)SV!!IA_D)W\G'IJK089A#TH!YKSAAY/68<"4<,<
MY3BV&@9$8&:T&9*Q!F<'#&3G`Q4KV0@F)L'SB$!S$BA/;&B'N8Y)@"AV2,%8
M(&`:D(7N3`FXV-X@$+X,R,QK&RB`IQ3^L#DO0$`"$0A0^^#T`8ZMKE83*-Y4
MFF:!"Y"MB`SXVORHE@2\)6`#%#``40X`@9E5J8I>P.+,G.*!JZ6I"$'0S`Y&
M0H,-8<"&'U!`!C"P&@7LA0'.08!79#<""&!`@B3`G6XL%D3W%.T##6!9@G`8
M1`-\P`%.:9SZ1D`P#QR@"HD:@0(PEP':,))#8M*<QH*R@05<@(T=ZT"/-+`^
M;M$O0`,0P?U:61C3.&`K''#/`N9F21VZS`L($`S!S@1*!71I!+?48Q]QV#S7
M;"!C*,LA"FJH&QB.@$B2W)Q5!BFU+2B0`^.;Y9O<HP`MD$T$'?L`+'_&`68&
M"'JU2D`')HG^@F&2+IQ4NMW\')"IRF6``5XYP084H#TWL1-Y;CN!'ANPD_G=
MJ0`<&Y0J:1.!]1U@*O7)(R[;N"T<>9)#*5,`C\;D-0>04P(9<.@0=EC-6Q;1
M0&09IJ8TYE#-\6X$523!)>NY2%IV"D+/<0\#1-`TF,$T"1`REH%(JH6*RL:2
MJ'0."XF9@4>"":@O?(!'-[>3U=PR`:EPVS2]\#&?#J$#!/#*`U*6J`V\RE-[
M.T".;%2B0)8%KD&A@""#.8.:H,8)$KG!AC;D1@=$!P.)R]8"''`".SJ30PX8
M7#>XHZD[FN8`KH$`UR1@OA*X<SX5H(#.5@,A#%@+7-KTPIS>21_^"KC31@CP
MG@42,(%.C0=O$G!J!H`3(!O-B3^GM='F,H!0#`1G/1#`7._::1V>MK8"%J`L
M!5]+`43"!K25G5%^>F/3%ZZFG/_C976WL(#/]<^W;NQ<J_(8($]R(+PSZNYY
M+X"`-'7@8NXM5E@Z1)ZU[66^$D!`0'/6&P1X@("$_*UY?3";$R3M3O11Y'**
M>M\&9`"1+TL!?*T27ND@(`-ZY'`F,0`=1F;JMCH3ZBV7N;DJ>*#!;GIIRTA+
M3-.N%KQ=/$S4)KP%_]X.M%XQ:LX(J:!I-3=NA=S"<B`P`0I@;F+($P$"#!'8
MZ,"7)Z,E`6Q&A:D`=>$!C$3F>5M,R`W^5,`X'AB?6P,*H?$@F+4B&,]RFPM$
M%Z1$&#@Q(X>"LZ$%`%<";,'2`S2G6/,6IKC.B0!V]I)FT_R2I9CEF&;?22,5
MQ;%)!PC0/W<#RLVRY2_\&8V9_FJ:]`&-!&/Q0,B$>J<9O\F=@QH2C_88'`9<
M3PN"]L`".@70!_GD6R,<7G2K\&#7]%"SBTT!1+>;WJ5Y8='#CO$B`]3JI?'(
MM,[++5\6P$-BKX<_&ZBT%22@D^O62MQW9DUZ-#`!G1#,>5K0CZ98%!TMN/$!
MSN&M.TGJ/XWQF)#WS<YPP9J"#92H`1/HLZ<H0(&>N#-6&_)>!^X@U)=Q3Z%!
MRT"^7RQ4C'O^!U"9[H!#ET84GG)(:ITJ5?/T+2%GQJ8Y&6-&D12`E`?X]LA)
M/E_)N8H!!8C)P`6?%%^\G1K$^OP"%`A:D!#YY7%QR`)6V>,#6O36!TEVKBD?
MSP%\(BT9S)D2]/",AO`\7!`'IPI#\.\4J02XGV[`G;")P/`2V^848FX#[NF8
M_T[@`!LNP"K3/1,27*F\E#G3.\>%\0,PYP,,P)*."]W;FJ<9(`%LI;@?D+R!
M>K1#3_5(;CC>W*P+LS=_:NYO6SC\%C:TX16UF*=3I5]0V)F4<?_`D[U\I^<+
M,_>=<_R&&D-"U&[/G]A8'@)[XZ?K@4^;$TSL]J(=/&TJ@$@$Y%/^!+LG;&1A
MUFZ`0T@">L;HG)YDH_))`',<4"3&%<NC:7(`4\[&%HX*TSGI`LGQO>36>/C3
M`$?]KZX"`*.;.&!#Y\<B;K5(;.1\O<=64D<"X]$`1)%MFO-@/?9YBL=W"Q@<
MA>4#SJ4QFI-,&/<V/Y!;;K-.8I<MW`)]ZU!//D!0/V`:A1=\UF$'XO0`&=,:
M:!9W6]!I=X1##C`_FJ%7G8$*-1!4"9A3A2$!$G`<8&,](^<4%V,VSS%^'-!,
M$W,J1%@^"?(#2(`!&Q,![J$42=,!$X`'7@4Z#N`59K@%WK1>=Q(!8M@78W=9
M^H,ZEV!4I+8=S2%)G>4H[Z2'0U!;$7#^AOJS/M[T<"532!<C80;2&P-VA%NA
M/L#A%$>(.4>H?B0`($@()%NA@E<X%1`@:YBXAMY4&$DC&**8B'\H`FH8')C5
M1ITE`2>0`6VH&SQR`6M8ADT2,IZU2"04'!506Z8'**1@!QN30CT$<0BU&VW6
M*1]X,0_P%[#%-1U09I^#0V)8B1QRA%XPA%!#2-M2AJZ4C=.T&AO0AEJX/C\#
M,E:Q@UO1;?&D&B=HC9LC`K&(,B6GBB.`61'@&C?64V^R,1,`*$&4,C]5*S03
MCP?@%0J0'N,'B1J@/I#EB1<3%)3HCUQ3&`'2`6(B,T:(B67(,A.QA4F6)<U!
M?&^2-*^XBA/^@0!=@P<+(`)12)!#B(_H$9.A=UD9%0,.(P48DAP\X%))H6)*
MX'Y6YALMD!4_60*=,&9WDGACQ!2IP"\E:%/#X7[>42C)EP)[%2*>$A3*%!=1
M.90HV`)(J0).@EZJQ`+2&`-:N956-@AAV0]:J98N@)1A20.D$)5H.9;.,!LJ
M%@QD*1N=8)<DD'/4\0*`R11%^1R9PI9)0':T49CQ1':#H'2)B8*3X%(NM6&^
M00IV:6<JD!#2D)=:%P2-201H9`Q)@AN?*94L$`$MMP*D0W4\P"9Q-@:5J0.L
M&0JZ*0-B!IH[`)4PQW5H`7&Z>6H7@).OT4=:P)M,X53*Z0G:`(3^8MD0'5`!
M":$@[=(*)S(3?/!&D(%=-L`!X3D#W`F=Y``18-!7>M"<F."#W9E7\%D&[6D/
M.ID..,$+,H$NK4D#Z"(-]&D#,2(B-Z`M3-`4\;D69&>;,7`!,@$:*M`5U9!U
M<.`,MV(&^QF@ICD&DX"A-B`/%])U/<EU+1"A4F!,1.DIP2!RBZ2AYM8"2(%8
M'/*BN:D"^K$A\6DG./!IIO$2,>H"'2!X2;`4:+$"*]H"/40*L8*;.1%D8@"5
M."D3[D8M;X$CI.*3;B*8052!-.!SOYERAVEA(J`?`(J@6F$?FK*@8)J>=)8A
M-H`.KC&8;EF"0PD\2$(=;ZEB>HF8[O?^3@K2&GF**UGI#'\:F%E"@#Z@`00(
MH8J*F-D")V^Z6/CUE^BP):2%+"CJJ"W`9>4&J5OY*'DBC'TD)Q_SG&_YJ$T&
ME550>):$,^(DF:^JE_232J.9+2KXEY,P5O'4F2F0'M'E&X\:<,JF4?&1EX#Z
M)B3@J[5JE,$`1.2T&L$PETL5(BJ6'G7*G\FR:-F"#I1Z`$[Q,F^9EH&JF-&J
M2A,2E_W@9+IS`_8I!=!`G2^@`$@(`6VS,5K`3=NSC)&"9&Z`,0E',0<P:F$3
M`1G568SWFKYH%7.BAT#5AH8@81J@`"V#!!10`&['&DCX=&TD(HT5'ZO#.J1'
M2"$GKU,140/^$@$%X#ODB+(:DS(+`"`KRTTH`QBITR,<$+$MXP/:@7"J\AR5
MTVPQ&R`7`#Q;4:\Y8BWF4V9"DDH<((8NV48BH#=S0C"$90$_:UF.TD:UM3D=
M<`%(V``AQ#$Y@D@E^R9(QY%!@6X0D#$<5C6:@K&,$3;S2D$`ZQJBU2.&!AUD
M$8NL*`&?6`%)(U)6D`!7Y8LK5`G<TQ=(%B`YYXN9L3E:6[AUU5C@:#8>T"@O
MEDY79XD<XQXVVS(0D+/T-@'SD0054+'*=X3'L5+T(P)<:`(-P+-[^YS3,@&"
M125<=AQV@'"-\@/F0[*V.VPMTSB:%#+&E+:%9+<OF32-9%D=E![^(?EW-PNZ
MI%8`+F,S)UJX`)=S%$"T'%-F8+0W%Q,Z@B45Q(<*]9H>(/.Q/=(X7.-<<3LO
M+\"N4;`1-*`V'#(HR.AH$#*#8[(`IG0"<M2W*;`>%55+0CD5VA,!GI0`3M%_
M&E-\Y*2.&*`!`^`##8RF*%`V$/QNBO4D&Y5G7G"_'5*8CP<S4;=Z*+Q)#O`-
M=N$#W%-YWFH5L$4E`S`=BG?!3K'"MN%)G_,#>_/`PIM4%/>2>Y-H;H+#I>(4
M^JL%FIO!1/5)/_`Y6C!3V)*((YEJBW$",&Q\/F``2%"2%V2O7K-8@*)#FM.7
M'D#&"ME!(W``;M`X1J8%P+4]<^&)0++^Q%(!#(3D!CR+2G?B41OUQQZW`0,@
MPYRT#I'A-`],<*7B!AI@>2E'QX2D%G0<2@;2=#TR'@",42JP%P0C:RC86$G`
M4'#D*0Q0F`:EC\XE`0301IJ,0XKL!L=543DG25M1`3;1>C[,R-&@@`H`RUCL
M<4-@`<XSD5,\:.ET)[2A0`:".2<0.H^4.:3F'@:`RP)PD;Q'`Q_Z,*@9`SP%
M/(!3*AI3B\PUGDEFALM4/LRY&\M664$:*9J#<;&A6]AF7;^5`;'611."D.7F
M5CEGI1/@LN7F3,K%363<:3K";A)B>SE'(]RW`@5S:M7V4F:\F,1$P0KID!*&
M0W.B/QB@:@G^AD/(:&4.Z1[]/%-KM7RWM$];P&JN`<[7F0"1@EO;1<:+17!^
MTD)OHLZ.YJ+X=<'?!7O$]'DOI3XG0G"9E<%JYLS".G)R3$$:C3'Y?-'.E=-S
M8AP#G=/_E*RQL7QEL4S6IC(5+:PK*&CX94E9.,Y059@1=2*V"Z%K-R+6^J4=
M,RJ1TAIJ2TXU1UK;IEMNDWVE<@&1H@"QY:(H5[;_91^*Y==\[">P=W\S_4;N
M9!I2\P`2H-/3=B<,($Z]!!J^)=!3<6,\^FXPUQ4:2!,00PLWX1EF!,Z&_2!-
M,1869SF60S-C`69#XEUY-$#,%8#(AFJAM!R$UQ:(M!XK>L00,C+^BT,`L.9L
M!JTQ!6`";*;8L:T]KY4!8S$O497/R3;6OF6CP]46&S86ZV<:W68<ML%;FG0!
ML+D!58-"2VT:L9%G;S1]BZ98$M#15U?>&!?=/186G&T<7L#=>Z?4"GBC/`5@
MHJ-+;JPQMUW41]QWX0W5V%W>[%=NBB7@S/4QAMP`>E0!@[W07YTE)%5B/9QL
M%JV`%%X)437=X+43.*2VV5T!0/2WF404:S=]Z&4L]($4$4``9<;7Y]78!1[8
M\44?))9CWY5J+X@"C.T%[:@S`ZX$]\??2YD[+C.PN*T?IF1'5TZP!)`![4W5
ML8WD(6X.I3F=-1!7@A)F'/+,Q24"`DW^09D"9D2MUF_>8O+L4*)D3E[Q,QDY
M`@LF-\+UW!-RQ!K8CBC`*6LW`@6P%2OKYCZP5JR%PA%5*Q;L':?%`OPQT;RM
M*41!5M.19TKD3A9H2<1:5H7A'A?PQD\N`KJXF59%/TGU;TOC%>?QQ/YELR2`
MP7PASK6>8F="<:[2Q%4@X16""@T`X"7H8Z"5-W8>;`3M)GA$/Z02&YP^+:34
MQ.2D4*3&/4N[T$Q=29_N)@FP%:/^T_.SD7R1>==>D.5VH_&$R&W4&QK(`'CP
MQ@_0PI0NL()>(7H7Y:IFN^S$>.`RCWO\)D6&62>'I2G7V!'P[1>MQ"@0&CCS
M[>YF[S3#`A3^(&&=E/"$-+NIS<V$@)\T@$6R$Q0R)#M#$"8C\`"=DCJ6<^<C
M-WGUT1O+5%LV)#07(TX&4$1!<I'U`2C.[4P2'Q^*Y68<,!9.DP0(AXQWL,`A
M%QT/8`$#5CU3\2IS8E:YH\;F8P`BL/6R<S$YXCA]9#/QBFJQH1U5"^D47\!6
MGQD8KAU_VQ<,!3)"4@`*4CT_(W>>Y2&B=#_"RO(!I%P=@!U$]Q/;00'>:@)<
MXS5\U$=(>#U63T_0$3II5G*NY\-.?4'\-.TS[P;3SM1T-Y%A,Q'+T3@7HRTE
MLCIPEP0[A-M0;S64[^09Z1]Y9/6\N]`L?[*:^,.1*'XI,`"ZP0'^5C]!8.(?
MYG,Q5&(=IA0=5Y<;!^(SHXL$S<&]81A;+*,%Y?,SXN8=Q05]5(S*/D-@./\`
M84]J:&*O"XT9(A7*&R?[Q[$A;1\_M2(`0C+_SI0;$94B4`,"D_9]'D4Q&K9\
MU6-!1<<Y%761N;[G$R!T>,(AD>?Y2```27&8X'!TGE$.2O($29W,L9/5:;*:
MJ'04A$0^9`[BL[E^.M1X*?O5'$EDNGA?RGQQ;'@<17'D;>5,T97,A65-Y0%^
MH.QL=!`R8N9P9=;IY4W9@9$%O>4D?.E%0>)E06%IA6;D!*II:&2<CI%D4,1Q
M?42HJM&27'I^X#'&@GUM.GL^!WN2-1_^KYTJYOT%63"X5>EP4'E@!!I#(FHK
M8P9!WF%Q*^=ML&OM+&N=>DPZI(&)<T3#O7:>[&E9!FW&A@0"]1S#E"<,"8**
M:/E1H\W:/'K5JLSYQ&D/M&*R](3D=3%(LT5W"C9!\H-8S)I#?"PI89,$@HP[
M?\:$``$.&Z!&B70\:C1"2*5`D^J`\,`IU2$6N''`(44(U)A=BWRMNL,"BR%A
MQ:)5^H#FTR87L"2PD'8N7:=GC1Y)`J0N$9P3C%)(>K?F66X8,.@L\8LO8ZJ#
M&Q?1`!`RY<J6NVZH8#GMX\TQ,TBHX-,SZ=(Q?0CH7#5)3M.N7\..+7LV[=JV
M;^/.316U:J7^>97\[6W$V([17-G6*B1<D:'/@I$3\4(Y@_$F"*E6M^DA^XY@
M1[D;@0[>]G;*)8&./RI=7)'U.6`6'Z?;O1#ZNK?JA5X7)Q/?O1X@]AY/_%"R
MV%@L=+6`7`?`-$A,9'V`0$&(O/"%!V]`6%@.0I4P#S?+D0`!!=8P(($$M'PE
M003PF:4(3WM@8.(1Y6U57!LQ<?!`!:IL0(&)?G145&(N"I%A"PU,($$0$FK7
MA'`7QN%`$Q4@2,1:1G$0A()#[F#?&QP<T.(0AP0U5!Y,"O8!AWD(240&<N5A
M08`AHJB#+UYQ1<0I#KQSAIE&J#G4%2SN`%66-0)*XT^\><9:?U3^K:F'0Q$"
MR9:1A7ZP94\\<#!I$Q`>4!V$40TUZDX<,K;!C7K<N&573%85*@D6-/!)!'\2
MT681IL[*`"WVV0B4D1QBH`"E>*7UC4A$\"H$FC\E\,:6>3(`)PD7@*.J4=%R
MR0.J+Q;QK1JK<O6`A^8FQT,#6LW5*40?,*!9I$)$BBT<1E6[TZW=-I'$`/K1
MQ5IP/YD@@5P9))!`.C'\E8`-%`11@683.&`@63$&V&,-F<JU:8P0>Q!#8#QH
MK!FH>W"0)&(;-'"`7!4ET-,%"L3XL@D3L/N!!0X,%8$#%YQ80@6W'O'"+QI(
M0,$;&3AP90XQ*ME!#!*P>2,:&$10P0C^%$R`&`4%0!#Q!)IUX(`%%U00V@@Q
M[NB&CQ9LJF:M1R"LL-`&7Y'V.6'F.%;2VS'@L@X.^($V"14@IG<'?%>`AAYI
MH\@U#L,*BD`'#I\PX]#HZEA!!A!@'.,#461`L3$8^'A$!6-'>7@%'@1^SE0Z
M3W`T!1M#6,$_SF+RP`00:*8&Y(520,!0#&0]P9>-IW'!`0R<PK(!&+#!=@YI
MO_S?Z%^'W4)H$U$0@0?[GA#APRQA'^)0,8X]Z>J:#2T:!4,Q?24$?Y'`E,Z[
M=\!"!_.GH6P6T`S;5-&!I-%B:!$00<@(\(NU7,``#!C?4%)&`6.\K0&"VD#@
MY,(!'\UI?'K^8`+[O/&\-Q303A)P@"X0D("FG.8'(#(*?XSR@%]`@`GS$A+8
M/L"S#_CN=N$@`08$\`8%R.4"F#@`[!9D#G!D`!RZTH$2/6"Y"[`@;O"BQ;I:
M4"7U?>`"`\@2DW3T`21>RU@CB$`!/I"!-FR`%@\8R@%^P8$):D`!;-C.%S!0
MJRB.:QRMVH`$%%`TS:!Q4[\#(A,*0(L(&#*,4JI$'861FBL<0$I'0-4-U<0$
M!S!A.ZE0`'&0,!7=Z>R+&I@*5HQU1JF%LBBZX!B\<!`$,Y)R!1M:G[%Z^,,X
M^I".ORBBM&J%`2D=S"$7:,`FYN=#)EAM*%1R0QLD,)4@G,.*'J#^E08<`I.>
M>$``<D%COMC"I`48BP(LF.4"-..J6?E/G&>4BXJ`*"@PJ>$(FY+`4(3(P66@
MP5X?\.50*J:F-#B.`"-@0!L76;%"'L$!@^";*329*0P@+!S6_``&CG@51W*T
M5I6X0@JT*8$V9E1(YY37\?"`@/%Y4P"/RI"O/M#%(S1`+@ODH!LG2,L+3!(<
M5\"!!MH@+CSEIU'``4H&:D4"8^VK"C=BD@6,A08/+"!`1QC5J+34U(YU`'HA
M^@6YNG117<J*$@#9``M,M4EIEB6K//6B%ABP&%3%S0/3W)2.CK"`"T0U!PLX
M103(.HX"4,",Q!+J-$/E`05@HIL=B";^"1;@B@1,0*C'NL(#$O#6D.8@IU+2
M0P%2H(/^A78#NLR!LG;0`%P\8*Z!U$D.8:`30!XI`\8Z0@00H+LE84BS>LUB
M%$:U)2%APG)B+8$AIV`YRD*H(5@U:U8SP`*[#L%RDPW1!&Q+A$T=]T:?G=96
M6:"M0)V1$$7-P1QS8+GID@!Z$,B>!`PPF4U5H`$<<.H9U32!15(3J^I=0%0W
MM3M6"18'\7JJ,3:9AC!E"@]6)(,S@5B[V?5DN\?:T@,,)J@Y+H`,WZKJ!R:P
M5LU>8"H+Z$`#"/N7+5F6$%H42!L"NQ/4``PMO\G)8%17E@BA5ZK@@A"'WOAC
MKK(`:Q4X@`;^<OJ!4#TA1`\>`FB6G`%=Q@U516D6AXR;@0P<8'59JP4#C%JY
M0X2F`>!@$+PJ-K\H/*``<\CRE(6\2YWY-GR:.8`7PIRD$5$V0DE+6@7`H<^,
M_)!#A=:)`C*KDPX0()+O:8-?#_/%D'')!MW592'@&!K?+O((%\@SZ+!X9_=&
M89H<2/.:BQM7#[;!`DDSP.764$<?`1J,TVR(AHF8-287*PX+>"F7M&LUKN&*
M!^>$M1NREH"A3`N>LW7<K26`/Q+$>009IG2FOJH3"<@4U;G=+9#O!^!.+8YK
M62LP&;(]VTQIA@,+4)@K"5F!!$"3!`DHK(GS`,G508`#!?;"5*/^T$[_4D`!
M-H!`'D7\)R+?<U4APW26H:T9!/!;?*Q-6AOW]9@CX-@S-?Q)6(\!CAT6/)5!
MCM#++`#A6VE`J*1T\DOG2P('A*&L1'0J*:V[6:;-ZI0__NPT+[H!5PJ!`;6K
M7/_>L-<W=)@'$ZC2"V[N4D&2RHU(!U<J[(RJK.:@FZ0E!L3CT(`CL,R*KWBA
MI.-["G`HBQMF/&T#F*EV23TV1!)P5T6V'G?TGLG59\00<54.+[FPU<0\>>85
MNHY@>)7*O&V@&1%E?N4J:5#99)0RW[-K<`^.$HS15OEY'6>YF[!`5BTN`3@H
M,#=/;O18RA(J3^\G4)='Z`NH`ET.),#^@A3G(%]%*X`'76GZRLXI!T(\M>54
M*BUYX8R_\ZSLPY,\6@O,C@1)TDS5?8B8@U-^!_Q<O(UMHI<9`F7D/W%!DVEQ
M5+NRH;C&>L`P*O`-,F"``'):,0<4;@$#--F"8$(#@$8:8-6(_,][^)\!7)FQ
M:%$$G`@SJ1PW8%%F"-662(4&B,;CK,`&#-P<80`#M)JP>0[\').!L%@!OMML
M?9::/(`&1@%^I8#6:!BJ6!<&7(!<2,4&.``!B('6O);.U)0+L$P"F<V.M,$;
M[4%3;8`9-4L'%)8&7%!EE87NH$U1+$#7($#/S)>\O&!@F%H+#HC*\4P(CJ!Q
M:49#K,`%?,W^`*:-7LT@%T7`_Z4!6V'`>L6<!2A-._W?Y;5`")Z#@>3>XH#1
MK0R0,*@"SV`5XK5!%F(`Q@D#SE4!S:P7>A6:!I8#XCC`7S1`!)!#B\V=FPE<
M04G)ID!(8A4A>C6`!.11F%SBCD25;6GB7]B<7\E%!2Q3`9#!`DC`(S(!A-W@
MV>A`)TIAD(&7:$29!#`3AZQB,5I7!E3``#R*O%V%B305)%#"7H25"B*!1`7C
MG)`%&Q:`.2R`=]@$HU3&C@W,3W#`ZQS#/72`9@1#(B`$!KBC%E#'G,3C%LA!
M$'B'!<Q!/+K@:>T(("0"!LR#!F2/'/``1B5".SQ.2/1(%%Q'@%S^`"#0@CG:
M8Q"T8RG-2CDD'T?IP'4(#Q5X1SP&2,:P@P5D3SOVPRS<(T<%B$LJ`D"ZT>&P
M@UZ5@D=JP0!EP;=LT]K@Y'7$XQIH#3"\!SO,(Q5<P#ED9!<8`T7T@QL4I"2\
M3`=8`'$HY'4HY$V6``X*#3E@`BUHX!M(A9W0S3MJP09>Q0[LB%0&2`78PRG8
MY'M<A3%<AUZ54CO.P0;NXTBFX1L(Y#P:0SMFP75LP%5H%>*X@38$'%^J@:!4
M1!"494C(93WJ`$OR``PV9B]T@3S&R5P>PP;.BFB^AU8H9$>80V:&1%V>S3P8
M9C`<QDZ`W$R(G!(\RGW@"Z'H9F_ZIA'^S!C!_&9:+-=P$L9K)&9F\J9Q_N;Y
M789,M$8Z\@54A`7Z@45;,*=PB@E2^$>(!`]I6&=5A&=XTD5GD*==(`IMSL5R
MG"=IA-QF"$QVRN=\TF=CM&>3U*=VYN=^\B>F)!5\XF9_"NB`$FB!&NB!%NB3
M.,5_6H9?\(N3*,-W%L$E6()YPM!QLI:$7L]R'@-/]@LW]$@33``V-J5^$H$&
MUL2(%H&*/@UBJ,8>](.'XD)W!,F7C4-&4.AF?AF'*H4*X((NS`!D7,@\!.E.
MJ$!'Y"@/=$!'H65\R$=59$9ODLD.L"A01.E\,&E2CB2/4JD,*14`7-M.O(GA
M-0$!2)\&`(#^AQ;'+T@->F[B#HP(+9V%M=GD!]7$II17$Z05&'5&5N[*CQ5!
M<.X`K/"I$!SE#F"`#(3(!4"`])68"PA*![P`!)32`>",TRB``4A!`$Q&%;C,
MH:ZH4N"@"%Z`!FJH>-H)`(0$`Q#`3E"`#7@*"1!`IX8=Z"B<&DPJ<20JC"@J
MC@ABB0E>GLB&;CG+>'3$I>#):?TJD=0$J"J#K09/TB@>$JB;<*(C9>Q8*-&F
M"`KA$!U#1R3`8%W/`6C5&[`)2_06*PB$.;I!<YP6%5S.HTQ!F!V>>T`)-Y!8
M#D1`E"'EEAY+<'EK9X++34:5%:B!&]`-RNP;2+B(LK!#!]Q#3TS^:46(FS*L
M7!P@I!KLVSS8'[<P@@(0E8NT%W:)G;B-5`,D@(NZ$0+DYN,I`O4\3:HQV3YH
M`28,`L3"!*ID0A10`3G4`DQ0A!;X+!4=@&1Z@`-XRBRMAWML0GNI#O)T2R:L
MUX*5;,>2@=6ZB;FFZQ5H@.`HBT1"A4HP)"@XB!MU`1;`Z#GH@1S,B#HTCAN%
MA,3FPTB64ABTU@8<@CN<A$G4P13L:REP1)`"TVEE[.5HW!4,1!NLEF5I0%R%
M9$PP:&4X"GHLP(IA@)^-U@)%0*<J0/FXP00T``'IB`1"(`0"$8/@$P,LP.V0
M3><Z#Z`VSML6E=/HC`'\!:EN#`WHCE;^RID6/,`!)-!\H8ON7MP4))D!K$[F
M5FON'9T>'D`:-(X0;:$2\8QDSF[$9(UDAA'RYA?IC.X7%.TW&(..F!&?-2\%
M'("VELX$&)*JT&[%Y@`I^5`B_@+F$8<IED6)](<'\)/VNJP;A$:T'.VM_(\!
M',SH<E0=J98!F(CTM2"'(-;0B$@.<=3W*@+P`(\:&("(^-3AK.(IP&H<&`P2
MK5*()%]$+88%0*#_=@<+D!L!PN]F=<D(R\4#(,`<_-]?8`#R4DS^F%BG,HUF
MQBX$^%6U\%-AU8H$((`%3,!4V-L+14C%E)13U0X4"$7`Y4#XUA00N0#\-`XX
M],^K)@`X=&[^!2``"[G2ED@,!("#\^`B!"!`\`K1OLK/'.FJCQA2476/BQ#K
MS\S*YK9<]IVCEP(HF!I%E[71!R@,!@B*`IAKA/#@)OF17##`&9R(H*2"+A6%
M`DS%>D'`:#T`TC69]J7!Z!T+)RM#&SP`+;36X11`@$274X6/]Z$"643!!21R
MS\V.S3$1DI!`^I9-?%D`%%]`K-JB,LBR`7)4(C.CG^0`\E(".(Q90^3>*O+$
M9&0!_4V?LK'#2-4""E30JD3;$D<1%605P[6`CPBR'C"9TAX.SGE*47B`!.90
M1BWS4X7D[J7!`+P!).D;#3@S"5@;";28!Q#`&^S.5A&@`;98&TC^!S6?'>QT
MA#U/UU'M`,A:D6!ESXP)ZB>(7;-L"BXS&",_%3\P`!FP#"F?T37IHIIPS:2\
MTZ(5@&94`@Q+XA1]`#170F&Y@2%E@0(@S6C570_;%`&^VL&>T9?="(1HP&B5
MXPKQ1%,T;1J@$0^@T;3HSL9T:V?X2XZEA?H=YUD673GRC)S$11:;``[42G4A
M``;`@`.4]:CYH;:$U^$=SH]I69B\TQ@>5RI\*@64E0=`\S1I62J0RP'TJI<Y
MF<I!F8C5#@.,:@2$F$#'L0X<G):M2FMQ4UO#@&915191`$OR62KPJ[AD`!9!
M6_;H@!8M3E-@`8M=@CA;"P)TUP@<`<W^@`80>2`+@\D`44%B/@`+2$#*!M(P
MNW6C^ISAF;(^`UF0=6[*PL"/T5ESCQ@+2`DC9W0<R%J8`$@&L-)J!T_M7"R5
M&DN;C+,?=+1V3T`;%)U[$5YE,<U\/6++54E>TU+I(1L8`?<9LD"29$H.C)J$
M?O:3V9_+18%;,]EB9W7+$:`KY0M'P8T?ZHQ5,<`%8$M^N\'"V@EJ;[,.^%YE
MO4Q6!T^S0"XA-^A2`467Q553[=TLN=<,0`"C)C7";`$M*!T'S!*$8*$'A<EB
M&\GF2@HMK?;G9?CBX/@DN(BVE)T:0!:Y((`V&QXI=1^MY%YI_Q<S98"V\:K*
MY@N0,SEKE07^K=#X'7(#_C[9'5('I93VG]A`V:1VL>9``=!JUG7PZ@UL\,D%
M"TF)1>L*&ZZ:4.4?(,0:9-DHD@FSBS`WA*%*HQ&Z/BBRB/UBH4)(!#!J;"N#
M!*A6K`F%:I]165A1:"@`%/.`&$7!/.>!)-ZY#(,!*XX:F0[9BJ\BCFM#L`GT
M/3E$7?O7^!V4!DS`GT,RZ:UBIVY`^NJ$F9-K+D1!:%].DXVX`_BX48,X$EC`
MY4@XD?')':[<Y?"7Q+@YO(W%&.5/\*S.JQ[.G'-GY-HG=*XCGBB:Y8W*/.Q3
M.=+2#>N$.L%!=.DUL^V,OAD:ZT&=.W'ZLE&3MP]))I"8CI\T%P?^$QU8SKX8
MUP7<$4&/`!,]@)1`VMX1VZ'A@]-Z>UC!F68<`0;\"[R0E6VO-H88RP_I!,5;
M_*P^7N:9\L":KHLT@P,@Q@_EZYW[%?Q<=K*M()-\.)S1T;C4B:$+^:E1&QA%
M2#>9_/4,!4\)276K00-("3X=W.7J6ZRVP&C5`A#-#I&**[9)T]9Q-(P*%@&%
M";(.^$6]NP[<*B$DO!GA^OV@+T\@S!M\^-H[`*UU?7N;N<H;7ASG*P+DE"N-
M\7:%DPJX4AP3J\IA@&?15J0._&S!O(0V7=A-2K10LR(W?8K:9B&W+&'4`%#=
M'`ZD36A8=JJ5A1]+1I)$C+4%#QJPE4W^X8"\74O2/(!FN=$"+48#A"2M\&#M
M^\\"87HMU,[>85L:M+Z!)`FT&9SGC)8?RQK>9$H0_!EV`99X3_8'204W!.#N
MB_?3M).)5$1A(7]E';@F^4@OOE*))0UV>7!^,4$4<7JF\"RH*8D/7<B@?6?2
M#$/J@\#W4=/78-^&B%+T/9GX<0A)?5E#0=`W00_/1_+@;"(4R0?C$#%%#I1L
MJ!R6%JSJHK.!)#M34B3&P5(_0DQ#Q*C,L!N'A&(&3CN(25(S;7T@52(/#182
M;AYS$AQ3"XLRC2(-%S)Q<W418"(6#1MJD2@5$H9W+2X:$7J?;R(1%72A;FH[
M30J+3Q\5"C+^'A41#AN/MDT>$Z(HOA8+H',/3:$4#@P?$=0,*$2Y&CDR#Q$>
M&$@E?A^%43(5#A4-2AJ$W&T2%B(7HI,?]/%3^OLR$P`"F?@)'$A0B`0```(1
MW.=!"#\/CA9.X>`0340/`04:;#*EX<*,^BCJP]@Q$\D[%46D+,FO0\J3+/6Y
M5`E2!DB1'VO.'/ERY<@.'1Q5Q&G3I\2.^X*:#`CS0\"=1Z.&]`E5JLPI#F[(
M!&HT08P['(`6C4KC9<:F3@=";+FK)E((+E*ZE4&DI-&M8VUF!&-!&AJY`TU&
M1"FS9TFQ(A#3M$KWWUW&1P\"*/$8,N/*$CE4V)!LKN7/H#6&EHK^>;3I@J>/
M&JU8.K5K@;DNET@M9(.;UZEYH(FJ(<%@W/J2[09._+(/Q\7W25:8/+F&"E*:
M2R<]O;KUZ]B35_B=O3OC#<"D6N!CO<-7[];]`4R/D#GZ]\4=MH9/O[[]^_CS
MFYZOO[]!Y-5)1IEE:(&F`1C1T>29942-!!I0$565ED8-"I2!9^!)Q\%Y_7VV
M$T1!`:971Q5"]DUQ&7:HXFLGIH8!ARL"I]Z"M`W1'H-(C!*:$`O(<\`B:210
MP0,2,#6"5E9)D$I2'&%@DD`0K"&$`EY,L$@A^<R0HT\9")GE0#T.M\L?/90&
MB5-FW,&1?.2D*<*%"V4P@".B0%8&<4G^1,#'!DKF<D,Q<XA0P0\<<="*,J'1
M`)P0@%PPFW<)LC@#C"9^YI`&X26&@J)6W?5`!33&&-I!ZP6(T*-2=8`H3#49
MAM0'82(0D7!OG`>&$*RIQ-`'<HCIH`<'D#?A%!-$X-<'LLK0FP@)\*&`/';H
M4X$97HTY)@/R>/27"+IM^Y(,R<ZP`AI&BC`K%KAV<,!7$KX)0`]D+N8K/YP.
MJ^L,N^!*$`72;)!`2@ATH,&XG^(@Q#HI`(.!+BW)U1,>A=UQ[[9YF1NO?-Q%
M;"^Y*K'F:@8'@(062"2+^,`#K]IT5<J)6=NRQ"(H@.0(NG"0P+QGL9EO8@=D
M*JJDI(::VG+^\RY$P6TV(1&!P@I0X\(%"SAM+@3%PBI/N&WN5D$/,F,PQRFL
M..F%-_LL@+*Y9D2@!!84%$`V$A#\1BNR$;4B:)%KH,'`2K0^F\+82\B\`;8F
MQ)"!VC?H!HXA')Q="+B.*.J!TD%AD<$#%%#0<P8(6*`V+@5`P(L##@PF1#(,
M\*&XVMO!VX!?#T0G.=Q`*5!!!1Y`T&L&@&QW=BCZ_,(MTM/&.\.:?[A`R<W[
MN,+`#1(TP,-M$G@!P;AHD(`HZ1%`H(WR$MB#"[]N=/"`'C+W@@,J6CD@SYT.
M>/&"`]VC@$&/AB3A0`P8``)]`]US0P0*@#L9'&Y)\:-`)N+7"WG^D$,4;HA#
M.OSEFX6%0@*U49H(%L`#"(1G`L6*P0(2$0HBH8%VJG+:-P[0@,@UX``8X,`!
M0B&Z$U9M`CK8``>\@$%<0'`$H1/:SR"C'OZ,QA\)@<R99$"U):P!`P,0`@(V
M("<A-(M7,6@`.MR`->$(P68=,``P=,,P!7@`!B:8F4H,<#9.P>4#!Q#!%/_@
M!@EP1`9]D4'3J&$U330@`PRCFSXNL*X'F&%_)J@`R'AD@70XI0%@\$WW/L``
M,"B@'<#X([@T@!$-Q!$)0PA"'!.@!`X(0`,:&$`D8Q`P=4T,CPRXTQM;^(%+
M)F",#6B(FV0XC3H&H0"+L`-&(%G+'&3^,E+AZA:LW%"U)<0Q,0EX4E88P@>(
M12".BO(D&!Y@`)L``Y"U7$,R/&"&+:BDFBL@G5,(0((>0*)@?N-EU&(F3EU<
M0)6P:H(&I%')6G)``G%4`42PI[=%8`Y6RJ-G"@[@@7:P@0-M2(MN[@D&!I3@
M!$/H00&4H#M<]&!A']@H+GY$23Y!#V4"B,'S^HA'+'1@`"A8J?Q:,`&_(%*+
M$(T$'[`VQ-<4D3U)9(QO[J`+(3`@`_?;8`;`"2L,:*`6?"(=%X&4-7-%<URZ
M^>/EGLH!#4S`35.XGKBXY8)QR<H#4]0`!@A:U0FEPWU^S$":>'J/6VJ@"(#L
MJAWERH8!.-#^CD;0`01+QX%UJ"^0</3"#A#@`;MBP#=7?00&DDK)JRVBICYK
M:3%95[I*4,`"'/@L!RY0)G,Q-JT7B*Q3&-`#P,9A`J$@YSY(:CQ_R2`*"^OF
M!N&EB6?R`Y6?A-<*NE4O$6C``BL(DZ*TFC=E#<QFCJ!:,79@U3XJ*DS670&M
M"+>!$796!S^08U`(.LD9W"Q,'L'N`B[GP$UTP';<Z@&M-K%/&41SJ,))@%,W
M$#+\FN%Y"]B`!E(+L7CY3;,JB.\'[`JU229#KPXH&#FD0=N>UBAHT_G/9(I&
MD`EDR[2[62]3%8#4,BX5`1BX70<(5V$OWD-T6)6O!13)N0S<3EC^2-$BLLBZ
M8[JIZP*WBU3Q@D._]GJPN>:<`JW4,3`;;P=JD:@!*ZQQNS_H@<J@XD`Z$BI(
M\_[X=AD`X\UX]"*&Q<H1%2"``Y6,!34@#LL=2+$B.6`!$DPDF@<`\IRQYP$&
M<!#.6M[:/F+)BMDHTP,6`#*\'D#0#0P`QV&H@`6"*P)*S\"WB'!%',.48,]%
M8,TCD'1_HYL$/<#KNO)(L'I3K=URICIJ6#9>*\?%J%,G%]3JS4%[L=`;+.AF
MOG\L*K(Z<,NL(4#2DA9D'BDY@03H.<PQ[J-#A.-&%^3Y=EV0KU=<L>)==]G"
MKOEI=9#H'HD,+GB;D@:ME,%76%V`V`'^.3,L$V,`)T6[`SR`2#0ET@TX6M':
M<ES$%?GA8FY(X*D;1$&U*"`E-M\-K0%9]P4<["9`('P*#RBV0\*E*!++8+G5
M)`!270W'B!0O);0"*`7:K1(@N*2F@]F`+@8^5D8XH+F"&*H^ZM+83!1;'X1[
M:DHBZI-)`FL:PO5`:D4P`=U6=J'9U=O>F%@FAB(,CNWL,]-=L-(*%("ERFWU
M!E.M`"A37;RNI$3>JH;=F)4I8!@X&P3$]TF47>#KR2OI$IJ0+.&L%')5[=%Z
M/XY5E!U8$W"(=K44[*^(+WH2%0;W:0Z"3U-M&#)><X4+M&P!-*[[120?TN,B
MVD443P"-"9;^-4=$7Z0S*OEV\.+!!!"@A&=&X`%4=-\$(#VWVZ$##.RK`GL?
M`/SH3#K%Q,?%`PJ!Z/^Z@;73^#1'>]"].@N!`FREK:*84(@-N/)PA2B`6DE^
M>R>?P/6:14,`7$`-ZU,2=L?J0#'DP?V#%U@#%(A`+JOG_MESZR(0T$`LD";_
MU'F'<``4`&3`8$@V-@E5)@3M,`=?URW)TGX,@#V;L#6;]C[/U``XUPYZ8`!!
MD0X48``TA`NM`"\Y``T;.'8I('91UW[3%W"\LC3G$(`UU':PP@`3!SYZ\#1;
MTP,:H`R3Y@K$Q%ZEHVQP0(*3,$<2%P<6,`'>]TRZH0[1L6(KQSS^BI,.15)>
MK+<(2)!_-/@"0B1Y`R%NS:%AY486<&)<\I$)0)()'X(!7V0Q4Z`-*2$4)L$:
M3C("QV)<."8P'A$1&>`0&9!9'&-`/F,$'2$L(7.'8=81A9B(,\$%B3&).Q%G
MYX!S^/)Q!A0YRM)4G;@3A?@-B\`O)/)Q<CB),R`4@X$I=PB*YF(KK*@..,!6
M'W`@J@B)4T!%2P4&7;54SB(^:,`'0.(0$6*,$Z&,.Q%=7(8&,1`0!P(&W2(P
M^G`A8)")R$B)*N$(YH$KVUB,,B$L'^)N5<&(@$@)'7`!_=*(GIB(N4@>2Y$8
MAA@><I@)NF@3R@B/&K`(BN$!;9@P*B/^`AM@1&:(%!@V;C=RD$<Q!OUQ.`MA
MD`6Q>)!QB-/PAPL!`93R'HT%"DA#'.93'2I`(T.'*J*R`!\9%7/#D"PI'3,"
M5`/2DC+9')\%&J$E`9$";LDVDWT`:0M19SJ)B.:6DCQ9E*`A!"]I>6MHE$S9
ME$[YE%`9E5!)*A)9*0(BE5B9E5JYE5S9E=>!ABYY*ASFE619EF9YEFA9E$CY
M#V4X&D23EG`9EW(YEW19'U1I'5=9EWJYEWS9EWXI$4F9AC825']9F(9YF(BI
ME?]1*M-!;F.9F)`9F9(YF?V1D(TIEI29F9JYF9S)'@)0E9;QEITYFJ19FJ:)
M&F`9'X,9DZ?^V9JN^9J3:9EA29BP69NV>9MUF9K)(9JXV9N^^9M:27EM.2H+
M"9S&>9S(V9*Z61QYZ9J@F9R=@IS/J1_321Q5^1B@N9S$0335*1$&N1I.V9W0
M&97BN2-':9[1>9J+.9R@@40F>13@H4,%Z0$%F1C`0)_>9#KRB8S@<1/>YTT.
MP04"JH^-R)]P"(P1\9]&T)]H\)].X3-<H$/="!XOD2+V*:$-NJ#F`AX)>BL6
M*HB4$)_%*!_UR:'U>:&U$1`*&I__J4-&\$7Q>1?H2)^9`@R6:(D?QQWT:01R
M*)\7P4G>]''YF*$B&J$2"A$,^A`GJH][$:.[4*))FC`4^J0MRJ+^8."B)6H$
MW&&D'HH3#16@F**EK:B.,Q"?-?&B92J?*KJD'W>D#BJ(.#JF]JF?0R&?$V&F
M#6JA:+!\<TI'&N&D<DJ0=@J@'3&E.XJA<QJ@:*H22TJC$9(IZ$A$;(F7F"D5
M&8`0`!```'`[`$`>#```(P``,3`!`H`0?*!A`'!6FOH/C_(`FBH`4[<!`)`W
M`T``'C``430#L-H1`L`\!P``?B$`6$``>.<!P/H!!H"ITG`0!L`C`*`OGZJI
MEH.I!2`%%T``"`%#;)"I`*`+EXJI*/"K"($RQNH7"0``X7$`3O>MFAH#`O!,
M"@``YH&IHBH"%("M`'`SQXH#`'`#JXK^$+]`KS&0K`A1`"8I!!4``/+PK:``
M`(4%JA30J;M1`'BG*P>AJ0,`#-$*`)C6J[MQ`,_DJO_03Q>+J7'`K=V$`9@:
M`#078N^"<9IJJ[OQJ0A!`"K8KQ^PJ@)0`M^*$%^19@AQ,ZNJJ0&+J:BTLC_'
M=)B:L0N&KFB@KC)`LP@A`"%5K`"`!<FJJ7](3@BA"T-[K/Q5L$CB+YAJ!$FD
MLOSTK")`L?9:JBS[0?5::=2J%;^JM3:BJ3W#`O5*`:7JL`X0`!G3LP2``L1J
M0/2*`L[*6RHPKG<[J4;EL]L*`-$1K[Q5LGF[`&K;``K[&8&9'&IX&9KQ+F`0
ML5^!N<?!!\#^JG29X@\6(*MKT*U<RP>:ZPT).RZ?BG^22PX`P'7R*B8'0``S
M,``<.P.[^P&%BP;'2@`$(#!@X)B86Q&?:AO]*JL0T`$%$`#\^B-AJU+HFK`4
M0+TX6@"J!`&;^@%72Y#=:B.(RZ_56Y\'\;W%>ZFBX[ZB>USE:EQ))&!7ZQ(:
M4+]"4`#+.S`XJP_]2WTW0KXF`*K^<!['2RP*NP$!T$V8&Z93P``!`(S%ZP"[
MRPNI2B[DNQV4U*D2*K\>0`$!4'GX"P"YN@2[VP$%M*V8\JE-<*DED*]<:[;M
M^Q]QPQF3TJW\6[^Y^"XE?,(!P;H0'%#G>Q"R\UZ=N@ALB[S2H+S^7941!P%:
M%@`1_:L`0/%2*:4J.,L!$:Q#%B`P_=J_C_BI#J&\H5I)&2``^+3`,B"^YH$`
M&T8`JB2AK*L!`1!''7"L?;PWH&6^8.4NHE.X3\R^UIC"*VS!J"0/![$=/D.S
M52"N7]&_*IP)>;S'L/*L&OR,4;&6C.FYQY%$!GFI50#'(1RJX/&R^@#';)O$
M$NNQW"*QMYH`!+`"5@0`%P``=[0;!Z&_KAJJ?'"\QCJLP-L8!_!USSNSH&JL
M+91$IOL`#HN^36"ZSLP!M`G`_%K#TB`$TIQF!&7*^H``MSP`[H(J!,`\*K&O
M-+S.9B#.<7S,'S``N!A2P*L`")``NJ#^QJ9+NA-;L?T@L?0<PCYA`>5[$'S@
ML=[LM*>[K171O[.1L!_IJA'[5[I<-FJ[8%1[J3<`RZN,SNJ\"^?+KX$`SP9]
M"`T]`,SSS06`BV@L`L1\O@U<P=,LTF:0L&LV`'%T$(-AR@7@6R]MS\ABSIIP
MT/7ZOQ4[T#,-QVHLT>RK*PE`M?L@SI\JU$+`T?I`T9L;4D2MMS[)`+T:1QH`
MJW'[``)0T4H;`_P<`!'KR4D"(-/1G%;1SC8B`':=J<?!2AQ+C$8\J^9KLP:P
M!NU\U9<7`9FJHJ7*4/N@LADP`3"%KA$@U<EJUZ4J#9/MUX9M`8^FN="+K@8-
MOPCP``2@!$_^_+_`&[V?+:L!4*HQ<+V,-F;[^K0JC&.7NMIQJ[(7S:^VW8^T
M6<SGO,Y^4=NL;;Q?][@UL0#F7`"#`+P#@#*FB\I"/2:D`@`$L`B?FMC#X0$!
MH`L'8,YT3=)Z^Q6?*KQQ!,_W*P,$H`O[V@'8>DFZ$M2_+*LU'#H%(-B96JJ\
MK00OP<[W+<*7=]YU#0#`I!*_RK1CLLQP]`]W;=G_X-<.@0%$ZXW[^M*/"T?`
M6Q&UO;F/2]G#>ZRX`LL,7-RI_*NEN@:&S0`-H&8$+4=[[=7[4,`>P+;:["ZV
M_14%H-Y^H1Z84-=$_`@!D+!_8+!Q>^/FZQ<'@>(J3K-.]QFRV1S^CEF1EW<0
M`3AI"DS+]UJ^_X&W%+':!2``DR#.A#T;F+O5@E"^#`$`@R"T$W``X]+EM^,/
M6""^H7`-#IMQG,W,7<NOREO=QBO/0BVUW@JLKK`(R?JK<7&^#I&P9R,#:#LH
MF4"^K'RI;5`"_5L%'Q[<_\W?6C0!8%"XC^L32AP`SR$`*NL&SQVWQ.TK4HY<
M<?2IF0-JF^P!`C##I+S-:;VM>N`&YNWANML#YRH4$*"I]QGK>KO*'2T`!B``
M"ROH&%3IOG+>E[KI06SIO"[EA.1;BLX/".[FKG"L;CX!,+(!FBNSYTWAJ6P`
M`,VO=%Q:KGXTR%[DNW&_!Q$#0N#IFXS^K`(PYS:2[(RUXMF#K75$R[J"V]0M
M#_8NZ=S6Z[7$T+V1KS82@+?AK!UPU@?P*?5JT+[NM`=Q``'0[PNPQPS-N7`]
MFZS)&Y?GSZF,\E"\&_ZP'1_^NL]$`+ZEN:>8$`B`PO,N$`GPTQJ5``-0!:6=
MO`#M#^`1`-?;V?U(V)OAU^3[%?*[R?WXVW'\=1R_\H9KDM_-KZ13KUDO\QTQ
MTBI+[9B.*J6]W?02``M@JY?Z\14%L4==M<I1KSQ]Y_N`\;D[SS/?NPWM[T$\
M&_XP"0>CX*6J$/#L[^+;]^8+\[:.WKXETF._&W3]]P$=`SD/WD@1U$$_K.F^
M<T<]TKL\&\;^J@M-/P4<+<U5@/E?%Z\.P;HV(BQEKPN'?!P;$+$W0/>)<;Z&
M[9/RNQ.'G/6:R^$*4=4J'[6@B@":RJE9I,("H*E*0/3>"_6XFC'>>1R?F6&K
M:1ET7?E5[0^JLS58WM`?C@4:S`>&O0`7(,UY\ZZX\++_01X0\(>0C@(:/.16
M.ZS*7F4Y'Z_K\>F&6WM4:TH@,%25,&P?`W@?FP&-16%?07P58'T`<E&G2\(:
MNF"4S`<A^'``B4_1,D%*``M+1=@`0"P#P>GC`3!:+RFR,+!("(#+#=$9T@`'
ML?OY60`^$T`$%HU`#-+*'\3%P5(*107%')U;P<I'U<+%P\M0E0;^2^/CA\8+
MQM8=B\?`P0@%#U-B2A@*P,@!@)`+Q<["AP-`QZ@14H05EI`8F1G,Q,8H0ZD=
M':+B0&40G=AL90VJU0>!B"-=1H3B$G*9F*V$A2W<1DF%!03'QNTW`!)?)8'-
MA=V%*@=65`E489`4-SH*$!IA*=\'`0@^8,@A)D(%"+22V-A@0(<9(=L(_0C&
MQI.`58]<59A`8F(5"(]DI?`#((!-E*LHM((),<#$FO_T1$B'[2B=*@(B(6WJ
M]"F+*O<J0:4SZN"'5IYZ+=%*(X``"'1P($$UP`$4+BPJ(`!@(,**"`%F?&@`
MAH57#P'*6`.*-X"!2`@FBAG0X$,"`0'^`@RX`<`3!@&4AC@00-6>KC\'-=@5
MT"",@VI$O@C8=&!BAP$*!I46<C4;"PT"9@-X<.TA!@ZS`VR*P_L.AP2+"8#\
MD!HME"^\#R=6K(#N@0+8-!U+4)M%Z*R[&RN@??CO`+<S'(!57);R]4ILW49`
ME?4QBP?E'V\`&X``!*85Y@YI$*#98B+005YX"&#UF@!H512!;E_TQM9O9B&7
M@7*U-<@8/>Y1P)AX0[Q&%7:B)4%8*F@E%B!3K0!&5RK?&0>!&PO,L,(&=O&F
M01.Z:$#`':%5,A@+&/!!P`.1D*#8$MTY1]>)C#GF"7D<C%%&!P2`)58'`?"2
M2S:8T9%8>`_^<##?`Q9`Q()_'&CDQ`D;.CA!-MFE5D8K'.QW7IHX0/G+`Y8]
MU%XR5;GWQU*"&NH400#<<R@=(#)ZJ*.-8N-!I&0]>BFFD#X5J7M'@3@'B"MP
MFJFCD=HCDJ2=9HK4J)>VNND05+W**:VKONII4[?&BNNJI/+::ZY'$;/5@`%P
M`*RJE8RJ:Z>R[LKJKF:>9RBA3"$+E51P7BLHLX@^R@&QVXK[[+CE0GNM!QIT
M"^RZY;8+V[GFRCNOJ[VV^VXOQ0TA$[W],@K,NX3BFZE4J/I[,,()*[PPPPT[
MW._`#TL\,<4-)UHHPG\L6G&J$K<:<;P<_RHR5,[Z2C+**7?,\:S^DXZL\L35
M'ISHQC#;?'/"D8)<<LHZXTSOSBLCZ_//15>L5-"'9GMI!_X%(,2&95%`0&EE
MR';`L7<BU=T`6I:U`GFZ5'E?F!P,H-RT+"3VM0$#S*!!`+I4UG4"6`VA)`$'
M>:!&:;ITW4]M'6ST)&**Y2V&&DAD$(#>=0$P@)4V)$#B65D%`-D!]QV[5@D!
M-$!IVP$<<%X%;AR@K6S5%5`E81\<P$NL$,Q&P.8<%+!Z;&<'H,"Q'1@P6X*R
MB**[`B=T=Y_=$-!]X!</M$"U\Q1T?E@KD)>V@?(KX*#M!0*N`"0>R)7N2HN(
MQ5T8<A[(WMH08X,3^.`;;K#!V>9EXT'^VZ7!*9_S([+0]&+NH*>QF$Y;3%``
M6.`PMVAH0'?XL18)NM:`.5"H:P%`0G,.MR%/:*(L$3`!*O('@/U=QW_@LT1C
M^E0@43!N'+8H0'[49KB#2.]O23,:NQ[B)X05#%Z"HHX$A%`%)"C@!2T1BPNN
M,T27,20+X:%+?0`PF9;PH`(:<$9+K/4!,P%@-6+@S6JNP0>>K,,]#+$`'^!@
MARR<8"6KN.((6?"'-!`BC1\`8UJ.`84*V,(EW[`!,GC1B8BL`@+$*D@KQ&*'
M=@#@!)>P@":^TQ8.5$07&CF(+V3A`:HYPI`L6)-8TL(`$DAG#`>8!V,VEQ88
M^.6,?-#!%LK^5$0A5,0):U%4&0J"B`Y4(`40T$4*1*4&%DA$$M()I"B*D9\Q
M\,(`4D0'"PK`A2SH\09_,!`<CU&%^9$AB[%:HP0\D8+_?$,Z]C#`(\32BO,\
M,I(L4$(%,#*+"5!`!RY@P`6VT+J'0.`/8>RF!.;@RE^L\P/U>8(]G"<J<(KS
M)B?HQP<T$08>S5,<+H#3"BIR2F(0AB$7*&('$LD3''),9AE3E`$/=3MI-+()
MU4S+,.>(E)4BPXL2"(`F6!2HVQQE`05(P1RR5(#_G&H/*H@F(*,I'2X%ZIOI
MN*@<(;)2I@Z5FRG5!E*[D<M&%G572UQI,I9(@&/.XECV:$!TAI#^N?KPHA*M
MH`L="J``!!Q3C$?=J5I",@L:+!4`NFBJ`6S@@NX<:W):>D@:CBE3K*;%`98:
M`DV9B5BGLN:OO'@KHKR1%FW]@9LOA>804F"8/SK.6G\@UEA#^XL=&(6QFXW*
M&[(A4XA"%;)]'<&9JE`!7S!E2G00[6%6.@JQC$((^R#"5(P:B3_`0;BT>"Q)
MCP:`'1YL:8_2Q`'HTEEB:,\AQ2T`%LZ$#6ZL()BNDT,)?9L6'AD@7'>$0$7T
M]H($T.,>QYUL-`6``08,0$I@0<#A0%M;F3)DO_W=00,2(*::,=:9"#B`+00)
MG_`X0)4YB<@3[)`!""<3HZ_]@$;(R0+^,T%.>`FP`8A&80%B`.$%%R``7Y*Q
M`IKFT76-*3!_/5#01'F6`(":P&$'*0`]+-&U*1!`6X>06F2Z("P+Y84J'#"1
M9`#8.".PP*?P6H#3N$$#]N!1`8B5)8D<;@%/N[%T!I#D0YRIN-FXAG44L)44
M',``6UJ4>FV"$0&TQP5@]@1$R?)8#V0N`*'\'UBB<Q`SMX$&@.2&1AH:G3MK
M2[(++4.@\X$#`T#XAM%=E4DA]A`&<XL"X3E,%3C@"TJ%ASZTD``""GJ4E9:W
M#RYP'@("`"K-N@`!#F"`\'1+2&0T@$)F$@)0HTHL9RY&%V,@@`-DU`W8N7FR
MS#[?&!K0P&/^8^.^0VT`N,,*D0V,DYW3M1]O'C<#GM;6%^)UW$MIW!\`<*`)
M9:@(;PQP+$OS%;FTT<6UX53DAW"S`@TPT'^\H12P:/=,]S7.;+08V9U:AP"4
M2@8!#)`*,_&"MHH*0*AXS0,'2+F1H_`UL+]9@&C#@0\TD,`!;-#41)6EMC7N
M``1X`R<^-(`!2(PC-"_613.@_%BV6*%,,QJ-1@$`VI@P*OY@#DB-=&`!@$Q!
MSW]^C#Q+5IHKO$0#'""J3S/L8EJ4%YN3>ZDBOF<#9@))9[TDD7?;=@@#F(@F
M#`#@C0CNJ:3^0!%/<SW6TJ`MQCUJX:BRTK.!EK(?%FN:4>R-`AC^_GY05^JT
M\<L$&=M$)KO^W-`]((#5K"#2%`&``RC*"?&"C=Z-,EWF&G,5%V`I4$U`RPKN
M68$P++XQ]C@T`I.YDBWO@I\5`-6%+Y\-;HSWF'G>HE^+#]$%&."POMB<>1T_
M8*Z2^ODU^6!J$="8I(AWR-G0B/`@I_P:.Z9Q?^``,0["4QJ(`.ZL;ZI6?]L'
M\!]S%!OJ7_9UV!"(WQ"8R4&H@3Q$5=J07<,HQ=G-BW4QB@9D@._80">D@@`@
M`?H550H`P`Q@0)$H&0$`@W7`"3C\VA;P0M^907[@R!`TP0$X0,\!0O$1@WT]
M!@=L0?HXVF1U$3!LCF09Q]G,#]7,`43^+9'"*<I+91_S2=8274`'<!O-?1,O
M\,$<;`%<X$!'6>#&_`%<F0'64%('#%;864<&%%7&U=0'7(`TP=7\'2%$V$(%
MJ,\FY()>T&`2ILUBQ4*]914V8*'CP$D'7(`'5,$,8)P-U-*]V<$)/)R`+<HV
M_1XP]%87I<L)U$1JN(5-,$`'4-)[6$`'G``6>H`6!HF7'58*>)DG#-<-E`!3
MG!;AT5ZZ'`M$#<$?@.()/)]Q5**7[54'E,8IN(ZBE$4JSD]:0$"ZO`<G9H`K
MDI8MTD(]E)[=,*"_L!EU^8O&?%95;$'3Z<`2:4"N*<H``,,]P`U$5-D0.).B
M^%C[#6`C$5[^6B@*YTF468RC-^S-#8IC_XB@00U=NBT=OUE`N@4`2'"#/:R&
MC$F3'M4:/SA?$GI"JRD`4PR<9.%`*/7)=$GD0V"%$FS.(&&#!:CC8W2'AUB!
MFVD"'/SC1XQ#S4"4/3Q!U95&Y=186WA"'F)#D77@TC%?H[2%HGQ'$J6'-RQ9
M$:6#!4B3HNS3+OK=,736*,BC462)/$K'<6G$*;3!QST$;Q0*1NY.)-B"'324
M/#:#//)`L$&$=9`C5)83;%0!;X!<\5&%5"J*`5R>50Y!WJG66#[E,%J"&P#%
M5M`:;,GC7_$%-9[4-?:+QG@8I#1#)0`#'33#!D2"NK``N.SBH3'^@62^8!BL
MP"0:%!#.CY<QQ08`(1.HRV3^3V4"P_Q$2CU8Y@G,3S.H4FJVS_R09NW$YN8`
M##:\IF72YKY5IFQB0RB"2&FRP'&J)FE6IG%H0"1`9E/(YBRZAV-N@*@XIT%Y
MF?"@@G5&YN88HVJFV`KXYG%Z0'<VBIB)YG=:6&3VXA#,YGO.`7BFB[5(YU$D
MIR@HRU9H)W:^IRKV3F?BIR@8HWDV@YCUIVK*`KB(9FS,#WL:1W>F"XU(YK'T
M8?MH9QC49F2*Y@GXIBBHDGFJTH(V@QA@*%6X)W):6"C6@W`^X&'*BP/.S*A=
M5<)T`#/8C*>]Z&'FJ([F4(_^*)#:BDW^8$QU*:$/!2F2)JF2+BF3-JF35L$X
MRF@/.2F55JF57BF69FG"(,V6HI26?BF8AJF8CBF56B.//D4/G2F9KBF;MJF;
MONFEA!HV&BF<UJF=WBF>YFE5<"D/>:F>_BF@!JJ@9JF<S@O-:..@)JJB+BJC
MPHS9)4PV-JJD3BJE5JK"Q.A)Q9&:6BJG=JJGYJF9=NG??2JIEJJI-JK`2*F?
MGBJKMJJKYBFF'LQB'NFKUJJMWFJ9#NFF(L64XJJO_BJP`BF4NJBY1&"P'BNR
M)NO-\*FH]:JR/BNT1JO"A&JF&HRT7BNV9BNR%"J]S*JV?BNXABNV3->N'H6S
MBBNZINNU6B/^L8H+S3"FNL:KO")KK,[IJ,XKON8KJ]9KOYRKOOXKP'IJJO:I
MI@:LP1[LI`ZLK-(IPC:LPP:JPOJ+L3XLQ58LFSYJ-8Z:M5HLQW:LEG+KO$2J
MQXXLR58IR,J+R):LRJYLC[*KJA8LR\:LS$87L]HKHLXLSN:LR/`KVFFLSOXL
MT)84N8HJC0:MT1ZMH>JJJ-XLTC:MT_8*SX:LEY;KTU:MS+HLP1:MU6XMUSK%
MR8[+H=)JUX[MV$9LOS(LV:9MUV)LD0*=VKXMUWYMN:0LW-:MT]:L8JZJW>XM
MT+(MT,RHV/*MX+*LW(Z+OPXNXJYLX:*+SR:NX[(LWM++TE#MXU;^[K-2:]LR
MK>5NKL$N[K;0+>>&KL%>#.6N'LR*+NH"K.?FT.&FKNO&:]3"J-Z^+NVBJ]^>
MK=K5KNZ&J]EV*]KN+O!F:^]*[;T&K_$&Z^WV[.0>+_,^Z_"B[.\VK_3^ZK`2
M[?1>+[`^+]@V+O9VKZLF+_%JKO>.KZ6N[K9.+?FFKZ=B;>:JK_MZ:N2:R[N^
M+_U6JO;.+?K6K_X.*OM*;/3N+P#K:?S*KML&L`'GJ?D*:>L>,`.3*?A";^XV
ML`2O:>R:B[=.,`:3Z?T:[O]FL`=7*>;^[?)^,`E?:07C;_&6L`H'Z0:+RP*O
M,`SW:/42K/C&L`U_V@`7Z^S>,`]38P[^ETN:]K`0?UK_YFT!#S$2&\T/<_`1
M)[$3VTP"^\H+/S$5>XP.M>NVI-W&5C$74\P),['6=K$8,TP+?VX'CS$:(V;I
M1M7IIK$;%RF1BO`.OS$=N\N08K$+&^D:US$:SW"SGC$?!S+4#FW6"K(A,VX9
M7TL0'S(C9TH4@QH@-[(D0\L2,^X43S(FLU0<XVX8!^T>9[*2?G$>1_#@9L`"
M8HH'6,"#'LH&P,&E9,`7'DH4XK&@:$`L1]<@A@HH5NT#6_`<_ZP$?$$!K')3
MV`D+U"*PV)S0X(HC6@!<C8J\'<HHP*O+"(HC!LT:LYDAZ-4GXVLB(\O$`NU0
M20`%V,:A&,#^,5F`OJR*,C]*`,Y?4T2SH804,;LSXI$=!T`"2W8RT'ZS`D=R
MS&*6-'S!,52`8=R==2*E#2P`+S00`Z`S')"`)R2`'F``0;=``@P`,523!D38
M'!AT`R!T5"#9?;6"HN">?(!7\_D",C*!,XE=9%K'86S`X1RE`?#71+].6"#G
M2U?"!(R>(P;S`!R#J84T`H2+!"C`XJA+]1U&`XD-`3A;$?&.'RCU!46``(R@
M&$RUA3&2$)3."8"CCRT*=IWRS/:RN]H$*>?LB<&+1@216E2!`A##:DB/`.@"
M-[B``0`9%R*!2[K83G\!'T6?>I2#`#B/7,LU]#&`6U;"!FC"`A#^T5UK`DBL
M@"U`@$:(!8]D@%Q]B0`X!%2MD30A@3-%@!UM=F>;"6/?Q-B]=4P\Q%P/739\
MT(EIP)9Q]A/H'<$53@8H@`U@]8,1PR\=2W?T-EE]@"I4`!PLD6"7D49`DK$<
MK3\/<A/K+$]^D1<%'X$=$TU-U3W41$&EEB\X``6T346(!;?104`0@(2E@0VD
M0&'=\S6PXC<$(_T=\RI80044D2>L`!^T1UI40$5X(T2DE@LHMQ50@!5N`7'?
M\^ZP0/`5E+S=HF,LP'[36Q6@@'2<'`7X0GCI@)DDP+&,P@%TN-MF#E;$G5J8
MB2YDM000@XL`K1_;+-)>G^.!=X$?TY+^>=SAV81?O[<=\,@SW`-4_4C>%$![
MDU:R/=PUW(:\U2*/M$)T'$`"A(N-D"-N44&!"]9SV<&6(4`.KE;VJ1>.^[7S
M^?A#3#D"E.8(X<?IW<YM/]91`H(]W,YIV$T'%)%T1"*11]_CH#,"`'C05K(9
MM['.5H0<T"=\"\YJ?-4Q!=:,]56/M\($C(ET_`,2N)TIS5,VN%EGB]5O^U66
MP&5LT.`WU.6"T($M8$`PC($0\!(=S`"?6]$F\,&/I\5?O;HN$`,D+`93F%DG
M#AWDD1\2"(ZNL\#1;0Z,K06:4Z!O+3LI/B82X+A-WD$*"($"U.46;2?.AG#2
MAO//5@!2GF/^4LX!J-_2$N3U#5HV#PS`,:W)=<@%8-0,']S=5MVZ!U1<UUB+
M=5@-4K;6!SB3,X59*RJ*'KR3HMS9X8V>!Y+6-9"`HJQ&!U2<8C!%!_BD'$S6
MDFDSYT0\;!GFCJPCFIOT`*RB0BM+JXG%$LF%'=S#Q7^<>^GL(Q.,'C?M!&9`
M)5Q1K."\0<F"SI.H!U#@::("!9*H99[A"ZI+!K#GTGM`[_`\>'XHN'S*TA,]
MM]\FS_]/!C"GUF]%T(O*L=@X@0J]<9CR.-1;S.L\T:\`BI:]7&[]SEM8NO#\
M&.8\V8N!*8,()75FUG,`SM_]!-+RRA(ZZP)T%4>,E!519E:SH8#^3#=S2],6
ML>3^LB=7!8_FZ.,?16]+&R.+\K8L,BB'/DY.E^"?;PJ'?N9+\'2O"KB+?N@3
MOKUPK^O//NP#"^C.?B9+/O%2,^YG<NU3=PWWOB#/_*/,K_"#,EJ/RZRF_O%C
ML.<KLN$W?QVO/LU7M_0?,O47O^Q??R,_O^EO,??SL>Y#,#^'_QO/..X&O_F/
M\>^C,N`R__KKK[?[[NG'_Q@3_Z5<LOUS,>E:+_SO/PA\XDB6YHFFZLJV[@O'
M\DS7-CD!0G>_.2#I"8?$HO&(3"J7S*;S"8U*IR>)CN>T`B;4KO<+#HO'Y++Y
M//9\K+NF6AM4H^?TNOV.S^OWS9Q`W@?^`,1'6&AXB)BHN-CB!\CT$\0X25EI
M>8F9N?)VY;8FR/6H.4I::GJ*JN3X%)GJ^@H;*UMJ-8"UQ#DXN\O;Z_L;QB:J
MI,4%?(R<K+RLHK::)2C)/$U=;7WJ=PL)^C%\_0T>+CXG_%0\CIZNON[DW,F4
M&\<^3U]OS\*FO01WW^__KRZ?.6X`"QH\B.Q9(%T(&SI\:*J<DQ_&(%J\B!&1
M1%R?MG3+"#*DR#+NVD!C.#*ERI70_GCBQS*FS)DWL@WTZ(VFSITT.9EL`I.G
MT*$T!4Z,1C2ITI0*F9S+N32J5']-D\2;BC7K/Z-`N4'5"C;LM)+ZB"$5BS:M
MM5IED[12"S?^[B^?7XNTJBLWK]Y,59'DJK@WL&!--H^B'(PX,2*Z+PDJ?@R9
M3^&NAR-;OFR&Z[;*F#M[EN*S+9*GGTN;9J4#;P]WG$^[?FVCI&HAYV#;OEU#
M\SZDLW'[OCV9R07>OXL;'\%I0.\;'00`6'`\^O$%J:$8`!`@0@</';IS[^Y]
M._CQW\&7/R]^?'KSY-N[#_\>_GKNY>//9U^?O7SU^]?[SU\?>OGUAUYX`/JG
M7X("JD<??P@6*-Z!`SZH(((4)G@A@0Q6..&!\C7('X0.>K@?B?=UN.&'%*+X
MWH+ML5BA@1O"J**,*6(8X(T9UACAB!C^V`$$`0!PP!-J5"`(=@'^!"``DTPV
MZ6234`H@Y9-0/NEDE%I*6:652V:)Y914?AFFETN..:6695)Y)9IGJNDFEVM&
MV26;7[99YYA95BDFG7CN2>>;>?IY9YV!;GDFGWJ6N66:@W+YIZ.(NFDFF)3:
M62BAB0+Z:*67PLEGF*'**6:;F9;Z)J)K+OJIG*K&R:JAKH:Z:J2"8OFJHK9.
M&BBJJ3**Z::0GGIKGXK.::=S@E0@!9))/@MMM-).2VVUUEZ+;;;:;LMMM]Y^
M"VZXXHY+;KGFGHMNNNJNRVZ[[DH;`+-3<#`!!`?<:X`!]^Z+;[\'Z,LOP`+S
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>;\]]]]Y_#WX3^.*/3W[YYI^/?OKJK\]^^ZZ$```[
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g109112dai003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g109112dai003.gif
M1TE&.#EAJ`)P`_<```````$!`0("`@,#`P0$!`4%!08&!@<'!P@("`D)"0H*
M"@L+"PP,#`T-#0X.#@\/#Q`0$!$1$1(2$A,3$Q04%!45%186%A<7%Q@8&!D9
M&1H:&AL;&QP<'!T='1X>'A\?'R`@("$A(2(B(B,C(R0D)"4E)28F)B<G)R@H
M*"DI*2HJ*BLK*RPL+"TM+2XN+B\O+S`P,#$Q,3(R,C,S,S0T-#4U-38V-C<W
M-S@X.#DY.3HZ.CL[.SP\/#T]/3X^/C\_/T!`0$%!04)"0D-#0T1$1$5%149&
M1D='1TA(2$E)24I*2DM+2TQ,3$U-34Y.3D]/3U!04%%145)24E-34U145%55
M55965E=75UA86%E965I:6EM;6UQ<7%U=75Y>7E]?7V!@8&%A86)B8F-C8V1D
M9&5E969F9F=G9VAH:&EI:6IJ:FMK:VQL;&UM;6YN;F]O;W!P<'%Q<7)R<G-S
M<W1T='5U=79V=G=W=WAX>'EY>7IZ>GM[>WQ\?'U]?7Y^?G]_?X"`@(&!@8*"
M@H.#@X2$A(6%A8:&AH>'AXB(B(F)B8J*BHN+BXR,C(V-C8Z.CH^/CY"0D)&1
MD9*2DI.3DY24E)65E9:6EI>7EYB8F)F9F9J:FIN;FYR<G)V=G9Z>GI^?GZ"@
MH*&AH:*BHJ.CHZ2DI*6EI::FIJ>GIZBHJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^O
MK["PL+&QL;*RLK.SL[2TM+6UM;:VMK>WM[BXN+FYN;JZNKN[N[R\O+V]O;Z^
MOK^_O\#`P,'!P<+"PL/#P\3$Q,7%Q<;&QL?'Q\C(R,G)R<K*RLO+R\S,S,W-
MS<[.SL_/S]#0T-'1T=+2TM/3T]34U-75U=;6UM?7U]C8V-G9V=K:VMO;V]S<
MW-W=W=[>WM_?W^#@X.'AX>+BXN/CX^3DY.7EY>;FYN?GY^CHZ.GIZ>KJZNOK
MZ^SL[.WM[>[N[N_O[_#P\/'Q\?+R\O/S\_3T]/7U]?;V]O?W]_CX^/GY^?KZ
M^OO[^_S\_/W]_?[^_O___R'_"TU33T9&24-%.2XP&`````QC;5!02D-M<#`W
M,3(`^`$#ZLQ@E0`L`````*@"<`,`"/\`_0D<2+"@P8,($RI<R+"APX<0(TJ<
M2+&BQ8L8,VK<R+&CQX\@0XH<2;*DR9,H4ZI<R;*ERY<P8\J<2;.FS9LX<^K<
MR;.GSY]`@PH=2K2HT:-(DRI=RK2ITZ=0HTJ=2K6JU:M8LVK=RK6KUZ]@PXH=
M2[:LV;-HTZI=R[:MV[=PX\J=2[>NW;MX\^K=R[>OW[^``PL>3+BPX<.($RM>
MS+BQX\>0(TN>3+FRY<N8,VO>S+FSY\^@0XL>3;JTZ=.H4ZM>S;JUZ]>P8\N>
M3;NV[=NX<^O>S;NW[]_`@PL?3KRX\>/(DRM?SKRY\^?0HTN?3KVZ]>O8LVO?
MSKV[]^_@PXO_'T^^O/GSZ-.K7\^^O?OW\./+GT^_OOW[^//KWS^17D;__`5H
M&(`P$2C@@7!MLXU`"OI##B\+^L/+,-/,LLTTO/`B$#W,\,*,@\,(1,Z']$SC
MSS0+EDC/+,P,`V&''V(XC'_,D.//-C9V.$P[$S(SBX$%`3F0D$(.V5"1_B!I
MD))*(NBD0*M$(%`-JS`3P101,.(/&2LLL`4A"TRQA7_#`+#%`H30$\$F_NB@
M99G^U+"`/\,L,,T6''#`!AT`3,$'/0LP,<(6S`!`AS]B;@,`$VS<F><6)J+4
M9$*;S)+DDYAJU$X$PY`S0CLK$"+A`C8RPH$_A1)8J#]\K.`/(V[6_R#0JCH`
MP,@T`+2#*!/^$#+"A@!4R$&9')`C)CD`$#C%%`<Q(^HF6A*RB:B\L.$/*61H
M"2VK&M))QY[7TJ$E+TRL\NHFY/"Q"IM\3+.)N7200P\;UI("0`WD##,%*03=
MR<>U3'Q("!]L;,.&N9DF+!`1FVQ"A#\+A-A.Q*^>6F8-3.A:J`X1F$A/K9;2
M"8`_([!1`R41V#@%KY0`H`,;@-8``"_31,"&F%L@B['*O&Y(CJ[D='QF.SI,
ML\(J+4]#AJ]W1D#TA_ZT3$H$L[!A)S,+;#+"+,.LP`0AS!3K*B.?ZM#F%F1,
M$3096(/)9I)ZDK,)!Y2,L,T*1-#!P29V*O^<\"8ZZ,!F!.9NL\"'9--)ZD!P
MLM%SX@+527*E$7"@Z[*O_NK/Q+/40(>B_FQAJ*(V^H>Y?[R,0(E`6TQ!!QTK
M]_HR(5,\W#H?=##!K$"),PI[Q8@RNP(`-NJPQ18.#KIZL+B23,HJ`/!!Q+\B
M7\[LWCJ00LJO%/N-Z::6OPI`W;N;*C(CF]`XOM>\_ZH^R5H.?SFOC"Q`R2KT
M!,L+![.,7.;GMDK?KA#2ORK9RD$`@)F9_-$_4A1*2SJ8!?0(`0!F;(%7VX@`
M'3C%"#_)BH+=F@(`%C0%'1"!5TP@0LWHP(=V?,L?*]A7E#;8CA$T[%<`")'W
M,+4*A'G+A\S@%SG_&$&(-#F($7Q@!("".!!RK,Z!$EH=`RTU#22NCA(VV@0O
MI,B(&2%1B0SLED&&:")&V"AJEMK$A\CXJE)M@Q)[8],L0C8-.H0(B_3@PX-<
M)1!>:(EWE/`//0A!CFWP874]=%`1O;6@32B(35C<H22Y0@D^-F0;-KS4)#?9
M$2`Q"2)%\J0F#32I(!E)DZC<D(A2:<HDT2-"""$0@&1Y2E)R,F&EW(:N3DF0
M4K*2(D2*I2_[LY!A)H0>QDQ(I$#4D&4NB2&[-,@V##3-9!(D7[>4##WXY0\!
M'N1"UX)E058ASAH]I$%)TF%!1E21=M"CD!L)T3L5,L^#J!,A[&Q'-"OB_TUT
M,80>4C3(C!AR1H.0DR#DW"=$_)E-R-#C;6R:!BE*1(HS+G)=.AS&*G9)B@L=
ME`Q"),4TZ$&S%84LB$,4%:IR=J-5G!%;)^+%BER**IKRHG"KF,8TS"6O1=[(
M/]/DFH-LM"`7#?6GS,"?!>5%#G((54*KT.$[G2K/J"Z5'!M=4%/IQ`M26$N?
M_JB2@^;81_QM+I%8[=9-_T@.0M'I1UP52#NB^M`35=1!5=I"B(PZ"PV1=*,W
M:NDNDVK&:X6HHPWZ&3E$>J*<'E6P;85:0QU3UVM-0X]=?:.-M-?-OC(CJ=.0
M(CGYL(V)4N*.I>4%M2CA([F5]GXB^M<V&+$-(_\.(UHSF@8SV/2Y'E)BFHQ(
M:I5Z-`MNLLA'FW#79^_HC\]M;G6;&(8:L2C;FT:50A:BWC:L2[-55/2RW>37
MZH;Q64?.8ES2W>UG6>LA,Q*U0MQE1H6V<:@DM5"Z56QNA$2Z"@DN=AOHNI6S
M;!0O4O!"@NT@+;]$>JL%E3;!B]VICR0*70`#>(C#N")1:6M&TD[V,95-'WEO
M>UY=&;6B#YK%_=Z6TP4[]6=\4/%-Z7189\VB4E)]XH(F="-^"7"+VK(LC]DT
MC!I_MEN+C:JYZ#'<;CH92JOHJG]:?*,#%W*."PID3'G15',Y%I&-I%,0@<JO
M(%IJFT5V\E,92(B^-G7_CB;J9S>G+-&!Q)@2!QX&(=;U5`&RZ6W\C1H#'3F0
M#(6UMJL(KH?ZVM]TG5=N4$7803UDU@\[YK=O3-(L",$O`!D:Q;.H\RYS^F>G
MFDC+=1YR.Z1HZ"2-5[P.%N];Z:$E1)9Q&/Q*LP.//!!&:$F)!ZX0K04MD*JM
M2*9*7%V%9O'F-*MT&UA>K'T!',YNML.!!^ZQA'B1O@.W:,ZOTI!(=\IEJH9(
MI8*.,D#;\;9N:K6B4GRC?P1X10555-8&[C2J+&7&CD)II]L@0QF1Z>3(1HY?
M_5:HI1.SV(H.TJ49YN8V4:7/$*GXI-B<D;1#Z\@8[9A.][NVITVD8G5"/$FD
M_Z"$I334HC9+Z$8F&D:#)BH0SH86L%M<>1/Y-=?D,G"D\JTX`TEA1'+H5)^Z
M)83%+U2ZE,L+:5AMAX(`S"]PRIP0,G70)E@[C9]]B!2;X.;+M^ES,<KMMWNE
M1*Y/BZ&7RPU=[;`XG4AZJSY2(GUG-SHV:>XN$?NGA0,I.9T6+AIKUF2(!?W/
MC8H<LJL8_B'<)OQJ'M_*6$IDF.B,2#"'E"'*6UXGGSR(,7FA<,D_)O$2(I%$
MY%5YC#15L@X:R#[I4>04#51$G5IE$]?)8U4ZA$#Y:A$]P/I,@YB3EX564CM@
M?RF:]A+Y#E)]10"TT;83Q)RA;+WI&=[+@/Y2].9RI_]'N,P@'\Z">N1@0T%O
M2R&`2A!`8'=LC/MH+8*`_9[7=V9"G$H'F1+\F"?R=>)T$-[T36(W$*7U?051
M;C[D$'`E3>(%)/Y6:*BW?9'1=6%')TP@+]J3137R+F]D(F"7+QNH2Z'%<K#%
M.">2+V$W2R'"#"6B<NVP!1&U4QNR6PQ":/)B5-O66%#25.*E4I3P1P-Q4"!G
M*<Q`"=-`"(<B70M""C_2,`5563B2844F0-X%(+@35HP0,C<63>N2)C?&##@R
M>`["!UIT(JQ%"LBS(H0&A4D8(?2P!:208/X&8.J$A[2'*MLP!6:G/0\E<%.@
M3EU%2$DH4S0X:`6U11]27!;_>!C7AFO25FLZ55'4,E&BTE'Y$DA:$E45%E45
M,A"KXR&8)G%/-%<4<E,B:(."U&[^!E32\DH;E8'7P@@TU4,?Z$/^0726TE2T
MI4<K(G-81$BB,D3$EB1O0XI.Q6S:,R&LED8CUE5+6&SG]DZAU5IO,UMAA$4-
MXV6ST`Y*U$7#>$:.9(P!YD10XUX)&$B4H$]95HG4Q@B#92Z$H$NS=6T/DE,J
MA8-I0EN/."!5PER05',VF&9/-`VX=D420@HA`E]==BGCE53(]#8`=2TOYE0T
M8UFZR"93-H"K=B(2A#!0"'_+QD3VEWL^HD?7$G?RA76SV%+'6%GDE6N'=3]1
M%3D:_^)2*58I(7-0(K8*_P)V$9*`N,8(>68N6E8E+.*2\`>$W7197454").`
M?X8JR<5-@>9-)V9TY\=D/==74+)C&N5Y_P@73)9F`ZE%4<DO/+8Z-\9LOQ96
M28AX.BEVY,1:7"=V%?4G.CE'(9)<&UF$*7(CVY!40^5-!Z4K5Z1$'#D0#H1,
MHD);VY!AAMF./\,FZSA+R<A$NC:69X1K%HE5<O-*?<1E];@Z_U(M3<27$J5+
MAEE<VI@^ENF87>=C#]54`!)<^E11AQ))`A%=:QDU`%):@Q1:O3)7*)(^$5)%
MY/`L9%F6;]%U.7(BFG9F)K)5)J)+8\B'B@5%U;1,3&9:S_]#$-=F*=445"<B
M=4.R3-,`-.T@-^'W+@55A@N2G?496`+A+N;B+C_20_YAGFEH(NU@(K`'-4VE
M539B(EL$2^:)3`NB7H5F8'0275;)>5"49/!$)W>5G94B>S)%H'A%<V=EGA(Z
MF4/27YL#H@-A9B?2H3R"*JPU$!*5H,\)G9I1@'K!1C8Z'C5:3)\W$[-4(``X
MH-IW))>'$<;4HSN*%X($?;]$FC2AI-=T1O]7$.*D)/HWI:+7$M,T$5VZ)+;T
M?*(W@$NJ&/)4@:+7;H29$-L0?@?($VFV.0I760R!HP31>YUT>8=%I@UAIQLR
MH&A*3VI:IGR!4D:%9BCW63GS3G/_U2T:!7O%A2X2NDB-:J5+)D>:Z"#OQ%A)
MHE521U.>NB(1XE0X]R&&V2DBAY])DE,2M4;?Z%2G)2+Z=&"S9(OU>:%@22>)
M!E3^X3$C8I3%%G[9)E=$Q2%PE9VSU%]`A3^B.44H5YN?.28WEE&`=2.Z$BDX
MPECWTWC;E)T'XR"<JJ'U*58,M"Z$^A>?`YP:M5./>F-:LET]Y"$^8DA%V'*%
ME%R.R%]BI$@5$D@(N77NYDB$)FC355M.)J_H!H(NU833M5-OZ42B2"%D&$B`
M&&`Z1#/,<"L^I&`#*F_/(Z_9E9_XLP63V5X=DB'#P"(:*U?0E5X*.8$7,D=#
M="'!!6TN_U)R](4B#/(O[R*OI#8KYD*R041J&&:8O=(I.T6A`NLQ9/AK&F5N
MZ':N>E%7*$8*MHAG5^N(&%)N?15G`)(^V\1D[?)MZH)GUP0VB19%T=5H,>:/
MY0IG$@*:$FMRC62#6E:'5GLMY)J`/48'*^*4O4<S"/ED%5FU=-`.S(:17HMR
M<U1<'%*38,<BS%5S449S(L4O1LAF71NWO!-_HKE3FAE6375@]Q-0SS-'4=5F
MM$5SV;A1*=94;1LI0<2S-(8_=*I-)R&EFE<;A=ME1NASD`9M%H*1U5AS344)
M@50E'1(U@XF`;NHC`&4PB(-,`-)6E=A&$[5K8L20EH6Y,O5;VO^#N/67)&8T
M2*^"N)=Y+6JE6Y-;N,8ICWWI(;U2A/%"".-U6+EJD"LJK<A6D;]%D#OE+C>2
ME!+S3G[K+!OR1&\F:O0[1*NC1/[A7A29+ML5:J]"O0,\OZ.85+XHM7VA(3LR
M(GF7=S0SH,R@3XU(=$.R=1:"O$]X(UN7>=A$4MND<N#6=]$$>$@C3RF'(QY3
MBU@4=V?U6SFU708KHRJW1>EC3DGXOR>B(`I::'02=\B+*EYW+7>WHI;"(B<2
M<]O48%$<6R@7HV=7O=!B<;25L8>EL<%U=\MD(2<LQ#*FQ9S;=RNB=O!W*R+,
M+W8,)6KW<@W"P@.2D85Y@^MGH,RW?$#_TB%`Y2(#I5/X5&2[I,@P-R0G+%<=
M`DLCLDLC(EDCLLA9MWPNLB#+IRO@A"$E^TZPAR'1!$Z8;"`NHG"4K+,I>GVW
M-QB3Z2,I$7D.D;G'I$9$P60-N!TN9#PC\"```"\I\RK&LP+\4@-F,R0R(UFK
M8#PU\"\K,"A,L"`+4%]!$@$U4`,1L"",$`'^,0*\XA^B\S9LT"<+4']D$#T"
MP0>+LB&U0LW6_"^,8"9$L#ID("4DXRJMXC+64D*1HSLZL#L9M`"[9#4KJ@/0
M_*:O,B=Q$BQM\C!AE<\*N!<DE74?@22D]Q"LMQ`F2A0O.GT<H;N040,K8".Z
MT@ZV4B;\<B8>_X-,AD(0A,`$PR(0+7-F)Y+,,@K4Q@?4.01#9H,L4C0+1+`"
M?S0"9B,ZR,0!(R`KVR#.]44[.QTU`'!F-@+-!+$"T<P!?]0R*7+39<)6K#,%
MX6/4`\$!LO)+8(TJ$7`T\*/52Q:H9[%5O91,55I\,M'7,0'8Q51Z*M&DL0$]
M?C40:LT!L@4`H@(@N*).1H,UW1(!/3-OQ/,SUY(LIF0O8671:"(A(Y0D*\`+
M-?#8]D,.H6TE6^`J4X`R#;D"E"T0EMU+"Z!$I6,_(M,M9*`YD=TFIZ))U5PF
MN@(H`34"_"-ZMQTU',`$.;,`"U+;*DT5OIF?<%M,8LFF8\H0#H9Y#/_!8T!E
MI=/-W1*M$&VZ(7SJ$'KMI>6MJON'U[V$H(NQ!9I#$)O0)[Q#/*K4,L6-*-8"
M`&0@VHF])8M"UU-@204A.F3``8>R,3K-`?Y!"+(R`JY2)CH0)KQS,C5`+GRC
M*XSB#P`NVO>T,3H0X(42(OL,((/"T\23/T0H$"/@4@"0:Q741,/SXNK#+\ZM
M+W!2)OC7%G4$5-EY8/5939H:>PST+[@6(>3U?(7<Q;Q`/5UGV"AB,.[4JRD"
MR72RG&SPTK?,A[H*@U;^(*0<?=%4.C8R4%2ZIODYN@"R(]$G(@0Z8Q"RHEFW
MR;,B07U$/618$#.B(@]"(QK2,)&CR77>L03_8:+G7>=/;.4J8L6;@WW^P4Y'
MGJ`D]R_4>WR?1=A[0>&I=-]0`]4$L=2!%STM@SPM`WLUL#NTC3P'P0%$D)&;
M[>',4C-T.->L,C(K\-9I8]I,$.6_TC^'M$"IKDGV$DU\<CG1K"CL_"N%TIB]
M8C]\LCI\8B#M(#,*92_^X2;3T-QF`^IRH30D%79<)K/<!G;\TG\?R4!-V&:?
MU5<Z%(DQ)E]MK.1ZI,!;Y"%DP&0LN+;WXU31U:MDH$]&2825\EO,P`>/JG[D
MQ2:C]7Z_B;B[I5JBBU7SPN2DQ37X<S\ZU85LP@8^LD51%O`.DB'PXHA]E<7L
MWDU((UFVN(0;%546_V+RVZ+QD4**6.Q8C37*4753VQ5=PQ#@>?LN'/8\M->T
MY.<CC4KNO'`H[96%*;L*4?L7[6PB(S7/P;W95:<K63(08.UK*UXH_[)5`-!N
MR/+C"-0MIB,K^5/0(T!$1/`K.L`K.J`YJ@/B9C,"HC("1`#VR"/V1S4%;RT0
M[8Q`"-,_9[3B$_,PKZ3:7U(_JY/0,BH0'!#@">XJ,!TB%]Z$\KQ5,,@6=25%
MV$8S$*5&/-DMBPZY`+NJW[8)[`:XS$5ER!A6=78MH%9:5,HFC&5H"1B)XE9G
M6.6WH;9@$7)@<Z0A\(4CS.9#@MMF>Z9#KM^]@K93BU5025AKM%]U4\F,F_^3
MC-U"9%BG1QRWO&V+,,'/[]*6\ZMKBXS`6;-?EYO#61(;1-'4J(ZHD7%+D[8[
MJ'[1AW@3S0#A;T4-?P7IL5E!9`2Y:0!TZ*!#:0&Y@EMT%&2T0L>(8<,<$F'B
M;Y-#'90*GAS)S!^]@ARV^&LXC1D`7@4I<:"WX"6E"/[(`9CE#ZB_"*1&4O1G
M$6/"$4%'C)A2(^BV&CJ(D#JY90'+;0`V%5Q5=04C.B-.KJ#C;\$()B$MKGAY
M\J1+?ZL6;$L*0*6_C!N'\0*`5.Y@PH4-'T:<6/%BQH7I?:74[O&V6;.V;6K7
M;M,P.M-6$6I7<!M67L/\D2)EFN7*57_]F7Q-*FC_:;XB+U.D9Y+4Y<RHR9'#
M2H\0;I.S:I*:YM/DM%G,@B*'_)K<K&E?=QODL^JROUG#+&];U2ZXOX[D8#/#
M>CHY)7+1IP4?[L]Y[M=UJ\M/#[[^?9CIEY^?1;..^,)K-9,BF^6W50KB94%_
MP-L$+^E6TFT;^CPCC1D-FY-K$]`PTVPT?WAA9D$229$,ML969+%%%U^$<3!R
MM@FMH-].8JF=:9#Z;<=M!*.'G-7HV7&EW[8IL$?!#%K2I]""]`DW(^F1;$J?
M;!0MRI/:$=*@(H.<<9HAB\11L"Y/0O+!U;0\LL`T"^N22B;E(A*W)F/$,T\]
M$:-G068HH63'\J8!=$="_T;\RB!*B%0I04HV,XBZ1J<A1#O,IC&M.C[H^1.K
MW7B9$=!M0"6G(T9666V3Y#:A)#WN`-61CTV.8XX4/D;4+\&3^#CN47KH(840
M7MH)JB`-3]O$4TJ8,6_6NN3ST-3P?&+5.NX8VN14@S#C!5#!5EEV%I96V<32
M5MOY+T*P;*5GV.FVG94<7K9Y=)MI&/%T5+QFH801<OR<1B9T-T&*EZ_^#/0U
M3IF3CQE@L]TS8HDGIKABBR_&.&.--^:8SC7IY),P.0_[M;`:"WK28\).'NSC
ME=8\.4?$S,-QR,2J]*?*DE7.F>>6/[9Y,)P-8FGG(=<<V3"6C689QY!%#GHP
M)/^'<;!CJZ_&6C&70<9SYZR_!CMLL<=>*6,.R4:;[-&J3KOMB[=VF^2XYZ:[
M[JZ;MCMOO??FVVUFAEERF(]-.^SO-8^U4<R5]B)S1IC^%EP^P9B14.B_@<1T
MKP=W=-A&T[;I*/*^1Z^[<CKQ_AFFQ-0EO777NWZ]=4*8&&&!Y,)Z:-RJ=-AZ
M%1VVJ.%69FJ88@0R"B(#@`79X&`E`)HGZM:GMF#B7P`D;(CMD^@`H'@V"B*E
M^PB8"(T#0F92B9X(CE]A!.I-CSU^K'/DL9T_L?Q8R%467.U,_QE!&5*@)"0H
MR<^`!T2@V^AA&O31`P",<"`I'`A!KY3-)LI[63MT0A[_O?B#`R.X55M>$X$5
MX`4`T^@*_Y*R@)-0XGJ%T<B(`'`HK8CD>BD4BFD8P4(<)M"'&:-'<_A`BM]0
M8A:,.!XC-O&8NMB/$;.@PZ&PTJK($&(3Q1K&%,B!,(>Q@5Z4V!_K?CA&,I:1
M8G1H'B-Z,I-9D(*%#4G42<9GP;(8"P"[T0E!.(`5,M2@!K/J2?A^PY(:O(0E
M9#"+RW("&[;X@WC^@,II`/"K.ZHE+4<YDQDU^2)@N29"`-3/HNJSFR62QS3(
M61#5K%.@Z#SF/;5QC8HV.4M:UE(NJ^@@7+@SR4+N,G``()SSCB>?P&QB(3KH
MBDHXD"U",*)Y6P``$Z0BE#BZ_Z\P,\E4!0&P`@ZL@"4U%`H=C%F1:$[3EN<D
M&2F841.3/&86"RJE;EXYHE,ZIS_Y6DETU+,@DPQ(EN@$:$#C-XL*0O)04VC>
M"`"(T,&D!$<`&"8:_4&&D+BD>>H;QB;\F)9>LH2@>^E*'`WB#SY,4I+M``PY
MV&#21WHP*@[JJ$!ERIIUGH9>J5EB*1O$A@4R8AC582(8V?,5[>1S1(]BUA1-
M*9('S=2I3Z4;0:LV`D)$T(-5K:1<9I*6&R5$DE@QWPJ)P,$@K6`!6"DH2:&W
M2]0180I\J2`?FL<]YR4J>2&I*U0%"K0B$1!--6)(4U>CN*(Y34M.LQGJ]+I8
MQFJL*_\1L,AZ%G"5@FPB`CIPE5SZLH)45H4)6-G&`H+"B+B:12`L)"@10.(/
M'2R`"3H@!_=>6RR#1(`#4R!"HE:P`@[*JX/^6&E-=JG:*<"ML<=%;G*56S<P
MH;!_2[J18>J$(\49Z21=(D>-N&0D).&%2VD*$I*:]ILE;=<GOZJ<>;F+PN6V
MU[WOA6]\Y3M?^M;7OG$SKM;T>U_^]M>__ZUE?@$\8`(7V,`Y(Y%H&$<1>\'D
MIX;;8GD*PUZ?_`U4)^G<241W8`YWV,/PO0D3B$"1ASCO)1Q("QU6X)#C:84,
M.J@)TE9ZJ!5N@0A!\5WNN/,0WGW8QS\&\DP!\Y6B`2`MR>S_2GI&4B`CBPRX
M'/CM"N+XDT5IDX(B#7*6M;QE!!*4#-@#YFLFB<O5(+(@#>%%TG#$$QLM@`[B
MXDM/&C*+3;PQK5S&<Y[UK+?P<6`]``A-\59X$FO:D`@U`"!A!,T=/I0T+;HD
M*#UZ2=`[[=F,Q@4:TKAF0>ENFM.<SF_4--UIPX[4,5$S=<U(76I6@UIK0'-R
MK"U--X]"E+6\A21'XQ+2@K`AD88905KD8DT.+#2A`-Q"3V:];%H*F-GHI,>^
M<FD67":GH)0NB/$.DSV4??6J5C6?59]M1I5N(2W"L@D9MD`X/FR!$'1@`QVV
M8*LML*%&I)@"`.E!!](LB\:SF((7_WW"ABWXJR[J7D5L1<,'<C#\0:=2-U:0
M.(6,)IH/FF/$%+"B4C+P].`:;P<=6$(*2O"!#/(.%DO*-8LM;.$KPR`XC9D1
M<7J8?`O)(<\6')X=D5""$!NG`T68L07^T6%3/MF"2M@0[WFW.RV4:'E0DK42
M-CAHZBLAQ!0T-VZL;8,M>RS(,%8@8M-\%'DF#6T-7@L_2;*$'%89@9(7@-G*
M7A;+7$<@2SRRBIHH--OKQLL4F,"+)R:;%V[DA0X(0H<(\*(&8WT>7_[8O%6,
M@%PUV3LA>@*\86QC)J&9B4$GVO$:#$,E(V##2$@1`>`0I""*Y\4""-$5XWQ3
M!YW_O#\$/_\-P[N1(DQ8.HR!XL8!\64!O.``\RA!!Q;B<A7)]@<A1C`-#E"M
M)P2O;#1A`H`%A`:7M^)%[Y77]]0#FGK$'*ON\<J&VV<6[U9C"'2KVX[T"G!&
M2-I:="O,LAL]]_UE9(8%H!Q(@HT5<#A>8+VR802S\`AR,#>U"`IR.+ZG$"<=
M&*<1D*5AV`J!X`,V&#'[Z3[R8*&,@"1F8+\;H2JQ`RZ_,):)&!$.B#UFJ8@1
MDX\0G(*W6D`1#+1X&[$2V@0.<)S7,`L1XP!^N8@5H+%E2HH(N!768H(50(J^
M(`=&4`B*J`%2*"&^,`OT28X4-(LM>"LF8`0=6)`;[+7J^[\T5$/_%_$((G@)
MOW.D$2`"9M@$7&,)9^(@'3@AM3`-#4(^4F""*;!`LQ!`"YJ)WR,#/G`MY``T
M#H*)%>`%WB*#\3&)W6JRGWBKL`O!86@\AX"-9-.BA@BTMY(^'?0'X&,\#K@(
M%V("87,AV..`&L`@./2[DBH6P-`WR>,#1M@"B9"/A5!"/)P))GB)&C"KM#!#
M/V."XPG$K`"`N%A#NW&V:'0J#5P-#,PVV-!`C&L>CW"D1_L>4N"`KO",:*($
MLZB![]$P`/`)F@##L#.IF6`):7H),VR)<H&>8BL;<BB*%93'LK''`,0+'4BB
MYA%(UK*YG\@-Z+E#(*2D::"#BU"*F!@&_\L#0N<)IHQH""8(/5`<`=["0X]8
MC65:A9Y8QO")"A9ZQRLA,VITR9>T(QT(B8V`,9H,"CZ0PY`X1V+B#H,<@8W`
MB@4P#0[(+0;\21T("H]XK;0@@[F+$(?8@MBC"-(*BF33`0#"QK@C0+D@A9]<
M@8`)P8*P1^!*B!K`"Q+T!SJHBAJ@AW?4@>QP"'6D!#L40'ZDD8>@*H%(B]_)
M&:$LF[GT($8(+7)HB@=AO7&:"9D4"`""08*;@B8L0N;#+$(P1AJ#R8N),`'"
M%--;B6G@!9S;'&,1$@O#BS>IL/+@E,&"GP;C%`9;)\+YDK#;B\""";S0$-`A
MG%$!S9:I+L6Q'_^X:9S2&,"5N##1Z#PT.4XN8PB\"!/)L)?^8:^1X9&B^1$L
M<9("(I+JBC^#L!>*N+\KL2XCZ2NW\TZ788C^D8O,D(OSG)/$R9$G$9(9L;_K
MLI$:J<YHHT[KG).2B<_K^A4>29,NX1(P*9-HVY'INDR,238F6```4LI6E*0I
M&)_R0<:><"&+^`HW*YMDLS'``8!;"9]@:HFTF(F:<(@IV`)*VK@;1*0%>:V<
MF:&D@#(BJ"JY:L;"<"$0?2$7:A)FL(JO?`TBF,2Q8H:V`-)5.#0,`D19I*T$
ME:]I=-(Q<J"T^,B)8J$-9:&CH+UDL\*+L",'F5*Y6`$MBH"T6!-N(RW_20+-
M\+&0RZ*(*@&`[P&,O="*.PPSX](!NBA%W3.M87LK#A@FF%@`5%F`6^%+P7&@
M?J*D?TI0*(T81Y482,6O*`6;AOB+XW.DMT(*'7BKL1.)!4`HW&C0*PF?P:*)
MD5%$3QT,-M6]BS"S+F$>D@J,G&$)-(N^*W6DN""$&<(TBV(M86NDD?(($S(D
MUAJK!G2@0QF7606+%]JRWW`_3W.18@FBDY@71HF8XF0,>9&83'H19L"Y:HT;
M;VVU]40I]5)#E8LF#=4@C1BKG."F$?@F`!B*/.3++<`U,3NT1)L)*"0,:'JM
M)EN!\=&!+KR(1IH%VS(T!O721-T>AT"=!D0F_[^CLL'`UW8D'(=JAY\L*9!:
M@'9ZD#L+LDX2T4B%#?H8%[R@C51;B6B5M;I@.\,:%P61UDZSC$^35%9;6?J8
MG\281D42B9Q=-1_SM;J8I*X()EQ2*9/BU*H`GT9LB6(MVC,5V==[B9]0B8\M
MFT42BF$21.`R+6S<I:TCK;L[#724T.085J<Y/QY]$-G;QV&X":Z(4S19`'7<
MLL=XMY-8$)GH%M+(#.$"UZ`ME3^YE.20NL=@A$2S#\CY"V!).`:IGB]*CI'K
MITUHE$V@`\H8$?IK%40)UWD+.56!%N&B%H(!E^<(%)<S#U<!E6S)E%:I5E!Y
MHG:X.$+!O)(+)CX`H_]1X8X:J0Y*`)WL2C,^"*8CD@E`B;8A8@:?XHO/I3/2
MP!?N:!@&6:!*61-28`1>Z!9.218B`0_0$0YU8145N1=*T"&IHX1NF0YU^ET/
MR\LG%+,U(82Y8D<'VA^:T+U\_8E@6H%`+0AL:QD`,(FC:`C-01]'XH#00#U(
M>@EN4RL;H0C-V\Z1$KPXD]=3S->3P"T/4L<MP`DLF88%^(H1;L*W%38NZY.:
M&CG*.+S3<`YH%0T480-,H3/Y:(Z:^(IDR0S&707/8(;9XPM>F`4:"ZHB.@D`
M:MYMJ!1VN@\B4I=A$$R'JPLDCA`^8&+"<=_*$`E>J*HFVI];(A21:`\",HG_
M'S:)RZBY;<"7!>$[@P"@]TBX.&(/X$BX?T&7D[@/>B&/Y@@**>)CSX")JMH-
M%_8,I$"1'Q:1.^2.H$CC0/D;/\YCU$@."&(0>&+C$8$G.I2Z]O"PM&N+FF!0
MBP"@W>JM.?4@WFF?J"@1DB`8`"">@B6GK2$HTRC:77VM[]E5KJ`>Q?L-`FZ[
M@C#&`&:+Z2O))N$`\#.R=O"CDB6/RZ(QP*`MX%F!]!B![D%*2'K&;,[;U`@F
M>NF.FO#,!/F7DZ!DU$"/G&D-T[`."6*J<6&.+)K*YI`0)DJ44F*J83@?SS2-
M'\8*?PX[1L`4<Z9953D?T2FEZQ@0U+7-.`)H@*80__L`+7&Y.'`U$<)A(LJ0
MV[U@HKH@F.D0C[)QC456)],XXU<"CXX`#7(.$#`R9V*1X<I:*LR56YF@&N8(
M::/`"WQV#8"^CM*87CK;.@,+K\HYDKZ:SFA#&0OI$3$)KR)!$@H+3Z'A$>\,
M$^:4OZ+!+C,1C.?<ROSIGU^I+L((PL-"F;%N:O(,&,7ZL#YQC>WYX^9E"#HC
MLA$YMRGJ%F9HAU4XHBXFXA/^83\6SMT`30C:GS"V"98(%!1"CJ!K#CH@%N3(
M#4Q9C>X`CE$RO1JIZ7N1Z\,S#M/39Z3X8>MHW]MAALX`+:S`W!WY84(()CHH
MD1U)47/>'\N(WI!.8L"9%?](9B?[N+C68(]-N6.L>#.")N>J>;E34A5&T!#O
MB&%/H9K3UK#9@V*?8.Y'R2@:R<0?$]KX:9?NIE2R5C."(4ZD^)N3V:XSF1?1
MN#"*D#`;"1+U_!Q=L1&\X$SZ7`D.H8S*33#YB+&S69PK08JW%@UQ(1:/2A_6
M/IG^-.^@:)?DL!,&J8GIR+`'23!/UJJ],!SPC)3D6&_U+,_U58GI@'"WFQ`L
MP2[Z!/$5?ADA"0WO=##&S2C``4]Y6:`'^0VS#>\=UR1RF1CP7A$@WYLI'.H]
M`9;$\/&*J0[DT+#T08QV8&X>EW):6AJ.<39,&]H80;6W.0RV_K2668Q12T\@
M=S;_]=RO+9GR-'<J^?OREY4;&-F:*P?SQ,@D,W]S3B$/:RUR-Y_SQA!RGPWS
M/`FL/U?S0J<U\@`2_)[AO!'7``;RH?$:G]6GCKXNTS4;&;%T/V_2C1$10_?T
MU^$7YDBE66G+KS`8R5CM5V%MD6";P-)K.G-OF!",[":7?2%=:R488)&@Z@@*
MS?`3X7V54F$""=D&BN..ZS"6);H,E3"8[+HB"\^9'2F5]6U92*GVG68J\@C%
MS'B/ET@39HF0QS#=AV%GAVDC>?D12]8<@UD%+=(,"2(%;X>4C<ZH7R&%!6D/
MK!B&ZB&4W>2.9_^3+1)>PW%?VOP7<:GUND@0[84G[?GT_X>OFTW!7.>@/W_Y
M%#3.9,Q`$H%N$`E"&MUX)_.@#R)*=AV9=I("%O..#,W0D/T![57`BH`?#D(>
MXR0.H@2QS-2@!W_9A.\UC_<HC4`Q/0TA&.K0CDQ>"<\KX/JP[M-0$$^F#9SB
M"SFVD4.I#``*>8OGNP1)E(8C$I/XC9!?(G\)%.&MC'])C<-##^#8^;34OX+8
M%!)IC3$63%A/N!^N+&;Y#;F-/LUHEW="%4*'^,&W&"8BHG_Y%^&>CBL"%7@B
MC\_0CY7E6\QUY]&&6?"1$(-9>F0OJH[VC7(FD>9M$$^&:)L(VLNOXH:[>MP@
M!%AO#J,@CW3NB,"/HS9:^I/5C?^POVS:6(6_(:G#PSG]R"AV&CG@`""C`$WP
MN&QB.96]MMW#N^P!(3E*7FBFVNLE82+F`)6;)9%I.)[W2(^.#B+M9:JOB/Q,
M)_ST'YN1AU:36&D46J(946VZ9X[?<&W-*79-SGARB`^8P/J$`PA&_BCY([7-
MG[]IE,CYVS1LV*I9Y,BMFLB'V29ZY.AM*JB0'L*!]'@9%(C0X,"-PQ;Z6\6L
M74MRC`CR&D;*'R]FLZ8Q,\E+HD""'?UQQ*F3%#V"TW928L:K(#.-",GQH3=K
MUBI_6+=1FK;*("\V(36NHM21U#2;25,R[#CL*:EAL^C1>]C0'R-ZVX;E'8:0
M'A]R.27_<I4YC=2LIVRR(MST]*?,@0W)S2+5CBK#D)HW<^[L^3/HT*)'DRYM
M^C3JU*I7LV[M^C7LV+)%,TM(=]NT3;/\4?;'K"F]:;YQ.KP\C1'%W5-]DF)(
M#C%(A+^WS7(X?%ITWY0.KLJZC5X[W%T3ZK[NNS;"M#B;AYSFG!32W-PWA:?'
M[.!$X1-QEB6J=5-M`8:$7F4'2>3/,`#NU\XJFV1&#B&D1"7<>NWP,M$PN874
M#B6[,2,<?,)=^-Q-M>U7&R\+G>C;83=A%1(A$24$$T;DJ)?5>`@Q>--7`I)(
MSF\4SC8DD44:>22222JY))--#ID9490\Y225F\DU"WI&;L,8_VB&-0EE4:*E
M6"6999IY)IIIJKFFDG1]%ER1V8TF)V=T@F9G9_8=-!:1;H9FHVAXUIF:H)MM
M`V5IA;*Y**.-.OHHI$/*J==FBGZV'Y^J"?K=7X1ZMM%EH5E*&D@;F49IIG>J
M.MI$Y,#T9G39C<K9-$)&>BNNN>JZ:ZY;OO86:WZ%MLJ>G`G[IV>\\#3EI:\Q
MA-)HM6USTZ;*A70L:=C^M0H=C&3963NOMI81K^6:>RZZZ:;&RRHT5N1/.Y5Q
MR1],E/E5URPPX4?64W9=6]M5\-KDW"SX\;+-%BC.2\\J?A';DK`Y,;/%1+S`
MA"6\O$QY$(,3D?+8AS?Y4^Q^KE[V\?]FS]GJ%9!/'69B2\7ZIIR_"&YQ&2,7
M\H:69KY"I%'"."G'C%\_[WQHT)P]O"6BSX$J]$$L&SHR;^QF-PS%([^[#;/J
M>OTUV&&C"21&_M!Q&#UHD3(4;\S\UM`J.;7#QV%W/63C)LN&M`T=5CV$)2%.
M,[(-(>W`!QB0@T,IH4L%N]3X*K7R45!'3375DTYW$?+A--/R=%_.Y!`T%4&4
M<+3-M%FFO<TFQ9[M6$VHYU51P2'Q`J!`=!2[S>14;;EZZWO/1?<JB"<&D=F'
M\C'MZ1(2(G-(S1E&2'87D3,,T6_ECO98!#7W5=T(\<[;X(3X0TC78JN_/OOM
MM[:20!U%?M/_M)JM9'Y%E!DNF5L.7S0-LWS%B+5AZ2G5J<U2#B89JWR+#[/P
MEK(849;*_.4L'H.72_QR%G\QC&YN6PI6OA61W61D%7PX%N\>>!CZ6)`BANM;
MNVK7&)#,3S-%J5_K',@((5'G.?P;R-INTA%?H840#YR6N#1CF8<!2SI9>0A2
MBN*]8JV%=@<A5Y0*<I"'%,]]7OPB&,,H-'H$Q2,WL8E_Y$(/\TFO73<1"L,P
M$D>G[.TF*$.0'1/DD9V(!"&,N%=#]E01:(UG+2@1R$_H*!31^;$E;GMD6.0T
M"SH\RW2)&4M>_&3(B6RB<AV384N>PHAVL`U>!*D?)3A$E^ST\"9E_VP846XH
M1%6"!(N;:0XSWDC%W[@M?V6$5A93"4NVK06-R$&*&).IS&66BY0=T@J"+D,)
M2AS+<)3(BL7:$97'$&43@^/*0G`3DNO!BQ2#8P8?`(23:R*((0\A7+[VMHF%
M#.,RWB0'ZSI2,&8PY#?T$Q$T^9(A2B`'=:B;AODT0XZ.U.4WV]$,1NAC.P1I
MA&@$I2@_-T2*IN!D,SNI2T=_8TL@M<,O'AH&1SBZ&W+N1B$$H:.M<,*0!G6-
M$:VK54O,&5!$L4X@JR!$\/XRI0EVE)E&/2I2DVJL]!EI5GE2IU)5LRRF=@:8
M4;TJ5K.J3*E`:B]:/8V]2&.JKY*UK&9UC?^?9I-$>+5FK8&*:3O2*AJWGHFN
MCI+K6?.JU[VZIB9Y0I1G4%6I4G*$JZ@)4VDT=DNO!*HM@HKI."VU)^B)JB%.
M)0I@04/9P&YV+.X$Y&8^I-#,:I:OICVM,LD)++=)YWH)/91O0!*<@[@)=>TI
MV_7HTA%3,60OI8H*;SP;E:((ABX9(LHP>GLL0OA%FR=AK',9`AYX@606DW-(
M9EC;*6U*-[GH@]<VXLI6WY#C;,$%DHY>PAN4BB^Y#1$M>8.[2IWA9'()R8Q4
MXFH?>.FN:J]R$TQXXI_.B2^C6ID<1/:46X38):.=K%JI](,>"VW$O*B],(;%
M9B^-?>@J+6+&*L3_,HS`=(B-UYS(+%8R%P1]A7H-RQ=:_F@XRFBLO'$CY;5.
MV*X2RN4A#MJ$2[8D%X3082Z,>&!#&'MDLXR$#I-IB9,C5#R=^%4R4N9(8NB0
M%0?:A2!'G@4;:F.0:W:DR%DY<FW\UI$8S:\L97-0BM_%+;CER'O'F<5"R("=
MAG71KVAIBL;*0JQI\<+)4$:0`Z/"9Y#DA!*D*-XT&?8S.O"SR+M)\4["G.%-
M<_I<PT!?A!0"'S8HIWXY64I"$C.1'8MLAG%$W_(>=Q6=7'-P68%=&N'B%6;`
M>B\70=Y&30B2YO"Q)@7DXZ<A`J"A^(H@V-O$VD;7$;<0+2L/ZQ]4IL10__@\
MJV[?0Z$)+>L//F0E.0/C`R\N,C(8\V8H?(Z<5D",(/11$B<:7"@^(4-CX9#+
M5WY&9Z$9DI,S/I+7Z6;=R(3(NW2#^+*=?CC$R:00A.0$EHQ,N%'JA^E#P=@R
M(3'=Z0A"%PE!Q'SL$I\=^0`3D`P9+<02.7WB-K(.924ZS5&L05QB[(*D""WH
M1KED*@[:TB'H*5Q!B;.?LAV1921M\%[(60XRIH6>KX_I3$CD3G@^/_U.*2)#
M)]%T/421,UB4C8F+1"C#Q[Q@W,]<B26"T"@Q?HI<EI/)I+@CKO>]JXF`&5IH
MWGAQ9)$0C7($2;O%#C;`4LW3>T".UX?>1LJ/]?]FQ.-F,!T<4Q#*1804SYL@
M1Q"#D`.917Y<&PBT\2*<POU%F"SBD'5:LOF0=2B7+:'A-!L"Z*=4Q*:[<1%7
M-#]Y\TW30;=CB<K_PYZDC&2:^*T*1QY\R2"&9!4#)%S#G(+B@I#"OLQG;5;6
MQACL>6@:'.+\_GISD]LAY9)\?S_\J336J>AHY9NQ*U'$%:X-T2D[\W=)25$<
M4XG76$$):=$5_OE'I9#6ANC(_466`G9*I<B*N/B)>"U@IN#5.&7*!<(=;]A)
M.]1*JVE@!PX*=;T)?L6?"JY@,H7/WC`@"X(5M\4@#=:@KFR*HG!*4WE&J*3*
M:$4@$$K@#[Y&H3B<#?G_8!#FB;G026?9H!,^X6E8E=(TX6L8&)_X5720EEV0
M%J"DC'#4S-Y0X6I,BK8$"@2BBWN`RW_E'12VH1O:3KN,!"^`Q%(\E(XX!T@P
M"%3]3%A-A=4@2(#LAH58S+L(1KYHV<[H1W5@RT:`6+W@67-IQ9[M1H@=S4F(
MQ6_XQ7/X!2&\EOC,#&_TUE3('-0`HJ0118I)1]8T$82IS.CMF292B-2MV.C5
MAH7@1UQ(QVY8!7;DHM,P#(501O$(QL4`C+UAEBY>C\M(B#\LAB4J"WCDTA7Y
MS1M6HQ,""41@SH4T1V!L"$&0&D5\Q:DU#I!5&;2QC)/=CDWPQ7%H2(C\E`:E
M_TY)8$L.H4US;`[1?$SG@%!/I,UAB(C)>4O!L(Y7B`R6$(U"8$27I8?GU`0O
MF(_N/(Y<@)A?C`]B4%!#((5!M(YCY!*($<T..<5;(`]>!`FOI4=N\$13<(BR
M2$AB;,XV_!&%G"/[E:1#Q-DHN021Y8;&9$AA4%,@Q0V"[<1QM`2088<U)F4,
MK@2`^$5<P(7,7"16+`6*X1E\Y`]CH(3+]5%EU(;WQ,M\N(H#=<AN5-ESA5_=
M*`OK6,M#MDOQZ)!P^(P&M80'3<F/D,L!W04&74073=NXX=D#E<53%,50D$O^
MC&7`K-$#.<5/-(>CI9ZOI`T=P8MU-9S6$(4.98AWO/^+%G'?!>$8Q12D;'G/
MJJ4-#%D$8)9E<FW"Y.2<&"HE;&Z:&@':'N'%1F07&QS&Y.3/3HB,]/BFF-5/
M7'"$7WTE+,''0;`=PL'2GFQEZ]A1A[$'6K",*ZU2VSFEZ;C$9.(%_OB%E,RA
M21#$XTQ$&=GA0XUF2KQ=S.!%'J;20`A23(KG8!(%(A400H@GE=$G2)RG;Y@/
M59R$4QX2@F!)>="!R&S2<U0.920G'9X1?%0=>RQ/;$ZHWEE3P0`4GI6.L%"=
MO-53`%K?0X2+L)B3BC371AU40#$,4*V:=F2$0B#'[3"85WD(0>%3YQR9Z`"E
M92B$1!5$>(C(BQX$,G'?S@#_98HPQF\,#O<=WLC<TT+9X4X`WIZX5T39!X[.
M4V[EQ,YXBW0\F#AIQ^"D32HI1,',4_`]QQ\AQ$\Y2$;Y$R/1!U".7C25%/QH
M1(ETDE?5"IYUA$Y\%X7^:0Q^"Q*"AA2&!L_0AA'&ANC`(*V$G?H4*JV,#J!.
M*J6B%6?,'ZL4H:?(AH"5!D50%94D:I>,RC"\9J6>J@UJH`DFB@>.AJFB*JS&
MZH0"2_\QZE]L%O9LY][8B0O^A:T.JJP&J[!"G&KY!7QAQT.*3S_)%H&QE6VI
M!_8P5G!U"GJ%1.IE1[KY1VU=!GOEWWFQ5UJ42GAUZ["6J[EB%46\!990!Y;`
MAUR(_Q@=<,@LL)$$H=A*',Q/I-B'_%%1#-LT6%I(,()`M%&A24:&H!-U&`W5
MP9E<<,W)T0%?F.6Y3BS%*M.(/>2?C5JI85.'I5K:S060M<<\?5!W*%9C,);I
ME%U!H)@/T<0C30.ZU5M!3"2]X9,WW44N5JS.[JP739Q16-SHF-I]K)]<K-J/
MS,Q"/9)<=.-S"5%TX!SJN%'0/=+;82L;X-/HZ,3YC<Z8\*S7?NW7^)U[F(53
M#)[IL%8G'5[%6,B=Y9.$U$JM&-HK_MZ`F*@1B<1S+(]Z7.6&D,%)`%D^>0]>
M%,>O@JWA'BZ;E&!FB)=<P6!^K54J)DJLE`J=S)^\Z0CE:O_&_B$NYW9N4O4J
MD3Q'`GHNZ9:NZ9XNZJ:NZJXNZ[:NZ[XN[,:N[,XN[=:N[=XN[N:N[NXN[_:N
M[_XN\`9OGQPAL!)O8!GO&&I*90DO\S:O\SXOZY*"WY[/3="!#E`,/4P!$3`!
M$5#"%.C`%$0'&^B`#AB$#@@'(R34^#+!;C!!;:S"%OC&]XX.$0PL&_`"^8J%
M9Y!!0HW>]<($(Q`!'=:`M?AO_-3`4)#!](X3&3#!R!!!ULQ"#0C'-.A`#8`J
M]&9PADT#`#!$!&P#&ZP`.4S!"O`&'7``90!`>(7$"'B+"F\!Q8S`GHP`N@'`
M,"R`7S#""-##`A#"-"P`02S``N#_!0)S@&'9D`X`0/S*%@Y/P47H`!W$KPX0
M0@W0EF_HP&V.P"SL,"-,P1:83W3HP+M,`2%\,3W4`"'H@&^T`R,`@*AJ,!QK
MU0CH1@G;,%'@,%Z,@&\``)!%QPI\,1&,S`BL@'WY`P?0!P#P`@>0&A/HP";H
M<1X;<@ULP2;4`"DL`"E62CO`L&;0P0H(,`QO0P3PPA"W<$C0P21G"`"T0P14
M,K1Q0'LL\N1P@.<AL!X#0&T,PQ3H;QSW,H;Q`1N0P>38,3W8L0[O,1M4!4*L
M`!,PP?1NP0*(2PUP0`WDQ0*0<0TPP2/[T2WSPO<R`2D``!^,#CW00=^$Q!1,
MP?EL`4<,_S+";($HST(IMPX3\`(9U,`J+$`Y,T$$K`("DP(LLP%S`<`L''(%
MU\`4;+,=/[+<^K)#\Q4SK,`*U`;XCIL1XP4L#X,;:P8'I)(Q0S)"F#*\V#$A
MB#``9`4-^P,``!``,`$EP+(2(1-(3($#5\<VK#0,SP(XJ_$*S,(*N,?@\('[
MPC0YE#`;F+/?/MHT1``Y6#)";,%"]/0*4$HXO_%#7[4R$4$@CPP3U(`.",LF
MJ#$S4+,`(P03K,`(Z&]8*Z`C_\4*:)`:DT(-U``9T,4(4/06S$($3/)GL`$O
M-\0*Z,!!L($,XT0$2"J\3,$<^\,6E"]1:+6<4,((J/,JK$"\#O_$*)O-"N`S
M5G?VI%HU\I():'LV:8N1;*F+K,S&I)0V:[>V:[]V&$7'Z$;@:#,8J=QV&H*+
M<,3*\%9*LRSO:A3NKUI*":IVRNP7;)=NF-@2:PC&G"#VZ#F<56S&PW2&KZ`&
M+7(&?*D&0Q1P;."4<'O&=G_*8,ZV:^`4>)12<G/N<M=%*J5-U^1&N3TH=L!)
M8\3O?[B3;:3-;H3:WDR!2;%'=0B'X72-+KM*>1`+<2;$VFA$A/26Z)$(2&#$
M[DR!R\0>0O#!Y.2&8'!4@FBBCAI$+G8.@+_@<"3(%X8B*>W)?KG'<^R&AB?$
M?^C'.6J&<`RX=A#.Y"3&?ID(@)!"_+;_2H0?3D[Y7XK;Q)#"RY%;1XP?BGJO
M]^&&B<]I1%<\FG]P$D\PK-OLHF_H4^]M4ER(Y8QI!!E9Q9=717/D37>,4U`<
M1L,^)[O,A4%03T<@1_8Y"+$X2.`$K$;D18YH!0D9'>'@!77$Y$L0#AE1!MJP
M1'I(Q,NM45%(3"D)!1M_ZD_<A<HYB&60Q%AT!)K[CE7`N%Z\$1D=2MEHS$+<
M.77TH[B@DNK5#]!Y6:&?7`U!>><NM]8HYJ'RQKQ^B`9%7ZN3>DO43:T7Q<V9
MSK31D+?!$S-6T%^VSDX<&;0+*6-M)8,4GO-41G:XA=&U&M2RV'457<Q0A,$B
M#W.OS8(:Q1G5_XJ!(X8/I8U=5,ZPTP^U$,4;K6S:U,5<"J>TUD\N[6(&V4T!
M^\I9Z%8=_5"N\A[HVKKA.@1NP0>6&%9>2$CA>9E)B(^7QV1#5/K'T,44?=Q(
M?#EINL01#ZSYQ03)%P2,H5*I9]]39(1`S-]"0#I',5CX301!F$__A,?RW/O`
M<40*@EE"I)*+)2T=10?")&>Z9HZ\$PNQC:"\&\3U-`6.[,S<J!Z5V]M"Q`4=
M983H,(OH3HX/P[K5A_NIV='",_S7,DSQ),5<,(Q[8KQE[(?#I(_.5,9[M/U7
MM+C]J0?>(\B,,$R/,MB>F4Y]EP7<6\9^:6*$'P0"E4=[^$5N"&I6I/]ABGC(
MR`B&@\")M*"7>@Q(UN8-47S%1$"/<KRXFO;X?E<'EZA^5,Q@OJ#'6K;;I5T&
M)ZU4U,B$MN3&;IA%JZ5'>9C(3&4^9*F][!Y'X99)=>>*3`BJ;`3:JRI)RAH_
M'./38<6);]>VDUB_D5Q/\B^)]E/_UPH)IHP>+/'BAL!2*.[-_46$>8,&1%A<
M$N:)=U_J?'8&?=W2]Y,3;%@&*U(<0)#S-Y!@08,'$28DN$VA05X"&Q9DZ&\;
MO8@7,6;4N)%C1X\?0884.9)D29,G4:;L.(S-0'ITABVDM&T:/4K,5DT<MFG8
M*G^;"`W<-L7@SIH(R<W*2&[3)H$6+Y+R1V__4\1M4A62FG;P*D9Z4K?YW$@*
MJL&NE,H.)`5QX"JV)"W.8IBV8<Z"<A5N:N>/U$25?P$'%CR8<&'#AQ&G9&JQ
MW:R8Y"!C#3N5TL!A,2O/HB.0%!^',?TQVT26&25>F[;0^PJ6#[EAC,1:?AR3
MT2;12J?Q%,J$ES\^E!YO4BH4Z*IV3<GUGL:L+:%-#&<Y11V:TB9ZVPAM*[W5
M'R\FD.ELVBH:M+]AP%UWG\:;8&Y*3,E,F])[8/3-IU?1VU)UE5.7JRA1BA3K
M!MH$N%6D8DHI!?6K2JE5&%'J.$IBLR^Y3?+;SY_^WOK)(K=X"7";F'BAQZC$
M4$Q1Q159;-'%%PM"_VL@7LJSZ2:^F"&%$<OHZ,N?68!<+:UA>B3G.DJF`8XB
MGQCA)3J<?IIF,HMXZ2VL=BH+BA<`L0.-P*#Z8B0WJ6P*#:Q5@`P+(MOX(D6K
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M?+[KT$`0A1''):0=W#$)7>A1O@HBI(L&"6/SAK,0FFQDC`GY8D?0MT4][I&/
M?4R,CZ;BNX(<*R(<Y`K:_P`CN08V!)#)V5PAUW@9LEQ$="&S8T*^%9%IQ'"*
M?O3D)T$IK)JD\4=K"4UH%@>1L27(4S?1G+_`*),$8LA03LD1V+Q'CFT()T:Z
MR<V"W$0E4N!2EZ$12/D(8<I=QF0G"=M*^<ZEE+J=$H<E&I"1:DB?W/AD5R,;
M&R[YLH6?*.E5";H<5/0#EGNU+3],><@SQV.183"A,4VJCRD'XC@$"21$VR"#
MRW(BD)CD!CNR:MTRH\;+<\4FE`UUZ$,%,R>$C8T<BI-;-`E"B$W.R3H<NPDO
M!L8+@@VGHKI4U'*T(A5P3F-+(HUC=NIT4M&<K2O9B5]EV/`04K2#8TYY#Y)F
M<O_!V-'C3MZZ%ML*]"U=E@9']%$4P9R2$Y_8E#K<VH9<O#6VF9+I)\P!FU&I
M5=33^(,1.UIA17\BTI?9R7)V^LKMT,>F[%#-.G=*CD]J:-&K7*8GX(/H7P$;
M6)#LBBP$BI94=HJ7=DUE8`133H94,YK'-6V#?%B.8RVY#2=%9F=M>Y5EIQ&3
MD.ZK+:1PDE.V]1P^@'1;5#//O;9UKJ,ZJTQ;D]M1#34+C2*LJ9E%ETA',S"Z
M0HNSLOT?E+XRMBIM@C[O(IN3`A0;K61J2:1U64R\19^F/<F"#]&<4`4;7O&.
MUR"4",HLW+(CO>C.+QJ]*F\]*BWTDK5VAKH3625',,W_456S]=*<12H#W*\L
M)V,UG<@TR+`KSW3%.N\QDLN:NX6MB#4LN-I9;S:[H]'BM[&BK2E$=LFVG/UO
M*E1S%VF+.F+CB-4?9$`8&QY'5+/EI"IL26G/SK8*&K%-6K@BJD#QR@R+G@TR
MQ@'='<F;9"5_$DU3J13V1A,UWU4'+`S)#3->N:$X)A3+DBWF3D86OP2BSXS,
MJ1M3R"90\V`H?[B)21E/2=@XMQ?*VM4-#LF"LZ@5DR)>9@ASP%P6<VUEFK/(
M515U5C[.23."NYI%7`RUR&$D4#5;.4]YRC<>52U(*2_TI6Y\XCB$.JX=-!%3
MU):<:E7ST4Y(1DBC&H(K5QL-_T&KMO6M<=W0!&ZDDT)98T%ZW:(WYIK8Q3;V
ML9&=;&4OF]G-=O:SH1UM:4^;VM6V]K6QG6UM;YO;W?;VM\$=;G&/F]SE-O>Y
MT9UN=:^;W>UV][OAK<<J&NJ$6,ZGE+`L.#/J.WW<*74')W(=B+"O@/"+]\$1
M7FQ2<&`@.M`*!XC`@:IL804+8`(A%J"#*4!E!2NH@0ZV$0&I7'P@-0!`3#8!
M@.%M`0![F<(6R`&`8"><YC5W*#DBP(QVC*`=-9#5*B(@$$8P?!@R+\@(T`(`
M/NE@$S4@2`TBX)DI`$"<V]"!#G;$!)BWW.9=]WI@';X)'?AC`6\N.UE'8!X`
M:)SC(_\8@:S(48,%('(%6YC"/)E`%$)L814,?_DVN/YUP0_>DY1@`M/)OJ`%
M,(<1:6?&`A0]D!$`:@0"(03#"8)T,F"=#419@0[(``!R;"'!1B?\Z5&/17)P
M(.B^F?L*B#"0H:O]7E`9`1DH`8`)IYT@'+B7Z+<@80`(IP9D"'[,\Y5ZY2__
MB$V!EH8LLR/0L8$.4*$$';8`&EZL2O:(TO#JG%6:R[6##M1G_OG1GW[UKU_Y
M:&S(S*48?_;/G_Y&*PO[C*<U8!NDB02GGT7@+S%0Z")^K2/<3XIFS8H\HBP&
M4"/NI_X@\$4DI;0.22'(09!XS5DLQR]V#5AV+")B!B',*"+_(,,OYJT@`"U9
M-D)G/F(`74LC#"D"93!%V$`L>H1Z#(5@?$(%YT1[>C`I3-!;<FLB3FLA5,@U
M\H,2=D1-.J@)ZR1^LF?2.LA)(BUZI&DKC,-0H(*E0L.(WN8T0.-L'N,)NT.(
M3$27\H,9MN!ZM(=9!.?1K&<5AL=IDF.&MD`[E"1JC*C$JD=T!.HAM@!1=&R#
M$(6F",)$C$P(??#.#!$(\Z@B'&-?_-""S&P/06PJBBP!9W`3I2C*A.PAZ*0G
MGL.T6-!-DF-+L*,T4/'>GJ-)0(1VA*)S"F:5UB*E]J*&KH4GD(2W!H9C"L0V
M0&HM&$'(IL%?HFQ5SH,9M(.@6B-,_[2I&.UD2TZ1%VIG^ZZB&"=G0R!C2]:"
M#W)D9PR-($0JNKAG,X3L6G8E-_:"&G5E&/,%26Z')HJ1=0@!2(I1)[+#7W9)
M.](D91BK&"L*2-#D..8D6NH$27J%3M!+'3=$&5-#(',C`#EQ$\.'3JA0MU;G
M`IE@C7:E'6ZC.[[1M43'&Z7B951CA9IF+4K#-@JF'HGI<GHB?K*JM]J"(0:D
M,;9"I!",+X"D0+80**9A;3YP)*$D9V#&67+&8'2+*<PF(U,+*J9K*D!R![VD
M;7"D'N^+:KAKET2J4$0GF91B;"+D8"YGQ[+)&W=)*7;L=G2K*]8%O5X#0IHE
M)JZ"F]B`0O\F<%>V!+VH<2DG\B\IJ:/ZPDDV"4U:)YF,9."("G-\8F!*DC[0
MPC&D0J12!1F5HBE*A">^Y<1D3W%VY'^"DBIP"T?:!`F)AT.8@0PF`I9"#$F,
M@S]`0W$D<RJ?9U5H!$L"B3]H`DTXJU%N3#9*$C3$IC=\RFFZHS'':A"'D5'H
M`:3P*CH`<$;PZN<*YG(V)%`4QV]`LC-^8B+`;T-")&H8@:O:Y4[X)FRD$C#5
M4XH>Q'$V<QAU+CU6P1OK`U`*YBJ$)FJX8R=R13EJPD`JA!)F@A0HY%U"1%\&
M9,U,R=#DPH;XPCE<0R``Y#(>S3IDI8.0`T"<@IF4D#M*HS_UDRK_*.3>?B3Y
MHH4OAO%;F.5'H,*:(&*3!NJ%)FTKE$*%L&(8^(!-5&A.NL5$2$4)$VB8"J8Z
M)BM'"48)=6F3.A2,!+0YHX8FI,(](C1$\N,W)C-?H$((_<-&U[-+0X(%#W'2
M8O`OPD83U:(`#6*^D.@#O4),?XU-52($O71.$R-'1A`P",8!.RDIE*@!,<).
M$<)/50)-Z;10Y>\O]`_8)/+6\H__$&-1#352Y;0DYNT%I=)2,\+_"+![7.*.
M^&0*#Q')E!!,,Y50%4)Q#H(:&4HA)D,HH(*0%&(:?N/--)!SI#*'-`)602A0
M5HA=(K50;:(BHD;G#$@U[(U^PNB&ZB9]_XSS.H1PDZ8B+))EFJ*'`5N'.?!$
M:[2F(N#,(!)T1FHG\MIE+[3BE&JFQ-@B=<XL:K:0?`C-S#*((D#L*`[BF:+T
M+=RB&"DB>B8B3Z-F2]C5(@2G,@3'84AU@KKC4CI(P@8B^_13*"XP@^R-)BI#
M.\!HX*J"&=A@*S84?1CC5]>3#GAS=?H#7O)FLOC&)]@@%P<$.?.&#R8-2!1R
MM<310'#"%P="9%>'1E)#7+8D5_@FCD2TON2P34ZM/IC#*2*$0JIO=0"H741G
M/ID"0L)F8((2NK;$--8%0L3E<BZT(,9S8A`$2:2R9<\E0`SD(>#R?R)$M_BB
M&#6C+O/$:8OB8/]VIBP"LCLT*B@;%&8IY!0+,FY7YW^8ZU6;TUND=4O^9U)!
M=@931Y<$=$ZZD1=@=D8R1E]7J"GHY)=`<C3DT"?8=(7<Q"\D9[7RI"K6XJK\
MBSE=0KB,\#AJ:2%R8G68`Z1X@?QP5&?HX#V24IKH`&1@HS/Z8I>N(TV2@A=8
MIEKB9U&6UW(,LTZPPCJ$C):NBH#Z@U]XIC\"1&%=XEH@LRR"4JJB)5\TMR>P
M9[4883,V!$`!99)FI%*^XC:'22\7J7$=ES]TC"D,IC<XIBRJY&V9DRK:<IM^
M)$<&2BHB$6I7@W2!QVGD1I=6IVZDXEC"IX$FHV+U94,HH1W^MU)*1%+_[@\E
ME5$JF*$>DZILE8)"_@<R[/%1TJ(H'ZUB-5!<5B<BOZ).1"-*6_AZ^:)R+@>1
MT,A9".FJ<,4Q<&)HIE*!)K!<?U@J>0HB\"1C[D2E^,)7['<B)W-L#&1O]J)2
M=LHR^*#V2E)`L<PS1JPSRF<TUJ4S'/0\D`1Y#Q&QK/,YOB)EE$I`T,DM-%!0
MHB-7"F*LL"1!T>(T\.DKP`CE"/0K7(E"#$U[36M=6+A-LF-'7I44U#<Z9N)6
MD^E'!O8FW$,N@,(Q^&57@**<^.`XF`NM+*,Z5A.$E`)L]&LT+DM5K(.0KP(H
MCL-?ML]]N070K&,T@J*$1>.*U?,"J8@M%I?__S"P@]`)BM%HF4$(`!D#FJFH
M(![G`2\I?CJ(FO^/F3%1"\'9(,H(&^_4F+T9A`2)4\T9FT/54&C"68Z)!4_P
M4+^YG:&PGL'9U0`0(B3*3(D9,'>M_U("G5S"APC+GQ7#%)5&7_^YH1WZH:]X
M0EN7)*K'):SEBZ_J4J'"8G>"N69D>0<$4B%ZI+.-J/(H>JJ"4ZLU.M,SQ@;.
MD@9B"ICC7E*8.Z;!5CA%*IX'I+KC0B$#54DZJ,\M9G8)20TD,W0,K_"*3U*Y
M.A[$DM.U*:A"=$PK/3D(2@KDA(Z%Q(2ZJ\N-#H;1.G(Y?7I15ENC*>IR*W3$
M)@>19UHW*!.DOLY4*/_$@BE]4BT0VJOU6MIBIBJ$Y%6$##)*XS+$Q(CF,RYT
M`Y#FY2<H>86@92):=6#N-G;WNK*]C0]R`B=T1%I6(2A,HT1LY::CAD+"I-:8
M:S-DI$QVLK8V,!;O^JX3F)TM>[:G;43B>5!VPC*XQWLZB#LBR%"&H=1B(W\*
M>O\.L0F/.YRYF;:96]IR.*^;.[JE>[JIN[JM^[JQ.[NU>[NYN[N]^[O!.[S%
M>[S)N[S-^[S1.[W5>[W9N[W=^[WA.[[E>[[IN[[M^[[Q.[_U>[_YN[_]^[\!
M/,`%?,`)O,`-_,`1/,$5?,$9O,$=_,$A/,(E?,(IO,(M_,(Q/,,U?,,YO,/_
M/?S#03S$17S$2;S$3?S$43S%57S%6;S%7?S%83S&97S&:;S&;?S&<3S'=7S'
M>;S'??S'@3S(A7S(B;S(C?S(D3S)E7S)F;S)G?S)H3S*I7S*J;S*K?S*L3S+
MM7S+N;S+O?S+P3S,Q7S,R;S,S?S,T3S-U7S-V;S-W?S-X3S.Y7S.Z;S.[?S.
M\3S/]7S/^;S/_?S/`3W0!7W0";W0#?W0$3W1%7W1&;W1'?W1(3W2)7W2*;W2
M+?W2,3W3-7W3.;W3/?W303W417W42;W43?W443W557W56;W57?W583W697W6
M:;W6;?W6<3W7=7W7>;W7??W7@3W8A7W8B;W8C?W8_Y$]V95]V9F]V9W]V:$]
MVJ5]VJF]VJW]VK$]V[5]V[F]V[W]V\$]W,5]W,F]V;6UN-&=H)V&68V3(PX0
MW8W;)3`0G>ZOW@\BQ@R0DM(B4=_]_?9=`0^"W5V"N/U=_A(UU&>!#_C@T09D
M4V!)/?K#E@@AC+E%75!07^ZK9P:"$$RC.QX,>SB^;IJKX<W'0!XD=FW4(I@A
M1RUO&)<#0T>C.?="-_)T1O>$/G0K07KC5=J"L>/H-#H^YZ$BYW,+6DJ'0"=3
M(/PC.>@A*"II!V,CQ)8W#Y60X9%C0\`(9(`>RW:^=A[-T'@YU%,26YTEQ*:6
M["%FL=T(YBAB"@0*-A;;*?\*\G$NV&)(DRF.(SK%`W09RL0*!5FR.H7P@A'D
MAB%(91I2XV'60EK.A3(6BY`8>BWJ1?'1<%QPQ5GZYT-P@NXSI%2B9,LVP8_[
M9[)S:#&0\H#5(B3ITU]B`[HE?<=.#)#$IM8^A+.(:IH(0A51E#,:GUNV93Y!
MJ$>^1:?]^D?8!"J<HW4;"$?+-5=\-.TM0I>["7;-HV`R1RQT9*>VI:\?Y5@!
M27752BUJ(WK$0BY6MZ"Y\W5-L2IRRI4G@Z"411EGF*'_]_O1*RD<(RCYPJE&
MW>]KLBT`8MJJ::3\&21%CEQ!?WQ(#3-H<-@P4MM6K2)'CPXS/M,8,BI(:E-'
M@]O_*)&;5=$?O4T09VUB!M$?I57;(/):%7'@+']T-FUCQLM?2H.;R%D\.3$B
M,V;#;N[TYW`8,X4J6?ICR8A24'\T#4[C-8L0(7H')4Y=R&<8HV'M"I+E*A+B
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M"=,FA+2W))</\<);>W;*EB:4O26T"9N0U622;,/0L].67`F%W#9;*3<-;7"N
M0E9;C?+&""/,;)/F?H(259-X-&[RXT@QSDIKK;;>BFNNNK+HH&7V248=>IC]
MZBM$]A%+K$'T_+JLL<H>*QJS;_]!&U.SE3'KK+')<H:LK]0.-N*PNXY+;KGF
MGHMNNNJNRVZ[[KX+;[SRSDMOO?;>BV^^^N[+;[_^_@MPP`(/3'#!!A^,<,+D
M;GOM9PPKG._#$$],<<467]S9M,]N_.S#UH8[84P.DM6MMQR#W'#*V:+\<<O:
M5BLQQC+/3/-ES$P+4X2M;O)89'N2,@MCV/45F$$W&[0*3+D]99&QLM)+#T[#
M!#UEE5/RR`>H2Q)"!ZA,^Y,D*3,9=*BH-RXX*25T0$GH-#;B%*%L6\W2T'U<
M5IJJ08Q8^)#8-[:'$ZQ/7<4(3F3>.`LE5"YIXT.'T@,8XI20$G/-EE]^<9I(
MLQ%G6^3_3,.C5!(%]9-)T^0&T40"D<,&;XHIIF=PL"^TB8CV,C;-3D.A[A[O
M*4E7X2IQ08307+-$9UQ-&7(E'EG'3[,%/;PC1I_S2W%GF(87PG8543)!MA5+
MO@'5VU8<@G=1150I%!GF[K]/,ZS+TJ:246\-L\I"TS&O+'(185\4J@!/*,1Q
MBE`^@B\V/*4D&"%'I(CS':&XA1';F`U4]B2LJ,QB(80Q"7:L`S8)J<0V1P%<
MT!"D$N)0Y$M<V9N&D(:?X^2N)@_*'3G$4QV2)8<D8!D?50BS"O/!;XA$-)B%
M9N$D4A1D3^UIAW6LLKSE\8\77Z$#0MQ#%0KEQQ];J$%'+A*;_WHQ@E"RL6)"
MK'@=0CR&@`;)&BE$M#SB'`0X&B(+37S4GN7Q0H11DXH!H;(6%#*&&6*!D]VJ
M,IBDZ4\F68%(J9`SC*RMQ#Z(N0]8Q"+!@]2D?47LI"?_11$EXN>"8".+_XK$
MC/8PJ3=?"8J%&"4;Y)#Q1D#CPRRV8,AY39)R1B%)AVCHRU=Y[XH/LA`-MY>A
MXQ@HCLT#V_78HTD:[2]I2_EA)ET32YF0@T+(J60W;]BSG9"%=T6YB%1Z&9QF
M+2YBGJF<9MRY&7C&TU_RI$P]Q56M=Y;FGJJY)W)L=)7<)(4VP_C<*HX7T#AI
M9(TH)"580+4*X#0)B?_YW%C:&2T31?\-4U:B8$>5`TRYI1!IE'*;<WI#0\:,
MZE++H1S8WJ,XN`VJ/62TV]C6HS61CM!&O#'I%X6R%9QH:AL]<1V7.L(+&P4E
M+W1)$T[H\Z-/2G6J]S)0L]I!#ZF,4SV\V<9(X'3#4[U,61`!G6RJ&2=>V*=7
M5&T7/W.EGJ7(=:YPHL=<A717!ZDGKDOAJZSDRE>Z*@NO=[V>7@L[5UD%MK!U
M[:MC^\H6KR#V>HI-[%T;.]FE'-:R@(5(9M&JDKLN=K.<%5)9F319S)9V*B01
M;6++6EB^JA:PCH63<AXKUU5*EK:"#>UG28M;T^YVL:"UJVOQ:MO3>55.RP5F
M7)7[$^0J:QK_<5VN<LTJ%+P2M[+'9:UO$<O5U@:WKZ<E;G'!BU<'1?>X?^6M
M;,4;6^$:=Z^%52]M`TO#&_KUKF]!+U/`BEK>SLBW]"6L=U?4C@4`8,$,;C`9
MC-;@""_8*C60<(-K,"$%6WC!#X[3AAGLOPI_&,,TTO"&.\R,#R\XQ"HF,3U,
M;.$M0%C%%&YQAE6,8A4#H,8C5A:,)=SA8>B8QQLF<8)Q/.,/$]G"+OYQA&7L
M81H;1,1%OO&'<ZQB%O>81A%`\I*&/&4;E]C+*9:R/ZC,9"N?.,D;7K*$C>QD
M!QMD"RI>0'C`?&8Q4T+',#GRE0U"ACH'2<?^6Q%C;-2H1-M(3'U!_W2B'WU2
MN#P:TH#*DJ-M)+:M.'#2C5KT2!+'Z4X#*M2*UK2CN03I3Y_ZTNTY]*01S>A8
M*OK5JH:TH@>'ZE#'>M.G5G2M==UJOW4:TH]9$ZD9\6M.=TE96=)UL7L][$BO
MXM*45I:N._WL6:>:;*M6=*6AC>U&DYI+-!3>L*M]$%LKNMCC/BK2NBUJXH%[
M5;)6MKNY,N^Q$>7:NSYWKN]M;FCK&RKCCO6`7CULHA5\)-/^]ZV],F\N\<;5
M`G_,P<=-'7@WBH)M[;C'/PYRCW\+7/DD*\E)/G)@3299V+J,QNQ9<IB;7.8Q
M7]G)9?[RF$OLY3I4N<FWI3&@9VOG*/<YN/]83M:1YYQA2_=YSE/V])FG'%I1
M'TS/BSYTFEL=ZC>_^=2=]71J(7UE3#_Y.'U#'<>$+B_;E(MB9!.J7K4#K'&G
M!R]JFKTET04HOI%-7](:I5"E_>[T`"O<0Q<J0?8=J+QQ#"^JU-6\^+WP$&G'
MX@W?51H>+>0UBYGG\;F:L>^SG\5RN3X-;?.5USSU23?]6U&$EZ3"92J1S,N?
M>N,0G`QD.Q"!E7R*Y)M.,8,2Z"&'&@FEQO>4RC^(Y`,O"D()X#_D)'28%`@1
M,@NP1%`M:A=3_AXTG,^EJ1VBXYESVC$%1,82?RQ1H'LN8L%M%(GS]$_1Z^O_
M/CT&!YC+$T]!N`?_$5V!0@IQ1:O`".2W%*YD%:@C$H#R':BC(=_$"U!"/NJW
M/`CQ?("R)'W3%1<D/D'1%5,3;%(2%%91230A-ES1#B@!-O@34OA7,6$!*\;1
M4_]G%:N0%I)!"H"!-,L7@#D8*$1Q4%81-Y(Q#'3P%+/!?X3@4IW"A)-1&"O!
M!R%%3'=7%>:S>T1!?HQ@2Y2!)P=($HI""AV1?5RQ$*XR(2>U1\[C>"/D.F+!
M$@,"'M52.S4Q2CAX@S9X0%R($92P(&QE$['1*84"$VK1A71('B&UAF`#&#Q(
M"ESH)>2Q1BVR/%\1%EJS/PV"$@)T$&,$A(J1.UPQ-5)1@<M##CTQ%5:$_U2D
M\R4LT1.Z-XI;\4*T,0MT$#6?4R*1%$IOX1M<HC6($2#BY!JS<#RTPXM3<W<7
MP8+^0`A"!(,Q2`<`L`6@`@!!00@<\&5<M`*8!!'D``!TH`/I-P)$0`81P!M3
M4`.,,`)TX&$2`0!,48W^P`%0-B'CJ#8&P@C2J"P`P`9$L`)7`0"4H`,C4%</
M,@)G1@13$A-$D'[^L`(XP0L`4`-OP0'SUPX`L`UDP`&;P`%$(!G,P`%LH)$/
ML0D!*8]\P01,`#;Q.(\Q$0%%,@4[)H^K0`8JZ8T/L0(ZP(-T]A``,(DU0`0+
MPHS8.`P1H`.,<!X."0!V!0`R`0!<R)2$L`4+(/\L$%%AX6.2%>D/4["1'*"2
ME;<`;,`'`,!!5PDV=+``T_AB6]"%.;EG[.@BRR,12.0@&6(E?O(?8=08;?$8
M"^*'[C&!/_$0`[0G:F<=!M(:$'@<28$0`X(>+T1\#D0I-;$2O#$1R_0I!!$@
MT80_HS87]$$[<*(8E#-M47-,+_B,%/-B#Y%@#Z&.2[(`_C`"G",9"49=33D"
M10(`!'&0LA$!,,$'.J`#ML,&3$`*(_`K9*`#DD$$6S`"5K6;T]"4E-";.M!A
M9,$(_TB6D[$*L<D,=L9%4S`"CS$"_G.1Y$`&Z4<.&QD3-6`[?(!A>[:<*P"3
M#5F<I,`!O\($G,,!$8#_'`!`#EN0?JTIF_/'16GY8L)RD6XA$P=9`[1IE0M`
M0=/9F[!)%FQ`8C:A`TS08?+ID/4I&^Q),@M`DA%`%L.@`^3H8ZQ)E1"1F[!9
ME2J";#<!%9,B'^!SHP=U0SN$(/A!$2RX!3^!$"62$B*1(0:"0LC6&-]C'5U!
M!H_Q0M>W@DRB$(VW*28AA\A1AHCA&\0(&U-A'+;#0,/7/=L0/4'$&Y64FA9#
M#SZI$@N@`VRP`O\H9"M)!$_3IIO010Y9`P^ZE>E'%B^Z#1$0`?FU`@L01K*)
M'$B"G"/`%PG&!.5ID'I3H0^"C80@C;DDG=-`"!BV#1Q`#DS0D"^J$A@IH`8Q
M_P4-66(6UY2,\*";4`,HV9#D<*BQ@9TKL`U,0`DUP`O_N`41P`8QB9,K,`4[
MP01;L`6S$`&3B*ED0"H'^8[DD*H%,0)\,`6KT)0EN07L.`S@V:ULQ01I@9$/
M\J"[BI)?F:J5YZ8$FI!"5B!N^F(ZL`4=H94%ZB(!8J-,1!8=425]89F;0#H&
MDA!"X2!SUW85M!*2IQ(UH2?"4Q,#FT)C(AL)82#8=1]>01*%=Q*5!+&R<5#[
MJA(=,203ZR8=(3VA)1=[>;%Q(CU%LPV`N*80LYHEAFS.^64"JP,F:BQ&V3JR
M69S+N04J218<T!T+QD%\$`&3\:)OP08+<)S+V::4P/\![,@(V/@@_S@8KWD?
M'+"<,;$"NUHD)4D)3!`!!D*J;6JF#3D%,C:B6]&MY,H+3+"-_B"J@\$'5AL3
MTS`"R)JKC."1791*;CH"3UH3'+H)4["L)#<-'(!AKTFB2U(#Z;>1=/"K,A$!
M"")D9,$+"W`L$3`%^<@2G1JW]/FG!G&LQO*XWM@1"_"YV]FF?2:A9$2JDAJS
MM6N[E7&1@^FF56NA'7&3QO*.@S$"/K$`[;`-;DH).LL!;X2W6DM6I!"\&+&W
ME#"60;&;^&FI'A9&KPD3V,I6>V:.=*L#T2>A\CA_;1J@*EF23T,&)%8#,L:[
M3&"2=8N=E0H1*U`#+-%ER%'_MP2JE621KAP0O)[%%=.)C6P0O@%L$@`0FU+K
M64N98+3I/`NP()&:O?++O^E7DL+2I@\AG%SQDI1`!`?9P:6Z1B^*P"=Z?[?+
MPI[4#HG[PMSQC]_)136P`A#*96OTM0[)$JN`OS4`$X30FXZJ-U@K&4)LG9N@
MLP[)CE1)#N8(O>+)%S%!"?\HG#L<$]Z8?M*)'ENPG#J0DYRS`$2U`)'*0<K2
MOBM`!J9TD!')$N68DC)AQ&3%!O$8DS6!K+[IP2-@G5PD8Y@J*_1PQ452Q2JQ
M!2LPP@6QPU,0F]#+!#KP.0`@MQT&$?(*8;#QC[,@D[\:J1JXGCH`E+S1Q_>Q
MF_Z0_[CKV:=%4@-\#,2KVL*OO*9RIRP%ZZ^3P5;-0GGUTXW34E<,0[&YK,MO
M@54:"[/T8%5M9\LD8TB45W@51"/U@Q&5T;'64E<)`2<PJQ(C,S(\]QX3)\S,
M\K(G,W<%2S+'_!ZATK'=F,4]AU7^RG+OL<OQW"O$3",)L5:PC,_YS'HNM\*V
MV\_Z#-`!+=`#3=`%;=`'C=`)K=`+S=`-[=`=5T_W='__/!H47=&CES&E!T\K
M;-'W\L_NU-%&%QHA_=`E;=(GW2XH6@/"R=(M+9PK[=(QS=(P+=,O7=,S?=,V
M'=,TW=(\C=,Y[=,[+=-!#<I#G=-%#=1'3=1'S=1-[=0Z_?_40BW5+DW42_W4
M56W44QW5/;W52=W53&W54%W388W45)W59NW5-XW56OW37RW69^W68QW7;)W3
M:CPKT*MC>:W7>\W7?>W7?PW8@2W8@TW8A6W8AXW8B:W8B\W8C>W8CPW9D5W8
M$?`T*Z+)"T8$(DD&(KD%9+#9G@W:H2W:GSW:H,W9I6W:J)W:I<T&G:W:KRW:
MFJW:LAW;K@W;MTW;K`W;N?W:O#W:6R"2OHW:PAW:P#W;NWW;R=W;R*W<S1W;
MSAW:K0W=Q#W:U/W<O6W;NKW<J)W=T!W=S%W=W>W=GFW=Q-W9UOW=L&W<Z+W:
MPTT&XIW>IBUB7=LB,0D`&HC2^:W_W[!,#B+FC"A"#UV6H=_"<Z"73\@"TC/'
M+:"'X*>G,JJ7<@I.=A#^<U@7=!/>>D>7=5LGX2JG0P7>=97W%KT\5NW,X2WW
MX6"'5>W<<U='X527=!=.,BU^X1QN=2D>=EM7XQJ>XD5''3A>X4#N=4?7XZT'
MY-92XP7>=$..XD%><BUWXE+GY%*>X4T'XF9GX>$2D3+)*P(.&LQ`!U,02?,G
ME-<!W%=1:+(AYL;""\AZ0\@Z!0FQQI/!"&O;)XO*!C1DIA8GH/XS#,9Y$&N^
M)%,`3%$S!9RS"LCZ8+SPGE*QGWGL?"HQ#'S;1E.,YIY%Z<;BK-+*'5;A0$Q@
MH&[5VH2^_QFG2!9;4!"$`.B#"A,!'J-^/&=L"RR42^J5P0MQKA(<P`OC.2R/
M&%4T5R4&TH$=J(-OD:CV9"`N51G!OBW8?!FY1(?.[AGA+!ES(11YRVS7<NRP
M_,)<CF!>ON"$X+1!I,EZ<M^RJ0,#\B&JRA"2#!%<N4=[LJQ2LY1*RP:,D+3I
M^KOM_I7)6Y2<4Y(D/`)<+K^V0P\Y.2`!6@-3,ZF*2BD<0`8P\:+POJ32.:ZE
M2\HS(407>3KN/@4J.0T+\*0WXBX7R3/MP.+2+IM(!``/=L-$Q00<$#3>J%;*
MC/'ING*(RA8F;LP0$8UWL@"\D+BF-X8DN^'"7A#$84>;E\LLD?\0^S-=@,@,
M8=NO]:PLT1QK),<'MH4MS4*9A#!Q(VLT5I'+)KZP='?C8%?U-X03!4D=>X)R
MT[!,`MWMBVIHX,X9V_"X$(&L>4P(<YRN;Q&K(U`3LP"JCE2AWYDLDHJ1Z>G*
M]!"K'/`D!WFZV;GPO`#&13(-[MF;G1H3IUJ_!C&[\S>\S!"^$,$'06L[."^=
M@Z.NU+4`*\`,IWJZ\I)@12'$3*"L.H":?/\1CXRBA]R?<%H#=,"U]+D*(T"0
M`OK($4"/(H.H4L+']$`$1$L2#_F/"::LDV@9"!$A6M$2H,..=S<+7`@53,@8
M?X(1']$=N;$*.$R,/9P08/''8R-_2L3_$U,S#6Q`"J`R@&L.$)1(,2+GSQ^]
M3?Y631.XB=R68?YFS>)ET!^I+?ZV,=HT:QJ;@@:'K7)(B=*J=@E)A52XC1"I
M6?Z&D7KICU',E:NVD:+$R!^EEKQFK4QHT>A1I$F5+F7:U.E3J%&E-J47`4#1
MJ5G]M;-:8^JP!>T.&MP6@<,V?U,RTJ.7=HI%4B/\K6!C4^Y82@!TD/''#$#;
MMA97,-DBEPR`*3H`,/.W22[=GP!JC&C+J`8?DWQJ$/)'YNT"4FX/MCVL@S.C
MNR.`^N/@DS6IN&,/1F!&*D+;*6\-T@'`A.56`-.F1:!$9PL3?ZIE:V7>W&B[
M!42FA&4$8,$T_Z:6IZS:0HG-%C)TB'"8M0T``%[3S@_C-6*+9']$,B*%+CTL
M'QTUZK:E1&3;`L86X"6"B)S2:1/^+&)F%F8(F8:4;59A[R)RMIFHPEF&B6B5
M!3=!BY+`#N*%CW9FJ1"ET(#B9:2"/%2I1')XJ8TEH)A9I:^8#")EFE4X5.A!
MF0AAAHZ0=FJLH%5(B2C$!FOS1T:/BFIK(96F26@:$TE9*#38V$H(*`B?),1(
MY\HT\TPTS>3JJC2;6M.K$)V:9@&TC)H".7_8T,'.M]IZCXX15KB(`Z-0HZ>@
M8?Y":@4='/)G"R+Z`B"B/SF0"[5$&2.DAE5TT&&5&GP:@0/>WF(C4O^+[O2G
M(-0,&L&U5UW=9$"C>$%L"O3\84(W@\@9@=>#KIMS&R)JR*@&.I9K<UFDZ`F.
MG+_RBD"LI;;QE!Y<*0%/3PZ8,2\X]19K[SU!=0#6(F>G,<\?0O)S;:Y?(\@(
M/0*?@K"HU0[:Q$.!+IIPI1C+LU!&B3I$"T&XVF&DG57((2?+GV2RL:![*6RX
MG9HLJC$F&Q4DA+T-G62&DG98,M+1)`O4D1Q2G)1Q&SYR-(C*BX"T\.%AA&P,
M080BAI"4=BBQDEFBBS9:JZK8C+/H-[/:@@.'&=-5-W(6J&L8>B!=M2I&1@(@
MM!&(H&<:<B@AM""_MB$GSEAQ>ZN=Q?R)@!'_7E9!;Q-"=<B($+DXB"`Y#Q=8
MA9>\MH'[ZD>1*\A69ORJ*#G7.``J[+')T5/#_-)2/,+.[C(H7?5L`H"O6:ZB
M)Z*6CVZSJH@`U8$1#JA=:@3D-@'@(3*V60&`;<(53O(51IC%,R9JX("OI5GW
M!]`5I@G5(&;.DF@$<LCC0&6F&F9F$THJ"FR3T/C`;B6@&HZ1%X=O)&05,'=:
M)5F-1RQYH!L9Z7D89LAA1,O&+FIG)'_PX7$SBXA`"((N.K"%$>Q32$0VL8I9
M!(9S#.D(,[`'02'=:$);^,V6%$*.VMP$1LFBQXY(L0F?U(U(,.$#F53W0ABJ
M+FGYDF%7M**9&H1F_WGP\\<TBA<I0C!J"YNH06"8P(=5;<%3VV@/$72P#=T5
M*R9&Q`H=2%@#<JQ"4`9APDV00XHO(H<-=2'"+`B!)WKDL(=,T`$3Z,$W(KB1
M7?G!"A-T:,<DZH`(O.#4S`0%QRD0JXW805<-H%A$>JR`,T_R%%\:%<,SM2,P
M:]N*4]AR$+'00RP.,T@[J-463FKR4)=,"B57)1;92=(B!4$E5";Y&]D$!I3+
MB1,]ZM2K6W9R&J_LE2P[6:<XM:B616J618!9)%C^,BFV+$B(>F849Y(E)(`Q
MBL,F"9A=0E*;VTS3FK`BPP7`AYLO7-I4RIFF<XY3G9945G-\N:QT9J6<T?]4
M2H@(V8Y<1H631[DD,Q4BLVKATR+XC"<TT34:4C9K$U(C)%-J6<K?%'2=$UVG
M-V/8M(E*='44?8I&E\G1Y@PCD#9IU!:U0@HR^(D,Y+B-5.AAG)$>E"FR.].A
MY*3#(V5E0D;)$"GHP0<E-84D,P.20?BP">PY!6N-X<6[FH(PII#C?TJ)B(9`
M>E6LSD9I+\1H5KWZ5;`ZAS>A:1?>FJ,8QA#&/!X=Z%68T4]0%F2:(3'-4QZ6
MHY&TA46\\)[#*"(2GY80=4BRH/=6*2&6:5)+;2F/AD`XEI;=*%]YE<D`4X*R
MHCYS&`ZK"`!GHM<=D6,*C!G&-J2VJAZA]G$CL=__0=#"2;69B!Z\X."35C')
M*4QC9+QHRX.2&5;@HLFB;'5.TKP27.0F%[FZTZ)-:F!6K:R""/U)RQ;6ZM(%
M>*AZP^@.&T9`""72@0PCJ($.\C*"?"9E&$);T2:FX9,64H(]^:O;X!I')?="
M,#3@<QA.#?+`87AH)1:*8+)&@KZD$`)]`7[O\FXY#.&$#*<"[%V/MA'@+'H$
M0B1:""/2NRHLU1=_"]H&#WW"")\@E3.#X\Q(&/(Y/IQ.:";B%TV5>V-S6H6&
M1^LJCGW\8VY20@?J*=MS":65+=!A%G]3RW6C0H\%F.M_`!CBW^@0`4)8Y2T1
MZ-0BFV)5\$T)2`!K&$7\_SJ+DU!B?;,*#<,^=!3S[9<>9D31DZ9PSC?R8AL(
M\Z#&]N63/K,K/8WA#(@N<I*?/<E&Z32CF>]ZL,#P`B:SD-`T*D(SG@S5($"Q
M:LL(@68;`UG4S;+*-WELPU&G6M7+6L$*MA`!-E#"R%IA:0UPA5+K*BHJT"F0
M[:9`"D)=V20<0`X'0.74I71Z(O18&)C\6B(360A("$%+"=?VQHGT,#``XY*'
M>-2.T*S71`J=&6_MAY5M4,)A)-/PYXK",J!E>R8'T=^/@)84]_*H/#B+B)<M
MIR$VG*XB.TJ(DV3':0>6K9VK3K5%8=ACAD=<XD^)'EI`10@BD,*D4HE-`*=`
MAO_<A<6E$:A!&;&8FRT8BPE,`"\':B`H8'_X*.J2"3U(@IV*,,.3;V7&-'8N
MD:Z1`X5S;IR#=A1`BV!MJIOEWELCHJX2EO-Q-A?:DRQ"<XWT[L(:8P2).<>^
M&`7]J)T=8#6Y)YR?L\^_H6&91K"#-8*A>8`6)`?.9=*OB3,GG1(EKE,<3DZK
M;#SO@R?\5E(IR81*196];$NH+>FP4+YV;=A1%;5^JSJ&?>Y&^\0QYPK_>6XF
M+2%]USNJ07]ZU(<U,#TQ6HP6/K/`H(26JX+J6&YK)ID?1<\&*<]2;'I0!!N4
M]Z%<BD^1TCC?IWXJ6O24$SVEQ^<W/_K1=[[SG[\"9,__5,>O7Q;$E?]]\`,9
MS[(QTCM[V^8G`=0B*S+F?F67>&5%T_SH\J7"V[)G?M93);=,/,\^)]/_>C^]
M,JSP8P[;.0\$3$`%7$`&5,"UZ*A2NRC3*T`*K,"O:A`$T2V%L`GY&BIRH(..
MD`@/^2DL$8[N28GUHP2'X`,>VH2,0+&8`#?9,PA&D*\>,HEM>".D>J`G(0="
MJ+KMR;F%^A?W,CY].8F+N(GU8P*&>0G&"A,=V;H?M#@HY,!-D*0N&3$5M!")
MB(G;LT#U`H\MV(+O*$,R!+DQ/,-M`0\T',,Q8H+SX`M7BD`8,BYS8I!AB(E]
MX;Y56I"($CX`#*"R"T0VX"&#_["T".HD]?N_0&Q$0$P^1V3$1V0GHQ`@28S$
M203#-!&*BV"&B@`*GZ`$*)J%H)$)-N"0%OH2F^BUQML83VP_FU"TCC"CSTDQ
MH2L9%V$71:,9#VFA_6$$A@@X<HBQBZ@33G21V2H0>@`3=9F(A>*A'2%%,-D7
M9D"B3?,DGI@(H1DJ&VD8DQ`Z38PAOQB=7:-#<@JGXXJ*;7@:#KBSXWB*O)@"
M\M"*6&$*/8FH!5BY;M&(NH`*H"JF&ZO'<+PJ]E,2!_*9]`&WOM@"!H&B&[E"
MF7C(^[L1F[,JLD@16620:4J(/ML1R9*)/.21QG")GIL&(7F0.G&(WBM&10NW
MJ7.VN__*-[C`$H4DB1VY)9[)QOS9GAC<$?E:KZ0:2$E,GOB3J3A)%'*$BK_#
MO`F,BMPP"$AA!"]CA-HR"K.9&H/@A2DH"I$BA+9`H3')FKCPB3@!HYR+`.5H
MJXCPKE7AC!%1PE48K9EA`AX!@!4(C3?:`NPHL3WD`R;(IQ_TRI=*H(.@@X#K
MH2T03#H@A-R:A=HB!3[HCH?0H9\BD8O@`S)PC<F,%4I@@K(;DMU@#,MA`[08
MD9T1RC,!LPP+10K)HI>RD>T1#B/!PZ9RH>X1FE?L%:!("/S9,^'X'&>3-%)`
M'XS4$`;Y2(,4K&D`H!X!GU7Z&,[@396Q'_.1+`W4$3_<KW3_T\"V^#0&>1"R
MP9_AI`3&R)V/V`K20\VH&$<YA,"M8DIQ>C*L?!1C^YH\H8-AJ(%/^HD%H(0%
MB`D^Z!9SZ0QFT!OZA!"](04VL1,=B!XDJH$:.*V#R!70`8#&``"A`2/GL;3L
M4AMY69L1(`-;20\`^!@VB-"D"AN?8H)]00XVBHC2X04R6`%H,<RO\92TX`!2
M6(#,#`Y_:)1-V).G4=`;25``@*`%V*E.6@SUL*7^],^@(91=X4/UM*19(H?-
M6A4MU:0>VCT8T5*6P1*%D-#2PB2C\+EF$@L+D1U6ZBW&L*EF$B6Y$HD"`;-V
MT+,\K*;':5-CNC8P7<FMN=*M`%0L_RT0"V$+L2C3+96K]*Q2IQC'_7B*I3RU
M^)2*IQ0-R?&'!9@"/L!0JP0`1M`!)&H-F?@+D]0!N7A*Z&`,4I6E2;$)0E$5
M:$I2X!`."Z6$NRBO+,-,/(&<4A4+M8`6L;`;+[.(6$F4,:*7`E%5`8D`6_V)
M6'V+3`T.\TC6AR@VH(@;#G"(!=B":&(".NA,NS`('04VT7!4BLJF'@HKM3G$
M1D7756N+<9P/]]PQH['#K+A459E68,Q2BVB51)F+C*`$VOB:+1`49JV(5OT<
M-BD,T7"F5V4#0@E87#4(5[.T=B`#KQ`+4O4+QJ`+8>T5#NA'8_6)1.&0S0(-
MJ!04QZ&-T/^IV'W-5EOED(IXQVF-B%;%4:-8!?)*D05HBR,U5\*`5Z(M6M1D
MSR<S1_A,1TO5C:<DU4T`U\,<"]OQ+B3*3S:XRT3"CU35#4!A`T\U"B+*VHB8
MTN?(QRF@C5*%UJPD@LC,P1I@N0`:@="@`[TI(K^H##+(N*,@U0!*,B1RC"W@
M+;W1@60!EUN-56SUAU>-3#I`HJ?EC*_]&I'BU*/@BFDQB#N9TCEY-7HU6M`-
MW=33JSBDTH%26DIE6G4D))K+GXN4T%6I&Y6QMEY!'\;X33IUW:.($&KIG>.#
M(%F*B,?ZG*!:E:,K&.C)D:DZB"I4$):HC3JQ$6KQB(/`FM-9E=O_10O7'09J
M@=X>TMZ08`^R&=.D&`%#Y*NK4Y>&$EWV;=_!0UJEC,!W'3GXF%^`=%]UH@?O
M.BW[Q5___5^P@M]ZE<!*=:7\ZZC/X;S?2^""0M^GX`6O9,2V$\FB5!9/&@MG
M(KW^K:F%`&`/_N"($V"_0UVC\;XR`4:F8(8(:".Q8(05L#6T6>$54+\W*HBG
ME*A9T-&EH5C/<0H4`V$@#F(A9HYY-=W/D5^N:LI'19A[J\86&1WL>"]82I1M
MBP"T2+FUY9NCX`TDVH(IX,2#L$%H8H((R)%9:"T>AIXQD0@-PDL$F9")0.&^
M0*H;R;8AOF,\_E^D;$]+VKXZ5.*F*)TY_Y,+/L`^8[,=#N*%1M&!W_"+#)F+
M18*;WIF4)#L*L$T6,HB`3HT((J!*UV@\(I@;;"$"0CB+EPVV%2#8II)2"]T$
M)D,.\GJU=IB&5YF,1R%9]]W@`T837<YC7U8=$783$F8:0&Z*""`%*V+<&P$4
MQHV(-FH/7/8+M4B.U8`;6U6,]9448"VV61&<*XL3V"E5M-B+=6F5(UT>&HT`
MK1PB/JB+IU0.WO'B<?UE>JYG>`UF[5O0)"[@IU`B'8@(``!00:'5L.$>`@2+
MP'A'B5B`OF!H43TH*L94+<'0??$E@+V='UVI6Q64@)[;^-B"!8+0BGC:;-T&
M,MB35O%?9E`++_^VUZQ8Z3&<@NQ[:99F`I>V9YS6)GQ>BDF]UV)FBM+1@;;(
M6KQ)"%=C&1TXXUQ*%,M;@2DH9=YLY2,S)E))'-;P"?/BP4(YLC@B6-U*W#RY
MRVW-$_NT2[>Y:L9=3@Q%U3R)U-`MB[A=N1)UCN%H([DNUJR`ZY5C@@7`ZYS^
M:QF2%`#`9:H89J(Q81\>(%Z@@SKYP*>C@]9:)1I:1O'1S3"&I2&9+3U\4^_(
MYJ*ZS$VJ$:ZD`T)*-[&@!#/60^Q0-QQAR]1BWZNTB%)VCMBF0;EXUY0VB-D&
M;-Z&H2+V*-$S8C7Y:7FJ0&9@R!$P-="MC+M@;N=(:>=NCHH=B]SN;>O_)IJ=
M5HJ>+AI\W2ASTKM,O-^/HHJD*(YL9M_JKFZ7@M7_4V_Y#.=_[>'KGF\S(5UR
M!&XD7EKZ#L?HKHRIUHKTEN^I@._HWF\#=X[L3HKM/FSB9E_X:U_HGF?F:)5+
M<F^IB'`+/W`-I[C2G4-/[66':O`-!ST,%_`+[^$,AXH`'W$6API(+4=]UN\6
M#S^_(`RU&&SG2!3Y^#@<;PZ_V/'WX.,9'W*C^&WW5&YBYN=5XSPB/XI9B",F
M<%O'DXI5V&M1G?*H>/*5<]L-!HSY\_)8PN#/^?+1"'-J*G,S+W-?.G-26G,U
M_S\V)_-^@O-8DG,V%W,T=_,Y'^(]AG$D)QH[_R0]")L*[@D-G5B*D#AO25TH
MGMK"0[2K)H_7<&I`2J]T2[]T3,]T3=]T3N]T3E?=#TYP4GO/U,T*QW8I$*$8
MM+A@LNC.:NL5EC`E:,K!.3X*=0,W[)`E4`H16F\AUZJF5;D\`#YS="IVX:8*
M+X[I9$]VM6!I9W]V9E_V9I?VF(;V:7?V:)=V:\_V:U=V+][V:8]V;/_V:A=W
M90]W:"?W;C=W+SZB(1;UR\WO4L\*]GLRK#"??4&2CGB(VPHW_O+!)*DEV,")
ME!);P-A-FR`(<>.]69G,$N*?#SS.E8ATBJ]XHX%W:/+C?0;UIU!2?TRMAFF8
MBV`0O&!>D2RAC7@2[/\)$_9H.ZM<O?Y)=0U:D27IGXEO^2JQ^."2/T;,8(/B
M^3`?\Y\_J/D3>J(_^J!'<SI?^G=2>CS'\Z9//&*_\V//9<%V:V&.\:/I;JFP
M2%?R,.S0B?TQB2KD&9K5$2!QX/^Z/X@Q^$WK']Y\B8^AWK5'F#75H1/2>;W?
M>P0_C\\M;*V_5W34BGIW):SXF9!`WZ]D"PBY$7#CG,*O&95W>8M`&/1%^/)[
M$L,JG]+<K,V3B$'D>]$?_:18QZWT<P+F^$=E*(_ZP820K1.*"<))(02YD9%!
MD(>1&#CKGMBU=8YXG!NYO>WQD"=A/5ZH?=1>E9A8>-)O?N=WCN':>$B2^E3_
M&BAHXCLL9XMXXM).>J=0$_;G#W_Q'W6@`''?$_'Q3W_U%]W@?CCT7W_XCW_U
M7'!F06SYOW_\#T?Z[[[WKZG\_W^`\"=P(,&"!@\B3*AP(<.&#A]"C"AQ(L6*
M!-M%`+#)(D1Z&6MP#"ER),F2)D^B3*ER)<N6+E_"C"ESI$>-_NBUI+<``$B7
MLU;Y(P?TX:I9,X\B3:IT*=.F3I]"C3H0(P!*-UM2[=ER!0!ZT[I>9?A3*MFR
M9L^B3:MV[=.:&UUF?:EC`:6O.(<QF3+,WRHB4X@PV[)%("-&_@37,.QOVI0M
MVP22TJ&83HVA;"]CSJQY,^?.$MV^K*F5Y0@Z4V8!__`W#``O7@"F;7I=H\:V
MJOZ8,/$W8HMK9OY6M%[A;Y;P*8Q(+2`WS3/SYLZ?0X^^DNI;K!]?CMA$9TL$
M?Y1&"!Q!BA0'?U.F^.-@^'QZJZ^_G@>PC4T$,BMTT%NQXK'T_O[_`QC@9M2]
M%)=+'%!2VP)\`=`..:QM4MX4N:EW&WH(^@,`,P_RTHYO;*Q`SS;;X+0%>`*B
MF****[*8$F@XL63@5E8QL0!.A.B@`Q_>@=?8;^NA-X)5"^Q%"FYTW&2:#LP,
MH\,4I+08I9134BDE@2[5))Q+Y.!$#SD#D?/E3>WXTPY.7(Y9YIE@DCC0B`)M
M(V:5<])9IYV9U605ECN-AO\4C'<"&JB@@S9WI74\]?<GH8LRVJBC'66TD:(N
M7C?IHY=BFJFFFA%HZ4DR;AJJJ*.2JE2>!5Y7JJJKLMHJ1Z!AF6I2])")$#V>
M?NJJKKOR^FFDJ"+JTC24K`(C)5\R8UE![6Q"R5X$;5.K0HQ0`F5#F^`:YF*]
M<MNMMV7^&FNP,5J5K#_,\"'FL0>MBU,[P[A[$SF/D<.+HO18-0V4[?#R):WP
MT@.O/YM,XYM`P_#7[*U!V?NMPP^+^N*A?:;$R[/8^D,*?[,\6Q`SO!S,QS"$
M\"54NNV0PDNQ`^'K3VM\\4)*P")O0LHL1A&RR2H;W;S*<H610XI0PW0,L=%'
M$TK_E56XE@2J2L.`/#!.&L,)E*7,;#0,4!_/0LXLCVWRY33*TK$)R:OX)I2Y
M5%N%\2JK1&T5T0,'S332=^,=):PYR;H2U`)1@M,J_&VC;$%J@SS-S5Z#C5/A
M+%M5[.`WH0WRY&WC-,LF!F>]UT;D;%)TWJ.3GN+>,?:M$CT;F<L7?SX?)/8J
M(V>L../#^3:+P3=M-/8V1A']<<:/644(,_@^O@V4?V/KI9ZE0Q]]?X:B/BY+
MY!`+XS#^5N<Q(UO7##P]&PHT"R.[WP0R/2`/PXA1TRRWO<NJK4*);]M4VZ7]
MQV^"L?3_`]`SU%N):)8RC:@IY&\!7"`#-26QZE&,@)]9_\QR9F*W!F(P@U`9
MH$J<IL$/@A"#IQ)7!%&RO@H6;CG,0!]!F&$SN_%'(/TJB/(02)`*^N,Q#B+(
M+$BQ'!C%\"9&:0@S<#@0%R:.A?3X"0M#Z,0%<C`E'DQ)Z$BQE\%-KGL$L1]L
MQ'2OL$#F,3"*V3;D5Q#_R:UCY&!$T&(H+=Z!\2!W$9T_SF<QX4&+C6-Y(A\#
M&$643/$DK7O>RV!G$(R!+F,)&DX._X8]4JQ+($%3B/\VLHT?YA!*O&#&+.J2
MN.Q52V;G<M]B"#&+U4&2CI(B!3,H$3HW#45W?9QE]$Y'P-2E1(&!$PC&QE80
MG.Q2:L"4VB9743=_T$%."D1()?\GM8WS!6Z10ML7/>C@%:"0R6<NS-B7&&%#
MG'B3E<PP3-C@9"WET3*=HWO@='")DKD-+)L&>]PA882M^B&):%#RX5"H=C`;
MUI.7DR*'R,C4O-E%;74Y!!\="N:Y@^U%4<=YS-_\B<Y,JC.C2/NCKZRG$G0F
MLHP#L=A!,,8UD%GED0.[Z"(%LCJF"0UP!GG<,.GAPR%Z9S&K:(=A-LDD[TP-
MH%+[Y_"J%D:-(O5A[.R@.U'R$ZK1X2=?BF1!CK,*36YB%DCR!Q^,TCN;I8L@
MH+OJEX*(LAX&T:B\A*/*C@6EQWFSH<*K(1_T%43_591>[>CJYN"4U+_VBJ,F
MT8E'5S+_#3%=<CD7-8B'8J@<&-4*B&WZY33X\\:;D$^.+'.I0.`7%A@=%HS*
MN<GS.&M:&#EN&M*Z+&!;6ZI375`DA"TA3+0E("^Y-K>E$VS3*J7;WP*W2K9D
M:F&#:]SC`HBW)`DD<IOK7,\L58I-?2YUJ[N63O&MN-;=+G>E,L*)=3>\XMU@
MN+)+V_&B-[VWM,F>M*O>]\)W),J5[W3C:]_[0HJ]X,4O?_O[$-B:U[\"'O!!
MYBL2YA(XP?$U<$@0K.`'B[=+OXIM@^L+X0MW][LL*2"&.YQ>!K^*3QX>L7A!
M;!$'DSC%P(TN("VLXA>[%KL;=C&,:RR@,C8LC@V)$T$L948*_WOE1@CLDD'(
MX1N[:;B=[K4QDY.[`!TP(:T.H0<`!J,0/@AU('4I""4TE![%$"1E8>'%CA8R
M7.DNN<EJCHY..D:*+?AF&'P@A-T8D:/E3&,+C"`$.0BQA8W8;Q.,V,+[MM"^
M*BN*"$P8S`JVP`:@4((.I`#`DK8S#-@P@Q!\V"ICRPO!-8,Z0!Y9`1LR%@%&
MC&!U`+!60E;0))+58`ID6`!L-A&!6=2`$CJH3`2F0>HE`@#,+JL!,Q9T'SZL
M@!01X,4TZC,,2J!Z"SJ8]"IJP.F+>'J]6@HUM]F\@)BR)P+C.5%"5@,BD+R'
M2)M>M0XVH0/W?$PR&7I6B4JCD5QGB/_,1/!U7=C`G2TP81,]0H]!6'P2#O^'
MPG?[8K<U0^5GK2("?%A`.RA1'H4PH08QTY"TM\`!$'69%#781&(RI#DF$$$W
MG'X0(X:QA17,QCZ=O#7`G40'`$RAW1)"SZ24IN,6IUDA(G))M!ABQA59RK;1
MX7%#`M9S>LFIX+9R"M.M2P\VCI0-\=.B05J:LFD0@@X<P)<W78@UWS!B&YIV
M'!]`JR?L'8<.*R3T3>I*B)21`FV1,YQ+LTW<\QJ$#E`>N5T80@\F.*F""A=(
MA9BVA1H4C0U$T($U;S(%*2/DZ*:2"'NF;!'0\L=3],BY#I9##FFSH4LY9X(2
MHS8"82>$'E#_CB$XRY.7GQ^$##B58$->3^)-/+ZT;?$[I8(NUE4``%[,`,!H
M73J,RU*YDV!9GS(1&R:<3(,>OO>8P5;#:L;SH1TP+]^MXO0E<JAQ+\.@"YFH
M+Q`'A8E?:8T3?SS;68/5"XA&IA4*C8Q9@CP?G&S#[D3+A)0)+P215T@2?R",
M))75&[V)`C:2)'V<F`C,10"`,07%"*2+M-T$`$C?&XG=<@B)TMD?0<2&P:P0
M8>P<G#Q+:/&8`B)@#@T@F\P+#8U/^YD?9O%'F+R)0*R@),U0P(B)[V5?@DW*
M^,@)DC5=CYT8\9F0B$'$\MT%`+#!`A@&/0C&%!A1.[S&*H#'-CA)_PT8A6"L
M`%!X'!=:'!O8!D%(G@Z4VLUI'$'X'CUP`%"\!\ZUW*(AR3:L0)3Q`4]LCY/H
M`*15&27\!<D0!,QMP>J<AU7,PFXL4:SIP&-0&@<P`2'8QB5F8K"5R19:(A%P
MP&#,PL<MP&!`69FYU!WZ0P0`15[H`,FP1X4,!!N4AZ[5D9/DQJ1EQV%LP>5=
M!)$(A.`-!"N^!B^0VP:>XF_D2`T`4UXLS4`0`:61@^`10:DQ0@O:&6[X@Y/H
M!G@0HY!DB"@.AJ_10018V4",0*.-@'+@',G@1BP>Q@*<HU&P`925VC340,`=
MWN,M!X9X6</%A(E5!(IMUOJ1R6KX`R&4!_\AA`C`!6,-1`!Z-%H=V0@SM(-]
MF$?*M<,"@(QMP,BDW<JJ90@+;9\XYN&7K``A;$,$-(F5/=QOH`<C+`@E=,=J
M[%YX[$A+S@(O]%H$+`T6F@>Z#</RU1%X))]19N-".J,!)F5JK&1ZL,&#&(6B
M-(8=^@,;@,=JG!Z%9.'!,-\4'$ORZ<9@5(A#:F%NL,P"U(`.M,,O7H4XLF4&
M<MF)C`#):(A'M$8$>)%JI,:DF0D(DH=Y;,&#[`4'BAPSW-D4D`Q`%B54[H@W
MTB%Z7&-M/`89;"7S8297Z0!JC.1/R$>9;$@-F*5A8)Y`KI>D[-=#(*1JU"1X
M>)R_J>)-+(!OW&'_R?%"<FS!Y!4'>I"#,(KC0*!:>+A'1*EC%G*`4>3AK2P`
M$["!7JR`8G3D7E2(0GY'^2PC'1K&:@@&G+GD!^[%<.:A=PC'>%K<87S<%K0=
MK7W%CY@'>LQ"=@[$*JP`'^B`A92)?,`EAM`AB!@96,RB8<2F>O:8,')FWRGG
M--P>9PVG;K@'_%09&3@&`*8&)6@)!XR'A!0F@&Z!^!%"I+T<"3YH>T8G?FHG
M83X(F;`'E6T#1#+"R-FE83!"59"#D^R&@Z+F3!`D11@D`%*<7WI'>6S""A@9
M^E!9Z-0F'W!`C3+!5S##%+2@/]0`&RR?GN#$\N6=EY%E?V[#"-PGE546_UCH
M2#L8A=C]%%`BTY).7AV51\%L@HV<*#F<8;UTX[XQ`Q$0`3EP`)*,IW@646HL
M)<FAWW*,I[210WV\RYO>RPC0Y:0QPSDBTPBL1C0.(\Z5R9YBJ90.!LF5D1'%
M9)F0&C.@W`<63(.@8*_AJ)>)A]=X3&I\Q7@PWWF&F]S91`V\QO*II>^-)QEP
MP#2,8D&L`!%L`P=L0FV0B:.*'7J*X52NVJ3!SS20P;3QY0A<B(`:48ZNE_"I
M#HU!RQ1@'WR6FLO@AJ<"'!-8"RD0`2/@Q":0`2%@HV*TJ(3F9)Y-Z.BE%1W@
M!IU97IQXZTW@R%;A"%#P@@Z`3&2HZW"0P2=.J/\;#A$YW./22-MCV)G53,&\
M@*MYA,G%BNN^8>PVH$<[^!L96$5C1)U`>-Q`X$4R6=Z@Y:081DTU,D'4;`,1
M0.*X]A@7@LD]*H:]'@8+\0%ZL(%1X*S#OAL-]6N+;L%RK`(VD@S,1LTF^";!
M"D30F@>_UIV=#<:?["-C+D:_J@83J.S+.9K8",9C3(..X,2FT8%AZ%XW7BNV
M%A_7H1G@_56-)NRHJ$Q+:A$M+D3GP>U9[.A$]&A'3)T3:A9GQ=;B':YLN8CG
M*82_,=PO29WA>9[BDH3E'L0T*!H=D8'5%.Z>2>Y__>VAJ.:,(0KFCF[J[DJ2
M_9WJFH[KED7@2L3@PF[_[<J$<CRK2.#N"5J$<B369TS8:MKN\#+%L`+`\0+`
MW5:$\0+`3B@O13#O\3YOTV6$MA8?W9+%PI2$_RD$:SE$R9;$^$0N<YB)0J#)
MAA491W@OZC)N$TZ%601,1#2?^SK%"GBK#RZ`W#Y$K'G)O.C71#1:_VY#_D*$
M[$8$[1Y,M40$M7R?12R37W7$^7U)7QU$FP131^BOO.001:C,G_#"A[YM!1M$
M)UV6#T%&"#\$G0;%L[3#A^:DS^1854*27:D$"BM41=PP0I"#]RK$_$&$_RS$
MY`C4:6XO]A%%OX!O0E"PT$T5^Z)$'88'[$7$]D6Q15"Q;DAQ]T)A1V$O#>G4
M_W^Q#E#<8,&XU`\2H20!C/R0E)O0P6.(U"]=7\.0&6*E"XQ$'2$`A<;@$$8>
MCL#XWPT?CPNZ3/C5BOW12A.=\4+26U&YE+9P[_J8B=P11&NTS$7D"Y04T?MI
MLI?L\62I%3VA$\>`">;(U"*)B!:A7Y<P0UJ]"Y&5B;Q$79>8\?:\!1][R>Z0
MSR&C%L)\CN)=$B]=,*V($2YGW\*@7PZU<0XI'I[)R88`\2&[5+R@S1%2:B9#
M2\?87S8K'N(V'QY?Q2VCK">7B<HN(#1S[T!,0]O=A/P(\R2WG1X?T;UT25D1
M#KU5745<,11/A#Y?L43H,]\VA`'G5Q<;!">!\;G<3/^Z)`O:()/F&$51R$P[
MP,T*J8QJ%`TSD$%E%45.?FB]\()1:-6[K#(98`U?H$_9U%'>7=';')_NH`Q#
M1\Y8*$_7:%4B:<WL9(S[[!X]P`TID`D=#(7@Q-"'YG1/PDR_4"W+Z$P3??1.
M+721$$\=Z<Q>_,0J7-M%"84Y#4?'#(-7V=.Y=(SPM09(=S"8%`507$X=495"
M`375P(W9\,58D((W;2=+RUE%PXR@V11#1Q75[)FT#`.59@S<T`\OL('R"(7N
MY!G\Y-T.DP'4O,V7],RUS34O;&?!2C0A6/;`</9"+V%/`L_;>(AH/W7MY!0C
M3#4RM4U*XW13AZLDD4$9%='_8:^"-]4,3A\1&7P)1)^+8,]G,J$V0[_-[B62
MSP3-Y'`,R'1T2/#S5^ZSL.FS/T.W<QO>%IL$`KO4)O`P0I0-E!@3LX218N2=
MZ4T39&T.'F5W3N%.6/C/&H6))CU4-+W1Y#""04W2-IF3X"P'P0P.)M>,FT!)
ML5H+MK#24`D$0Q=W$)%"SBP')1RK;X1-3!DXG.2,:AC$^212/'U-3CEXQACT
MA(.RM3ALWA%$%MG376",/S4R&PGQ0)03US3XA,.1:?9DVD2X:MQ,[L1,4+#2
M/I&IC<,.P5@%.JTQ4;U,#PT%VAB3M2B4=GN'+Z44*PW1P?*2;V@3R(3-ANN.
MS/A0_P.7<=J)>)@+5%IWN%6PC7<\^!`!,6?[%)9#^%HI-5^87N70$)34MTTE
M$GX##K.L#IEDH=K).#X[=S]'1./A!*%#Q%UR%J+'7O!^FD0P]'\%CN"$29+K
MRX&7DT+AC]:8#_RH3WJ_!3P!SJULP@<["'SG5%5O%M4<%+HL>-'@S["XTK&@
M#1\(6@\!>.WTD]?L]Y],3LNHN(<OC),'>9G8#%"!B7=O`]<94U9STX9O1*M?
MS)^`\E!,DJ*8<#-)TC[)";-\\&Y_'\;\S@Q&^[U$^V)\]`_5^H(KC@K-M:!M
M4L'>CDU1@BNQT5L)K`V]S+M3PLT<^*7CCV]8!1]`4K'.0O\[2%K9/:VO/T:;
M9PR9+L<F[9,OT5"I,P+%5SMDW`[F*-29'Q0\K;G<4+3K"%/W`+L8L1)`H=,J
M9=J"VQ"2<U6S%&NID\R:XW-I,;I#!&<5"_J)/H1`_Q>W3C(=F9EJLOI-R$PR
M+;OBG(OZ5--&H`UZPU%,!?M&5/2Q3!))I11)%X2)<Q.3@TE0A,Z1H8RS\S27
MB$B`UXU-D3P0"X]!!WN+NPW8M(.?3SCV?*)048W,*-0LJ%:I-<\T!<55GU/A
M&\3?R-(DE16@33*DM4DYE4_N_,[Q`+ZYY]3O_(YJT)GG_G==K(QJR#O3MT]1
MCHDEH?I([87PT(HHM3&4T(I51`[_8N6Q'8OQ:P\,E!P+TUO3>'A'(I4WK0Q$
M@3LXWZ_]VD.)[M!#Y>=46J>XXE\;9U^:\+`-J?=8N8`,DT@]1DVZT`2U6&4T
M-U7Y0@8Z1>RC[RY?!C=$^5=6IE9$K)D_22J<P5VWT`NGH.%9TR&0_(!..1%+
ML:H&*0$$/4J;Z/&BQ(C<M&G^&#*<1<H?*4K;&C+DY8^>1$KT(@[;MO"B/X(5
M_6UCU&X8QUDE*4UL2&_3R%F,5A5D28F<OU6$+FX:-LQ?NY@YA^7DQ;'A,$8A
MBU;DQ8@22(Y-CZYB1)$9I8K3!M);E;-B4W(QVS$D16IER(O;*,W:V+`=H;;T
MH,XB!Y2D_T"'E$AQ9,8((K.5+U>U+$B(&<F9>,^F)>GOXLJ[_H916G61Z\F'
MFRZ.933M(^6<?V=%MFQSLL"%#!4RK$Q0X*I-VU*2]3=K5<2E*/UY3LQUU6"&
MJTAQ=DBJ)C/9%YGW)D5HM?.!SOEL@TG(^E"SP2%C['RRN4V3!I$Z]`<Z-%7O
M))DR6MF:)"E>>-^WI%AQI-?=FZ:'?/P?0(P@BP"``@%@(L`$G2+00";*4Q!`
M7A@L$$$(*VJ'P$TLW%!!#`&H@<,01<1(PQ%-[+#$$U5<D<46`VR'(G)R.Y&7
MQ`+\RL465[DO1PM7ZRM'CG;LD<C'Z(EQQB)9%$K)`.DA!TJP6/]\,DH7J83R
M00OI(5"K+)O<\L,F1[1)S!!)B:[,--4,,2.^O%P33I*:BG.O3:3,<4XZ3VP3
M2#TM7`5-/P55T\,4"240Q$$?FV6;.Q,D9R"\3OQIPXSL9*@=_Q:-RC4<2Y*4
M'.$4'9744DT]%=5455WUI0SC]#!1..^4,B=2>"2G+(:@9"^M&9]L"%==*\KI
MUV&.*D]*>LIK!U><=`-PLDTR9;1+P!HBA1%6M=V6VVZ]_1;<)@N-$TP0WRS2
MH-S<VN0WR[#+#3!2<IIF$U+XD-)8LR@J#J1Z*;-,)[YF&8H9.@I3B9*+&+GJ
M,7E[,_0_6TN<)3'E@(4XW(PUWICCCCW__M+5<XF$55:(?KK,GXD@\N<SB/@X
M+[<29TL*KQJ'2>RRP<@Q>1B43\JH9\AXV6:E6:9QN*)9^"@1ID<ATHJRM9)L
M^N.JK;X:ZZS!'5?D'DE><QA"=N*%EX7.G!%0B#0DNIV5A[0H)$!CVH0FO,(>
MNVR1E%V%&<QXF<G>H]]TF&H`WX)ZOI*FQECKQAU_'/+(]^3R543A/%K`(>U<
M&;JG%1>)(4+P!6JLB&R<9D9Z,U\(ME4JN^VGE3@:Z26SB&4Z2T9M%RFG;2#B
MJ'#)A1^>^.*Q'A?.<N-D9JBA(V))(AF?)_H\RQCVBX^SB)4MMV$V(80>>G%R
M_G>C^1J)EYB\_WKPM?LR<LW0:0R&:&=*;`R5,%T=-9[__OW_7U!@8MR7%A"F
M5^6*).T06:Z0QI!?O8162"%'UV9UK@G^QVAY"19&$`A`#WX0A"$L$_+6]#5N
M%6<3@4K5_D380A>^$(8CXEH)+>>M"\80ASG4X0ZW!:8NK4EY/!3B$(E8Q`\*
ML'(&-.(2F=A$)W:,A(=2XA.I6$4K7M%/44R3";'812]^$8PATF*9@AA&,YX1
MC5U$8M>"5,!8I1&.<93C#CWT0RF^<8YYU.,>^X=$.'&1CX$4Y""OYD<@UI"0
MB53D(KLU1C$!DI&1E.0DZ>1(<2&2DIG4Y":M%+(2%A``V6(C)TE92O]26E))
M8%I`DDS92E>6TH?D<N,K:5G+3**R2)"TY2YYJ<<U'C),H^SE,(EIQ1G>L9C)
M5.878_E'3"X3FM$THB'55$9I7A.;.<3ER)Y9*0!E29C9%.<X3[7-'EFS5.'L
M(+@>)$QE*2J<7M-3/(%7D7BR"9^DNN<W7[)/?D+HG5/ZT@Y_B4P1;8$,YW&0
M/Y@Q!1UT:0I$8((.AL$''3"!#B09"R$(08J@_8E'*_QFBK;!RO]0A%(,L0Z=
M:!>GEN:(A?J"$$6^HCN&O&5,,?4=L&*ZJ[<-JD8/=%),4]:0Q&WHAGD9(+`^
MMZ+@_>=(([*5#NLH((.&J`8`4`@`&!J!%-;_@`V]H0,'*#(".B2D-W?*5TEW
MU9M`T2,E@(H.?(ZD+!O!-5F[VH;[I@$6&)7D/MNPT5X=V-?ST($BA,5(44CZ
ME9R`)5ETF`;9ME$6I#`CI.$C5E3IP8S'ZBI7%0P*1VH5&H8P`WB=S4L[[KHK
MS!86LJNI*](46!'4]H:#@'7@,"PKH&T@%B,V8JB,0GK!VM*CMJMHQT]M%9W;
M8HHCM84/+T1WGMBBSDC/-8M6Y-H0P[Z$M6[554HXV-KH*+:N#?E(XH"'%:30
M!C+51:MKQH*4GZPT**T=33V?A":8D"-&PFH((1CE6%T%*E>612]F2\0,RS(+
MKP+J[`3M^EX>@>:G_S&D9IK0:2$=K&`+S.`J$<)ZG@4LA!$C8,@(1.F/*4PA
M+*2CPT.>A!SA>F4^V)J%9':<&#9\914HR]F`&7$D[9&##D\1+!L4@AP`XV:O
M3B8'&WC1EVELH<DXN@S=@$6&IS"/H<*9\D_X4&6=;(-L-=%5DJ_"##;@["&0
M80;J-"28I"6&#RO9"&!<=YL@ZV;'#M3-4_PAETP1IU%LMHZ-_<$&B'@T9E+"
M36Y(T0ZC[6Q(P?$(1&ITY<0@YR+,D,]9;9N;EIQ9N37E$2$V(1L_)\EB=E).
MGU?!AKL$65GRL19':L2,,K.2$2_3<:^4*R!L59G19%O)L%G6:J`<S;%>5O^O
M?/@P#69<F\F35EQ-;8WIQ/QM%1EU39YSDQ'N$`(AVJZT50+=D!]3HF>X,A0=
M;)7DOK2-;_B9G3]F/-4M$T(G?PY<:3Q":8-$Y=?G00Y*+T/J'&YXA-V$$(NW
ML(D%^&,%V>K-`H"28H:L@`,UR$U;X<82.==().Z3ENGT%ERM:(5LM\'-G48R
MDHEH149]$TE9.#.8E<\&YD#1T,])D1AR:/QS,@(RFK02-'D5.*1LZ0W?+I+O
MTA4G(C)"TS3L<AH-.6LV)MNQT,OCT=N(.LP,F8V&=I;!%*[,3@3YX4XM!C"B
MKV:GB=-0S!\R(Y>\A"#JTU!-+<VCMUPF-V@/2E__Y`5W9IGZ80Y#.Z^M_6B*
M3.4B1><=VZ'&\HTT[4DGR??+<S)TGF.W(5#CV[69493`G&7:.C&;?!A29(M0
MFAPZYQO]`E.:G+><1&:AV#!$)2](R=GMA@\^P(F&<DCM+,RZ6WGS$P,TW%<Z
M93O-/E5=E;Q9BF@$=`.Y/TC,FA.S3,7^&$'G'[-63C.O)2>Y6,\H4N=6OUPW
MW\N.<$:2O8&4-"A<!RB69CJR8AI8C2\`4._\@0`7+OA4JMS.Y"P>I.DR+U1R
M@CAB;[ET;JJ:ALM$;65>PJ-Z!KM:Q]>PA>OJKSP`1<XXC3&PJVU:XB"@KZB"
M3'8HHZ-X@@%SHP'?)N^`_T(KL(4_VLU3KH7KRN;1EBM4>$0FZ.9[_*/H@,QV
MV"9[:`)(`-`B%"+S>"1?AL16JC`$-0<CU&86P$?Z].9]"'`VRNT!;X;UYJP*
MXXPC=@HJ6F(6\()V8J[29N)[H"]LGD,P0H5UD()JPJZ!L@[Z:H0_Z`:!:@YT
M)DMWO((9<C`%G6-H_H8BVH8#MP$!UW`X0@J&S"E'=$E!.$`K%N#BF,&KF`&L
M:B_]S"HT8B(LUN+];L:J<NLL*.+E%`C_=$Y9.`+I1@)ID(PR*,8",6)>+N,^
M,"=Q@A`L\B5L!(08AP$B#(8D*C`B"H_G`BNCB$_G\J5ON(YB^"TW0FH57L;-
M=/\QUZ!/2-2Q(?P%)]ANY+ZB&UVG^JA&*]Q,2K`0,JA11I[Q(HY$0Q@!"!DJ
M(-N&(\Y*K;J-#8#BZ9;K\A@P,:+"5QI"'R,BUSZ'=L81ZWCMVK;0J$#23M1L
M!1?B\R`M92"RJ#2D:9!&^W8',5B/MWP%1XSL["!0K)+"`B=+0.0Q<U2RI>B`
M6;0"*FK'L6JQ^O1M$HN*:+B.,D[B=\X,MU*(45:B,CCP'S$B(Q*2J$*HH+9(
MXA2$#$QMH:;!H5)D%1**WXB`"#**#E[&(A=B,EK#+4)0-W(O)]Z#;G*C/:3%
M*GCD*,9P*2"E.(YD(=J$%X[N=R2B*)YM(03./?X%973_A3@<9JH$3=3FC#+@
M*E,80;@@13;"9S648A;T@BYT`DJ0[CPD8V4&8R78`B>:0E2(PS@"DROHQS)6
MSBUJ0BT>T+L&(GT>)B+:XBGST3(H(LY>XTGJY2O`!UAFQ&&.(B4\RZ@*HUW^
M;NIT13LBXBCH)C'<X@Z]:Z\2(T\$0K#R\F$\4T#4`S+:)%MDLSOH078D@A=X
M`RZ*XROV*C2XPEF>0^A,`R),XL]88R&:HC(VPC9;(O=8RRA6L#`HXJC4*RJ`
M0C,!YT(L(S)Z`RA(LSYP@CJM`E<HU#UVA#QKA3C'PLFX#P"6*I?"LG_XT4]6
MSD1@%$*T8AHDQ44R[#%>,D%0_V]-\,>%_.E;+G-4=L4IJZB9@`F/5$1(B>1-
MA"DU6N2>2D-$D`5'%81*`RI'$I.?)@-"+H5</F:?FE2C,L9'BW0(KT@47804
M$V2Y+D5DWD<E0+$A;(HRA(L][JI/X@,BVF&BR-0?=$!#;`VJ'@,LJ,N>%`11
MG<H?R$`MNZ8=<N6A?$O<%`2<>H00@(*LZ""ARF-2\P*@K*HKAV$$'J1@R$#C
MY(<-[H,2V`"X*N*W!.P61Z353&03=(`]MH`0U@E3%B+.K"0C@P13_,06X^B8
MP'**-F0B<$5U>@.!*(PE9:\\GJ0=1RMQDHH75>HF'^/%"HT#"C51"Y7%>,=(
M$G435O^`-9*D@]X$];0T7)W$Q6!,T`!$!P!._9".!MT5H+RDMAQH6LN5!0%@
M&[9`7AN"`UIL7M^UGTZ+`Y)E7H<!`'*%(RAA`9`#,CB`HSA@)49`5P565!\M
M_<#U0=;)3P%`+4$U01CA6RL",*:``[R$#M=U5N85G,`BT`@"@?H5M^RI+&ZH
MK>R'9>XC67K62Y(ENO**J6:Q=H;%KZ2DMFX(N7@HE@"U4EPT0+!/)+!L&V*B
M0.O%`V4D4C"B,%;B*V!B)SR++QB*#X8!N](G,1EG"K:`'C@``*:@/)AA!)A`
M8\_#H=A@G69A!>A@`;2B!CZ"`W25'+9`!\J-"'1@%D;@0"+_`D&VH6^5907T
MMO,X@A00A!)J8`LNY'(QEA$B8"5N=042#ZPXMC?80`=4,_4`X&#5;Z(^EQ4A
MHP:(@.;,:@560@?B]N@NZB+H`$1J(-@^EQ)PM2%T(*QT`$2.UQ^8`"($E@Q@
MK#PN-Z+*@A&4MX/8`$1F@0@H8Z*R10<^9"$(00>$LM%T@`P6@`)#-N-J#UW7
MSQ\``$^900>F`7(=A!Y8%^#88`5T@`@`]W.GH7%Q=&")H&`=B'NG("=T0`=4
MEQR8(*+0M?W8=T=GP4\UQ7L2#S"6#;GL<BQ\@@$1*U[FI0#+C&4;HU9WQF&V
MP#,K3C)U@@]:KU;K=""^#B&$PCCJ_X4X#4(R9@S<2D)4MI8@B!C%5#@".46'
M(.Z1K/:;S`X`2\1U9$<@I$]A(@*EB.]H>(X71HYB<$\OU,Y+I@!!""%D74-@
MZ4#%(F!YO[<B.$!>5G1^MRHE6K<=R&JB7%&/.2"L:@!!`"`X(I9E50P`Z.<E
M`'D6TEC%*HT2OK7\%N!SV>!S:R!:*V($['4$;$VKIH&K1B"A[H02!)84(@#C
M(IF420$`<F($(D#%5H&4MR"LD((.=(`<1F`$V@&6_<$4YS=Q$:1ZAY<GT#67
M&V(5`(`>MH`.Z`&0_6$!/B.510)$IJ#,2)D.!/EUVY(>.,XU+JX&0*Y23XNK
M5)8A)!GC9O_!?YEY55.9#-!U?[H5632D!C**`\Y*8`D!1#[L/VJ`>DEBIUY*
M2*YMZ,BA;,YT)+Y"YUX&<]CNBTGB9:0NYDHB6Z:*[7C&:)Y*))9M:TNO'5TB
MA1*O/F%.U"SM,U>F=+*.^;1B^#ZM*T%H35ND3;&TK[ZB-468(9C`1L1P))H/
M<Q@*6X1P$R$Z,5Z*(<@8_>2$JRB!D#ONC-N!?G59*S;9F+,9@4=@%8A7CUD&
M70%`J>>8DPFQJ%'YFY5YJU)&Q;Q7!TCY?278'[IY"@+W/W99_9YZK%71C07$
MXYCAXM[7G;7:'[;`9#$B`E9A!>HW_`C!56L`*.0WE0F6),:5"5S_-0*VP(_M
M*0((806L39#C=AN,N:\CNP;(`*D9BK/MFJP6@G0=XN(N67&-FJP_;@6F@,6F
M-Z[G%[5LN9T3&"/H@`@.UZGG=V!AS.-(8@L:]J2>YD'21[*P4NEXA&IZ[2*T
MHJ3H@0^LHN@T12]^$"8H`>"F*A_%AB?RQB3N2BKGHR:HYB>P[R$`@\#:1LZX
M;D^U#PO3IB3>+R;L9:4_J*67Q(D+%7786XK_QH$V(3RY&XO[D5&PK]5@(VI@
MQZZW%E2)6IS#(IQ5C(_7&GD-5D,`0*Z[NK<3(X_;(<(]C@,2:K*ANH,\+B'X
M&GCHEY.+NI`W8<0^][4#]7,K2SX;VUYC_]?$)VAP!2V41>);+YD!+PZ5`6P!
M:H"L^AH`+CQYM8H7EGS%GOJW&WN2%X:=07&X$80<"IF9K^*9A?=)+(V489P"
MOY4C^&`%H&0$7L84MSRD(#9E5I8(!KBO$43'J=-SK8HCW#GUV!?$=#E;!)81
M0&0+0I8CMF`!`FN(C5M"Y>RGB[(BL,^@"Q(`BVPJ<+1I\HYY<B((Z^\\-*0L
MA@08!4W`L1A())TM6,?,YM`%^4U4:+"D)6:^Y2S?J%9X\MNIOB]$!F;E[">$
MNQ8A<N,KR$=(2MTN8$(B^HIK;S0H-$0B:`,S2((-$NI620)O(P)7!_9\<^>U
M1P`B1F"O2K4D%/_W<]NAK2$BCTDAVQ67#3AB!$!#W-\15\_2GL!]&Q895RF!
MQ%1L&B[*K=MAEG&5#)@<,L95!R""K.Z=`6N`#SJ(8MN:=TO$?)D`**8@H58@
MK"`68\;J2.0X4#6D83GU%IF@<1FXT!P8*.[6XX<A?,=Y!2C"?"FJT?QX!3JH
MV@>L!AB>(00U4.T2;SF"Y'/;@1LMH0Y>ETL*K.B4#$KL)::`=9?WVSW<@2O$
M@4(NC\]U6);-GNJE.IA==P!\6&*"=#ZC'-^#7YA=!(7X3N$O6_ZB(.JL."XP
M(MBE(@H#Z]0LA(%0(E9"U.P$?RCE3$CB:+`#4F:&?JP29_QEB3VIFG3_G4.$
M*FI)+E(5UH$<1:B8A22LKN6H-DXM]5W!B9[H"667%H[+-4&\),*ARJL%[<EM
M76'U]9\25DM%W_3!52M/OTIQ7_7W*:GJ'D\K'R[X];XOY%D%C.20,?/QRY[`
M0EJ0A87`]$+\BE>7W_4CIZJJWTTMYYY$YKMR?U^3UDHNQ)M69&:==%J57_4M
MY.9W77[YB4Q'"?;AM8F:]5OL%$#V-$"Z&(Z8^)*2%:`&"""F;2+GKZ#!@PC]
M;5-(*J'#APX7MEL(,2$Y>OXV8:S(L:/!@07);?)(LB"O80:WM8.X\&3*E25C
M(J2WC=Y(2AXO/J0)4:/!:15MTB-(<J@_H#*3_RI=JI3>1J90HS)U*K6JU:M8
M_=&+`&!DUH?MN-:0:9,<Q7;,"FY:59`9T:$$F3U52,?L*G)$R2$U.!3H-HKT
MTA:<1G`;G848T1HDQZS=W(*$V`[<*_>@T\I:,>-M-PPC8XST%!]M2`XEJ;TA
MD98&W0ZH7H.-"_YU67"C:(/M#@_C55-K6XJU7VN=>!0H5;PA<8,&3="F/YP%
M'6O%.`TIH5G4B?+52ACAIFU(/7>V['8D=:35M?:NS(N0SN*U;W^=3[^^_?OX
M\^L/VW6_V*1LS$()+_Z0L@J!C##B#R^KD+(0(8R0P^`J3S&S!6%TS$)*:`8*
M5A`CF\RREH,%'NC/,/^K4&CA--O,,@LCLQ#8SH&$>'40'3B!N$I:*;)ET#!\
M\,+(2BG.X@\AE$SCHERD:%@@C$;N2,\JLS`SC8^0K956C&R1`N,F'?K3(T.\
M\($21J20LPJ4!Y&SQ3!`\M+0*ML,X^)3C)!"RDBD\+$-,PTVQN>.SVT$Z',X
MS8*B<]#Y<R@E:*68%HXG&@B30A1F2,JE_N1)Z"8S*GH0E9M0PLPP2JX2:94!
M^C-+BF*R(9*C*9K&IGZXYJKKKKSVNA1_-MZW%0!CQ40/=*3P0N".S%AIY',9
M,>1H0[6-M`U.O#"3[7/`#1EMBTJZZB0Y.%G+8%KE%H:E;W1VZEB:#3'3$$;_
M##J:;93R,H012-J*6JZT6@7KK5?D#/FI4_!.2Z&8*!6TZ<$'C51OFK-LT^Y!
M$68T)3GM4)OF-.Y93`ZU_K2CT28GSWH3;AHEK'&[(Y&;TBP%+]@P1@-G-/)V
MA(ITJDNS8BHM,[-TG-$VU+:,[F.^-NWTTU!'3197YN''7[$E.2?F)B"Z-XR5
M!$8[$C.$D$)(V`$+G6VI7&MGWDC3\/(BU^UYR19.+?(F-D86^V;0:=%.2;;9
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M^%;R'8/P(2T*:I?C'I:O5=`!(<-@0SO(P09T0:M1)ZI+@1#6P"7VKT4[4Q8,
MG6.>=C1*6R=BQ*DP$B/L'(4M?>.;[P98H":B[GQH3*,:UY@UKB#1/O18`+&2
MDB)*+&08E(!;6J:1/"X.AO\2=CS(JSCC**"\:%W/,E)ILJ@1DYE*3'>9AEM<
M51`!D0)%TE,(I.)'(#X&LB##`)/C\*B1^.61BXQ`"2\(HLB;\(F!S^)%YBBA
M(.Y1DI*>7,B>+K:@P+`2B*2P4B_=(D'=K842*+&E2&*W"I3L:&=/02'Q%D3)
M9X6$6B(!R;6&6"H/,:8=G42-+"DIRU,>!(_-K`[(""021FSK*(",G.&R29!5
M4A(Y;,RG/O=9/F#Y9X[\9$IOOE8TI:Q.*BI<(,G2>,:.-"^@$(VH1"?*SV%5
M[3Y7HVA,/,E"I:1'HTH99TZ"!=*2FO2D*/V*/\67E?6E]*4PC:E,9TI3B`[K
MC?7_R6A-=\K3GOKTIT"=6G_RH].@&O6H2$VJ4OGI3Z+^9ZE0C:I4ITI5E:8O
M/RZMJE:WRM6N4M6B_:M/'`'JU;*:]:QH12E_3(@^LJ;UK7"-JURE!E:GNG6N
M>,VK7O=:E;KB)ZM\#:Q@!TO8Z%RUK>PKK&(7R]BN-A6QC8VL9">;5+"R%"M%
MI:QF-\M9M1Y66%Q906='2]K2[O.FZGNJ:5?+VM8V[;$85:UK9TO;VF8%MO;)
MK&UWR]O>=L2OH+VK;X=+7-Y:]J]R3&QQE\O<U>(VI[)MKG2GJ]GCQE:XU,VN
M=@?[7/KH=KO@#>]<47O9JP!6O.A-[UF[.Y_OJO>]\(TJ_W!S&]WXVO>^067O
M5UQ:7OSZ][\GM2Y]L0O@`AM8HRN%[($7S&")HM:NRFVPA"=L/OVVM+X4SK"&
MFS9?Z!)XPR`.\75)ZN$(B_C$*+Z*A;%RWA2[^,5,2?!U30SC&MMX)V[\)XUO
MS.,;K]B\&.ZQD&O<8>\&><A(1C%Y%9SD)KOXQU9IL9.GO&$H5\6]5,YR@P5<
M8BU[F<(RAN-_^OOE,K_WP4PVLYK]6^3V'GG-<!:OE:6"Y3C;>;MSCHJ4[\SG
M['*9/F/=<9\'3=RUAM7('R:THGO;9JLF>M&0IFVC+_SH2%O:N9\=L*`OS>G1
MYADJ=>ZTJ#G[9S=7>M2H;NRGI__RYE2[>K%H%E9R7TUKRDX:LZVNM:[UNNI?
MY7K7P(YKF,7ZZV`;^ZRQUO2QEYW77BLEU,R.-E=+[>A-2_O:4DTVL0$@6FQ[
MV[&9%NNLOTWNJCH[*=`NM[I_>FZACH7,ZX[W3&^MXF++^]XOI?9M[8WO?I>T
MW<;BM[\'[N#TP3LJZ2:XPB4*\#:>>N$0/VV.#PYJ@4?\XN=K.$D2CO&.GX_>
M4;:XQT?N-(U[A.,D3[G3](WKAZO\Y;P:-J!%#O.:BQD`.$6TM6W.\[:26.<]
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M>">`,+=D86>`*A=_T*>`"@>`\^>`S-9]%8=_$KAN]D=I>7>!_QAW?OMF@1Q(
M;@3H:R`8@MX&@25H@M?&@!&H@KI&@06(;IYQ=SL1?!7!0&F$3PM$@R7Q'@I!
M?9SB$?`F/D:A>C'%@Y:'@T'!>Y8G5DH($>!D$?;QA/9A2VWB%$%8&VU2'U08
M$\67@#%1(R/!2TSA@UAA'&57/JNP%S%"'Y`2/`?Q4%:Q#0H"2?XC-TO!,3>(
MA!PA&*CA-+J3%&&4$,"1$@CQAVW2A5"1%GU#$L&DAQ]Q6868%%HC%3H($?+R
M&-D2-P>!%`NQ#0314%@!*GHF>QI(%G`#.2<B&$2S$;2A-P>!13JA+34Q%/9D
M&?;4'*PD&+/3#F0@2R"Q@^<4-LNS&/^RL4">LT##L4"8L4!U4AO;,A3#4!.\
M`!.GLD#VXSEU"!M>9!9A,T3C1`^P"$7.J!<-T2(T$2R[887-(AMIT3E$H23,
M<8O>X3_(8C'"I!4T4S(2\A@?)!W:PC$3\8TELPTBU2(J<1`BHX^ZXT*.0@:$
MT2JS$Q)RP1@>,HW*6(1M$C\$T0XK@9$FD1;-,12M(HZJ$8B.XD4*D2U@)$L&
MF1QZP8LE0S.^Z))IT8K/00@KH2V>P2()83@E\U$AL8_,`)'X"!BY*)1$)!&5
M)!!#M(PFJ8P+:1:3I)'!@9'.`8\,V1;CQ#\($9">H8LKB1"`I(S*^#58%!)L
M($LK$3H:<R+_DTA")I%)G>,:6M&1IS,-F42)IMAR45<M"R(W>G$@0,$+5^(J
MNP%.@ODCBC([%C,-;%`==)")HR)":4(GC&&8#,,]=-`95((2V[A`7\,]P>0A
ME(`78P@H!($W%$(&NE,V>"A)AMD.1;0*R!0O+E(G,L2))%(;J&(DL%DN6C1!
MRK*/J-(E?#`EH,@L;RD_-X2;ADE$SF0G7R1"PT`'T^`X")$FIE,Q:D(/190F
M#&,DV[,N1,,]D;2&DYD\>'B96L06:C(-(').X5(]%2(\AJ$2DXDTBT(.KND/
M='`NKB(WUW(BZZ(5EV0DL5-*#$(0S<0]UL(6G<DP:^B?>TD/Q[E`_VMX'2_"
M#)3@(@0R$FM9)3IS&L.0&Z=R&!@:+EQ##THB0C42A,K2GN[!%SMR%X:!%^%)
M$)?4)35:&VR@FPQ3)GWC$@\Z*]/HHS)#G6U21(_$)R+T)[QQGH.IF=S(#-@9
M-R-A)YES4&J!$R2B.LV"-KG1&2/!!Y(QH/L(&\)S$E8H)@$9H06R.K")-NC6
ME_6&?S@R)Y2S$@J"H<0I(_:SC5>"$6OH%8;Y0;UY%%O:$#!R33&R%^9QF8?9
M)@*2.9QR$H8Y"ZX!/32S4,]!0]=$(:HC0Y2S+R#1FU*$&T`2JJQ#*')#&B8$
M,JT3.0H%$XO:GGWZ'(>9+\P`)DVIJ)-X(O]P(DEP4AX+@JQV0J)G!"B&*A"@
M]*LK`:8S<D`9L1*#R!WN0:(($3W`4RXKH21&0P\*TC<*(A*<2H;BPC``.@W'
MLD"5\RS.D9W0<E";<)B/@183](9$PZS[$BWE*AEJ0A%;VC#Z2JS0XBJ4J9!)
M4ZM:"#@F`RV4DZQ(&JEDN8KAPJMLD2T?I!;:VCI`L8:+*ALC$;$.TA##0!H&
M8C$8\8;;^*[).J8BLX8CY!NK`S,Q:Z<^@1,P(S,RHY!:U+$&02CSZB)[$3O`
M\VQX&G+N![-B(I^[E)W,4(<"(4&V::<B`2[4PK'+`AQ6FR3^@*8%PB!&&XE4
M=*]QV$SVDRR+42K_3<0HCV,T(.0<!T(E4=2U9?.A'>0DS2,0\OF6F\*IE9(G
M`V(R4SLE0$&*'4.>S1%##50V(:(_0&*;*1NM6*2N&LJ=!C(4#;&):,H("/F6
M;:NU(4DASA&XMCHY)",2\DD0H?04E;,)*`$=Y<(WJC(OUH(==$"YUP*J3V*;
M%X&=N6&;8PJ8?5.J#E.IG1A,"C(Y!/HY#?$OQZN/T>NX\D(V"`L=<*(JW5H[
MR5@0'00]G6LEGQNZ,(0J:7D:XYN6)W2OC*"<C.J[8<0GS("F2>(BKZ(0E0.Y
M)*,U:#FF(P$B*/,44@0X6UH=.ILV).(@]JNSOXH2?,1`H;0S!@F+GY.&_[]E
M<,;W=E5S%[`HNT>BC(I24-H1%P2JF7R`P-.S&$;B%&NX(PJBFFR1N(XQ$K/`
M!P@1(<<2&D%CCX>#L)*S*?T++<XQ08`2L04L(8B!124DNAF1%A-$"-S3O#>Q
M//3BJ"#;0*$1L>HH0TJL'J3!%DXAN"AKJH>6(!]2KIWK3.SR0LG1+Z8#%#=D
MNM0JN-@2HE53N784BD1!AW.:L)!B.)B)NT+#O03!!T:B.YS(N4A3C$-$(34A
M.3?AD102-SLS#9=R22%L.&NAF9CS.W@S1JM9**M3.6%[(D;"J9F3E:BAN4WT
M$T9B.*%,.F+\RJE#K*N<HPUA)KFL)I5K,!21(?^.TJ1V""IB7#.9Z***LA`,
M1+,WA$5LP!;\(\'6XQ9LD+-^,Q"G:SFMLQ+:X<?-M!*B<HP.$L3?V<19J;1@
MIVPR(3V3M":>20DSG$H(^D@A(<^.0B22\AJ3M!AY="@C<RVFS$=PHQ$HH3]M
M@C)X/!>T(9]A0RZ\$1A`!$J,>J\2_1>.XJ`#4B@",D0+E3EKD1$BLA`I$DP!
M`[8BTA#=H3);:J<8'1OP+!K+I-&%L1"-P1.=B!Y`H1@833FGV1V91"XS[*"U
MXJXGXB@NZKJ@M#F(E$=9A!JA!!+U`JW#H$4E(Q@HP1@E@SQ`P9UOQ$<'0B`?
MU$WP>JZ;`Q302BZ*!,7_VM$Q(;T@`_(72GW4R7351RT@!)&=/@G2/H*VP$M-
M<F(9>H(1_?P3]+P@*J(0GU@JK8&#!\W,'PK!LDL0,[TE*',4,'$7/QL2(>(C
M65TJ9I%'F(S/8N)."/$JSW1'1,$+I"T;%/&9"H$7A2@0&`JO6FT3]KS4`T&'
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M3A%5316P#N@1`1Q621,PH>K\:#PZH>EX'A*7@2GXQ!Q=2!PPBT_";M0NRGN8
M[!M)#1JNKN#EOIVU;$$_GA+%#AA/F>T+%!YZV!WT<$.#P33"L4!!V.WG[A07
MD<+4@>RNGN\7,1!O(1M*2!-WOA=X+O`/L1L7P>QC;GG[M\$<T3<E_:]H*IZ$
MP`<(;B!=0A"'H3&1(9X-0B`04AJP`AL-<BQ@PHAZ$J+_JKDWG$GRLB%J(KAR
MTA!VX](-4CPADJ6(C"5HP@AK4BF.0P?!U""@N!:Q'!DSG"*A.+:,^Y-+$K?S
M$A*(O"&9`RL>OPI<XRHAO0K_?G(EX@GV&J(G;`$SG7,@;F*>#1*Q\K(*LK+R
MV+V)4\!`5\+<#`$X)>TH160\+Z)+!K)`:VDQ-$L*9*`_V6G2R&,BL9@[!7+K
M;L\(AD0EF?\G6^`688\P@`/U$D+W88^P#>P0(*)`U@(F).W<KQ(E;,L7K[)*
M<6^;21(9`2XFIL/TYDT($X2S9@X;@SWY">0G>02L2,.V+^_X>+$%&[OX#,NV
M"<)`JX\B;,$,A[\%)W$=/M+R1Q(AVK_O1?^=`<KYL6CU6@';.M(@XGGS#A%$
M`D*OW.J%,RYX^-<BT^P[(:P_`,%KF#^"_C:1\\=LV#!FTQCQ(D?*'R%_TV99
M]+>*_QDI>@81%LS(C"`CA)O\42*X:AI'>BA7;>/HC]1`@O1,DC-);]HFC`1G
M&NQ(D->LE"L)SF*V4>8VD#]7#5OE#^=)?[QX$329<9M24DSI\9*(DA3.EB`+
MOB07U6)$D-L8586*D!G$60RE4F++;-9%F=/,DGMK52:Y64P/;@J*&*1&GS`;
MOW5LUM]"@Y*K2BR8U1]2J4^ONI5*:FQ"7NTP5X0<=5-DQ#\5$V0+5"5(P%*S
MTF/4CJ]-?Z"1\O*[VF0[Q:!Y)1U(D:IDD@:WF235;CG@B!V'77U:D'C';75%
MFAXFL6O3=ME?$[R^E"K*]!VGVL9*CV_S@YA5QA0:-G3"J/^)BT8'B1[E4/(I
MJ:NH"F\PO4**:;2)*IJEO';>>J\CL-23BJ+F4+((H[HD$VR863C"RS(3"Z(G
M`@!R.K%%%R5K1\4:7I2L.^#\X0TEDQP3",?X>EN%L./J&HC#H0@AA1"8.K(I
M*A1G,2FG*(5B9I6.7#)JLH'<XV,31KK:),RY?'P)*)"&H42^+(\;L\RS_`J/
M$2^GG$PX]*89<ZR-*-'/I%5F<=(L/JRB0ZI98B.(QXVX.W0OO^@A91HD"='+
MKXS.XW$@C@JC"J>KSCL*NFF<O*^B0,\LTJSP^$21Q3++&W.;J$R+J3NV=B(%
M,O%&]8DPPX+JS3Y?VY*(MTU6X4/_-Z]0DK4J9C:AA!*2LB*'DF'88C-5,\U2
MK-0NH\4)V;NJE),02V&SUD:_3&N3J8*BXQ14P<;3<;(#@4P4L['B[:A4N*R\
MC%7V)B6J)@(7`KC5^%99Q5R%L+)7)MV^5#(F2*W<,<)#B]4,KL&((X4/H'B;
M9JARSRV(,HM$/(U&%%4DT&69+4L1@!EG3NBBJW@UB5F)!'O38T;>0O;*WBXB
MJB/%2G)7JHS"4]JCC,B:1N2N@O3G(84)HJ0=F]B2KLSSI-.K,*P9P?.J\3)3
M3:F:ADN(E$,5Q&X:#O5#B1DV/CISDZ3\3LLT8IT]SEG"2DZ(I&*U<GJ6>WE4
M^W!ZZ*"G_Z.W0$7HJ2`QX\.H9H$52MN:*#(J*`?3FRM6D:$J_#BV<BO+L<,@
M+C/-K?UL6JK5D9)H$V5QW/'GU''DK7*#C`+N8<JK=;JFB43"J_>/2('>ZY,$
M`YT>Z7C2.2%*\G2WW[28LCWENB>OC+*W8</,3[\ZSQK2S*O+NB+](@-]M+%`
M]6?Y@U!"RI@0%+D%*<T]SME1D*Q4*+<)16VPH@IB>-,=C+@'=+P@VC#H00:1
MX,P?,5J1!T6(HP78#&>\R`H&DT84HI#C*H#Q2DJTMAFB*$4^4KD*+RB!F%ET
M9!:,H`EZ&,%"'!&%.)3P"TY($16(&&03D:*-EY(2+9,P@Q(4:?]B#POBEI^5
M)$S3V,IF^':I8]GF>QGIS9<^F"N_)*4JY$`3(8@2E:2AI!VY2QA@VC&,=MP+
MAPGQRRJTYL*J\$DMX+I6X@H&FZNXL8FB$0\CF*)#D#!CB&BLUBHHL8T7OG",
M#=F,670X0X*8AA`Y9(1:1`(84APD(Y3HI/?4:!,1F1$A601=M3;Y1MI\"2^0
MV@0AZ)'(C`2ID8'DTPUE0A)",F,;84PE7LBAG(+PR5IH-,U#GA,M2$FRD+YK
MBB0).8Q4=D4D32Q(#Q-YJH1T\(D2(0J>VA+,:;0C6I-$B#4'8IHS.@E*IYQ,
MWNX9(%*<48L@B68@@[D->=;)D;?<H7S_?$BI4,)QCQ-JY1CE"1&<2"N4-R2D
M#M/4G(*LY(D&%"$(.S9"EX'P9AYD$DM9"KH7T50R-FT13@-$FZ/DSBQK<YY9
M=$JCR,C4131%J@B'FLN42&>$.@4639NU4Z'F5*9319',AGI3%CT,)/R[*<U<
MU`[I8%6F6WT1_VP*5;'2C$5!I1%:V\).$\GU76TES@A5:E29N92O-QWCS)`:
M6!!)!YTGLNM?A0*M#IKHL(H%28D@.]FZXDR3NZ2LBPB9V,QN-K-"7:3Q0')0
MRFZ3KI]]$6E1NYC5TN8JG#WJ5JFG5Q6]M;4U>RE?=8*OK6Y#KD6US%[L1P]R
M.+6U6CUN<I6K_]OE-M>YSX5N=*4[W>;6+&;']2O.NB.=CR!D&FR81EJ<F4Y+
MD2.\[G'<*A]WG/X49%C]NXJ</MB1DKF'%TP*(W7UNU_^]M>__P5P@`6\W+TJ
M-[LS&P:OZ%41.I"#'&S8"$+JPAA"N*2X&WG+3(@B*TNVC!X:P1H?B!*MP5B$
M%TS1\&3H@+(!M]C%+X9QC&4\8QK7;*6K/;!6):6FD>W(),?IB8XZLK:?82<N
M<?-11I(('::D1R6:$8Q&O$IC*E?9RE?&<I:U_#(`H`2V3Y41SG!BR?+\BBJ*
M$F"4PC9)HN2JH/0S:YG*,IXHEVZ9!6V'`+>\9S[WV<]_!K0'"YQ<>O^4,+<T
M2E!N7,<&'/D,+I#2B6J&7%S;(0XAZ0E3):.2GO%PVH7U)`<GG::^0)?:U*=&
M=:H#/&CLAAEGLXAH,6G""RN)Y)EW<9(&$Z(30I31BC%!X8U`XA":,`,AMS;V
M9@@Q$"ONB"DL5G6TI3UM:E<[KK5-<FMS;&UN=]O;WP8WEO?Z9:6Z.MSG1G>Z
MU;WNXUJ7P.9F=[SE/6]ZS]O&[S9AO?6];W[W&]6LUC:\_3UP@A?<X`(&^&IK
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M?HFMAWWL93][VM?>]K?'?>YU3PHV`.KUMO]][5\_"SZ0H=ZIUWWRE;]\Y@L?
M]\&G/?1G__M9T($2@&K^*J3/>B^E_-M$SWG,7016H=?TNJV=Q1:\KV[RE]]%
M;FKWC5T.,WP?^D7E_\LJ7).,4[;N/__ZAZNH^K_UR[:@$,`!#,#_RY[*\C_]
MX[^=*HNDRK\'G$#)6`7UH[?S6$`'9$`#',"U4L`/[,`$1$`.),`-I,"@2L$&
MS"J@DD`37$$F.3]P>[E6RS>9:3_WJROY^RQ>4+_2.[4<U$'+`*K;XL%N`S_*
M,CJ9P;\A/*HCI*STL[=M<<(7@3\C5+=Q@[D;=!DAK,+U42X?K#<O_$(,B3]U
M<S<#$[\6(<,JY`WEDL(,!,*6NT*%@T)K2\+)6L(NG,.5>\/D$D,Y+$,7*4([
M1,.)VT+[&[\^5+D_5+C-^,%Y:\,JK$/4<L1P2\-$Q)E)',)+7*TXE$1&'/^Y
M(?,I2[S#:LM#R-I#&N%$'?1$U!)#4?RS)AQ$"RS%HCM%:DM%Q3J]$VE%]WO%
MSP)%>?M%]RM$4\Q";%-#+J016JS%K0%$#`S%9PRK2L3%9`PA6;RI-?1%;0RY
MXDFN69B",?3&D+/&G)O!^>NR^MO$<M2X8,RL88RW8BR_8[S&=-O%O^I%$Z''
MH(-'5:R*2"1&=]0X>\PYVZ)!9=3$F>E'H/O'R9)'=FM(H#M')<S%:7,W@B0A
M9DPKC;RXAX2L0)Q&:I0,@[1(;+Q(W;(XAO3(B`-)Q1+)@23)DKS%@T1)=N2L
MB:RYLH!#:93)F5R,FCS)=".]A61"NXJIMK(JM*+_P`T$0+%BRK9R2@*LJJCL
MP-NH+*1</Q_RR7D\P*HJP;#JOQ$409RS2JB,*ZJLRK1<JR%#&:W42N"Y28W<
M1\O029I[R;^2PI:\,F<DR8K4PW3TMDRT045L$5A*BL143(58S,9DB,94S,>$
M3.2`3,F<S,B\3,K,3,M,3,[<S,QDS,\4S<[D@\GTS,L\S<7<!DH0R'B#)3S!
M3,<$S=3LS,H$S=A$S=G4S=O43-ZD3=F\38>XB-`<S=OD3$HZ-R91R';C1LMH
M!PX`@.B4SNFDSNJTSNO$SNS4SNWDSN[TSN\$S_`4S^TT/GGK"#(8S_14S_5D
MS_9TS_?L3@[@RQC+1[ZJ_TNA"I-6>J+];"71R,]W^L_]%%#][$\"#=`"_4__
MY,\%[4_^--`!!5`(==`$-=`&M=`)E5`$S=`(U=`.Y5`&?=`'Q=`0)=!KHK=A
M"),4K=`1/5`.%=$-95`!!=$695$(55`/O=$6M=`*%5$/M5$6S5$:5=$$K=$>
M_=#^G$\8JT^C6D6@=-(G)<FB;+>51*ZLS*H#C"D!Y*RE4DHF#<`8O%(5%%/_
M2TH/--.:D$`M]1$L;<"D5,MU&Q4-^@CCR=("=)XZ]9%KT9XU)2[BH:IATJ`R
MQ5,#-)YMV)(Q/=,U%5,/;%-%)=-%1=0[;<`^FAM%3=0RM5-'35(9Z[@WY<7F
M-/^19SD4PNI2U+NO,@JUQ3J0_(J(KD"AQGH6*[&4E8@*\_J@1[&4\0HU<GB6
M31C5#_(MINB@<X$2=UF)@4C5WJB:YD+12@U+DM,+N["KA#DJ]@BB4@J00+$)
MJ^C'NVPQ-+&;QC(4D:O!@.-(%UF+OO-3%91!J#0N]E")XSB0[_D(CQJ,;:@6
M?"6(47$PW@`47IT,]9NJU?"'+I&)!,$@C[$5*V&"1C,8FQBF@P`4@V@'H_#+
MST(BMV"2?G$7XR*Y53@0\[*G,]JAS/&;;6"":VDRF6`A5^(/CUD%GDB(:ODQ
M)G"7'ID,.A-6*_(G5_J>U=0+<?VS'OF:DR*%+:B<)=K_5%0K5QP#5<G8B8YH
MB);8H8FP%I!1""9P,!8BA]*\F(\P"<KPFP-Y#5FIG4?IF.=@DK%H&2NZ%LQP
MG2<:C`2JBL^(D%6P)XRIB=P($LWPG7#Y$>52C&@]%G+8@BK:!#\:.10*#8F`
MB@D!"O.B"&NE"I%AF&7M"\+I(;Z%BASQ$2CJ#;FE@T;1B)(!"X<`C=(TE=&+
M&(\@C+X]B>MXBXM;TK-ZVAK9)(:(#GNJGX.8F,J0G9V8B+T8D(1@`\1(CXD@
MA*B@'AL:D?X!HBWR&YD8DVF@@ST2$:B`#9`=%8L-ELE@`V3!6P42B-.@@R6B
M"E(LV(+Q5E8LJZA@AF0YE':@_X-MX(-K';F(@`F)L)6P^(I9H(BP'8@I:26@
M*9/R[9=H'>#TW8P.N@X4$A&)W5HH$8BI0@I$`33LD=C"E8A4X@S:74YS-4PK
MI!Z`Z9FG$0B4<+1(B8HA"B^(25[U>8U>"Z:@V(G38N'(R)9I6J3NLZ14@9R<
M28L/RYK;$`OZJ8R7$)N65`R!``Y&^#`',Y?04SF&&I\_H55(02!Z$!F\X+#)
M#=T[(H@J&0P4=8@/>QB3@&*#D3IF0=J0&0S"J!;B<HP$6UZA];/P6$TT[EQX
MI0>A+#@I%6$Q<YRA:`B&>0L`6J)AT!"$(`5>X`/'>):&$F`A&H@AV@I2,1"-
M>(CRFO^PO%JB9]F*^'(5D2$',C`,?!&,A64+<2&(^Y6(<-T$A,$1*,:/Y!JB
M1\Z:;;C>H3"(A?#8D"N/Z/CCRXB*9\M99&6VV9C5Z06>AJH2[G"PBJB(<]$-
MO/T@6V,*WRKFG0B]28J.]A6PB(@0'&&8)KLT@OW($%:X,(.MN?`:^F)<A)"+
M1)KF/2*'/<4AIR()?1ZF^_JT?*Z)=OBTBCBQ@IB+`S+H1V$2XR(KV(#H/:53
MZ>@(I^*;DK'H)GKAB@",EN2D[A(V2R$UFML+K.&K9'LN@'U6*.TO<J"_DQL!
M`!@!H]H(9V6ID4:U[F!IA:NGG58Y1HC.E.0K-HA.)@@]LD+_:NW1'J3V&J8F
M*^+*YZ9V:K**:J?6GJJNZ*<FZ*G6:J8FKJG&:J_I5ZLF:ZGF:JO^ZJ4^:ZHF
MKJQ.ZJXN:[-6:[BNG.(BZZIF:KQ6Z[W^:KJ&Z[>>:[F.ZZ6>Z\#>Z[?V:L0.
M[*9>;,'^:\1V[++&D;7FZ\1^[,<^;+..;+_NZN(B;,@V[*3N:\<N[,$6;;LF
M[:E6:M.V;*DN[<0.;<_NZL\FZ\;.;,T&;<B>[=UF[=S&;<9VY.A<`$"F+'*H
M`>&.@`6(@.5.;N56;N9V;NA^;N>.[N:&[N6>;NS&[NA>@.G.[NY.[NT.[_&V
M;O"^;NX>;_-6;^8.;_0N[^LF[^QN_^_J7F_NIN_S=F_M7F_XUF[]IF[I]N_G
M?F\!G^_V%N_R_F[V%O#_IN_O-N\!3V\#!V_OUN\"3_#TKF[RMO`%I_`()_#Z
M7G`,/W`&]V\/O^\2?W#U_F\#YV\&Y_``!_`,+_#XIO#Z5G`9!W$8%V_W1N\)
M'W$);_`21W#VMG`1G^\7CV[I+!3G:H?CAL\GA_(HE_(II_(JM_(KQ_(LU_(M
MY_(N]_+T7`"1<:Z@B%DFJ`$=J($S3W,T1_,T=_,U5_,W?W,V;_,SK_,XQ_,V
MUX$ZU_,YEW,UO_,_9W,_'_0]_W,W'_1#-_1`[W-$AW-'MW-!]W,X#W1"/W1*
M?_1$EW1#5];T2,?T2J=T4,?T.-=T.:?S2S_U->?T2<_T2K]S5R]U4\=S65_U
M34?U66]U2'_U1\]T5H]U1Z]U6N]U44_U3>=S0+_U8+=T4L=U8+]T0.=S9=]U
M3V?U9O_U93?V9!_TPU5<G_;V;P=WG%E:$N2V<?\O<X>I<&<N&4/W*FMW=8?W
M>)?W>:?W>K?W>\?W?-?W?>?W?O?W?P?X@!?X@2?X@C?X@T?XA%?XA6?XAG?X
LAX?XB)?XB:?XBK?XB\?XC-?XC>?XCO?XCP?YD!?YD2?YDC?YDT=YH0L(`#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g109112dai004.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g109112dai004.gif
M1TE&.#EAJ`)P`_<```````$!`0("`@,#`P0$!`4%!08&!@<'!P@("`D)"0H*
M"@L+"PP,#`T-#0X.#@\/#Q`0$!$1$1(2$A,3$Q04%!45%186%A<7%Q@8&!D9
M&1H:&AL;&QP<'!T='1X>'A\?'R`@("$A(2(B(B,C(R0D)"4E)28F)B<G)R@H
M*"DI*2HJ*BLK*RPL+"TM+2XN+B\O+S`P,#$Q,3(R,C,S,S0T-#4U-38V-C<W
M-S@X.#DY.3HZ.CL[.SP\/#T]/3X^/C\_/T!`0$%!04)"0D-#0T1$1$5%149&
M1D='1TA(2$E)24I*2DM+2TQ,3$U-34Y.3D]/3U!04%%145)24E-34U145%55
M55965E=75UA86%E965I:6EM;6UQ<7%U=75Y>7E]?7V!@8&%A86)B8F-C8V1D
M9&5E969F9F=G9VAH:&EI:6IJ:FMK:VQL;&UM;6YN;F]O;W!P<'%Q<7)R<G-S
M<W1T='5U=79V=G=W=WAX>'EY>7IZ>GM[>WQ\?'U]?7Y^?G]_?X"`@(&!@8*"
M@H.#@X2$A(6%A8:&AH>'AXB(B(F)B8J*BHN+BXR,C(V-C8Z.CH^/CY"0D)&1
MD9*2DI.3DY24E)65E9:6EI>7EYB8F)F9F9J:FIN;FYR<G)V=G9Z>GI^?GZ"@
MH*&AH:*BHJ.CHZ2DI*6EI::FIJ>GIZBHJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^O
MK["PL+&QL;*RLK.SL[2TM+6UM;:VMK>WM[BXN+FYN;JZNKN[N[R\O+V]O;Z^
MOK^_O\#`P,'!P<+"PL/#P\3$Q,7%Q<;&QL?'Q\C(R,G)R<K*RLO+R\S,S,W-
MS<[.SL_/S]#0T-'1T=+2TM/3T]34U-75U=;6UM?7U]C8V-G9V=K:VMO;V]S<
MW-W=W=[>WM_?W^#@X.'AX>+BXN/CX^3DY.7EY>;FYN?GY^CHZ.GIZ>KJZNOK
MZ^SL[.WM[>[N[N_O[_#P\/'Q\?+R\O/S\_3T]/7U]?;V]O?W]_CX^/GY^?KZ
M^OO[^_S\_/W]_?[^_O___R'_"TU33T9&24-%.2XP&`````QC;5!02D-M<#`W
M,3(`^`$#ZLQ@E0`L`````*@"<`,`"/\`_0D<2+"@P8,($RI<R+"APX<0(TJ<
M2+&BQ8L8,VK<R+&CQX\@0XH<2;*DR9,H4ZI<R;*ERY<P8\J<2;.FS9LX<^K<
MR;.GSY]`@PH=2K2HT:-(DRI=RK2ITZ=0HTJ=2K6JU:M8LVK=RK6KUZ]@PXH=
M2[:LV;-HTZI=R[:MV[=PX\J=2[>NW;MX\^K=R[>OW[^``PL>3+BPX<.($RM>
MS+BQX\>0(TN>3+FRY<N8,VO>S+FSY\^@0XL>3;JTZ=.H4ZM>S;JUZ]>P8\N>
M3;NV[=NX<^O>S;NW[]_`@PL?3KRX\>/(DRM?SKRY\^?0HTN?3KVZ]>O8LVO?
MSKV[]^_@PXO_'T^^O/GSZ-.K7\^^O?OW\./+GT^_OOW[^//KW\^_O___``8H
MX(`$%FC@@0@FJ.""##;HX(,01BCAA!16:.&%&&:HX88<=NCAAR"&*.*())9H
MXHDHIJCBBBRVZ.*+,,8HXXPTUFCCC3CFJ...//;HXX]`!BGDD$06:>212":I
MY)),-NGDDU!&*>645%9IY9589JGEEEQVZ>678(8IYIADEFGFF6BFJ>::;+;I
MYIMPQBGGG'36:>>=>.:IYYY\]NGGGX`&*NB@A!9JZ*&()JKHHHPVZNBCD$8J
MZ:245FKII9AFJNFFG';JZ:>@ABKJJ*26:NJIJ*:JZJJLMNKJJ[#&_RKKK+36
M:NNMN.:JZZZ\]NKKK\`&*^RPQ!9K[+'()JOLLLPVZ^RST$8K[;345FOMM=AF
MJ^VVW';K[;?@ABONN.26:^ZYZ*:K[KKLMNONN_#&*^^\]-9K[[WXYJOOOOSV
MZ^^_``<L\,`$%VSPP0@GK/#"##?L\,,01RSQQ!17;/'%&&>L\<8<=^SQQR"'
M+/+())=L\LDHIZSRR@+2,Y/+0,+<<EXRLZS2.*S4[-(TM`A$"S,6\4P2+=/X
ML\LN"!U=D-#;Y$P/*^-<Q,PFVQ3U=-0&7:T0,:.T,]$NQ,C4M,X:X4SV=O1L
M0,=#9Q_4SB9M(\1*V`.-`@`5`M&Q@<MD;_^SB4";``"T0U1(L``)K#`4-T)<
M`.`R`&04M+A`;WO=>-MDM[/""E@C5',[`'#A#PDK"*3S"B28+E#C_@2^S38`
M_/TTW1"ULT'L_KC,AP2\,W+0Y`G14X,$2YB^@@1X$R3S)IW_[@\SN.L,O>P'
M$0.`X+DWY+=`)*3^$#'(9YU]18$#[?(HO(\B$"OI2YX0U:UCKSS:D(^O$1D`
M>*WX\[AG'S@`B<-?VU`G$+,]Y'B[:%S/@-<0EPG0'S^3"/Z\]D"'$.)ZA%#=
M_`P2P<TAQ(,$$5K@BL:*JDW/?B@\R`@)@C]6\`&`*52(_@8BLW9(```D<-DT
M%@"`&B"D?#%4'M3_W'="\>$O(B`DX$.H<+V>;<1E0`3<]?@@D!=&3R%0!$#1
MQA8>>M1O"$-8P]TV08(%_&T(-6`B'6#&B-X)A!)+(,8"#`>`!0"-$`M8`"4$
MLH05J#%^/%Q;%E>@`W\\D!4D`,`:<G<[`&P`@ALHVBYN1\5M))(,->L>__YF
M247"C!(2T,$05N!`1R*M'20@A@XBQX@%4(&)`ED!%4=)A06LS1_C8"(7U#80
M'=01`.,0XPNIH#]*.#)Q!?'C*-=G1W^`KVCXVP#2Z"'+T97.'WC4(_=6($8Z
M>(T/I1NA#7=!BU_2@0N%-.00")++'H:-#M>[X@,5.0X23$,"?Q,CXOA8_\C`
M$8,*ZU0G#0&P!`GTC!`DJ,$UL[E',5Z/DXE<@P/I0(D-,&,#B1O'$'I8M!/2
M80$;Z-Q&ZPBT-DK`=ZT;@O6`9KOK/7)SPH29&&M`.\K9<@.BRQT)EJ`#">SQ
MGE18@309N;9-+*"C*R"HUZ+H#V,&-99,_)L_Q+@"NNW"<!F$Y_7F)H&J];&6
MM]Q&+7>YMAKX\#E>%%U2-\&('NY"!X^L`0`884PJOG`4=LM@&]&XB27$SFN,
M(`8E%E`UN6Y"C+N@QPNY4#27&7,3$FB'&(T&`$)<M7BTV,`&>B9.`.B`%47;
MP!+&48.`QE("NR`#":*V@2%LH[3.5"0M;DB/=O\P8AID>*0-AT""3>Q"D:RH
M(SW2Z@_#XJ]GC7-A_03"#%_F<ZX7I&(Y?0L`)PID&@#815NK1H\%+)(+"_"'
M;7'[2'^$;G3>"^Q@"SO7NOJ#=:Z#'=P6VXX+5@T`5!S(!FC:N'%LHW&$Z-P1
M84>)'2XAE5Q`;5M[9C<ZD*"0+[QO?G.GR"7@;0-\T$%Z!0O,;>"/$%X3[6O7
MR84'<\%Z>V0&);8A2O[-#0"4V$7G5(F["^(5OTV5`!J+!LG-%C=VQ_7'"XG1
MUN8%-Y<2<%D[YL@*7[8#NY^50.J("T1:;.*B1<5>%NTV#>S:;8]#'NPX0$>'
M>X*X<50$XEJ#G-P71H[_"Y%#ZWE)Q[\]LJX&WJ/S>?T!2W\*I(+T8,20T5OG
M31+$=618`SS]H6&!M+5HFHS?.%ZH/[M1`8Y:S)Y<;_BWP%W:KY,&IB$=YX]M
M$((,"WA<\O`7-28^3G2:/.%Y01?GU9&:=<3U)1]:>=8_YV\<R]VE/U809U.C
M>KCUH[-X&0'/L`F5>ZD[8GQQ=T+L;J*<C?6'W<(&[$4:D\>^-EP.L>L[<G/O
MK&*4`-"LC>V!T@&RT&,&GBG';`"$#8B>QG0P15U$8A""M_P;!93!74J!N%(@
M?;9W,KU'P!."5-"*'%]/(1B]\QKS=;B[G'E%9\S!L0*A')=?_*8A2S[4P-K^
M_WCX"_EPP350(JGQ`QH08XV[@]-Z.EZ,',WM#(!A,[QTRY6V_![X6SH$-VPT
M_YOUI)K%;3`CE#T'X<RO&;A]PRQP.A`E%:H6R]*1X)%8UX&%)4OJ(SX6C\B.
M\P3?V_.<$UK6D7-[]M8N0+>O8`$\7<(M&>E97^:0XJQ8`-(>V];'Z3QU13^Z
M-6.9.O@"`.-[7'HL=0#00VO9XO(KI6]=!KT4]\^#]&`B"?1'R,K#S(MK`'8-
MPDO`Q"N\XTWM^]C%R'G<H9H6)3;T6RM+D,O)7>B#&P@(DVY>$@Q!['N\+@!"
M*=?B$??B!&8[A4->-(7N(HVQ-Y^DU\"[U.,.A\=?`O\KQ!C^R`$1]@W_?MSW
M'!WB[ESZO@1;_1J'<=%%48S0=)SUD%ZZ:O-^($#D2^$5.+1`3=>$9TOU>,&U
M!NTP9C"&2U(%;=GG1;XS#IT&8ZC4<_-6>,05/U231\@&:ZES0JN',\OE,O@W
M:J_F#T5F-&'C,K]%!8KF5]-T.^E$0(6W<80F0+\%-'(E?V_6<]/V-]B50=CT
M4`0!.J)S0?>6>2HX$$6$.O103GMD3.B3/&UU1106.4DE@BJX?]I67>*U`!7X
M-VLG:Z)#!2,8.^,P#3<W=[?V>+`3<L'G,@CX=KCS5/Y00@/15HE&!TGE-><U
M0M&G<0M0`^W`1-,0?22`-T#_U'308V_1%U3GTP[0@S3,D#AVDSA39VAR98*L
ME'S.X7;O=V<]Y%G<U3AWDT6#LPT\Q`P9N`0U@#3$QV<1QXI[N'PNHU4ZP'7E
M-(#88TP]9#2-E%.,5VIWXTS%F#L;55H])T=W@X@ZF#NB=SLK2&>=1UF04S\P
MXXJ/1WL=J%4P)!!#4%[(6#RC)E57%8WMX'ZILPU)=7Q(DU1RU8O2-X0(5S\[
MM``S)!"[D$CX)$7!QW8S5$0L5D=K,PX2$#G&E#C8E6K*<UXOE#B:U$GRF#MK
M18S7@S>-XS4G9$RNM$[0PPJ_A4-<9VM*QD2ADX`#27$2X'.&U@Y^M7S@1CP#
M44X9_X1YD$>0L;<!3`0T8B1:#*EE(^</FN4/*)>(+E4T@X5!&%E=P04TQ+<+
M/-0X.G=-S[$-7C,.6..&XE4U'C0--?,Z-+0-,M.&E%,T[8A+44,/9FDZ7FDZ
M;UEJ)^E?8\E=8BD0KX,U3W:2!80U9)D[BTA#=GA-[5`U@-F/6GF8>KF57:D_
M'OF`[*267*>5`^%?BNDU?!.8=CD0C)F8I88U]*"6+L.5HPDSC.F6UZ4_HZD_
M..4V<?F5!<&892DSH\F7S-"-6$,"QC@0VQ`UAUF:HDF:!127H\EUM(F4NHE+
MU^4RKZ,SR4F7M6D09,F5N3.7=&F;>;F956.9M)F7R6F:X/^FE?0`G'[IEL[9
MEMCY.C/T9)WS9,/UEM9YFI13:-;9'4KD/%.Q!,>771Y!#'X42@PT%(Q01GZI
M02-1H(1%&P"Z!!N03N!!5YX#%36#>W1PH`W4$'S`!1$8%)/C,JS`!4C#$JQ`
M!2,*$P.*H`N1HBHZH4.QH1WJ'WQS%"R:H311HQV!HQZAH_S"HW#AHZ,!I.LQ
MA;10I%`#8N*C/+2@/V@YH07X1,_C.S!#3HGE$#HSED.4I,##0`Q$#$5*.S[*
M#.])"\U#.8/3#LA$0Q_!#&(Y89[IIBS8DDG:HBLZ$D#*I35"#\0P#;.8FT-0
MIK\CF;B70HH%./V8$8-:FB='#!+_=1&;4&#F8X0&$6`0,3FTH#X',00_`VX4
M00_R-J+,L`;;P`=IZC.B(SQP"A*[D)L0>IFFY3)<8%T,0:D_H3.TZJ(]\J?D
MN`W$,$.\.ILUL`1>DZCC\*3TL`DK@#1S*33,A:&96)K30`PU10S;D$"N*A"$
MP`BC.9C%NI7F0ZV5R74:14/(.J(X(TDK`#?-RESC(*;B1:8#L0OZPZ9+BDM<
MP`6`Z@^Z.A#34*7/TZ[MV@[RBI2R^CS$0`8CN@9(DTL%00M<"*?TH#1TR:W$
MH#/G^J^K&;%.-&;CBI2C$#7C(*S^&JL"0:TH]*Q&DZXP`XOKHYG$D)OO:CH?
MZX]<5[&F_P.+_BJF+$LTUZ66JWJS,/L\G/>"UZ>NSH2A$<MC[0"O2-D.)HNF
M^6HB^ZH#92:B>\@'S+!UODD%H^`[@^I"V[`&0$,+.E`T0]".9$`+O3I5K$`)
M>[>'N]!7SM1;)8I+.J"V-5!K'4L'>#4$B44+?#`-:^"&.31^VW!+=!!\.C!A
MM'!R2'EE2R!C->!$1D<)WT4%4T,&C)!:XT`/9$`,%%5<:T`,5IMH9[.O+$@)
MH6HY8EM/5W9JM$`)DCH0),NP?S:B+D,+K_2V@,,,?!`YA!"Y3\,'_]0YTW!E
M0\`,M""E9/`VO@N\OE-(Q$"29XM*JHNP[]4S:]"V;TN2<LNGUO_%"KZC.4@S
M#;N6.``:-;IKA$/`O*A)`M>+7&0@IF)+"5[K0WP@NT43NY30,X+K#W10I&L#
MOGD3NV]+"XD;-J$ZJHG#!9B["9I[L!@JM5BC`T@3HH8$.'LWKDO`JZ*34V&+
M2P$U!/1`"-:U"5*%N=D#,R?67`C'#(R`4HQPJN(UBVZ+31DT#L5F?F1`3%/5
M#I*5A$O`!Z494#`SJ#H0-2C,1SI<@=)(")3@6^*U3CH0-KJ+PS&D`]<V#<QP
M2X#[7AG%.=@49Z@+JSVS#>MDQ@0!/32\0>M$"5043!KLF3X3.8OD;^.S3C%,
M#VF,K;XS>LZ$-YAK92],Q]FKKS.V2&W_NT>,4*2^8[_J0P>I%:6^LPM4I&0K
MX#7_!,9"1KEAPP=K8']_@[7FVSJ._$9GI,0I?*:8-!"BFCMO-KZ9C,4KLJ^Z
M2@N#^UFC`,J764CCQZC,0,-GV[%_.EISQ[>L$$>>R0JL4`/,0+HOO`9.E*AV
MR\5>0P@91,VZ.@12M;E$-C]T$#EH/!!<$\KZ6C5<@,RN)<VE%E#9R@6,L`FC
M<+:N!4&BPW((8<&PB,T%1&(]T['\C,@%007_;%JQ&KL]H[M4D*KC,`K(RH+9
MK,N\3,ZC8,X2=6VEYM"E$\.,YC/)O$?I-*Y<T,7(K,R4PPJC8,'GW'OUU=!\
M-F;WC*8R.57'_ZN\[1#`OAE0(MTS^\H(&41-Z[8V<;=(WI2VIKK2Z3P*R4PW
MU-RQ[Q6J!8VM/ZTBMJR^8EL\8\9.Z$@&?'"AM<8%Y3G"[7!BV<,%&766M\5G
MS!#,JP/51]W/JN/3SK1("+>'9,`%FDP(Q)M"U1M0&(W$46/6N*3&`,T(5""6
M^G/+2SC5!;&O;*67'QS5V(12J+LZ":L_J=>`PZISC`W#4:/'V8PW60V`"2TZ
MHT`+A#":C.`UA<31>OS)OJ/3A82Y:Z`^G>N9:4VRE>U;?S,WMQ18G&C)1H/2
MSD0,?-`Y';O3[\5U\3S&=/UN1AAC&<0'TSQ+Z)Q1(90\U#@09!"VDO\=T%2-
M-8KM#^)7:F>IT\0&P'\#Q5,\7"3\3^5I-$O@G/&*U<Z<M0CWLB0L/,;8L2X3
MT'R+37^C`[:57V!4$%6SR>UPMGQ\1Z*3O$9#PJ5VR..,392`P?%=SX,J:+E3
M6P2!NO,[54A3N^[,OF5*LBQ85+5VU)HS8<SV/!MMA.5]V^0(-!LJPGJU-LRP
MT=I*SUY#!;YC4%.5053PLO,]X?Z(-^V@TD.0EWI)!9P$Y24;N<[DM[!\R61P
M2VHI`8FS!AE$LI/,UM,PV^IC5(.C2NKS7T#,!54#X;MPY)0Y53_55!DT"FM#
MT.TLU4B.(GR@/W00-3`L7FW;-6\Z$/C\-/W_>Y-]?MS/LPE]WNB44%,(;-S;
M,`U&R`CK=N&/33EOJ]2FT[8,EC@E7#7@G3NQNPGZ`[A`S`?R7&YE!NE(@^GB
ME5^;@+Z4H+I"YI%&2`A_0]8#X4V>^:AT$UBXE%_$G>MJ2NS^2`F8NL8H10]+
M$'R.#KI[B*F(CNJ7R>KB^V=T,^UKP\P`_#P!S`B)0P?$<&TN(^O3<.N2;NY8
M*^YUR.95Q&-BI61K)!#LW%1.E-HRR0RC8+.X[K&LL%1J68&OVKP%A%==20A;
MY-!`HV*Y$[>8RC5/6F#B982LT#.I*BA&31/;@(YOP:+G;F4H3/+RS`HHK-0I
MC](HS/*UWK4K8&67__KR+4_SS'SRRUL##EWR.X_2*E_K+'_S*%_K)4_TUW;T
M-(_T*'^H2B*D(7%8-DH2I5E3=AKU(!$W3I\U7`G$6\_U8^;U8-^`7S]FS<7U
M8C_V''OV8[8+R6OV:?_V9R_VFCWW',N5=6_V<G^?AN*I6?\;4;L0>F\S@C_X
MA%_XAG_XB)_XBK_XC-_XCO_XD!_YDC_YE%_YEG_YF)_YFK_YG-_YGO_YH!_Z
MHC_ZI%_ZIG_ZJ)_ZJK_ZK-_ZKO_ZL!_[LC_[M%_[MG_[N)_[NK_[O-_[OO_[
MP!_\PC_\Q%_\QG_\R)_\RK_\S-_\SO_\T!_]TC_]U%_]UG_]V)_]VK_]W/_?
M_=[__>`?_N(__N1?_N9__NB?_NJ__NS?_N[__O`?__(___1?__9___B?__J_
M__S?__[__P#A3^!`@@4-'D284.%"A@T=/H084>)$BA4M7L284>-&CAT]?@09
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MGU[]>O;MW;^''U_^?/KU[=_'GU__?O[]_?\',$`!!R2P0`,/1#!!!1=DL$$'
M'X0P0@DGI+!""R_$,$,--^2P0P\_!#%$$4<DL4033T0Q11579/$J>DYZL:,8
M9YHQHAJINM'&@G(\B$=_?-R1(B`?FG%(I&XT4B`>DR2)R::27+)%*?MBILHJ
MI[&RRG&4S#)++(EI1R`LN_1R("O'9&9,8K;\D<PLP133S3,'0M/-;;AT\\LP
M_:FS2V*FH=/++MFD1]`N__?LLTM`!9+32D+EU#/.1A?UIU$M\3QS4(&VL932
M.OM\U%)$KR3SST`SS3)44@^5%-)3$V5&5469@9//3LVT5%8W1YWTU%4=Q51.
M7F&EU%)F[FRST5JQA/587!M%EE-+@]U53&+R3%.@<=)L-,9?-?5'6E>3_;;*
M/4EJ1P(`UF6W73(8;3?>=3<1J`9YVZU!H'86N)?==ROMEUU*Z@T8@'Q_Y#?@
M?XDI&("!_;$WX(/3+?A?9AJF%^*")U9788$8+CCCB/N=..%^+<:88(GU-?E>
ME$-6F61].SX97I@U7MF??2NV.6"1-V:99X!O'OG>DH6^F&B@=6Y9WI<#?KAH
M>?\/IJ?I>/\EH^`%P@09ZIB-%FB3AIEA6NBL`Y:`ZX8?+FD32C:!.VZX*2%&
MW[??EGON15G!.V^W61DH[K[QIMMNM_.^>U%:^D8<\!_]EIN270R/7'#%&8^<
MEL`Q)[QNG0='_'+(W=8\;,CO]KP=S"/?>_2_`Z]<<,_'6=UR@18?G9+2Z7'=
M[=1KUUL@OG,OW9_#8R_\<\%#OQUXW97L/7G5CV?>G^%/=]SXY2.?G7/!D;W>
M[^<?=UUZX-W>V_GLH_]]>]O]P1U[Z.?>/OE=SL]X^MQ%/[WT:58G7)AX5S[/
M$0-_E',?)9`U)0:^I4@$B=*/E-2C"0(I1Q>$X$)B9,'_@7!P@@C98`<-4J,'
MCO"#$A1A"DT80A6JD(4G+&&0/NC!&*+PA":\H0U?&$$=XA"&%.QA"WU$0AEF
M$(41?!$/7UA$"0[)@S;\81"9N,0,UE"&3C0B"'-81"15<(OTV&`-D]C#$H*Q
MB5`\XPRS:,4&MM&-;[0)+=@T#L#M@A&`NI_C6$&O;3`";M:C!)O"18A-O(@6
M`MS$Y/Y72.W%:!S%@V,D"4((1H2-#O[8TB;&L25FT&(7V]B&X[9!KRT-[$6[
M(`;OMD&'+8VB'<3813OH0<=1;#)CE""$)'6Y.3#Z$9.[R-XN=I$Q1HX"4-O8
M1?%@R3M_U)*.CQ,3+;9!"3Z0_VT:F\C>+B,YBF1.8Q2`0R8K7K2-43#3>"_*
M6"@UQTUBK,&5S=PDX)C9CD+2@P]<(%LA,Z;-2&Z"GIL8Y4!JV8[2/6Q@Q(!D
M(;?1#E0*=!STQ"2]:/$B1H1I$[3@PR:H0"E^NI%>V&SF-@@Q"LT1@A*L6"C<
M[N1/^+W-<_X@QDM16JD_CH(/K#@6W";WN8[JTHQBVL:+VK&-:;SHH1\<JB#1
M.)"@Z@R482)J3Z4Z5:I6U:I7Q6I6M;I5KI;(24O5D09%`J6Q,@2+#OEJ6B]"
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MP0LF\(`A#.$'W]>^%;XOAAT<805/>+_XU;"'-PQB$1M8PR?F<(@M?.'TJIC$
M#E[!NH:`$BJL:Q2!;5$[8@R`G:)+70<[XAJ]&,00BA&*+!S_XY&CF.0@&Q')
M1!YRDYE,129+N<EJ=.&0RQCE&!9YR5RNHI.U+&8U;IG,7L;RE,N<PBX2,<A+
MA#.;K_SD+LMYAVN^897IG.<OFUG.;_ZSF@&-91&Z&<V&%G(:S2QH*-]YT$I^
M8!C]L8MYF81B0,;QBBBVSY%<.M,Y5I<IF_3C3[.('NKBM$@\76H5;=K2I"8N
MJS%T:@#0*]836;6L3T1KMHV$UIC6-8E<79)<!UO8J'ZUP8QM(EJG.B3%7G:(
M*"9J7Y,ZVB-J=K*!?6T/99O8UN8VB%Q]:XE`.]P<&O:H`;""<X/(VSY6=KL]
M-&VPR@C<\M[0NSM];WQG2-]CY7>__R^4[GW'6^`9(KBJ`WYP"F6;W!$Q-\,G
ME/!G+USB$>*U27Y]\0O]N^(&Y_C$D?UM93\\Y/^AM\F)9/&3,\CC((EXRQE$
M<9BS7.8)>OE'8GYSG(>ZWAS9.,\?1'.=VUSH!2*Z1W9^]`+E7.E&9[J`DFYO
MD$<=00Z'][:MCO219WWK"L)ZP;7^=:EW7>QDO[K/58Y6J*-]/U/GR-+=SA^G
M=\33:Y\[>^"^D:#G74!A5WC5_>Z?<7M]\`'*.,G'?OC\[%TC?6=\?^H>][9'
M7CZ.SXC<A8/WC'#^KA6)M>=9(GK98!XCFB<1Z4NB>O6D7-V+)XZSQK$F@F`)
MJ<Q(XC0XRO]4VO=H66BZ4Z%V3Y!MF6L@LS]7MCI8I1FU`UATPE+SKU00+"FU
M]HMRONZ9;ZL9<8H>8])^K)"_HU@1Q/E-92KN"^)\]2MD6V':U@(Y=2XNT1\Y
MD]\(ZGLS#1V0```+6`.&(8$8804`H(*!8(05V```V`#`68"M63__F[&"8(45
M\#\)R*6(X9=\N9C%.QL&7(,768-:4Y('/!?C`H`;"QMVD8`E()N=(4&!H(-U
MP;1I6)=+,K\E6($'S!>Q61=^J1M[(9L7L9==6$!VX1<^X(,8M!X+!``,E*`9
M!(#Q(A@JA)\CU`'[*XBLH9>L68!%&4%;:\(+Y(/EP#^-T+_=H(3__Z.#H:*7
M&8R:*?R1(5@WP,$I?S#!@BBO_UL@?QC!#:`$>B`&P"G"60J3#DR($1R8)0"`
M2N)"EEF`,:HQ`.`""1*;2AQ!'?B1CCE`@=@QJO$'1E@7=AL(AED`+EBH@;E$
M3)(EC:%"(?P12JN!6?+#&/S#0$2H@=BQ2HH16-26!UP39Q.A,/2'L_D78JQ%
M0*R4;#J.PCN[XZ`'_^NQ3>$7.J)$X:FZ?8%`@N`"AP&`2WH1&Y0`Z_-%>-&Z
M%WE$ALD79*R:2-07`^S&11&;-=`9"8C$JI$`.E2;&L,T$EB!);RQ%V'$7C,>
M`*!'@BA'7T1$="1!<;0^@.&#&I"`,=(!_SE<P8-4"!$DP:SQ/[(A1AM<@(=,
M#M-;J\K3#8:IQ!LA!``@`QUPQV($@)=*(GZID7%8@`U(%Q(8B#4D2(T9A6V@
M/41$"&*DM!G+&D+@%%/<DS5DA/*JI()\EP*<L7T!1!X+Q5HS.(:A@FTPP%]D
MMQ"Z1$Y9E(JD0K(TQX$@1IY$HZS9A27L,5A\D8M9`#X0R8)01)BDA`U8`IBD
M%[5D/=@XP\PSR=R8QQ[910DJ1TBLD<+LQO$BQAK9,7X9&*$\B*PA@TU0%\WY
MP(1)&X()JG@3&PE8@19\P0>T07JL@16@S*RYL1@[1,'S01JLPH%0R)*KQ2YD
MPH'01IAB2=JT2/^!6,+_Z\EA),$1Y!L`:`=B?,3G<+UG-(["S!&QP<F!,,L*
M>L`:L1=_6LECS$V"V05Z:$7*-(BLD8`-J('2&<%*&JH\I#02F(9MB+')$1L=
M6,(:V)+='`(2&`<`0,IX&P=UV85QZ,;)!#ETZLVC<D7?'*^+T42!4$X2#*$U
M7`).>4`V2<Q*F<2=XI&[?$2#7$+<%,;D",S3&TS<L,$-"+Z"$,_M7+\\C,O_
M:Q<(+"\=N)'$%$_B3#5VO$Z83!A^J<3"K+$;VYF"'$&BBK<U;!E2]#]((M*"
M,$LBM,B%O$WK`0`:+0A[Z5&'F<T;64.,K,R-),&5I$.)JM*_!$RS`SC_P1N.
M&MO*33$3D)L&?F&I=I"E'7V1&2RD+7E$'0,`/A"@.ZG.LQS*[D1&;7R1\GRH
M]90`J`28?,%'\%07=F-0@:##5)(E>P&4^E0_0"E,@EC%JYQ`@&G0*>53/]69
M=K#!(9@E>BA*@0A43A&(;K0U.L@ENRQ.$AR'(QR84KW/32*#X0P.DK2(--R-
M$5PW\WQ38",&>Y&`[,1#`/#'#5@#$GA)^`&`"1P'1ER`'7P7>XG6`Y3+%5#`
M[-'(?6+(C*D:`&@F@R2(&J.%`J1'>H@Q0/F_%XFQ2D1$H7R1E<1!1N`7?US4
MT!17]Q2(&MN`&-N`NGE11^5+;='6':35W/2__R"$5@4D@SAUPKWDDVO$T8;U
MAY6,P6S]OQU<`ZZ$/=\0UHH@UMT01#ZH*-T<J1&B)SIP'$I@!$(@!#[`)4@:
M!T9X626A!3I@I$VX64(06DSR63XP6BN<-#[8O;9<%'J@A(%A!:2<H+:4)CXH
MG;8DFZD5"*C%)$*"J6JJ/4+:H&G(64"9AJ3-64'J(SY()?,3VX]Q6@@*VD`D
M6OH;!4*8G%&X626D%V;(V>)9PN';!4+`H[K]$5SB*((ZVG9@!&8<#L!K*UB[
M/Y4PT[N($3K`0?-(68I8V=[HHH18-!_*HARBHA;2J].-*QY27=1=JKZ**])5
M72:Q(B4249]3/,LC//\T_;B3Y5WY&-&25-/@K8_F##S@U0K6R]RE:-Z<\"NZ
MDEZ\ZCP:X;N)>-ZD&%Z+V+CLE0HS]5ZY@L:V"+VRV%Z5+=&GR#[=&Q-,8H9S
MT3TQX2@LT4*BLCVFTCX>>4_B<Q9].99"Z4/OXU_X?5^$R+X1*N`!)HC^O;Y-
M(9MM85]F"9<(7A3[+:HM,I,^#)?RVY0+)@C[Y6"=N9+HV^"S[</XJQ$!AK[\
M10@&EM\TF89S*108YI8PB5__O4\8)N$/9I:'+!0M_)$=%F'Z);XQ25W=5+\-
MXI8;UDWMLSX!MN`:B6`7%N%D85_CXQ+K8Q8-%F$NY@IG3%ZPB,UV6:48'%+_
M>JA7G6'$_V/&D=F`IQP9$N"#&6&%BEP`'2@=K@2`16'$6.*7"H;6$+K+=ECC
M!6#2*UP7*]49/O"_#2"#%'W,1CT^'7Q`&JW(,HZ712V:@W%C%^P12HBQ!5B"
ME_+67OS-F)$`*K"H>*'8!04Y*;3"0(7!=6%:XXFQ5'[%=F&;I(D7>OF_/1&;
M=UG#=F':D4GE/6D'1G["1RX('PS(@EP7TA2(#]P`'9!<;2$#=9'C/>'E)]P3
M`XWF&F`;6(QC.A"JEGD7BE+`=:,#J]E5998`9D88=A%G!$R82@2+S\7>]'4*
M6LR:@;D3';W'/,R:,OS)*^6Q=I!&C8DE_S,H:`4E_X=>P7>AM(,T+JPA5#"]
M)(!JT04(1NIDUS7<`#:)9*$D!A]-17\PRW&@AT+<$I?>DR)LAVX$@$,>P1D#
M&<^)F#@<0M^,)7=EU$V:34G6Q75YRJ%&F`58J(?,&E6EM)CTSE4E/G]8PW?9
MDG8$YMX,9DQB:1&JR)^V2I4.:094JDG$9T8=P8.YRW9N1(/(52V]:7.<)>M;
MQ;SD6').:(G6QJ6.$3HD`3N$DZK&I!>A0WH4Z?LT09"9'(99@6VYYN7UW9HK
MWJU`QBF=9S"Z3GP$X@3=:GNI&^CTOVB!5B6)L0H$@`6*,3E:MPQZQ!T]B$Z5
MH/)*R:NLU<H6RAHC2+A,4/^D'FI1!#:N),5)`P"-M9<-V``H+6:HWFK8'FK*
MO)B(G$@%E2!#/0C@'HCR(NY3%B'H3.H866YVY1%8W.H"/.N5S*4D@L<]OLAZ
MA,#EI+1M'(@EY$5_Z$;`44>$Z-1M`,($]>PFU4;Z*T!@,]!XM=;RYD^F@<`'
M#=$O5CO#^XIRE:`11,II..F!=L>*]&2#,$M1+$-8K#%Z0<D)ZD;/>6\M'0BI
MS)KA(T8,?ZD)DDM3G6:HUI9X*VEEV\^OG*"$_$U[^<D$]L5V6,"HI6HM-:,=
M?&FLK*0+Y?%QH((%R"<#A&""0:EI"/"!8$NWE.X2C$D5%@B_]$3D],GY,PC8
MUL;_/QD'%A4;*H@_@UCR)B>;K%%8G3$XIG3*]99*!X50?Z##9R88`>+-=[F8
M%1#+[09O?YA!U)1##R?!,B=B.#>BK6;(.&^'DLOL&/ML!F2DL#A?T.5GJ(CD
M#T1"S(;`DUZ7);`_>Z&D_SMR"]P`<VY2M&1"9A6D%S'K@R!&4A]N+93"!7B8
M0,7JAEU8467SWWQ2G*DTC2%E.8R1RN;O/>:"!1#KGHX9\>IR?/D:V93S1668
M?]GM>B1F@F!VLRP:3AOPZ;8:8;9VA.87:H]VW71M3)UT4@S-&A!ESXED9O_U
ML^SFS@R<0N_L1(=6$MB`.2X;=B&;"UUO5_W-=L1L@]D`_Q)@FS7>@$/>BDW?
MY\G&"@C7R%W5;PN/D78@A`6<;8*1`&G6&#J@PS*DTG3&<SUZP@-?X'5I\0@/
MV9#O38-@A@S5\]^<]..V;$F^T79';I#^SJ[N]ABSP@]%2/7&5*[<!#I,;C!9
MZ*U&T*\&(UFL]@EEA@I%ZKUNAUGW!Z4W94!QZ==FUQ)4ZC`1;*K7PB(<A_C<
M>2JDRE-:M_<LPH+4@1FL@3V)9%D]H@V`[XN9L0XT1$(G<%'L5H!'^3Z%Q*"R
M4&4W?`FJU`YBP++A@QA3P=NIR'',Y\@N.HS/BGLWX\S.P^,K?=[6F!AFP)G4
M224!_#`!<H^>5P@Z?7#/39NLUO^"0/R"/&]K/<@:/Y@E1>A<[FDEM\@";'T)
MNI@#'*=X@\4E.%CM%F^M/OLL%THL_4$3UVV&/XCE9RKGU^X)(O/2_VXO'7Y&
M%9O>+Z^#],+L_U%V#5(\SQ@;/&WBU)Q])<&@3_AHK.EF5WV?!PAZ"Q:T\V?0
M'R$`9`XRW`1@C3]Z_AP2BNB/UD-_[0;ZVP5@"4.#7`!L"FGR),J4*E>R;.E2
MHP22+V>>;!>S!LV<.G?R9+A&IL2?)2,.I"=P@41B!C'J"*D#`#.#$OT]5?J3
MDL&?7$0"H&.0$0`^$P%L/6B3X$FA_I1>!-"4X;9I!LG(;+<!`"M_TV)&]:=6
M(C.W!OG_`*C15^[3OE2A'DSLE#$K$F%-#@%0L5T-F8NC$@/@6;%$QU2ZCH4H
M=;/!P#BG`1A";QP]CT,,.I8ZL.#)RI>?#JU]TB%$B?0DH"UMW&1HQB/%VL6K
M]V[4X1+&M6NW;8&$L0L#OU5+K#(5DX$ER,6XH2!WE,#UCEQ1T'%FJP"PGIV:
M>@')@M4-KC?8/.]>C`DDP7L`*,7,-A%EIEA/#3KHX'!`/;B2385->"&&,TE$
MUU!^:7:440"@-80$F4G`UD$+AJ2B;`?118)D:R0%P`I2K3"?11L!8-]I'/I#
MHHDHWK>"9""E=F,-"VR0UX8`;%`#"4-T]I8_C.!'P@H;T..;_XH&949"#1N$
MY\^7DBW`R$GC+$'C76AZR9@_H\&9(@`P?B210Q*L0&147:KF88?^2-9GG6%R
M<11N)HU3698`N$GFG`SAF9%_^$WET$*4`*`GD7(Q5.9'!S&#)'9Y&3?5:+2P
MDA$]-RI%UP8W/L3C0:Q(4"*-;/T9TJ2X?C0.;8S%UU%K&N&W0@T2B.4/,R9F
M-E1_1Q96:J4`%`061`Z%25J&W7IK4H6!?NO?3>.:^^TN?'C:D;I248*5/^]*
M-`XE?%"2Z$&C$`(L0_H"2P\EC-A'#R/WULK'+J(2`J]![Z*4;H+TTF$PK]/P
MP0<M)DU#1\(,[<(((1<S,@XA@=)C<?^[_N:[;[X@7PRMR]O@JR@AHX2D+V[;
M,#+RS2YG;-`TA##"1\C`;D((;NW4'"\C^&["AU*;N,Q'2?*J-`X?-C?$,DH6
M=QR1PT`CS*S01//!;\LAF\K0QE_[PPHA"1Z4+BW;C,UN5+N438Q1*A%#Q[K^
MD*RUQD+300N/1P.+,]@",QWRX0?1T\XF:ZSMM<9T"!DO)1(I/52Z4)\[^H41
M,GQNA#B1OCKKX]+:NDJONR0[[+7;?KM%IY6.^TNT\_Z[N>&N7J'JP!O?DN\H
MT9Y\[I+S^OSLL3</O:0\+I\2K5-E'SURT5NO^_017>]\^"N]SGSYVTNJ/$W+
M#[P^^MBSQ+S_[-HW>+[\QQL?H;CC$J\_``,HP`$2L(`&/"`"$Y@3X9$N=0I\
M(`0C*,$)4K""%FP=_\K7K?]=L(,>_"`(0RC"$9*.@:/C(`E3:"[\42]_YM-0
M^J#WOO?E3C@YB1_^DJ<^&\+P)#247O=\Z$+PJ;"(#8Q)2>+7H/\IT8A.?"(4
MHRC%*<[$A*@K%Q6S.#\^D$%(E"!#AQA!ANJL80U]V089L#*.-!YDC8]:"QGX
MP",QHDU2?%@#'>2VEC+"BQAD6`,7R,"%!#%B#600)".(004NX/&07+"85^C!
MQ9])D@[V&0<S#$F,F;&-"SP[B!\-R85E26H35.`#9ZAP2#J(4FZ4_Z/"+K*W
MC5U081/7(@._-L&%DK"""VRA!QWD:!%ZC((*B&/(%]$F24":,5'+#&0MJV1(
M,NP"7[WL8A.UZ$33:3!#*-0F.!FRJE#1"0">RLPT6$/./_T),!8ZR)J<0R<&
MF24FDS%(/%7GD`TL80@ZD$MF=+"$&G"L!DNXRPKZR0SB&"4F6B(*4@RRB[N0
M@`H+*$M(II&9(=S(*_QQTA)T8!K)/44'"7V;01$:4KE00DE+P,[7QC$:"2QA
M!0NY453`L@&YJ,58Q6DI/Y7TM2X9JS4W6@"\=#2$@:(IH$\A@=SHL@*39C.<
M*;1B\+!H5:N.A`33*>="%K.-;7@&``ECI_]@4I-6P4E`,@N9BF.R1YRTCN-6
M[XQ6L.@)J$I)H*&>H<]MB"6!G[5#KY!*XFC@M9[7:2J2/.KI6F@$+&(,A%^9
MH4/2%C.-<6R*7ST]2T$\LH+)5C:ODKN51&AQ%_HPE"&.^0E$6J21K88S@R74
M*FVU.)PAK*HB$LG,:``*@+@4)DK,LE!ZW(D3B:QJ%&O2(U$EI:31%*0S/]$G
MI>:YOL]::D`ZV`!$"T*7-YXD,!CE;(V.LSZZ5&2]=?$'71(F$;!@I3-&ZAND
M1B$9FP7E0X&-KT7`,A2BTD-$N$D(2!#U*<9@:BQCRBTXL>J_<E45PA]L;(&+
MEYF)A@>=9.4M5%C_@Y-='5?#PW4(PZI2$R=AI"1D6(!'L+N"-5"AO9E9`AFH
MH)3^#@5$!=Y`9[!B*7\0IR!Q2>?ZZ"`A2$7%(3.N<4@"4YB?':2GPRG.<6>C
MY/YEYED,H<L0'"DBB1195,5BLEF*8A#.]E4@9!%D@C+#"F9`1R,4W42%+>S!
M#.:Y?;C5<Q37E+#@OFD;FMK&4XB+DPT,0<0E-O-;',W9V;S)L`4F"#^)3`6R
M8I>?-3!-0`>:,1[;)J(<L>@XBG)I\7HFHJ>!+)HUQ4\=A%6<=U&(3S2S$2S_
MR4<K*NO:X$NC?CX%*0I6J^I4))PQ5\K8^!F"/X7KF26)2E8UZ#.@*2@\_VR_
MY)O9=J)'+KJ&&X5510^IS#0X/19-C5@PRIT+C0")GXY%5W(<6<,"5L4*=:NW
MTB:Q<G?Q<UQ"W$4B=_G7-`+;$$?EC@1HP2MR-A&3'>\U6/\B%D0(@R;[9882
M=QEUQ4&TF(M[Q#2^.79GP"OR>3J$TE*AQ8VPPNUO*Y";MWTGS9VHY"6$U*(/
M51%A8J+HB*R@7&0EP516%1YZ;&`!5(!V93Q:[VH1JS+M<'2_T1P2[CH;+2_%
M3D%^LJQ=TXJS#WT;63X:G"#NE=3SO:<_UI2QP"Q`CX76%`EPP_5KP5W0_BXU
MJC*R:WP]12Z229!]()YS$DKX6PY<O!$=GBB_J_^H.>;DMT/>J95MC.(S&#\(
M6=,KY[C8G>P.W)5#J(!)9OP6+]M`D$4`'E$#'Y?VX[@1%:;!#(4S)"$UV(9#
M%M"7!I\$;N/H_'FJK!F-W(@/[1C-@Y5,`D9L@Q4E41&82>U3_33_^>2$U+Z9
M`1O\,(,6DB'!O_!#C-<#:UB:@@@S\DB,.D->A;8]X9_K'\)5E652X:D-6%S>
M6@74FO'!42V!J?@=7#E'9I05E<`$@<3)9*3'6."'9RA%`^)'\0!<FV''5(S$
MV;4#'SQ%8<A(\56&!*R!'BG>4MS:"@@)K&$-DG2..!V49Z")8XR#9*`)=_65
M?Q""9-0`#0:+`_J#!;;_AO.12ZOAFHJP!@GXPS8TH`0$F_Z)4.-YB[=5X0>-
M`VQ("A=J1!>N61=2A^2081GBB\R$1#M\X1JNH1F:!;^\QE28X6NX8=)P81O"
MH7VLH7\HTQ>J81BFQ!M*12`B!W70RAJ>3QWQBAGR(2$"BR/V(2."2QN2(77\
M(4/881=&8B1RX<QI80%=X0;E'RCFW"<&D!*=(O<,T0W!CBJ6X@!QTRMB#RG"
MHBW>(B[FXLWUS[=DH2[^(C`&HS"VA"AZ4RT.(S(FHS+"XOV=BR\N(S1&HS1:
MF"R.SN--(S:VT&G,'#>RW?QD(SAF(A(-SS&&HSDFT"R>XRT6(X8\HSH*8R7E
M_Q$HX='IM(\NJ0N/3`,>+:*D[`(C\8U9\`$7T-,ND`$5$L(:\.,[(F,S9A7.
M+60RZHAE6(2<%$]5T<5+R9-$Q)-A-<Q'W,6R;,.M/,6C;`)^U)KW10I$(F.%
MR)PUEN-*XN*5O5-=P:1*,$-UX=PN#(1*LDW$$`>PT`5B``"P*-E=A!73;8J`
MQ"1#CN/-%0]3!N./C41.7I=$'13@S,4_S85KU(3"Z<#3+27[H!.185=>$`,K
MO)]%;`(Q^$942J53XM]#OJ4N"L0&M!A\P=@[#<'$.%Q13F0[K)7S-)9!=`8K
MK$E',L24/-JI9-W4T24N;IM<0B5DRN1M9)H$;!I-3O_#Q^#(GW2>VU@$6=4=
M;8#78TJ*9,S=7;%*8_Y=9>HB.Y9.3*37:T:FP*W!%`+`**C;[6V*4S[%.'"!
MJTG*4RQ+9R#-C;!"\F`DT*RF6$S*2+EF;=YB0T[87$XG*+I9U5F+HQ%&5`0&
MM'3%`KS58Y"2IAPA4+P.73R8/Q2=1'CG6F:7=&)G*;9D-V'(-=(G*)I>N?S)
M3]#"-/#&FO'DYBS&$HQ#.LV+S&3&J&5:KJU`NFV6/Q`&(;#&`S:8?9RF?D)>
M=?:B36XHH"G8:%1$<K4'*ZS`QOG#2#R@;8A(606*8V"$;]')$885(>#'$M@=
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M#>Q)$`.<8L\@&A`]',C#(D]HM@_"ID2_LDZX1L3!9FQA)@]`JNFS>JBR-NS1
M+,$HT`(M;$43;1(1A830Y,X0+.(<S:C@N!Q*T(+;[(+;<`'`DL_.NNR#T`XA
M&-;K`4V@3`/AT`3(W&?#-(VH,`);/D\[>-1*X!$MB`[4MA&+BD?$8"WRF$3+
MPA,E2`WZ<,%0M=>:24!TF,40C,+9QFP`C4-3`&V#;(/.LD0U@1+.'@1F"2WL
M$0+;ML[1=JTWILG>KD3@=DS-GH3CVEU/5".M7BM+E.U%+/\$ON"7Y+3#Y.B`
M8NP'7%3)QA5$S2+B5,RL^"S*D3K/.'B4Z-+!Q:GM]$BI?TC45N#&#P6LI,Q,
MV?F0?023003NY!@$(6S.YN(+'\[L^20*%:Q-.RQ!00R,["0-K>`M+3S8(GKN
M[>;L;'7N0413[HAN&_$(]QZI/S8&L#""1^WK0>"M1`P!%22*:J$(L+"N7PP%
M^8I/]YZO5/@.^?;-]TQ/\;[&FLT&W@JM1BBO]:SAWBZB,H$N2BB36=A'-!'N
M^J@AOO`CY_*OX+"$_Q8O\#+$]GKOY@JM#3&##A3$@=**"IONOC(LA90L%D;K
M06#N+@P!+>R,0:0E)5#9-M`!';#_`LQ)+2V\R\^DI2T]+1_DQ1!0PBCP@=QL
M@M0H!0;OC+[,!L&@;>78TB9@Q28$$[`XC$2,TM;N&-4V3?1N0L90<=Q\!RU\
M\428RMDH+4)JA,I*377D,<\0S"A0GU\PPS10P<Z@R2`?J!]UA!#GS=I-A-3D
M31C[%M66!",`+2,T+3%,\EJ(%+^T`X0>1.587TG(E#_00<U03A6?!NVR+L!(
M38*8\BAL@O4-C>#HP"Q/UMF6Q"X05'5LQ2B(L518GR^5,AV`S(Z53.74VN.6
M+14/)#V,2<"HZ-?4$F%M`AED#"M0K<Q0&A^@B?6M0=6LP6[NDLT<,26<)2$7
MS&\(,;#X_S`Q,(.;)-+GH`DQ<,&<`9\8U;**T@+2Z`7;QC$8Q0L98''49C'@
M%O/Q:@04Q\W;H"AN[`)$Z,P70^E$>!(CG*5(5<G91H4(A@0Q1+)>"#'(6?,1
MET07<V$:,\ML;$-XK`$V(_%$`+-':_(X?/&;0B'5[H+=6A\A3`4QP,L3ST4[
MD,$T4,(*V,P31[$K,<(*./$YU[$C,T*Z7BJW6N=RT03FSE_\CI571"]NV+-%
M/&XFS<58F2!"4&U[K0`E>X6^",Y"[,PXU$!!&&"5Y,716+-(5,=;2,0V8!05
MQ!9(7/1$R-%HO0T]DP&=B==N1C1&I2$=E,0&1`4E>(7;2A-"E/]$(NO8-#S4
M$EAQ142.#B!>7O<PFC!#>,A-CL[M?#7%HDS%4`-+R>PS0ZB6IS#"6PP!3MXM
M5L"-6]O'+G$.0M@,,4#$7T/A"UXVD4FV5^!2<,=)QFR#].ZU?R0(,8!$<>\"
M2&R"D2P!T>+V4/,-=7-!.[P%!L/OC\0??]#"&NBT66/&+E!"5R9(.\Q&/E/%
M69D&&;P>9]/3>!_$QN`Q&HD$,$6%Y:BP03CV*&R)BL)SQE"M5"#>;%`":\_&
M"R-$\5QW>#CX<!O$XR[%5JQ!U.!@O#2%WI9QQE`-/U_$<_HW/JT1DP38;=-+
M6('X1%0$.-.N+P4Q'D_#XOK'&A0$%;#_GM%X!8W;650$M/>^KEB,]0K/MT&H
M=95@+?Y".?L:-K.PI[-6M>/9,.YZN$@P@[V,U1)T#$MKS1`D"#4MQ<6`7$MU
MR#)OQ8$:K]RZ\0'30Z,Q@S\^[8\DB"YY"O[*MIK,M^YAMY/'W2X(\A+@=4=L
M!170@QRWT3:L`9I0&G07>J`;B8KJ8YF6!=Z&C&S3TM=T>&<+L@X`2SIQP2A@
M%$*T5X?SL.!8=]".-YI@\%E3A6S'.>E:!!=,S&Q$KZ[K8\;@+P]3.A5$\ZL#
M^FST>4;1`@(G#.O2[J(WQME^#6<>**5AL#$=A&ML`H'3PT!&SIK]D\[\C.XU
MA9X_[C6K.3-P_WK05K1<@%&Z+0&8O[.ZJ%Y1F]%Y;4SGW.T[$S>^E'N5M)>Y
MMQ<KRW:E8WJ:A_8-K\$T8)3TTC>K)PA8SVQ+7VQ<=/;S-:WJ(K-8T$*MQ;D0
M&D204\UF=38KY)Y)3#977\:]-[Q%"#O;)J3/V@PC9,P0.#"'`TO9\C6EO;FA
MDWK%\LHX=JPXGFSWX#"G9U(BL6RBJ,E"G+EL7X366@0EU$!/<WB"E&VI&R\5
M4_&R!+H.$(.JZ$Q[X;KY!;O+X6VEA[VJB%_/L\(NT$+YE47VUK4\%B8EK#M6
MO(6:X&_?IWTFO?.8='I%)'"SN$F'\]8NP/U%</L0F%+OL3J_T+K=2O\S`<\&
MK<_LW6;,UJ^ZKF>,Y2CXE[NT]];Z6_2UGE<^WN+OV?L'&X_"YGMO`N_\CZ`-
MY=""<Q4ZMH=Z83&"Q<1))H&<WR?[*.QRP&.]Y4N]:8N$?(5$9`QW(A%Q1ZC*
M.^,V*[!".Z3O6G`[%^R];%^SV(X"W..$G@_\`;_O<S_\Y]?^PJ][6,\WP4B^
M;&.P2T?G4CA^PD!WK64^G=/^S2\*0-#QYX\*,SJ$B-&BU<X?+1*T!OJCYX\1
M&6:L%FZC1(P/'694(HX;,I`0(XG^-A&C1(\8,S[,_`T9UVYDS'$-N82L*1.G
M/QVL=M':%9%HT:+M)`#8=-)H4Z=/CR:M`?7_*:V</0D2V\3GJ8YV2V[NXNKO
M)3&0$PEM)#.0IU5_E"A))$./$:5I2P9NFKH$)DE"`QFQ.LD*)"N3$[D,%>F/
MK\Z!:Y8.W+6"I,EM0_X.'(?7'QV3&[;Y8[7&'VC1:^D,W;:6"S%B5[E`)/37
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M\F+4C`\1*V*K'9H._(T_\MH2TDFJBJ(GJ;@`+110I`"8RE"B@'N2NZ'28D4P
MR4;APZ0$IWEK$^;RPE*CORAI,S2WRC-,MDL9H66-D0RBA9)VCGQ0H%%&6>-%
M.EY$S#U_6MUD&CR1HX.539@AYB</21S"24+XH&6)N%;8A!4ZMJ$G6E;XR'2<
M9E^JSS4-<Y,ON88\!!.[B+;A8]@7UTC5Q<XV^8L1"8]K*+#,<HQH$UH(@?^H
M2EKBU7%%D@R;%+$HJ9B&GM2Z=>[$\DRJ05HZ,BTXLUW((&:S-6M]\4$R1F'$
MNEWI(41:*M;*4[(O&1D)RTV&,"G'B7C:A+,<X6*$&7IJH`7;;9+#;D:5L>.4
M5.<8\1BET5[D0]I)A]@-6U?I:92B9JE8:23GIEEAHH%\W'3H_C9)E8SW[!NI
M'?"Z?8MB-%T2ZZ:18AUBU"%CM#93/D*3Z"!:7&2FTLPH6@)@KN*<AFUZ5,T-
M)#*&<EK2-5DA8QJ`B2H;\TW64'4MQ3<%-DXI"<TZSSDW&_5,U)<@,J=TAXUR
M443_7-1V$*6Z/2(2Z2&QG:_'R92H;83/#?CM0,S_E)Z)Z`F-1'^>_W6@WZ?/
M]'EF;EI>W]"886@:)ZF'/J)IMGN^Q]"6IP?Y^F0'F_J-^X:_*(6GE\AW=&\"
M*K?L)1R^;^._AIR;A"]\U=M=`"72/<"8!'D,*>`VS`>]KX6/?A*LGT0FPI#_
M0:]X/6)(]A2X.^=94'R:&4?O#DB4=EAO>M5R8`!YY[NOT4-XXV#&_V@H/NV5
M4#/_NY]/D$>/$"*G>`7D%4-0.)!?:>^%/>),1'*(1.#MCH73FZ(2$5A!4N6P
M?CN,WN^^M@0:O@>+)-K&!N>%'!`%D(O5TDSZ--,7(3)D"4JKWM>`QD/IR9`H
M)[2B9I)7PB0&,H;HZJ"A_P2E%-TM$GJY8^0C(>D4!#9EDB&)TD1VL;Y($L5,
MDA28@R#).*(PXY"5W*0G1W=*VYE2E5#4'2N?8DI8WHX9_3,*+&?)E**`C)*`
MRB55F*7+VQ%"().C2@!3"95?AF0LK71F*VGWS*<@2E'2#*4UL5DH6$7P*$ZB
M1^V.><IE/M(UPC0G(K.)S7&FDYWHW`68VFF4:1"*D?-D9#GCF<]U;C*:\:1F
M/@$:4($.E*`%->A!$9I0A;9RGP5MJ%$0%9>'OM*1"[7H,R=Z48UNE*,=]>@J
M/QK21R82G-;\ISJMF4M89K)0=#`?+1[*APA6$J8@RB<A^L(,PJ&S'1_:I$[/
M&?^HAK#1*36=R#C:9]-PNC2H*MP$/(DRBDFI,J.NQ&@X=>;,A\IR326="#/Z
MTLM84H6IRNQE5M')SFTDM:R,)&D^3ZK0I&G5E:S88$0(L;YZK8F;@+*;)'>S
MB8GXE$R[J:HK#62UVY$'DI@C5:$VT5>;BJDHE-#DHO;Z%#),]2V0RA(C,;?0
M:>S4=@;JS&47-=IGYLTI^+S=1L0*)*$^A0\W,>TF#PLVB`0PL[>+9FZU6=%%
M$:,=+-4,*S[8%WQJC%<>(]XT^L8,'<A4(K0H95"4.(UIR)&XNPC@Y=#5NV(-
MA7'1>I[=B(O%WP@6BAA!CG+G-@WF0B\EWUS!4'ZUB?O_]DAXQ-5OE+9AQ_EM
M(GLMV=#T6*&>#5FE:L/SF`VW`9/B?G`($W[0UZB#KE'T]ZC=HP(5JL:%=MAQ
M&\@="'%?E"EB8(06+[*P/\@PP%$,I4A$(4;QIC&*[$&/%?&=+Q1ID=/IDDBZ
M`JF0#4?9%^UNM[I*V\:'M^-:)3ZW1]Y];X`CHK$,$^-_QGP0^@R<03[H(*RY
M(7`"+P+#!,]L,NS]C1VQ-Y`XM\.NP=*!\)A,26*,XFMBNBMRTUC<\FU",=NY
MW(AY5>+_?>\FTJ5NU9`W#IBJ*2+,V)`0+8U`6D0+QD'>()=5>$.8('4B&;[P
ME^4\#N*.@UC3LW)[(=*.OFUC_]+9,Z[M^MG.1%9S436@&!_BLA4?P60]:TC9
MEN!""Y!4:1>^>Q;T+!(P$/F*#VMA1`T2DI-VD,`N2K)+C+,RC0V,0MG-TT'[
M?/UDB'@%V*R0(Q>&%6+N0"3=PVE'8@3+I-"@]\[E,<Y::Y"I2GWDKK]I\93H
M08*D+2%351H')23@,6(\Q%EY><D21MRS=C!C#=/(T09\U1I*"&8:/S+S-(8P
ME+^ZQ=@/HCAG*C4.B_@$IS:QX3BRMAJ/:TP@'M\%>]?S&("1)BC&"DV%P.J3
M;)FV'98+V%?HN9FX4*(&5TI9793]EJJ/YB5KD-T:E-,9A9B\<$/!UD<VOH$6
M4R$T.O\@1*8Z1PG2P/O,<:=#PA<>FN@@;\7$D`G>B=&ZPCT\XDH\]V."8G)6
M9&DM'(?=6S!>'DHPV"BLV+/+FB4[)DV#%2"'L4$B2X6?4^0O0Z#$DTE0'^&8
MI.@ZJ-:SQ\$%E\B,6FO8P/,802PRW$GA@>\;#76P(+:G2$NN(@TF-<YQCU^)
MY*3IW"988[G*O9-7'3<MW>7-A=IOH'<6H0,]$9F4DDHSKHMZUU=\!+:U[+X=
M:1G'.#PR%@6-R:;.`<]`^*"TK^$G9</QQPH8@A@L8BR*I""D:]YDRR=>Q"TJ
M;#I4J,(<96"P#7I$#R0T8R?:@3S2*"8R<"3&!24(BRG,@P3_&,(\CN/P?@,W
M"&(H4B9>&L0?M(-70`P`/T9Q4,(WOJ91^L3?4G`@1`_&CHHT_@I(F$%(`G`-
ML.1!GFA@;M`'80(M3L^GWL4M)N+^R&(H;DM)4B9`7`)%`.8JIC`GBH,]!N)<
M`(,K/G`KZ`,$?2(T-L4'=R'RFG!%IH0''TL$_V(%;L($MP,%R28RS+`=2(,8
M_F)(>$-/?D/^:N=K9`_8BL(!ZX,Y7*P"\8K0?N0`N2`N3N1K8H0*("+_*-`L
MIH<&'X0`"<%:2G"G>,)TM@$WWC!,(A#<BK`+]R6TP&(-!(-S(F(-&.(%!81$
M5&5CH(<R$`)Z('!V!J6IG*G\#.4X_Z@`^DYB)#9%*[1K4S:!"EB!38;ELQ#P
M.$:'U?2+]"HC)L"&"V)E,1C$`IW#]8ABY7*B#JE`Q,8G:A!Q8(ZCPG:A!N*"
M3SK0+^RD'7"#28:E(V[)9TQ/12"&'`\&3;Q%NH;E($3Q/C8E5(!E,;[CTT:!
M#-:"';,NF(ZF6/A#)BB-)[:!!-M!8LK&,S*#%B0&`6&,#FBE,21%60+F:]PQ
M(KSQ+SRQ_F0C,W2`'B@!&]D$8"P$*\J#*PR$"GE0(#?A((H03?Y*^Z2*+^Y#
M(,@`)D<!&RTP1NZ0<4;AV6K"!"/".6@F219L+0:K'0A-0'#$-99-*'M#F.A,
M+X9B58K'&_\9@0IR#V:J1A_+8U,RHQ4'9C&\<@D*!")B9E.X`!II9COB9$3"
MDANC$B).Y"JE90FBQ"TDLFQR@C1<:@V&@Q48KG/*L`::#27S<GQT0"!4Y2D/
M)#%M1K(D2?S@2KB:L6\,Q^2XH'GVY?UH@1$T0B#\:'06TA`I(C)JB2'P8RS2
M`B&?K#9Z)"<8!%SVZJ]TT#')B"!P2AU5KF]X@F<2#`-%QR?O9"1V`23\R"AJ
M3BP34@79)P)EKT'NI"?N`WH^2`7KTV1\:E]ZH@[=@BMA@\M2IC[H821M2S#N
M8WD8HFR@J"77H"_@K82RRF1V@>S:8D"-,_<&AA%[4DHH0CC',";_5`=&_J)9
M2H0K)N)(LLZ/LJX_#Y2'""(_EH+"_%$I*0(FS$,%<W0L9>>O3+0AFDE2&.%W
M^&-+7N,HD:.2VB]),M-KD*0RN$!AGL=:=@$N=B$P1T9@UE,GUZU:PH(_ZA`E
M),1'QK,=F51@(O2E<D(D>H=$)J]`$'0B_@-L[DN,YO,1<:KC+)`#6V>0%N6M
MXFG7=&<%_@(:G88L(H,0KD)1=213&HX;86PI,.9C(B(_>(4R*,%K[N.$)$`P
M4B1C8`P+O^51&&-G</(FW&)*N(<S<D@75;7P"/4M2"-3OL\G?J?"JH,ASK,A
M)&!Y*JP=L-&#>@1X<-5T=/0OUH`K:`$`__KB:"!B"03#=1Y#1'Y'`B"B77(#
M`,#$)F&"#QYG*3[L0^$#`0_U4._QF]"R,Z@56*$G-&IU3_U.@P#R=_22,;QK
MWU#U+"A5`$EU%Y<B3GYU"!R5!_NC42:"$KC"X^Z$"Y`G3H*5>R0@4S"S/^*U
M1W(#!%'N@^#D+W;U/NDU+HX5!I45`)2F,6)O)AAV=S##XE""*W85Y3)EUB(B
M#I$#V^Y$0+8C5')#`J1%#$\H-+Z$05.6"Z;"8<3(*[03!I>"$M#R)I8`3!BA
M5R,"5"VB3".B,=+F-R+O?TAE#42DT6I`,'9A0#+%/IS6);@B`\<'!!MD"?YU
M`5!"#`N.*G*-G?^8L5`P4UJ0B!4H079B!3K5<O)$@[.@AT>N)+(R)_^,##Q\
M14>T8D,"UV.`<QHD)*MTHWAJBU?BPJ5J*7-+9%XP"3LF5"N0BQX6+S)HH;8(
M05<S]S?+YD+RAQ+`Y`652$$$=RR,J4JO-*<():M,]UPH=V:QXT[RCS]51DZD
MRC)"AE-*I9;*\`GY-DJHBRP61G07$#MN(JLJ92E&P4FV01)YQ781E%\^L=%L
M22L0]T95R".,B;K`$2+:MQ=MR61Z9%,V2*I`A&\E=3I@BRQ(Y'M@BU\882*^
M=R/69B",J6S^-S5N%X'A27=K#FS>YGL:ER@>-")<)<'RPB0"-Q<%(@?_<06G
MOO=M*FWR!%<K[,)TZ7=RU)+07$;"N*)51@YZ[D\E&M=T"6UZZ8L28!B!.6L;
MJ(6'D6,L-*)_>:5_JO3,Z$$>Z[=OU7<;*F5#DAAY?O,O@I<>1J%O5_=!L..0
M#H4V_<DV"Z6W!BI6+E"D6BF9$&H;EO"@U-*IT/B9%"N.-^FVT@D:Z3B/;XDV
M@<N7<F>?AG"LLFD,B56A<FN9TBNVE-&99(YP40I0TM,^]?B4YGB2%TG`0,J7
MGB9S#]F2!:INT^EN#T61`S6"9-.3Z7B%4'F5E0FU#'F0V^F&6%F/$PG\0EF,
MQ6F6=7F7>;F7??F7?1F4LTF4=8>RC,+-3*@I_SCOEB)"Q\8!JA:ISI!9F=.7
MD^;V*9:YCV]IQHPBP@I*EE/+D2F)FXO"F\>JSFP'F0.LO\CKJFS'C:!BFB'J
ME*EBF:/YFB/IC6<VJ8K"M<H$GZ''8XZJ@YJG*2*9H03(IHB!GVUJ%S#YFM()
M4'4-EV^G*8LB,O;*RQCE3(S"`/6ULL+).<A8SL10,^#)CJGB#I^I-?I96#3:
MGYI%@X,,4%3:*0JBI3%"G(D"I<?J.,;!-!>/8`GJF9^7*D;:'RL:53FZ*%CM
MHFWKP`S%TI3*H,F(M83*JIG0*=RML@+H2H3I`SU)=U!7,+9:C8GB&XD#M+SX
M*:3:MY)1FZ&"F(_)5/_5X^Y`A"5A0B;@67M8@HI?9Y3Z9CK')WM8<JT3K1O7
M!\D`0P[I@B<2XTXEHN"8;%(WR)Q/:"8B&XH2&5W09QI,DRBF8?>Z^?=^%FS0
MYR9JJ(C"JG?(IR@B='I,K\\2.U,,]I#R*#<^>WQ$&T3^IWQ@8F;`V;3#2V7(
M0U@8='VT"Y!"XX2$1X@FR-3D#(]()#U/R.$P"$2X*UENPIQ=*4;>[Y"@2YYZ
MYC<^Q\;0Q[KE;+P?>TH+3M66APS"[GQ"#3DXH^$8"+0=DW"(C;R:^R:"YT=&
MC"&@\[H/VUY.+'Z00V.-XOVF9X4(.^`PZ"M,XC'7!R9B!2@I+7C(Y'^BJWS_
M8N9KUIK)FBZ^_Q2,)SI1%MDH.&(7Z.#]N"!E)8(N:0YC<'1(R0`N9C9LI^5W
M)B]8I^-(Z:%9`@,E[FN2U%+9!$.DD<=4TG;,^F)M!+8^($=8>D1!+AC_9H,E
M>D87&V+Q6$-!U,?*SZA=P*]H6$]B`B@EC((1NO?,L[%"IH4ZKF5>XF4IXB9S
M1:9L)*0*GPCEJ$O(!2/(I:IJ0,(1*W536"]:TCQ7=O$F"!%1DWPH^C98X4]2
MJA!;!,.G:\)I1N'<T@B+O>,O="!5:,Y5T@)A'V130$PT^N5%<B^-TB;(W61@
MZL*N'HX6HKS"MB*"S]HD")5S/LBE)ZG-'F3+CV]?_W9RS)H['Y="(UD<0:V\
M>&C!,Q;BQ?5N(LMPY"!(&DFC979A`P&=!\T$0DB`.J*=9WSE7*9]R.\-@SMS
M`Q,&)<XSR:G<,.AO();7R)0EC?2B)P$2<?YB>1,V;_V2AF>=R8FBQ1^D1']3
M,)AA"/Y\:C('8P;XQ5TYEDS<;BD:*F*0&`3"JLECO`WUJ0B+&"@C(35H:\`*
M),Q0.X`E4%+>'K?#1Y8C+NZ05*C@+Y@!+[K%.S3#/2?#!U]D.Q(&,O`/)E+7
MHAN:.==M?2AM9C,C_YCAY,VQ1ZA@VXXN.'S$T3\>+WYQIW<3`<]%2UH8@R$C
M,S`)0U3.Z35IR!'B#1?2>__P`E<B8H;9&$CNXW)RHDHD`@*3A2:$9[R9A#<8
M'=C48V8E1(S^8S&.IB6:B7HJQU89SBG,8P-NPA'IWBEX(NBS0GSN7J57,89'
MHN?3E9?&,'6/GB-"(C<7N^^_*3+F(@F'P,5(0*>07CEJ8"+8#L:@&7)*I./Z
M'"_F$^4B,3=V8TZ!F#?$Q.L#9&,)XE2TA/#]+R8.`Q%+KE-.@LW+`WT?HVPA
MPN[%"$2211S=6I'@>IHVOJA"DOS/6$01,4;H@`IVC%0T$V!&HB".-$Q+HCJ<
MHAT`QCH`8I<_'>/\^2-$R."X(?YH<3%HT*%!+K3\;5O23L<N6IL8&MPUA%7#
MA_[_*'[<I6/:FHKC-')D2(?+-HA<!(X<6!`BF9S^Z)6LV'`-,Y(F+[;SB-`@
ME4T/?>KPQRBAOR$\#;):X=,D58.$&,F$R`P`GYXT@4K4,5-G6K!T2M+;FI7E
MRZ,0IVZBA;+=DISM:NQB53#IU(+T-M;0FW/(S%U$*S)CO&E3PJR$=A$;HK+B
M-H822S);67?;+CYD!K9;2*DNV:Y3N3(:J%JUXILE!8Y[>=.GP=DU_8W#Z+(C
M1'I4Z+0[.-9D0SIT*OIL)X'*:JE#$!OD$SDA0Y]D-BW9Z'WA[IG$Z>A6+I'2
M$&('I8[;M>FI24)DB.TB\QIJ?6)<1DG>/0Y=[?UTT":C_W!A'QF4<)&38`U)
M)UA+8*WAUEY<)41%14.,@A=!PQDVH&ZQC>@/=`!L0F***JY(CP0`U+!B;/>1
MM0144BGDT582";;)"CDQ%A$9[5`R#3'R$<.?/Q9"M<E;(TY#Y&4$;N4/)?G]
MY@^0N@%)H%$$,</,<1!M4\,F2=96Y2YZ?<;2EV$:U&-.9-BT"X6S0;2)2"*N
M81,M?#`CG3]D:(814E)1,0J%!M48%8!U^914ADKFQ`A3TY"URQ)\L`<1GQ_9
M656>!NTY2EM+7#H1,>-$6:B(ZVW#3$%4B@=1HU.U,R0QV^A@W6"TU;3+*.W0
MD6=;66T"ZZ4FB=<9%<Q@A^DFX_\PY:M>I8EXT&M/90M;BCH2M<NJTX!$&T2\
M$9H1K&_6Q<=32<T9$2'0XLC'*!?NU@X5#?JGK4[>J4L/K?I"1,>V]7U$$C$D
M$$/&3--L4B1#\QFGJVZ$K-$.,9<*5IV`\OHC*2&18:RQKS9B^A`C5P;*%3.O
M+:DR@3IH'"M$J^KZE*TQ/NHBBCO_K**),`)MT!KL_>>@13D6)!$?KQTGJ3_$
M;'`<16N(9&1)Q`#J#RMC;4,&/0*2-5%%Q,"H%5\[^<.'2)TA7+9O#%$A$MDE
M=BT445L'.@2;2NG9$]0V35.:H)=2:5`[#3_G#^$&[<2EI+_1*ABO=`BTR6L<
M\T0/=RC_2NJU;P^Q<FU#I3D+D>.&XU37.`TG#N<&1Y=6]6=8PTA'0L?Q,199
MLWH$*750C37.84O.UEEW@:[Q&F9PDK1[0CW^JNH2NLVV($X^[?HHM]LF1<=K
MV$*$%FW.7BTUC!*Y.E-O$M(]*D3M.'7R9X]O<U'G<ONSAKVLW>HGT9UL"2B:
MA@28009[X<@@E$"1F'A%'(A(I"",6()43'(V`EWF.")BQA!\XA-;=<Q0(*N(
MTQ8"0K:UI1TD2$U$'J*X@K2M+J1CSRB()Z22B"1W\0N>;U9PLO&MR$2I$2+1
M?B:T(_JF@90X#B5<B"<^@*T@=:K2)MJQ"3Y`D3\<0=$XZ-#`_X<(A1EM\8=_
M*,$,.!GG<F,"([78R""P5$J!56170NC`GG$\9%6;H$1:Z#$*1AC'?OQC#R6:
M0X5M5"9Q3,1?%J'8D"<")8ZMXY<+=R')+)61C:YK!TD:.!%<,=$G3YP(3X@1
MF;H1#G-]3*,9-V$>^TVC.A)\HDVX(":;6=(@W#.(?]J"QV&%$4Z4F$QD*,$>
M2NJQ+J4LR?SX0`A:4"&&II3:)NUSM36@B!G%%`DK&BB2<:B,/J[Q!QOA0X=I
MJ&04A&@++N$CE)+PI('T^&01GS@6_]2%%FO8!C&N*4QJ92N7M-@))V'(1%1)
M#98B&1:*:)')+,%R&O7L"57Z6,W(,/\BC:7DXRB<18]*^;&BC:,0*NG@S?QH
MTA^2B>@VUC!,HQF$&`U4X$PKA:)FQO&0],`HX9B!46+@U">1&45WV,4(>DP#
MI\/)TK98VDJ#J(25R)0?0J0Y/VT>L44G4J)72^2BH2DQER0B:VS$=E9LF54U
M\WL4"MD:([2F2*XCPA5<4[16^>F&KL/)JVKX:M>O*F1G@1V5;MK:U[_^U:^/
MRN691F76\>DO<8P=XA$1*[_$ZK4ND1739#GK$V+4Z&>?O>N(QF=6QF(V<2*:
M+%_OIMBZ&G&UA84(*_((0DH($:VH)9'8)%N5V$066P$#;5T-&R/:BJFVL!N.
M$57$59\)%FC_7!7K=*\;6Z].HV[8Q>YSX]?=\(IWO'9#8F_(B][T`LTRZFUO
M]T[K7N&Z,G&7,J)]XXO?_+*U9_I-HG[_"^``"WC`@F4&IPB,X`0K>,$,;C!^
M323=^/K7P=?]+H4OC&'U6CC#'.ZPAS\,XI[P=\/=G;`2QS'?`+<CQ=TE<8RV
M`13Y5?:L![:(0D];8W_4;+STR#&)4*RB'2N$Q4HL;GE]0]S@]F0<+C[M:9KL
MU0")C<E0)K"1@5;;UZIW&S?&L!"%3#0NA[BN_,VOB7\&J]PTE43;\-%9L^M;
MVG"'9099`22-F&9SSOC-$-D%'4+5P./D&;Z^>6J(?FQH`D$9R"FB_Y6%U[?F
MN)'E;2.RB6H8H:AM,.)`-7[8)M:`*B@9J"ZB904C;$*/#5@Z2QL0HEXBPYZ]
M5AK.>(W,$)[8#E:@:,//W;`.;N2;`Z*Y4@BJ"R,2C:<LNF>H-(DP%R(<9T:#
M929)J;)^ZZEDY43ZO=,AF[6S--WM$3FN+H*D>ZNK1#ZTI:"P;6YL*$$&[@;.
MM#^&6Z=2DCH[DX6LDU4W>$NDUMGFDH=D@65/?.)ORL(52W>+&7'%1"O?"`HH
MPP4XNWHW[]8QA-_CDPC')V*3XW!ILSK6P?@R5[AQ+"90(#P."M]2D*.^L">G
M^F$9#<*(%:PUXC8S[C1XE5GG(C<VB.,L9/^-?M;4$GV:DU[8T8EKLYD0@V7M
M(,1H8^/*):114HP8"Q8)_G5@QX8G"8?(4KBEUGH'/=)D-6MPVSJ^;<`06[TA
M+K:J<IR89=RWD66&R;=-EM(JG&T8QW*9'QS6(TYC"7L!"2T8X4*(4B+&B4O(
M&D++!<B[D`Q=(43[J-B6:2VH,$UYW*8A4JJG-9`1!7$9)5AQ$2I<2CJ?5EDX
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M"-_D'+I6;'3@-(0P#2[#0,S@3[`$;&3`!\['*>'W,!=3(MCQ4:]A)>R$2_;4
M.))!(2.H:SEG+^,@,JG!'Z-`#+3`'%7!$?'V&[]G>%UE9HEW1$FQ"R1P'(JQ
M#2N$$74A?7P@$%/C$UKG#RN`(H+$.A*Q#0513%RC/S7A>5GR1`GQ?"S5_Q88
MHR3;4$P&\124`"/BP1P&40/BTSB%0P9I5&TT(1T^1$B@QC\V\1O"1T%/\7)K
M,X;T\!0$U#@2,`V/6"(2HSE>%S])@4!%HU#M(#M0T18YA#HS135*$HTK)#%]
M.%I+0!(]<2ETP7.3MHX^H55D,PT'(A`1XA%9(AV,X1._P0Q2\2=+L!8VPRM,
MYAN@N%$UTH\>00=I=#5^)XZ7R&)4PAK"9G4]P07TL"GF)%TX*$,5(6P)Q']D
M!"?\5!&H0@4SXDRQ,8^9HWPI,G7E0I'`EC2M4Q"?=FAQ<VQ*TQ"O$9.)\SKR
M>#2OH8D-40,Q!S:EL1F=(W720044(DTE$4H/<O]P9$$%I1&5)*D7]+`-Q[$2
M:,A"TG*4;',8)#0-7BD2;D8K#<D_K`"1O=1:[<@0.E.(181?Z$9=`](LSP(Q
M(^@<!D$',\%N`J@A3/,0WS(J#R,4=(8@Q"`2A$!3VL%ED!&8-I@=NW$R@P$S
M-P(O65(:-6E&8_DQ@Q(1Z51Z+$0%%B,53Y$Y"C%-A6)V?/F)6@<:.-B$$/$N
M?5(ZM#*"L*1RX0./$R&;%_%3H)$EZRA5/W<:^;A/R$D+R#8.#Y,:$?)4NU`#
MCY<3XD$(G0,J8U<#_L$I7`EO*B1H3S%U*O=I0V%O)N$J#=(\.)<?=,,@#U-Z
M>C>"`D*7'[0)#JDX0('_/UKW)X2T3]M"#Z''G+'A%S+9(#TX(+Y%GVQS(W'1
MH-61DM'H(5"!BRJI)'HAF$3A-XHV+O+!$@PQ1A2"<*Q8%H7&/\CR&RSQB(R0
M2%QQF;X!FPWZF^^Y/^>IF.K)4ES098TS#3#2*%467?V%B$33*`+X&:?&"K0@
M(J)U3#7");V!/(?9H1:!3.K&-611$P7:#A3"&G[!"K#'"+LXIIF9,]31*T-*
M(%0)FBP%I@F!'HLI/RM`!JAB*VF:?Y.S'9Z1.W\A$J19(F3`G%W7IEJR/Q;!
M!?#FF(`A01[ZIV?*!9]!)\@Y"JQ@G;ARH#/G$].P`3]*/H#D0F#SJ`C($'?!
M_Q$FHW&A@4R$T!0Y-P[BD2F-^AXD(8`O2)%)]3V'L@G.,J;U9:-[@12X:!HN
M,PUC(2D<<1D&IC*4USB?"ICUT2,O"!%+4$;VPQUBDC1LJAJN2`Q\\!"].!&/
MJ:9+,`I_86F]B*C5(9"_\J&],7G"412<`7F4EW-K,:\EP:2.@4:+2DDB\Q\T
MZC$)05-#H5O;PBQ:-Z:U:ELD0'FC<*Y"*G8[4Z2'^")*E!1[F44C,G\RNJ4F
MX2$2T3=L(QVSD2CJ>1X5<4/3^3(*16D<@Z8A53<ZD*&],X8-JAJL$*X),1K7
M(1#.(["HPS&G43B1X23K42*?NK$I6JT"X4,]RS:6QO]",\$*1H.<I0HR0%5X
M"(*3_/.+0<0K8X-^ZVB<IT4[UL,V=@EI"]2`Z:2J8\*<[:JS9.$TL)$_$A0H
MA"D;[MD:$SIU:_52<-(D)&0N-WFS",*C*5D28:,:@EHBZH02H%JU=5%SB8*;
M4N%#(R*W$")V\Z&F_3-V'Z06UN0KD8-`8_$6]``:/T<@XE%/C!L_T,2E;3(\
M-L.0E*!%L+B?H[4)-9"Z2I(:#(FCXF$46&L5]9D?$CM6(X9X%UMETX`@<XLF
MN,==7P2"<](8I3LZV,$%I?%I_$2GLZMC6#$@_\01'!5-!42:<ZFFJ\(1.@!)
M#811.?DP?G(<A",2\NM"?'G_10S1$B%%'05A:JR0$.)!1A"U`NR!>_9B$LPP
M"H>42_AK1?.K$)KHAY=B)1PA(K?*-GG"P/>8)TM0.BH1&6,9/@-)&^#JP)S"
M!^W`$:/1)]@';(C:PK2R!HHR&QLE/]=)"Q7QO6O@O9\V$^%S&V/8)%PRI;C*
MMX1;'7["$54QP,1#N./!4A[1&\SSG!5QPZH1$\R`J:O:#H4W#2NP$:QPOY3(
M!SR1-(+!A7C2'&OP$(3CI!+4,$,[++JV:KM`"*^G8V@L*U?J&4#L?ZG!3^PD
MHHFZQ<\Q,OBJ&=LA,F<J+[2P!*F!4J,`OU6"?620IATQG6,XR<P($2?D)YA$
M>CW!_PJ)8FE@4\+M`#;V1S00=FU'&F8%L5RZ(6TEXG9RU58Y861*)5<J=S=M
M9\M'9Q!"MF*Z@3\2%U@\L3'F%JLD9S,I!LR^@<)G*7$6,3\0)S\*Q<R_I1"H
M@EBWS$O9B<)W,Y#'W%BL-63J3,WMQHZPY<N+15]@DA;;T(]=U@Y=1E=IP<O:
M[!MDI2ZN](G*S`Q[A2KT\"9RI<OCPSG]2,R\O"Z<Q<V#UUQ&AE@4U5;_$W5@
MTF4%<2#>QF5;N%<L!EBZ`9RA0<N\5,W9/%C).2(%G9@]EW$QMPMTQ<K!/,P'
M`4GH3'*Y-&AG*5=`;<M=Z1&L'-3SPSBCXDH(S4&>%=%*#?];R4PT%=N\UN5=
M&69A%N9/#8&V#G9?^?5MW"9@8<UC8Q8CLV1M.CQ>+<PBY.5BRN%B:!U?MKRI
M'$9$1Y9>9V;6_87'9+W7?]U@4`?87X5&X>77'@9[1%/8UP9M'4;5$B;+@QUG
M(';8XE79M";9F:W9F\W9'O;8[I5$AWW9G4VQI/5OI(W:J:W:J\W:RVN(=QG9
M/^/`W#S'H[(+H-HXB8U=IWP0\]6';EEI2A8CX\`*H/H>0..%O-2DP-T3M[U/
MN+T-37IC1L36=55X*A*-8+%SU,HV>R8C?^1CD[W.>;DSCV';M-"D(4<+S,R'
M\H/>?AU"XX9=8=P07T76O,9G>"W_V5PHVHW#"+@]9K!LL5:],[2P?4,@$%[S
M4FGD.MRD4A\Q*-N50E[E0U$S$+3`3>67LP!.(GY2)",2W5W3V*JQ>/E1IB@V
M$PUN)8/JX(I5I@UH@;)1S@M$8KVH;6,B;^8RD!H9(R00*._X,Y067I"'0,=!
MSUY1)8$Y0]RD1R[TW]YQ73<N7B@$;:/],TLE6"165?J=7Z6(FX!\76(KV45J
MY4$3V^OU$!;",%#A0@<XJ$)$"P>]-4"!T,Q`>5MX+]I&)5&)XM,0($O-*7@^
M(HC#:&'"E7KT%3J&PK>A=QK-YDI!#\WDYI?K*(4A)L30#C]+1<>1Z0L)$;HB
M-;IQ8&QZ_U[CP"DW[1O)QQZ*@>D],:TETMZQL00UP.#Y".IBUA!I4=-]1A+^
M]!RQDD9-^NDS(=52S4N?].!T8"^T5*"K6A?L2>+"TA-@0GGT(!+:AM"NC&)(
MTA/AV6FCP,R[L!F-,RJ.6B*N%";YG&;,L%V7GC$%0=R.11[L3G'MPF+<?NZ#
MANFJ8C/)]^EF_'-\P)5<-E_T$.=*;>=UH4XJC><&GT:AE19>Z*B%H8D@M`OZ
M=A\90VH1CV*M1]L<U+O<O=<"#ML76V0%XCB7F"^4HK;.JC@MSD*,(%H!0@*G
MUJ[U*AV-HKB.4C09<YWU-!K@AXJ3EY&Q0097)X!(\A!D<'G\`_]1BE(7@H%I
MN'Z`E;(VCZX:21&3+]]]-)M&U4$Z.G:G"`+*YO1-77&2)GIH)I%%@)+I2[\&
M>`@``V&:%?&<7$8131(;&6*@@/E-4J0H2R`^L'L3-^3V9T,+8.,?!;$2N!NX
MYI1B]OFUVR`=KBLHEL9N\1.CJM&'>1'SF3(3%21.PF85\%$C"G,7TB&,SO?O
M1B(K1$(%U<$0G[$-,]0L6W.=,Z$#>2,0-9!.97H73=\</$4"D-FNE+`D@-G#
M;6&=ZTT^Z92[-[3@_--`!2WX55(#C@E#0M&:XU#SH,_F4<D(V5^U?R)3*X&3
M7+`$WYH:01IC/V<V#BO)RD\)%,(%,H7_\UT#^&E$"S5`49H-$/0D`*#DS^!!
MA`D5+F1HL-W`&@TE^INFP]\N+@=UM!LRSB`A0O[H^>-"Z^!(/KL,TF%&;T4[
M?WP8^2,!DP^E;7P,KMFU26?)@QT/<B'&C(I!+LQH;8HY;9I.?W28*EQ#QB-&
MI,R(903I;]-4*LQ.^NMZ<1.Q-2:%DF7$9=O'D`D9#:'%I2`?8OXX^AORUM^2
M371V>MS:SN)7@V0HS40\LBTQ5L1T$*.WQN`F0LRL+G'X4H?*NO[&663&F:$.
M>G1&T3L,=I=E9HQF[H)J<!<9?[B]9C[*$:97L,SXM&MG&6'9<4,.^DS\]F%>
MD3K$'N0C6.%(_[;^7I(-N?;S6))%+?H+NS0F=)$?*;VVO5$Y&;^XL88W>K`&
MZ(PU\NX:GY355"[X\ZBKT)8KR!]*:*D/H<E$6V(;XR#\*Z^1@")$M[027*FE
M[6X:!ZJT-M%-/W]H"=$@*L91S)]ME./+HZ"N&B^L_PQ:8IPU6/&'&*CX((2/
MD;;!+;F)BC3R2"07>@B`J9)T\J`E(WJ2O%%*S,B@(=JY$:[T&%$)H;4(F6D\
M,?TA<Y-1J&"%%2Y8H40G*KY\,3TRIB'F*))V^3`W?QA1D\T#$1II$XL*I**H
MHWXD22I6ED"/2T&S?/"CMOSJ"CM(R2!F"4J^6D)+&&NH230=OJ*$"__#%AVE
MT5T$XV.:@QBQBIGDQ/N/#KS68.9*OD"UDD47::FA23#;&>?!]QA=XBEFSJ*E
M'3I,2L]$9G18B@\^%JQ()S)4:W2:378A)JZ#D'.1/+^FZ920!F.JS9]J,164
MEE$X-9-2OM(#RB%61JE!JRL#'$>P-3"EAY9&1\',H&.UW*M"1%$$.#VA0NOK
M5_*864.U--/D,C1Z*OR2VJ,P78L+$2ENAYXER(#)PKC$=`O?,S=98LTV%Y[3
M1#J4G28M8+'T2VB,P^IYE'I_UM'/?NE80K"1LDQU2JJKGD@@)JU.,LHIU\`3
M1X8MP\N@L0UBAMSF#&*D2A?+K%FP<6!B)*3_`&,T:!K.YJO;RYD4'4=>0>D+
M..*NVA0M(<?0QI(>0J![E1'''TV<4BZFH0?&M0"S+%7B1%/.\+_)"LR@D2XE
MB9GZXBYQ#14UTO*MT(@DO88J$[H8VZ-`MVW-'7F$T2!J.0N]0!L96:-*&'DL
M^R`>#6I^1SQ)#_G*3580=`-I%6)$+)GNS>[<?<=A!-:P=D5*):G0WCZFKZ#:
MYM,AZ.$5OJTD-I]HBSTJ,*D<#Y>=0%[%1%JLV%X`^>*7FUF')-@AQ.=,HBBV
M\,$OC&`%/=KV%;A-;F='$TV%3"*[M6#I*@'3F(Y"9R&=O.5G0[G<N;3V0JLM
MJ2"`@^%U(/*D31AG_R=,H<-,:'&4.R6$#Z.`":R(@1O->`Y?;9O)$&`%JZY0
MP2116]DNJ%"E_9F$4&))#JR<\QN#..=&AFG'-B1@IZ,P0C"T^!2+%((<CVPB
M(S_<4=Z`^#5,=45%[9"C2#RREOBQ`C=K",G?B+2+)02)(@#04;E"XL&_Z.@M
M6"%*GR3`,OUE)#F7>TL/W6BWOT0$D8JD!QET4IG:P(2`D70C5NCQEL!,(WZ?
M'()R7HF00Y'G2V3(GD?:008=%08A_3O(-K`S&IA0@1(6Y)(I2[0`Z"!2+_\*
M(DE,,@H`P&HDR*2',LTD%B[4(%4+&T4*LV1&--K-8K"[TJ%DN<W_A<2*>O]A
M&*K:P05ZN/(@*PA)RE3#/HK`ZSU,8<0*6MB.(\)+DTSDRQ.Y(\(2U2E+;@1*
MBVS4DH,L02S[*\HLWU)1)[J1#TPA!%,LJI??U5"E1<(:L5:J$*XY:0V=@IQ(
M1K&>@S"C4V#,Z2ADX[Q.^1(JO+,.[\:Q"4KHJ%]]FDY4"+$JO\1&;7E)(L.0
MJJ-*,J]3?MD%)2A!B&U,8R:B8Q%2Y700WHGF*ZSXC4XWT=:OP(1E<EW=5Z9#
M#*_":CAD&Q!3:!%4>D`%7)2`3@C]L:I8B84>;JJ25!=+V(X0`B92+9$$63'2
MPRHP*K]AT]V0"AU@JJV1%.$#6T7B)J8XEA:R&8G_N@C+):FD1R]VK2>F-L&(
M34R'$2--JD+=M,QI1`]>T=*0=1!;HO5DYB"MXE%8Q[H^V1UD&L0UX5=H00C9
M_74UMO$J(YQ[$#I,=B;AA==SQ3)88K0#*L>]+:;`M0E843:C2S'M8VDQ$KQ*
M4"]T$"L=>@*K'>U4+T-%WE7]D58^>$2J@U7)^M1[-_Y*EP[?92I%S%IAM6K(
MO@Y9[VA?^F$;9@W$,+WAB$U\8A:9!L5/$N2*BZGBJN$-2?MRL9'J-BD3EP7%
M+492=&NL-<,>2<<_)G*10;PDIM#PPS$U<I./-(ZF.IDA3JGQ+W6DY"*MB18L
MD>U$*"-EA>10)(\"<7I7_QQ<`!LIL($",Y*";"33M5G.<U;20%QJ8JQ)B<Y[
MYG.3QY%FJC$#T'TV$D8)7;5Q#$W-@SYT0E**I)`U6M)%;FF52SQI3&>ZS5C6
M=*<]_6E0A_I),NRRB9DL:E2G6M6K9G6K72WJ2KOXU*^F=:UM?6M<YUK7I+-S
MC?.\:V`'6]C#)G:Q1XQD2P-`S\9F=K.=_6QHTQK9LKYTM*U];6QG6]M$KC2G
M53KK;8=;W.,F=[D=TFL78\UZYF9WN]W][EUCC<TG!C>\[7UO?.>[S]->\:_U
M_6^`!US@>$;WBNL]<(0G7.$+/[>(^UUMAD=<XA-_=[<-#G&*9USC&X<VOU%\
M\/^,>YOC(R?YJBW^<8QWFH:`6[FQO2WR9K<<WC+7=*2E/(WL(41<Q/8XO5,N
M$68L0`(DV```:+&+;*YD`R/9`-36L`""(&0:&]C``K:T!`DL@`2C)48-`$`"
MR8J$!,:APP+&084-_(8,-0`<'TC@D5%(0)Q>V<"!%P!@.M3=)1OH-1\``)5:
M"JH&52<1'21P^+$>F`0`*!5V^'!X"<QDZGP'@%BP+H$--#+O(UG"!F"T=DS%
MO>IUGX8$#C0$$HAD\.C^Y0(68)'`BZ3I?/GZXI6S`LHSY?%9'X*'!35V%"T`
M*CH(+R/],7O2(3\A5#C\`@K2#MP7/"JCVM$94RST-3C_AP1:7WR"(;\`RS<_
MJXY>P0I^5QFHLWGR"]A`V/FBG-U'WB"C8+_6L;.+%4!]$^,`P-"+?O3Z(X&0
MB3X)F+"Q$+T%4(YI``#KV(;V`Y/:`P#E0+YI6(`J,;RB<R$'<;V\J#JB`X#-
M>;H%&#]Z8(2L2[MML$`6V8",X(.EPQ(70;\1A`Y62+KY:[YA&8F]ZSNADS^Q
MXXSB2#^R``!%0XB\.S#,8S_WDCNXNSN#8(7%JX%Y$XFGBSKZPSL!M(T:&(B"
MB#UZ(`'-4C,N++41\S<D:0<"`@!@XJ/*0PH`$`D`R`@Z8!+$2`]F`$%:2$#M
MD`",,+H=8;R_8CR4,+IV`,&+__B[`S.^A-B$-O0[)^2"!?"*-B2)-Z0'0(2O
MW`"`!7@+$E@WAV`\8E@!"<C$<@*`D*"$.*0-0\S$RP*`7=@&-5P*F!#%/C0)
M+@"`D4`ZG:A!#V-$0E@JVFL'I*L22[063(3%&D`80G")=;/$.6(%JF.%72C&
MI8`5,F`25O"Z&5(($DB]+P0`SK!$[,H:-3R).%P(6KQ%E;A$1:,%181$T<"\
M?L$\C_@/"60%IXC%M]K#I2BZL_H(`##%]/"[KYB*D;A#,G@-QC.(%4B]6VS%
M4S3%?BD=!ER*35@L1E!#MO+%I2I&VF`_OQ@4`,`M`,@=(N2+440(A(G&:2Q'
M>(FZ6_]4F)Q#20(R"7OL/;'0`8(0%@"@$!*0@$VXKFV`1:;@NX_"18;T1IU,
M$*_+"U14+$ED!#8R1&K$Q&LLQ9#PN[<@R#J4``T<BC?D2`\CAH#LIS9DQ`"9
M0QT:1%.1Q.FX1I@@A(I$C$XDG7/<&NGS.66;DCN<"D8$L&L<B7*L2X6XPX*X
M1NU(O;[\"P#X#4;TR2%8`P#XO,K3`4]$"/ZS#!+`NH(X1T9\2Z2\R\3X.LU,
M/7/$#4;$D=#$C0WPQ&OTB,#T!Q#D/V)IR)<LB%O$CFNL%D\424#+S"%H1I=<
MB<9$B/*S2]W0#N%,SDS$#E%AB(S\LSB,Q!H<2G+$#1T<3M+_2<R79`KM/(D%
M*)D1[)-)O,/$<\G%W*=U*T3A8D@J"$[U7(CT9$25Z,;FE,V,^$R$&,^$F,])
MA$/=,$^$T,^Z+,0A,$QT7$ZSR9K<A*GOM$3=($N#+$FW1(B^'`*S&TWL.$X)
M_<2C^,OEF$3)A`GM1$S99$TI(4SP*L[`04P0[4\`P+T*;<V#@$OCO$S]O,_O
M)$P(=9)8N[B]A#D8]4METX$AR+J0.4>_^PX+S1H=J#M1/"+/.]'T*$3=<$<_
M#".^XT.&D`#<6`!"L8RL0<4:,%(DI0>ALTRL<K[4LTUSE$-<E$P"`C^BM$,&
M?4-8]*ZOLTQ8B5(RV("WB,T5/+Q__V3$%:B!61I")Q2)--TZ?Y"`C+`Y^P30
M].!1H4,]K&)15&2T$B'"/$0Z/HK$!?1.7NE1P/$Z#,6-=FA4W[O%0]01-V7(
M];S+.R0!/J4)ZQD)00TC5\Q(OUC2?TQ/*Z6)U+M&5B"$!5`),M6!0OE/YA$Q
M1BQ3U'#&]#C.](A6HO,+5)0`U%B(2453;M4!;<Q$<36@)2C)-"O$*XE-77W#
M)?#&G`*`_Z,3QF/6&+W/=JU0D9R.Q6152CQ6.A4Q8(W7)$L(%U6V%9@)[##,
M%=B%ZJS3@\P:QV.\+\E1Q$2ZIAJ)%:A7G<3.,\Q+@MO+)_%/+MB8C17,2!V%
MHH.:!14Z,/_U!Z_+.J90U].\C(`D%D9<R['@`@D@2_E)QJ1#2Y,-33"L&U==
M`4(Q3=*!NH$0C&MLVNZTT\/L/_M;P"&@`_B`6:J=BEUE1.8T"%0L63K`#LF<
MQ$(D`3Y("BJ]4>2L5M.TQ*)5B0;55\0Q13+@#"99`NM9S'+,3@-BR`6@`RX@
M@;SXNK3]1Z3KB>*TUI'@4?240*SEQ%S-1)YZ3?[3#7I0609LT@.A5OM\6D24
MQ)*UC!QM4B(56TK56!PM23Y8`07223*+3S@$PS6X1=P$03)0G'9@!/UK6\JM
MT3>T5COUNH*]QC78F`6PG@;-5_W<UP7U3K2M&]`5C/3,W)5]WB[_8]XX)`-B
MN</_*!4BA-BH/8E-6#S!R%%7;5[["-SC_4Z6ZC4AU1J08XB()5+0I-2#H`*D
M7%!@\HOCW`#3?-+E,CXSH@*L^YW%5#+Z(X2ZHX2Q,TV+K<02?4-*`.#+I,;I
M<%7]]0@)4#&YM$8FN:_;9%L`;E=,2<\!=5:RI`,2D)(>#8JZ0PC'3<X91HBY
MQ3HLTX$E>!J:6`,2F`F^3<X73@AKK4OW/0CA,U+BA!'^LXX71F%B/8@-<*%O
MM-<LS"@67:2I0#H=L4\-/LG2A47%&=\7Q=\F3F&QV%0-98@:CMJY90@:A<,K
MJ<'LV0"+\+N4,LQS!:W]M<T:E!,[IML<_Y7+MYA@\FC,45V^XH1BL*S0(7W4
M<Q6+#DX/0EX(_75DQ!1C(G[;(Y8(9(O?&/JYB?#/#,9%:D6=<:B!9AQ?@[!/
M5,P+KVT'9L`\F(#+.[2,B.U<0CBK!2Q'I'-)])5@*FB':0A47)PUE\Q7!)5,
M1E@L"73#$S9%8H8)5^Y)2MR&1(M:>6%$6O@SC4T]1DRRDB3F.%)#8T$?@J@,
MB55.NQSF8LY$;)9,Z^B4L9A#:[Y&:^9;*J`';2I)?I87W"/F!<"-<9Z&1\M$
M$2-+'1B'T9A$:GW)99P&:A9`O'&X0Z0"7!D"5X079F@'56[2D!"]673(-T10
M5.QFRZ&]9[$3[/^51)1.TJ/`/VN^5J.3'Q9]XX3X5EJ%R6S*9H0@AJ'DSQ=N
M![[KZ&MD"H5FZ/1*9*%[&1:U3Z*6`*/.&FXN(Y<NP6>V1'<VYA%F0;/IZ(]&
M$%R<KI0ZV"C+983."V8^F&>V4+#>6PD4QK;6:+;:AKRH85"6MV1;-B0AY34^
MQ[(E@;-*X*1D$0KUBL5+0",*7;^#CO1$.@JQ#P"HDFF+X)"!NH",B%N,2Y&U
MRT@=39@`8+(I.DC5S?U]R8`<S-2#Q?=([8B`XI%`Q=1>%47$T+_!;)$MWX!<
M@*A);1UB9[W`[8C`9WF%"O[;1N?Y.IA@1`F8K*S!;::`;H3PNH!<:#3_=6V%
M<,=+6B[J;MB:1>V`Q`WJ_KIY.U+I`L>H"$C!;M+=#JDHCDVJD\34GEF>#>^6
MENV;]0?A_D?\?EEH9F/AO!($)>Z9QI+J#LF^O3[R7JZ-#<ABCCJDLPA!)4Q9
M@CH2(-+=EN_^0Y7@QNX&%6T<3N^O^Q+SSM$*"4MGQ=X*G$07W'">$O'U%FOU
M!C#Y&0C5]FPGZ;F0Y>LC>:7?*"/LL&H6D:NPHJ&4+B8F5C2#/H@_^PU^AI%7
MP@ZT4PB?9A%C(ITK%PV_2+2A?(LJ'\J$V`:>\FEB/HDE9W)%>R5LQF;12'*]
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MB*LO^ITGPZOG^*V'M#'T>(UO^9(C.;2?N+9?>Z*77Y!5>'<_$F)`F`I:KKS`
M.6ED'KQOJFWH%X8>!5HH_`K".28G?*EC!;\@!O38A5&H])WC%X3YG<*GEZ'!
MN6>YF\('(\?_:;S'E+M?DR@S&U8P?),@!CG!Q]XY"(09FG8P_.1!&#*#_*%1
M"N81%].RJ<:'CFV0=[U0B<]'?-<O_8M`&&F)?;S_#>('GNE8K-U'P\L?A;C_
M.?W3!QZ$^4>*L'XY@?S?X?N9)(91V`7:+Q$:9X6KP'O8-_P*6JSOYWZ=4WS(
M(/^^IX7SWWW18'V*$.'X7__E-QN`&$5K%RU:[5B-\^=O'"MZ_HBQHL6*F<*%
MHZ8IG$:K(L.-%34:S%B0'CV$_@8Z+)F0("M6V_Q-B\AJUT=6Q"KZVW53X<&$
M"R-:+"B1'LB9_MH5M.G/(<Z'%SFRP@C3XU*)!3=-VT:5&,V8$FE6)"9Q9TZ)
M"(F1/=CNH%"%!)]^'$637M*&3>_>;2<!P":\?O\"QJD70(W`>%<`D+``P!J%
M)$CX(Y,8P(J7-28W;K=FP5XJK``L7CQN#8!V_C8M_^"\H*\_TD,<0VZW8O%K
MG,0``*#HCQGHU)2.+M[;UZ%D`#N+Z[YMO")B"7OI*+R\E\Q=TJ$W^%L!>2D`
M+OX>'YT-X+5#WJE7^Y,.8(G#;<T7+#&]"P#TVW0V\54XA`130@`PXB>!::1E
M!QD7`#!%3W=-M1,<8P_UEIM;^4&XT2Z*[=68>:`!T!*'&Y`4W&*L*2397CKX
MXUYB\)EFX@*55:0#;KB]MN!N^>$VXE(WIO;?-OD1-QF*N^G`&0"C4#'C>/XL
M>*&1C9T&P`8)'<A4BN_%Q^-BNEF'&PFW_18E1>HUYA`E4B8DF6GXJ18F<B7B
MEE5^.O+6EX-]F0C`D'1PJ/_;=]O=V!=JBTG$X6+;\+D8BN8MM@%8/"VQ(HQG
M3NE/E0K1LT%H`!#")U/@Y4E>=).Q1\^FM)PIU9GTL"EEB)-!YP^?>VTS381^
M&H:I<+GR&MA@A?6JT`HK*,0'IW]&!D"*`%!'`K$5&0O6-@[AIYMD.3$+YT;%
ML8*LL2])M2,9BT%9IS]#(,@D=4U)M@`A2]6PE[6+4>?0L$L9^ZZS?P7)U+W<
M-0O9MS!59*X.V&GGSV=]D;#`2_-1H5"D[2PA@7X+T#-?MPK1TJ$_27JL`XH)
M2Y9@ME8J2-VW/Y)8D01+*$3'`@OIZ1`C`#"BD+EB5I3R0@=NU&]%)$CP4L<1
M7_O_8[W,/>LS3#BNB]/.@8J;+J8;U)"23_\JN(:".MA\[)D`\&&IU=\5?1(`
M$4^-4\E4\[QO4_B1;3:VZTJV+6COTK/"!C[FMQ=DMO:5;45O*S3.L>.8)NRS
M3_?U\E$O12D5XE1/<YE/'P/0U0*0T5WVI3T;COB]ES,'6<>%+_WCN^>BB%^X
M"GIG[#3MU#T.410&JRL`OUG9>["_!FLOH"L4EG"57?_9SC:F;>#=W!(FFVSC
MN'O'!7PP@T<:63B135IYO]NM(!7T3%N1]EP02\P"I%&D(!\$.O8X\@4ZW_A=
MB#_6SC@_>J=[RY$:^:Z5,-[0@F7B6H!I]%(#]-R(#CH`_Q1WO+,!0JP@9P\"
MS^B<1CJD6<Q6C$"?E=3TG<+@ARPU>!;A%((?@R3$:;A;FF2VD1#>A*EZUV(>
M3KBV-GJ,8W5,.E_Z=(8S]$&N:C9<R0!Q(C<%T>$S*B36F=B7+*:`Z7#*XLT(
M-R<T+J[E9A3IW_,J4D5B78LTU\O6^MKW/@!L0X'K<90<B=BB_XPC(;:*6NH*
MAB.PX:1:<%HBW&[#FAE6!#_;P`\7((,ZVL%I&HSC(![UAZS;=.N'Z;N?XAIS
M)H.\!)(W^]^#C#C"(O9J,"T37O'V`JQ@)0Q.!4K6$%9POO3,B`Z*6R7/[+;"
M'AKH/T6K`62V08+Q?*]CVYC/1O]N0X):TJ1!,P*>I18PGW;PH0:CD)`RF5D_
M]2E+1O3R"^(NHZ2`I>B80R`+;]9`#`F@Z#+[@8X@J44]TJ"(*<9:0+BB,P3<
M[:(&\5D.J*SF09XL!C=]X<V,XJ>V7?SH-P?2WZ5V1K?$..1DLPS28CSDIS.-
M9CRV#%YVFI;0&=F)0\.YT8SDM-)V$>:*=P$/=^C@*2V*B02T$)\+)63/6LWH
ME0JYE'*4-"8.+:U:.N73+/NHO6O2H0:?B2..Z$"()2CPI+^!*;!((X$1,LV/
M?;D9?1HGR&0MIC`[<QH.=X3`SS!CJ6<#&)R4A,:@XD2>)(".-!?S&V.U8YL4
M&1MH',+_F?VPQJLY8RAN<)4K5;*2E<3KW;X<DJ192F8-$HA8@<;!C':(<"E6
M.NNU#K:C$]J-"V28(*8VX1S]H4M.BUK/$/C)'2J,XW95HP<),$@)N/I#1G*J
M3<(L.S._Y79S/9-I9X$:P*:Y5D!&7`Q6L_/&LJ5P1S?#B%[V0A;%<18GFYF/
M/[*)']-0TF3>L1+NV/,9EW#*LRBCSV<2HL8=40%C<,,/0C`"2<>\4C+3P,AG
MYN*/FVF&,0L([]"V8S[_=6P40_2L_GA#B-Q2+4C,&'!K`!!#*SV1/OZ)(>>B
M-`Y*Z("G_MCF3<)&2D(XCUWILC#C_$,1[=1J<_@YL0Y*"YE/_Q7F0/ZXX`I^
M"T<Y4F<#-RL<;B5IM@U3#B:16FEQX1;2=9$V-UFQ<BE#ZY#;[**^*'ZDC01L
MPX(R(XX]?"/?UI-;T]B*%9KMJ4O\2YD#;6PWD1J%ZT!+4L/08U>1[1WQ_@R8
M?RD-L\JR\7<>EQWL+#?+4?)(QR2J+%JD1JAGW<:F0.,\OB`2D3+FG'$^<[N$
MAN8E_U)<LQR-*;=9S8>M#B3U6AA6='$'9@K9P+.2Y!Y`'=2(-7@-)1;P2T6;
MC(]TQ=T:=HD7]HG,B*]+]'ZI1U>UO=2@ZZG(!ARY:&L[#E.&,Y?A"$@B<PE-
MVG?Q8;./M2SOR&X<$M!4XQ2DZR%#!O_=RZTHA03Y+UI+<MXS>R''R"=DD$'D
MR%`[U]]8!^L_0])>CVO;OV0')ROMC-'"@K0_(E4Y>=,;)TXSG;?_?"]T9539
M*UC"7GLZNVQ)P-%=<[9D]T+-0?,JT#'MW6P((9D-8"2]V+/N_,HVGQK,#\O4
M>YN,;%HSF<JH,+2@`B$D4!@S`2"!XUBR`I-D&LK,CYK7^HS%=OQ"&][L-[/A
MP\\QLO8UT),$]6:N#P.H.BKPP>IB%>TLYY.SFRV!$)>Q$/GPDS.Z!D_>]$G1
M8@Y/,OJLX3>4\?E.%+2"J_['5DM@>YZQ13XXD8$/&]@`Y2S:';939/*1`N3%
MS;@>#';.;/3_&/JKZV[$PJU@?H>_T1#83@O-SX\>I+%ILY,5>BYL+,3>D4SH
M1P\@"9G(2F<*_&5HTM;]S;C?$GH['Y@BR.C3H^E\TL$=%9:8*%%5PDU2*)-R
MOX:<28;X5*)#I/RT=C(D,#]K6(-DPI1EXH/6>!""C/#1T6%>SGQ?8EB2TXS.
MX\E?'\V'Y+G?X9'53N!'Z)%!ZGG'S=P$%_!!I`S8>'!>[^@<+^$<8$Q6L*R!
M#JP0)?@$&5`'(PR!0ZS!:TA0#=0`($U#5*W`NM!"#5".##I$.VQ"#FX"4S`"
M(`548]#"L'#!YG`!E"S%$*S!-M2`A:P`32P!"ZZ`]!Q8/@W!N_S@_S:0@132
MPQ!0QPKB("-0SAK@8`Y^1VU4A`RJS[J<8<ZHUDD,"QF0F!521634"Q6L"S$T
M$AU(Q1JP1XEDR1WBQ0IR%Q7H@$?D(2/D8!=^#`N2P,;0`R3FX$9,@\@0$]_P
M!!?HP.S00BTQ0A]>(<>`8B9>HA%:DA#:!AGLE53086LDXN%$C0X<GGMH(1=Z
MX30,`0LJ63NTXHF]X0KXURD2T\;`(*8,0<[0!2KZ1!."RQ#<4EC0HB$JA!_B
MA2QZXTD`862P8`XRA37"!#:FQ":(S"8TCA`R8A/FT0IL1#06"SUV'"9N8#DJ
M8\>M0"2*E\B00"IF86L@3PZAHS]00C+:D/_(K!PMD-0.1H]NC&$Z9B,T4N`,
MEL@^XF`_$@=U4$QC4$%'2H\P9B,MM.)&\&**U$#.+,$_>N(PAN)IY4H)GF`J
MN=)-ZN1.`H:A\:1/`@:GF2!/$F51&N51-@50(N52,F53.N530F542N51[(I2
M[F0*"@])^23*+%?P**55[F2"W.17^@589F5/`MI8DJ56%D]@`*59OMIRQ:7(
M-25<)F5:TJ5=&MI>X@5;LM)6EB5>SJ5@QB5<VB5-TB5:RF5BSJ5A#AID/:7.
M"=54AB5BYAQE8F9?9N9FWL5A4B99<F9H%J5GMB7.D:9H+N9/"II38B5JNB8)
MOF9LRF9JSF9MVN;_;>)F;J*@S5GF4;9FSN512E!.'C%.SQ!GE"7.$B5('@D&
M<3+($C%GC"5.0OC/_UC2<3)(<28E<J(/<_)$'J7/G^4/3APG>X&G>2X%>/8,
M=*+,_Y`$<7KG4MB08!`2>:+2>M(G1Y@&$`5G7A"G_K@G3BAG=GHG?]XG?S9G
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M%FA0`>7(R-Y@RH%L6_`<"*+*B#0N"&%)`*.^FJ%>G:E**H3@Q@I\CZ%Z!V.1
M0'*XJ0[`*6[(Z4*,Z@JL%#$@AL<(2]9I$4G1PM]\7E/PZDW\&YKZ2:`FZF+\
MF*,""4N5"VY$S8$(:JM4JNQUV*/81K)VRZ5,`\CDSEYLA+XE$H=(@-?T#&(T
MDY)T2,?D2(SZAQ>:QTLHDJV4*>78$Z$F"VX4AO^AGI_M4>I+D(;T_-NE[NO2
M*8M@I<BHE@U/.*H$X$F<ZA-NO*II_`B4/$:F0)J\*1N@<2E32J;P")A&H)_K
ML,H"8(>MP-@TS!<5@-;3`*$5+D<-?4:L',4X^$<",1>:J1ES@,B210D7M(/[
M;$#C$"R(]-3O+0"*F%G\X02?,,)!+,F#Z58DC4-FV<T+V<ILY:P]7=@RK<71
M"BRS1*W-FH;?M(-_],4G,82T1FKC2$<[0)+>^H>N!4E6O$2DL,+=+AYO\(%L
MZ%>0:$6']-EL/(T.Q-%EW(30YL<&2``SC,.!2%AZK,`X$(-NT$T^,5=%:$4[
M'$@_C0^,D4#R`(J%^5G_1O2M0MS&UR:NV%88;@S)V*Q+U7I?AZ2MW7BM7PP+
MZ7:@L@0:"4`4,VS$8,P6+_$7-FU;3X5M$,77I/U/4D*K;C`4=8PISM;LU,[K
M[^F)V1CN0K1#DJ1928F;=WQ2\1;'3=!4>G9,*O;2M7P?/TW#H[37)LZ,@'4,
M=)#&"&V3K@D8BZD-_)4&H;7L4GII8-SOS%)(QT`4[Y!.U`S,LD"'D#')>LVK
MM<1:,)D<9&@,PU5$QVQ,WA%<W)BPQ%B,R]R;L21$N>V6?E@,__X'LK3-,]W%
M60T!Q[&P#QN<A^&%HKZP=FR`Y,$;]?A'E"&.ZU1$Q=R(I:5$]<S<$?M#%'?C
M_^*!,'W<!E5L`'FL35,,HQ>;*UZ<E;E5S\1J<'EY++-&R:,$VXV0@01@A`Y4
MC/0H,1T+$@<MP#;E4%*>\8X(V8X9<I&X5!!#,1SIAPZHL>DYED-$F+OQQA"4
MG<*Q1L<$#0RO<;.&6P6!LO98HMSLW?XJ2R!34/R:&('XC.04"R0'&LO)(;K,
M!]'B9!Q+<$[VBCU]U9IPLKA5(6@HAI_T%<(XF@.R3Y.JLG/\S<)*R9(P!ZP@
MWK79DKKT%!G0P09LQ$3U%/AV*[DEAM4.E=7L&(%<(!WH%(08B21UZX[4DT;Y
M3,\-@4:Z#WTH5W9$C.&0@`XL9`@K)/7HV\]E'7#]U/^/!!X)%'(-S0>?">!`
M-EKM>5ODCL)-!<F``$`FIL3OV!KJ/*C>W047]0VQW*]YR(NP]/.ZC,,QA>I2
M-,HX\\7E,0FF2>Q*;S,[Z\W.^05I<'3UL!:B\`&KT@'_*9!8GI6YX`XEV)KI
M*09_X`07(`RPU(D.;,)4*1`IYW0[&[2H-*"#M2JSK$$[:\^S]DTK.[5S@,:*
M2<B9?-7.EMCPL4]NR31KG`D#J:XKQ>B6QC-33G!@,$.DP(PB192XZ5)WL(([
MDLX0L(*$W8N_W-4#2>$(P\DFC`(K2("W;<(F_.$*2`"J>*Q`=[1W=,R[1$K<
M/I!&(DY2US631&+H9G1/A53_E*3V^)!!8N_.2LFS3]%SMB#&99"(G6XT3I0V
MYZ@:L6P`:L@O07>K9&PV$?;P3]D*"70;<AHJVVQTMR7$O\'O=<M4NOU@W?@'
M370;G.RUK"AK\/`J38"';2=V0A3W:?.$HD*RGK`")409`IF7@"Q(?$/RF<2+
M:A,&)--F>(N.LAS0;,Q,U^@%(2,F:__&>"-+M1$";G/$MAWMC41$#8QI5ON,
M/05XD&PV531@TX1UB%=/[[&6&T=)A;."C/128!\R3(OL5@VXAK2VV<1>R/[A
M+@^E4;YL9/$P5;%&M62UR&F4&*F;D)&&EEI<]0A+R:W;LR1,?@TO39`&Y_+F
MF'Z&_X2-3@UP'&HIQ'UIE"BG!W8,>9?##8`YLFXDR95/]`,%3QMGN5HSC",=
MTQ-S"1*G6R=5!)C?"$1#!U,(F$_P!GPUAL99F/KZQ'RPAODT1<+(B',L!DV,
MSJOAQU#26./$TIIW&.<VG!OCL!%%!&C4R/))"><6'AQMDY?_Q^CM\[IYVX'U
ML$PMR`KU=2^11D),NF(L!R4[LG-D"-5@#>`4^8ZC7ZN'<NLUU="-J;(G\KRY
MFNE9SBJ#&^(\V`LJ"VF\!-94Q*ZS-25HLOZ<B6/E'&\^Y5__!2UPM@2\!F$S
M!C'P26'8RAKLPBCX2<2EB',4!.<6*H+\R,;N-@E_BK?)A/_^>/8NX`=TS(<.
M*'SZ^H/5-39^O+N$+,!K2$9$H$LAWPP7$(.QU,N"!$_&HR07"]+%WXB];\)@
M=4>8';MN-#PQX$?6/)KYQ2LE[,+!)`@\3?R2@,<TC-.94`(AXK`)P0D?,(.X
M7G%P05JZ48T.6`S(%81SO`0X8XJ,;`(QR`A87#5^P!ABL\+-?/"^DL5\?,E$
M1(84KM6CW3M0J3Q&;(`.)#;%+P0C[$(-,<D0A-FCF(N.P)Q4;?:2")*[5T_'
MZ!HC\%'7@[&R@-Q,H!PD?49^(/Z\,@+14X>M(!\K^`=TF!XCT,(H;(XF)S8K
M<.[3_%6<U#LSC%\6GSS&'XE$-,[_Z)P)&6@]L[:^N2+&D*2RI`D2N^]"&6\P
MWR6-F'8',_C'NA!^<8?S7T8P4JJ[7R3*$&#$-L61:FP`'9@&,PA[*2V%!.@R
M&3H'&4@%'4B`0^Q'4VS3^)>_0D1;HFS)CBR!D9!!X^Q"?EU_0DC1MWN8J768
M]9Y(YP&$/W^L=`"HP8B>/WH;Z`ATZ(\/``D`=(P22$?"0`#3_*T!,&Z;!`D+
M`*P1R&H(21T"1VUT2(P*@`U\V@D<LG+<AB7^-@%8L(*80U8`F#GTN&W)2G]T
M`#3<M&#B"DH)'6*D*I#1"HJL!$X#8+$GUX08:W8%L(DG`%K^II$926;;10E7
M_;7CLP$`_Y5=#I?XY`)10EE_.DA`E$A18<<%&TB:7%'#H5>+#E-.I#-.)$D^
MNX@F7K-@V[8%B]&V6S$:P)#$DOVYK2EA,X"@`C^/H^72H]VY_B@!8.0/`)G$
M_OHN6%/3*ELRHR687&B2.`"NP1T^G4AB*L0-XQP29ON5)=2):-DN()^6UKBS
M_L:=#BU2)LV'+3GFC@B_Z-+=M)G_]D>_(P!T2ZBGG1YB!KS_.M-/(XZ82BTN
M@>AI[J'DAB`AH5$*DBHA1F2C30*.TA+QH1)-%*B=\4Y<D<46'TK1(!=EG)&N
M&5NL<3@;=7R(*KIPW)%&%W]DT4<@6Q2,1R.5-'+()25TJ$<GF?]\4L(F=\21
MGH2PA-*?V_(C4L>$O!2RQA^WI#)'+J5<TT0KV2SQJB:15,C-&6&D),TW3YPP
M1CW]S///0(&L4]`@"Q7RT#`37911/=LAT<]'"6V4TDJ3M)1)%2F%$3),/?T4
M5$8G#9744DT]%=545=U4TT8Y7=506&5-==19P;05UUQUW952/L\3=2+(:N7U
MSV&)/1;.9*]L$]EFG7T6VD$GPM-8(U\U$JG&'*)"@MD`VT`"/(D#5P(NO%6H
M!L9T*`HC<,7MDH0%=""OG70-I*<&":CPAQD2&%OBT<56P(L6SCAB9H&&_-F&
M!$*JPE"@)53CMR`2N!M"-3X6X,,F`\?_62.SO01">`-_U=IE`1'IV`#=#?!"
M*Z%I7!ZI*&YA)D'A;;BEC@Z(':)DI"76$HB8&A:P>%R\3-K$Y05J^/5;"?RC
MPN62>)*`,3JRG"EBI#NJ@2J9P5V@9@E@WH`1E/-K9X/T9B;;GR$,=(B6>)^6
M,%UY@^(#Z]2B_1OPP`^%$>I$K]WQ-BIHV800,0'(*S$RSHKH-Q(DH`7H!>NB
M:)<5,I)\DX@<[DEQIDQJAR2(IR$),@3)8&6!)>@9A9#@1FFGI_RX`""N(3)R
M:'>J2%A!H`UJ8(60HD@H3'+0_!E^X<4H&861H=FCW7;<%Y1<H:TH(=%U5C;A
MK@8`B*<'@+\2_Q??8<FO\H@.6F(BSWA6^"C*<_'WZHD05OI26""@$YT_\D>)
M_?F&?\#Y2Y<`P+&A<&5DP6$%)<AGONZM`7T<2\NC)#B^YQ6F.GG9A>FZIX/.
M?>XLF[">X%C80A?:J56,.ER0=$"\$G%A!<LIB_N`(QSH;6Y?$DI?6CX&@.X)
M9P,V;(V`@+.$MOF#$"N0(K_6PT,$D2=W*$H-@MZU1*JLH#!7?,CREK@!DY`Q
M-RP2XX@""(`L4:=$:Q1(OB1@$>K40(EMI$H[X$A`ELF1@'G,XA)KDA`>4N>'
M`LDB]/HHN6G4\$F`'%@=>^B/&H#0.Y(\GT`2*;F:#+$GXV!*M5Y82O]3'LM7
ME>)3IW2D'FH]!#;$4$L;:<&(!>R%C(9THQ#_,DJ/U'(!Q-C&>A(BQI(L85\S
MT<$?US,$EOE#EECL3$)Z8[PH\3"0"L$+'<H"1G]PP3R%@5ZYV,(*6GBKF.M)
M2PUTX+L%9`DJ0UC!6A(B2Q(,H08<(8$.Z+"3DJ"/6EGZYB[34A0"N62;92F?
M/!W6F_R(49?`W(M6&,H;ETC`G\))R#;&)K)TWC.?S^.G:H;8FVGPL2'VE*<^
ME0A1*J*%9V[TB`YJ()Q3WA2G?R-<I68X(Y<J<I82Z%3S&BB0*>JR1Q-1VA(G
MPC&7&I,.FY``@IAQ22I"19UK'.0</_00;/[_<!O-4UYA@K>"34`2E(]C902E
M284UK$$K"0$`SJC@+03I8`U<B,OP)L29-:@':MC,XD&+$E:?X*\D7$#+(.5(
M5`T:+:^+E0C-%/B0GMC4(7>E@UZ?MX*^4D<]?/!*4#3+6>BE\UUB),E2)4<&
M,C@LI[&5+:]22<HK!0M0+=)7B?K2SHEP9'?1V:L2-Z"4$K(B/]R+"7<6$$1_
M>"@N)1FF#A9`P#!*$'SJ[`FDL)F8X!DUC\/\"QFYQXB2%<:9#IEB)+6[/2.B
M#[.95:=1"T,%H_VEN27"IE<<EA!N744]/A3D@CS$D80$-R;#M2P`"'&[(PX'
MD"\=8WWO.T>W[@:0_XF<T$XZY)*MS*:[LQ7QB%>U4U;U:4<>F<HXB*&>&JS!
MM;X9J(271X]IS"\Q\'U2<+D8H-_<9B4ZULIXKPLUK0)@%^W@SD!KU).E6<T?
M298EGL@87,S$Z++T:$<BV0I4W>TR+^W8QI*IB)`Q6Q>:CQ..BI6\%\F-N29#
MF*6'H)-DSE2.!&*.2T]V08_>&'>):4;+\O1<4"A!;AOIA)E\S5P3,LIRB!:%
M,H(:MXV:@%',-5$Q`X,,QP-O!"3LH<.72%QJ4_=*1;;544]MA)''#:%V$9H0
MRWCH,DL^;JZ_0M]?J%)K$+JZN84<(E,L`KT>7^7(CY,`=[ZK7UP/(2%L>_\<
M%1(R,"]"L4^4(`&NXRMA0WN1'B11JWRYW5F!Q`0ZKHX142$SCITQ!$5XR4M"
MRO>XZO;$WM1^R'=M76^?&#K:)"$)6B*,H'+_$-T"$<V"#$X2X93/X7*1"!6$
MK=$VBGL:PRS<J3G>\3>9N%&K7)*-IS&.DC_$Y%J.T*/8LXUI3`-')T6YB$P.
M)68@2>8L7UA<;!SSLCS*Y2+2N8E"`RF71VCG+8\,F6T<FA/!'$4DJOG",GYR
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M=\IMH'"/?___'P`K3_O63_D"T``/$`']1/PZ[_42T`$?$`)=9*=0[T1>A0(C
M$`,S\/KDKU#Z3P,_$`0!<`&WC_Y"T`1/T/ST[P)+A/M0T`5?L/I&D``;$`9K
MT`:+3P;G+T96\`9[T`=O_XH#!<4#?Y`(BS#U@C!06M`(EY`)2>SW&+`)HU`*
M1PP)BZ4$IQ`+LQ!PHL_UM-`+OU"G!E`':1`,R]`,924'"T4)SY`-VQ!45'#\
M"M`-YY`.46V^H+`.\U`/$R4-!64-]Q`0`W'5D`\/!=$0#]%&JE`!KQ`1&Q$1
M^S`)&=$1)Q$0X;`0*1$3#1$2_^0/,]$3V7`3%U$./Y$4V5`1'4422U$5L_`4
M/RX55Q$6F_`)27`48]$6F[`5V81/\N@6>U$6IT7Z:M$7A_$&<W%-AI`8D[$8
MQ5`-7U$9GU$#)S`.R1`:J_$#N3#YJ-$:MQ$"C5%*.I$;PS$`0Q$5A5$<S_'_
MHO^/!P_/&='1'=W/&YT$&=^1'NTO'I<$'.M1'[^/'%UQ!_<1(.$1&-=10MHQ
M(`^R^?J13?(1(1O2^!1R31C2(2>R]Z3Q$BD2(YGO'I5D'C/2(WL/(K_1(#^2
M)#7/$FE1&TM2)54O))U$(E<2)CFN)4=N)&/2)JF0&?VP)F^2)W-J(ZUE)WM2
M*'V/$%%R*(^2XWX22%X2*9LR<+`16,S1*:>2A69229B2*K/R6)1R1RQ0*[\R
M_@9R&L&2+`7'*H%2*LM2+7&%*P<Q+=62(-<R4^[0*.72+HE%'<?R"]N!+Z4D
M;?YD'`AA[I1D%#8N$0532C;!,)WD+U^H,:'D,<&P+1/_,2A?D!BX8")F*4_B
M!$J(0=@6"$T&1='VCTJV9+T.A.G4"``@3UE:Q)L0Y5*21<<4)59(<TKV),?Z
M2(OB*RX1<#)AZ"U[$#-N:1L,:$>&8FU,+\*4Y#1C9C5]BBZ7LNT^CSHX4TV:
MI2]YI#K+\#=E!"M?T)%*)*QT0#Z6@@Z(80@XBQ+PH@8:@@S08A>6@!GH0`<@
M:!>&@.<4ZR1T@`O(C"!B8]$4C@O(LR:08A<HX2`<8ANX8`B8X34%HG/,APL2
M`B6&8(4BB!(VP4*AA`YJH(L<@A'X,R'X0(,&`J]H80G&H1V6X$!K`+;X16*^
MA!G2TW5,!"6$1N%8%$']XR$H_X$,=F%"%X8,ZI,MAH`\*`$Z%I1(V4-HUF`M
M"*$&@I0]AA2">&0-R%,AWI-H:#32QH%*M=`B;Z\R47"WGL0K2.`S\NS6:NIH
M_H.B'*:D9&)`P6.PAB@BR(`*X"8B=,`MZ)(,7LQIKHH*^H)C5D<"_M3ST-,@
MA*-VJ"`F.`;9?((*M,(BM@PV=()+(H)!@^*'(F)02>+E))50-6((/,(BA@)-
MMZW;/'549:FY1O4JFJ>ZAFD%Z&!CGN=W%N`O$&8%-":E#F,4>F-3J:@&?+5$
MT&T(/NDO4'4-5)5??L)62U0*H;(NIW#7CA7#9LES:B*+ZO0O>@)FTLJ@_@D`
MEF`;9/\IF90B(@)T802B-T*C*>@+VSC"*WA1C(9)84`FCJPFW/;%0RC!+I#L
M(08&Z:9(/=)M(_"5DXC'7YB!85@F3RE4-]4C7S,"012F.7WLW-3"W=RH=IA!
MEH(B)M*C+SBH!BYMV;:%8_N".[0D-7J$.I9@`6IB*(1C9%?T(["P.R5P3$TP
MW((L,8Y*Q\C(T'HB*/CH+QQJ<Y*V,_AH#88I,Q>`I&PJPG9!!V@J8=7)F]RG
MVNSU.8^,U-9H:P\CAFA!*W2`.\CHR."5/*9H)$A"`@K#F][(XKRM)]@6O&Z(
MH,IG(D8BXQ@,:+BJ;U-&XR#T;"L(;N&F.B:"UX;HM*X5XB3_0G&G-2<C,3AO
M,"(FPR:>:9@X9KVR2&FOM4Z%8[L6AEPU2,O\`:.P0IT<QR*8`F^S*2+B8IA>
M[UZ+"MN0CHHT:`,RAG=0!$<X0\!,%[9FMW"S20(FIEW3*\J@3.$83"!J1\R>
M,YN>!)N8MUT#:06@PW?&CHJZ2'CCYG?8XT1Z`Z:$@WG#MWL%@LPH]SGCLB.7
M<!RV;0T8P4F]0@>T+65_*(LXHR(J2VF1MGGS5RN$0W*B:@A^@RFX@!%BB#.H
MH':RECS4=JXH0<Y>;QR.YC<DAP^8`K/2J2GZ`BTP@P08`4K;MWXW[8<*@@X>
MY&\GN#!Z@@LH@0M(-S6T;3O;J(6I_V.-N.S:TBQ_Z6!B/&0!EDR6AH`2A-C;
MUH`0-NV(DUAYZX(,**$O@B*MD+B`FQ>)E5AG*Y<3>_8$Z8$@EJ<HF&&9..N;
M%JAN1&0]]T4''(852(#G7/0D]LEJ^XL1EB=%L2*)6&&>2D3;:N`^QXP$AH8+
M%JBJ-H`0R``TA>(Q.F1Y/I0MS&H)2EA!J<!?>%21A@>"N""(VF$-%-FDYK>3
M%\B/C2<_XI@$-%1:L6)Y$&)A"ED@#KE$"$$'KH(8"&,%(&@:7NPA<GEX+()A
MAF83./DEEFF7:[FX@@)?8.N4-V$)8`N85T!SI7!GCP2,[]*GF-F'M5E(O#A2
MLMD%K9/_F/]E6?CPG'>D)1YG!09S5GI3$$^2#\79FUN$[,JNGL,$G,LQ)?/9
MGS'E+)>2GO^9H/&Q*.?Y'PM:H3'EFEGD.Q<:HCERG_VQGR/:HB-2+"_RHC=:
M3P+ZMBZ7HT/ZFZ-S#$7:I#&:I#L0M^#YI.^RH5?DH5M:I&=Q!F7:IMUR,?EO
MH&^ZH*FUIGD:J%EOHA=RIX,ZGU^Z`HO:J+U9G@\E?I=:ICW:+2L:JD,:J4TD
MIJN:H*6:,D%:JR$Z+S7ZJUOZJN%$J<>Z+,OZ1<X:K<%2K=G1J]OZG\,4H:E:
MKA7:ITOZKLEZJ%':KO?ZG[D:./\:L/,YK,4TH0M[H]\:1=A:L9'_DK&S+ZX?
M6RX%VSM7FK(ONJF;<;(SNRPM>Z0)V[/7$K2QN;-'^ROI6J]1>Z$C^ZE9VRZU
MI*]%\K1A>RHW6R=KV[:;LK0=VK%W6R5[6ZAU&[B',K*SNKB'4KB3FKB3FR=5
MF[-%V[F;TK4Q>[I=&AA[9=MX\;K7,H)S.E`\HEQACB_;0<O*V[S+^[S16[W9
M&[VU;+W?V[W3V[WCN[WG^[[G>[WM6[[Q>[_QF[X!G+\#O+_9V[[_V[\%G,`#
M?,#YLL'3^\#SN[X5/,(=7,$3?,`S7+\W',`7O,`?',0EW,`[W,-+7,,__,(W
MO,)+W,(Q?,1;G,-5_,59G,;A.\8+',=%_WS"$QS&=YS$-<(G=%>&M,(G1L+(
MQ0,JDOQMQ</(,P/),^/(FYPYGOS)CUS)HUS*F0/*I;S)HSS)M9S+L=S+EUPD
MNES+F7S*H;S*OYS+UWS,1P/-R_S,U1S+E?S+X]S)M]S.V]S*\?QM]7S,WQS,
MT=S-]_S/J1S0T[S.G1S/$9W.[US.$SW2[7S0Y;S*#YW.V_S*-_W1^SS2\YS/
M.9W2_7S.W[S3X?S3_SS45QW5MUS5$7W313W193W+&SW3!9W4Q1S)F0/7`(BG
M_`W7@EW8AYW8B]W8CQW9DUW9EYW9F]W9GQW:HUW:IYW:J]W:KQW;LUW;MYW;
MN]W;OQW<@_U6/?^%0J&9G6H`W:^6IF@*W=L]W<_=W=U]W>6=W=\=WNV]WN$]
MW_/]W=E]W>?]:N\]WN?]W`/^WP5>WA%>WQ->X/V=X?<]W0D^W@M^XMM=XMG)
MX"N>XC7^XM5=X?M=XS<^XB\^X?F]Y.G]X5/>XNV=Y5?>X3,^XRN>X`^>YCE>
MX1U^Y1N^Y7$>WTG>Y4.^XV-^XGW^YRU>Z`?^XT'>Z(E>Y(>^X2%>YZ,>ZD^^
MX`&>Z9D>XPL^AS9!9+H[LUG:G*]S"UO31LIDML#^&*N2[&O3-ET([3]/[6.S
MH[V>[NO>[N\>[_->[_>>[_O>[_\>\`-?\`>?\`O?\`\?\1-?\1>?\1L*W_$?
)'_(CG_`#`@`[
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
